Professional Documents
Culture Documents
Our knowledge of the ways in which a cell communicates with its environment and how it responds to
information received has reached a level of almost bewildering complexity. The large diagrams of cells to
be found on the walls of many a biologist’s office are usually adorned with parallel and interconnecting
pathways linking the multitude of components and suggest a clear logic and understanding of the role
played by each protein. Of course this two-dimensional, albeit often colourful representation takes no
account of the three-dimensional structure of a cell, the nature of the external and internal milieu, the
dynamics of changes in protein levels and interactions, or the variations between cells in different tissues.
Each book in this series, entitled “Proteins and Cell Regulation”, will seek to explore specific protein
families or categories of proteins from the viewpoint of the general and specific functions they provide and
their involvement in the dynamic behaviour of a cell. Content will range from basic protein structure and
function to consideration of cell type-specific features and the consequences of disease-associated changes
and potential therapeutic intervention. So that the books represent the most up-to-date understanding,
contributors will be prominent researchers in each particular area. Although aimed at graduate, postgraduate
and principle investigators, the books will also be of use to science and medical undergraduates and to those
wishing to understand basic cellular processes and develop novel therapeutic interventions for specific
diseases.
ARF Family GTPases
Edited by
RICHARD A. KAHN
Emory University School of Medicine,
Atlanta, Georgia, U.S.A.
No part of this eBook may be reproduced or transmitted in any form or by any means, electronic,
mechanical, recording, or otherwise, without written consent from the Publisher
RICHARD A. KAHN
Department of Biochemistry, Emory University School of Medicine, Atlanta, USA
1. INTRODUCTION TO GTPASES
Although Ras was known to bind guanine nucleotides, it was the discovery
that Ras is a GTPase that heralded the start of what has grown into an
incredibly diverse and important area of cell regulation research (Gibbs et
al., 1984; Sweet et al., 1984). One is hard pressed to name an aspect of cell
biology that is not directly or indirectly affected by one or more regulatory
GTPase today. The Ras superfamily owes much to the heterotrimeric G
proteins. Many of the original models for GTPases as signal transducers and
techniques used in the field (e.g., nucleotide-binding, filter trapping assay,
GEF assays, and the use of slowly hydrolyzing GTP analogs) came from
work on G proteins. The three-component model (activator, G protein, and
effector) for cell signaling arose from studies of hormone- and light-
THE ARF FAMILY OF REGULATORY GTPASES ix
and the role of NAD as substrate and ADP-ribosyl donor; and of Mike Gill
and co-workers (Enomoto and Gill, 1979; Gill, 1975, 1976, 1977; Gill and
Meren, 1978; Gill and Rappaport, 1979) whose earlier work on ADP-
ribosylation by diphtheria toxin and movement into the cholera toxin field
contributed so much, along with his clever means of identifying the soluble
factor, later termed Arf. Mike died suddenly and far too prematurely. His
enthusiasm and inventiveness are still missed.
With the discovery of the conservation of Arf in eukaryotes (Kahn et al.,
1991; Sewell and Kahn, 1988) and its linkage both spatially and genetically
to the Golgi (Stearns et al., 1990), Arf functionality began to have a home.
The pace for modeling Arf functions quickened enormously with the
observation that Arfs, or more precisely the Arf activating proteins, were
targets of the drug brefeldin A, a fungal metabolite with profound effects on
Golgi morphology and membrane traffic (Donaldson et al., 1992a;
Donaldson et al., 1992b; Helms and Rothman, 1992; Lippincott-Schwartz et
al., 1989; Randazzo et al., 1993). A role for Arf in the initiation and
composition of vesicle coating became the first molecular mechanism for an
Arf action in mammalian cells (Orci et al., 1993; Rothman and Orci, 1992;
Serafini et al., 1991). However, with the identification of Arf as the
cytosolic factor that conferred sensitivity to in vitro assays of phospholipase
D (Brown et al., 1993; Cockcroft et al., 1994) and later phosphatidylinositol
4-phosphate 5-kinase (PI(4)P 5-kinase) (Honda et al., 1999), roles in lipid
metabolism became evident. Attempts to integrate the vesicle coating
actions of Arfs and those on lipid metabolisms are ongoing.
Though purified Arf preparations were heterogeneous (multiple bands in
SDS gels) it was molecular cloning techniques that defined the true
complexity of the Arf family, a process that is still continuing today. Work
from Joel Moss and co-workers (Bobak et al., 1989; Lee et al., 1992;
Monaco et al., 1990; Price et al., 1988; Tsuchiya et al., 1989) as well as
members of my own lab (Clark et al., 1993; Kahn et al., 1991; Sewell and
Kahn, 1988; Tamkun et al., 1991) and that of Hans Joost (Breiner et al.,
1996; Schurmann et al., 1994; Schurmann et al., 1995) described six
mammalian Arfs and most of the Arf-like (Arl) proteins. The high degree of
structural and functional conservation between Arf and Arl orthologs is
remarkable and has even led to the proposal that the Arf family may be the
predecessor of the Ras and perhaps also the heterotrimeric G protein families
(Lee et al., 1992; Murtagh et al., 1992). These and other aspects of the
evolution of the Arf family are considered in the chapter from John Logsdon
(see Chapter 1).
The overwhelming majority of studies to date have focused on roles and
activities of Arf1 and or Arf3. The most diverse Arf in sequence and
function is Arf6, which acts primarily at the plasma membrane and impacts
THE ARF FAMILY OF REGULATORY GTPASES xi
both GPCR signaling (the long sought connection between Arf and G
proteins?) and the cytoskeleton. And we still lack functions for Arf4 and
Arf5. While the six Arfs are difficult to distinguish biochemically, recent
results reveal that each can be shown to possess distinctive functions in live
cells (K. Hill and R. A. Kahn, unpublished observations). Jim Casanova
(see Chapter 14) has undertaken the Herculean task of making the Arf6
literature comprehensible and he has succeeded beyond my wildest hopes.
Together with the exciting work and novel model presented by Mary
Hunzicker-Dunn (see Chapter 15), we all have a much better appreciation
for the roles of Arf6 in the plasma membrane.
The Arf family is divided into the Arfs, sharing very high percent
identities (>60%) and defining activities, and Arf-likes (Arls) of lesser but
still quite high (40-60%) identity and devoid of those activities1. It was Hans
Joost and Annette Schurmann (Breiner et al., 1996; Schurmann et al., 1994;
Schurmann et al., 1995) who continued to increase the number of Arf-like
proteins in the database through screens and their studies of differentiation
of 3T3-L1 cells and adipocytes. They describe their latest work, including
knockouts in mice, and provide the first substantive evidence for Arl
functions in development (see Chapter 16). The Arls are proving to be much
more diverse in function, as expected from their lower percent identities.
With further definition of Arl functions and their partners we will certainly
have a richer understanding of the Arf family as a whole.
The reason these GTPases are often referred to as molecular switches is that
they exist in the cell in two forms, one bound to GDP and the other to GTP.
These are traditionally referred to as “off” and “on”, or “inactive” and
“active”, respectively, though this is clearly an over-simplification. It is true
that in the active conformation a GTPase may bind and allosterically activate
an enzymatic activity; as is the case with Arfs and phospholipase D (see
Chapter 11), PI(4)P 5-kinase, or the ADP-ribosyltransferase activity of
cholera toxin (see Chapter 10). However, many of the binding partners of
GTPases are not enzymes. In this case, the binding of the GTPase may serve
1
Because the original Arf assay (Kahn, 1991; Kahn and Gilman, 1984; Weiss et al., 1989)
is technically demanding and requires a source of purified Gs, other assays have been used
to characterize Arfs. These include the simple substitution of agmatine for Gs as ADP-
ribose acceptor (Tsai et al., 1987) to the completely independent assays of Arf dependent
PLD (Brown et al., 1993; Kuai and Kahn, 2002) or PI(4)P 5-kinase assays (Honda et al.,
1999). Perhaps the most stringent assay for Arf function, because it is a live cell assay and
tests for the essential activities of Arf in eukaryotes, is that of rescue of the double deletion
arf1- arf2- in the yeast S. cerevisiae (Kahn et al., 1991; Lee et al., 1992).
xii KAHN
4. NOMENCLATURE
After a section on GEFs and GAPs seems a very appropriate place to inject a
note on nomenclature. Like any area of signaling today, we are dealing in
each case with gene families and key discoveries coming from a number of
different labs, using model genetic systems, each using different systems of
naming genes and proteins. While it is important to honor priority in
discovery, names can quickly become outdated, confusing, or factually
incorrect. Change is happening so fast that it can even be the curators of
public databases, in well-intentioned efforts at consistency, which exacerbate
or perpetuate nomenclature problems. The discovery of the Arf GAP
domain (and to only a slightly lesser extent this is true of the Arf GEF/Sec7
domain as well) occurred at a time when genome sequence data was pouring
into databases around the world. Workers in several countries started
finding more proteins than we had functions. The presence of additional
protein interaction domains can help researchers identify biological roles for
a protein, but can also foster confusion in naming it. This has been just as
true in the Arf GAP and Arf GEF field as in any.
xiv
Table I: Current and proposed names for human Arf GAPs and their orthologs
New
Sub-family Name #1 Name #2 Name #3 Name #4 KIAA# names Accession number (length) Domain organization
Arf GAP1 Arf GAP1 Arf1GAP Arf GAP Arf GAP1 NM_018209;NP_060679 (406aa) N-term. Arf GAP
Arf GAP3 ArfGAP1 Arf GAP3 NM_014570 (516aa) N-term. Arf GAP
Zfp289 Arf GAP4 NM_032389; NP_115765 (521 aa) N-term. Arf GAP
APAP Git1 Cat1 p95APP1 APAP1 NM_014030; NP_054749 (761 aa) N-term. Arf GAP, ankyrin repeats (3)
Git2 Cat2 p95APP2 p95PKL KIAA0148 APAP2 NP_476510 (759aa) N-term. Arf GAP, ankyrin repeats (3)
AMAP ASAP1 DEF1 DDEF1/SHAG1 Cent. Beta4 KIAA1249 AMAP1 XP_005169(483aa); BAA86563(949aa) PH, Arf GAP, ankyrin repeats (3), SH3
PAP(alpha) DDEF2 SHAG2/PAG3 Cent. Beta3 KIAA0400 AMAP2 NM_003887(1006aa) PH, Arf GAP, ankyrin repeats (3), SH3
UPLC1 Cent. Beta6 AMAP3 XP_031298 (EST only) PH, Arf GAP, ankyrin repeats (3)
ACAP ACAP1 Cent. Beta1 KIAA0050 ACAP1 NM_014716 (740aa) PH, Arf GAP, ankyrin repeats (2)
ACAP2 Cent. Beta2 KIAA0041 ACAP2 NM_012287 (778aa) PH, Arf GAP, ankyrin repeats (2)
ACAP3 Cent. Beta5 KIAA1716 ACAP3 NM_030649 (759aa) PH, Arf GAP, ankyrin repeats (2)
KAHN
AGAP AGAP1 Cent. Gamma1 PIKE KIAA0167 AGAP1 NM_014770/NM_023017(836aa) GTPase, PH, Arf GAP, ankyrin repeats (2)
AGAP2 Cent. Gamma2 KIAA1099 AGAP2 NM_014914 (804aa) GTPase, PH, Arf GAP, ankyrin repeats (2)
AGAP3 Cent. Gamma3 MRIP1 AGAP3 NM_031946; NP_114152 (875aa) GTPase, PH, Arf GAP, ankyrin repeats (2)
ARAP ARAP1 Cent. Delta2 ARAP1 NM_139181 (1204aa); NM_015242 (1210aa) PH, Arf GAP, PH (2), RhoGAP, PH
ARAP2 Cent. Delta1 FLJ13675 KIAA0580 ARAP2 NM_015230 (1704aa) PH, Arf GAP, PH (2), RhoGAP, PH
ARAP3 ARAP3 NM_022481; NP_071926 (1544aa)
AFAP Centaurin (alpha1) PIPBP p42IP4 AFAP1 NM_006869/NP_006860 (374aa) Arf GAP, ankyrin repeats (2), PH (2)
Centaurin (beta) Cent. Alpha2 AFAP2 NM_018404; NP_060874 (381aa) Arf GAP, ankyrin repeats (2), PH (2)
Arf GAP5 RIP/RAB/HRB Arf GAP5 NM_004504; NP_004495 (562aa) N-term Arf GAP, FG repeats
RAB-R/HRB1 Arf GAP6 NM_006076; NP_006067 (481aa) N-term Arf GAP, FG repeats
Arf GAP7 SMAP1a Arf GAP7 NM_021940; NP_068759 (440aa) N-term Arf GAP
SMAP1b Note: 48% identical to SMAP1a Arf GAP8 XM_029830; XP_029830 (429aa) N-term Arf GAP
List of acronyms
ACAP = Arf GAP, coiled-coil, ankyrin repeat, PH protein List of new acronyms
AGAP = Arf GAP, GTPase, ankyrin repeat, PH protein APAP = Arf GAP with pix and paxillin binding
APP = Arf GAP putative, PIX1-interacting, paxillin bind AMAP = A multi-domain Arf GAP protein
ARAP = Arf GAP, Rho GAP, ankyrin repeat, PH protein ACAP = Arf GAP, coiled-coil, ankyrin repeat, PH protein
ASAP = Arf GAP, SH3, ankyrin repeat, PH protein AGAP = Arf GAP, GTPase, ankyrin repeat, PH protein
CAT = Cool-associated tyrosine phosphorylated protein ARAP = Arf GAP, Rho GAP, ankyrin repeat, PH protein
DEF = Differentiation enhancing factor AFAP = Arf GAP with phosphoinositide binding and PH domain
GIT = G protein receptor kinase (GRK) i nteracting GT Pase activating protein
HRB = HIV Rev binding protein NOTES:
PAG = paxillin associated Arf GAP (1) Some human protein sequences are incomplete (based on the presence of orthologs in other mammals)
PAP = Pyk2 associated protein (2) Several messages are alternatively spliced; only the longest protein sequence is indicated
PKL = paxillin-kinase linker (3) Arf GAP 3 = ARG1 (Arf GAP1) locus in human
RAB = HIV Rev-associated binding protein (4) APAP1 and APAP2 named GIT1 and GIT2 loci in mouse and human databases
RIP = HIV Rev-interacting protein
SMAP = stromal membrane associated protein
THE ARF FAMILY OF REGULATORY GTPASES
xv
xvi
F=fragment
xvii
5. ARF EFFECTORS
Despite the discussion above, that might lead one to believe Arfs do
everything, it now appears clear that at least a primary function of Arfs is the
regulation of aspects of vesicular membrane traffic. More specifically, Arfs
are involved in the formation of coated vesicles through the recruitment of
specific coat proteins and initiation of large protein complex assemblies.
Whether changes in phospholipid metabolism play an obligate or regulatory
role in this process remains uncertain. Whether other nucleotide-sensitive
binding partners of less well-defined function (including mitotic kinesin like
protein 1 (MKLP1), Arfaptin1 and Arfaptin2/POR1, and Arfophilin (see
Chapter 11)) are also involved in vesicle traffic is also not known. Two-
hybrid and genetic screens have identified other partners of Arfs, which lack
obvious ties to vesicle traffic (A. L. Boman, C. Zhang, and R. A. Kahn,
unpublished observations). Results with Arf6 strongly suggest actions
distinct from vesicle traffic, though changes in the cytoskeleton may be part
of the remodeling required for vesiculation. Whether all these effectors end
up being involved in vesicle biogenesis seems doubtful, but it is becoming
clear that it is there that we will first gain a clear understanding of a
THE ARF FAMILY OF REGULATORY GTPASES xix
molecular model for a function of Arf and Arf GAPs in cells. For this
reason, we have two chapters devoted to aspects of coat protein biology,
those from Annette Boman and Tommy Nilsson (see Chapter 12) and Victor
Faundez (see Chapter 13).
Some people may be surprised to see a discussion of Arf GAPs in the
section on effectors. I believe this is because GAPs for several GTPases
were first discovered as negative regulators of the GTPase signaling.
However, GAPs share the biochemical feature of binding preferentially to
the GTP-bound form of the GTPase they act upon and necessarily localize to
the same place in cells. By using the same switch domains as effectors
GAPs have the potential to alter cell signaling both through the increased
hydrolysis of GTP bound to the GTPase but also by competing with
effectors for the binding of the GTP-bound GTPase. In addition, the
presence of other protein interaction domains on Arf GAPs is expected to
facilitate the assembly of multi-subunit complexes, perhaps analogous to the
action of Arfs to recruit coat proteins to budding vesicles. Whether a “pure”
GAP exists, whose function is solely to terminate GTPase signaling, remains
to be seen, but I doubt it. Rather, I believe that the vast majority of GAPs,
particularly the Arf GAPs with their multiple interaction domains, will prove
to be effectors in every sense of the word and transduce positive signals
between the GTPase and downstream effects. The fact that GTPase
stimulation is a part of their action lends some support to the basic
“proofreading” model proposed by Goldberg for Arf GAP1 (Goldberg,
1999, 2000), though modifications are required to accommodate many of the
other Arf GAPs. If we add Arf GAPs to the list of effectors, we currently
have >30 effectors mediating the actions of 6 mammalian Arfs, which were
activated by ≥16 Arf GEFs. And so far there appears to be little or no cross
reactivity of Arf GEFs and GAPs with the Arls. If Arfs are the earliest
regulatory GTPase they will have the most layers of complexity to untangle
as we develop models of their cellular functions. But they also offer the
most promise of teaching us some fundamental principles of cell regulation
and the evolution of cell regulation.
In the next few years we will develop much more complete models of how
Arfs and their partners regulate vesicle biogenesis and integrate protein and
lipid signaling in eukaryotes. Efforts recently underway to investigate
global changes in lipid content of cells in response to agonist stimulation or
differentiation will give us a much more complete view of cell signaling and
xx KAHN
7. ACKNOWLEDGEMENTS
I would like to thank Judith Karl for her assistance in putting together
and proof reading each of the chapters in this book, including this preface.
Her attention to detail and organizational skills made this a much easier task
for me. The patience and support of other members of the department of
Biochemistry at Emory University is also appreciated. I also thank Paul
Randazzo for his critical reading of this preface.
REFERENCES
Antonny, B., Beraud-Dufour, S., Chardin, P., and Chabre, M. (1997). N-terminal hydrophobic
residues of the G-protein ADP-ribosylation factor-1 insert into membrane phospholipids
upon GDP to GTP exchange. Biochemistry, 36, 4675-4684.
Bobak, D. A., Nightingale, M. S., Murtagh, J. J., Price, S. R., Moss, J., and Vaughan, M.
(1989). Molecular cloning, characterization, and expression of human ADP-ribosylation
factors: two guanine nucleotide-dependent activators of cholera toxin. Proc. Natl. Acad.
Sci., USA, 86, 6101-6105.
Breiner, M., Schurmann, A., Becker, W., and Joost, H. G. (1996). Cloning of a novel member
(Arl5) of the Arf-family of Ras-related GTPases. Biochim. Biophys. Acta, 1308, 1-6.
Brown, H. A., Gutowski, S., Moomaw, C. R., Slaughter, C., and Sternweis, P. C. (1993).
ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates
phospholipase D activity [see comments]. Cell, 75, 1137-1144.
THE ARF FAMILY OF REGULATORY GTPASES xxi
Cassel, D., and Pfeuffer, T. (1978). Mechanism of cholera toxin action: covalent modification
of the guanyl nucleotide-binding protein of the adenylate cyclase system. Proc. Natl.
Acad. Sci., USA, 75, 2669-2673.
Clark, J., Moore, L., Krasinskas, A., Way, J., Battey, J., Tamkun, J., and Kahn, R. A. (1993).
Selective amplification of additional members of the ADP-ribosylation factor (Arf)
family: cloning of additional human and Drosophila Arf-like genes. Proc. Natl. Acad. Sci.,
USA, 90, 8952-8956.
Cockcroft, S., Thomas, G. M., Fensome, A., Geny, B., Cunningham, E., Gout, I., Hiles, I.,
Totty, N. F., Truong, O., and Hsuan, J. J. (1994). Phospholipase D: a downstream effector
of Arf in granulocytes. Science, 263, 523-526.
Cukierman, E., Huber, I., Rotman, M., and Cassel, D. (1995). The Arf1 GTPase-activating
protein: zinc finger motif and Golgi complex localization. Science, 270, 1999-2002.
Donaldson, J. G., Cassel, D., Kahn, R. A., and Klausner, R. D. (1992a). ADP-ribosylation
factor, a small GTP-binding protein, is required for binding of the coatomer protein beta-
COP to Golgi membranes. Proc. Natl. Acad. Sci., USA, 89, 6408-6412.
Donaldson, J. G., Finazzi, D., and Klausner, R. D. (1992b). Brefeldin A inhibits Golgi
membrane-catalysed exchange of guanine nucleotide onto Arf protein. Nature, 360, 350-
352.
Enomoto, K., and Gill, D. M. (1979). Requirement for guanosine triphosphate in the
activation of adenylate cyclase by cholera toxin. J. Supramol. Struct., 10, 51-60.
Franco, M., Chardin, P., Chabre, M., and Paris, S. (1996). Myristoylation-facilitated binding
of the G protein Arf1GDP to membrane phospholipids is required for its activation by a
soluble nucleotide exchange factor. J. Biol. Chem., 271, 1573-1578.
Gibbs, J. B., Sigal, I. S., Poe, M., and Scolnick, E. M. (1984). Intrinsic GTPase activity
distinguishes normal and oncogenic Ras p21 molecules. Proc. Natl. Acad. Sci., USA, 81,
5704-5708.
Gill, D. M. (1975). Involvement of nicotinamide adenine dinucleotide in the action of cholera
toxin in vitro. Proc. Natl. Acad. Sci., USA, 72, 2064-2068.
Gill, D. M. (1976). The arrangement of subunits in cholera toxin. Biochemistry, 15, 1242-
1248.
Gill, D. M. (1977). Mechanism of action of cholera toxin. Adv. Cyclic Nucleotide Res., 8, 85-
118.
Gill, D. M., and Meren, R. (1978). ADP-ribosylation of membrane proteins catalyzed by
cholera toxin: basis of the activation of adenylate cyclase. Proc. Natl. Acad. Sci., USA, 75,
3050-3054.
Gill, D. M., and Rappaport, R. S. (1979). Origin of the enzymatically active A1 fragment of
cholera toxin. J. Infect. Dis., 139, 674-680.
Goldberg, J. (1998). Structural basis for activation of Arf GTPase: mechanisms of guanine
nucleotide exchange and GTP-myristoyl switching. Cell, 95, 237-248.
Goldberg, J. (1999). Structural and functional analysis of the Arf1-ArfGAP complex reveals a
role for coatomer in GTP hydrolysis. Cell, 96, 893-902.
Goldberg, J. (2000). Decoding of sorting signals by coatomer through a GTPase switch in the
COPI coat complex. Cell, 100, 671-679.
Helms, J. B., and Rothman, J. E. (1992). Inhibition by brefeldin A of a Golgi membrane
enzyme that catalyses exchange of guanine nucleotide bound to Arf. Nature, 360, 352-
354.
Honda, A., Nogami, M., Yokozeki, T., Yamazaki, M., Nakamura, H., Watanabe, H.,
Kawamoto, K., Nakayama, K., Morris, A. J., Frohman, M. A., and Kanaho, Y. (1999).
Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G
protein Arf6 in membrane ruffle formation. Cell, 99, 521-532.
xxii KAHN
Jacques, K. M., Nie, Z., Stauffer, S., Hirsch, D. S., Chen, L. X., Stanley, K. T., and Randazzo,
P. A. (2002). Arf1 dissociates from the clathrin adaptor GGA prior to being inactivated by
Arf GTPase-activating proteins. J. Biol. Chem., 277, 47235-47241.
Kahn, R. A. (1991). Quantitation and purification of ADP-ribosylation factor. Methods
Enzymol., 195, 233-242.
Kahn, R. A., and Gilman, A. G. (1984). Purification of a protein cofactor required for ADP-
ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera
toxin. J. Biol. Chem., 259, 6228-6234.
Kahn, R. A., and Gilman, A. G. (1986). The protein cofactor necessary for ADP-ribosylation
of Gs by cholera toxin is itself a GTP binding protein. J. Biol. Chem., 261, 7906-7911.
Kahn, R. A., Goddard, C., and Newkirk, M. (1988). Chemical and immunological
characterization of the 21-kDa ADP-ribosylation factor of adenylate cyclase. J. Biol.
Chem., 263, 8282-8287.
Kahn, R. A., Kern, F. G., Clark, J., Gelmann, E. P., and Rulka, C. (1991). Human ADP-
ribosylation factors. A functionally conserved family of GTP- binding proteins. J. Biol.
Chem., 266, 2606-2614.
Kuai, J., and Kahn, R. A. (2002). Assays of Arf function. Methods Enzymol., 345.
Lee, F. J., Moss, J., and Vaughan, M. (1992). Human and Giardia ADP-ribosylation factors
(Arfs) complement Arf function in Saccharomyces cerevisiae. J. Biol. Chem., 267, 24441-
24445.
Lippincott-Schwartz, J., Yuan, L. C., Bonifacino, J. S., and Klausner, R. D. (1989). Rapid
redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for
membrane cycling from Golgi to ER. Cell, 56, 801-813.
Makler, V., Cukierman, E., Rotman, M., Admon, A., and Cassel, D. (1995). ADP-ribosylation
factor-directed GTPase-activating protein. Purification and partial characterization. J. Biol.
Chem., 270, 5232-5237.
Monaco, L., Murtagh, J. J., Newman, K. B., Tsai, S. C., Moss, J., and Vaughan, M. (1990).
Selective amplification of an mRNA and related pseudogene for a human ADP-
ribosylation factor, a guanine nucleotide-dependent protein activator of cholera toxin.
Proc. Natl. Acad. Sci., USA, 87, 2206-2210.
Moss, J., Manganiello, V. C., and Vaughan, M. (1976). Hydrolysis of nicotinamide adenine
dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate
cyclase. Proc. Natl. Acad. Sci., USA, 73, 4424-4427.
Moss, J., and Vaughan, M. (1977). Choleragen activation of solubilized adenylate cyclase:
requirement for GTP and protein activator for demonstration of enzymatic activity. Proc.
Natl. Acad. Sci., USA, 74, 4396-4400.
Murtagh, J. J., Jr., Mowatt, M. R., Lee, C. M., Lee, F. J., Mishima, K., Nash, T. E., Moss, J.,
and Vaughan, M. (1992). Guanine nucleotide-binding proteins in the intestinal parasite
Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP- ribosylation
factor. J. Biol. Chem., 267, 9654-9662.
Nie, Z., Stanley, K. T., Stauffer, S., Jacques, K. M., Hirsch, D. S., Takei, J., and Randazzo, P.
A. (2002). AGAP1, an endosome-associated, phosphoinositide-dependent ADP-
ribosylation factor GTPase-activating protein that affects actin cytoskeleton. J. Biol.
Chem., 277, 48965-48975.
Northup, J. K., Sternweis, P. C., Smigel, M. D., Schleifer, L. S., Ross, E. M., and Gilman, A.
G. (1980). Purification of the regulatory component of adenylate cyclase. Proc. Natl.
Acad. Sci., USA, 77, 6516-6520.
Orci, L., Palmer, D. J., Amherdt, M., and Rothman, J. E. (1993). Coated vesicle assembly in
the Golgi requires only coatomer and Arf proteins from the cytosol. Nature, 364, 732-734.
THE ARF FAMILY OF REGULATORY GTPASES xxiii
Paris, S., Beraud-Dufour, S., Robineau, S., Bigay, J., Antonny, B., Chabre, M., and Chardin,
P. (1997). Role of protein-phospholipid interactions in the activation of Arf1 by the
guanine nucleotide exchange factor Arno. J. Biol. Chem., 272, 22221-22226.
Price, S. R., Nightingale, M., Tsai, S. C., Williamson, K. C., Adamik, R., Chen, H. C., Moss,
J., and Vaughan, M. (1988). Guanine nucleotide-binding proteins that enhance choleragen
ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-
ribosylation factor cDNA. Proc. Natl. Acad. Sci., USA, 85, 5488-5491.
Randazzo, P. A., Yang, Y. C., Rulka, C., and Kahn, R. A. (1993). Activation of ADP-
ribosylation factor by Golgi membranes. Evidence for a brefeldin A- and protease-
sensitive activating factor on Golgi membranes. J. Biol. Chem., 268, 9555-9563.
Rothman, J. E., and Orci, L. (1992). Molecular dissection of the secretory pathway. Nature,
355, 409-415.
Schurmann, A., Breiner, M., Becker, W., Huppertz, C., Kainulainen, H., Kentrup, H., and
Joost, H. G. (1994). Cloning of two novel ADP-ribosylation factor-like proteins and
characterization of their differential expression in 3T3-L1 cells. J. Biol. Chem., 269,
15683-15688.
Schurmann, A., Massmann, S., and Joost, H. G. (1995). ARP is a plasma membrane-
associated Ras-related GTPase with remote similarity to the family of ADP-ribosylation
factors. J. Biol. Chem., 270, 30657-30663.
Serafini, T., Orci, L., Amherdt, M., Brunner, M., Kahn, R. A., and Rothman, J. E. (1991).
ADP-ribosylation factor is a subunit of the coat of Golgi-derived COP-coated vesicles: a
novel role for a GTP-binding protein. Cell, 67, 239-253.
Sewell, J. L., and Kahn, R. A. (1988). Sequences of the bovine and yeast ADP-ribosylation
factor and comparison to other GTP-binding proteins. Proc. Natl. Acad. Sci., USA, 85,
4620-4624.
Sharer, J. D., Shern, J. F., Van Valkenburgh, H., Wallace, D. C., and Kahn, R. A. (2001).
Arl2 and BART enter mitochondria and bind the adenine nucleotide transporter (ANT).
Mol. Biol. Cell, 2002, 71-83.
Stearns, T., Willingham, M. C., Botstein, D., and Kahn, R. A. (1990). ADP-ribosylation
factor is functionally and physically associated with the Golgi complex. Proc. Natl. Acad.
Sci., USA, 87, 1238-1242.
Sweet, R. W., Yokoyama, S., Kamata, T., Feramisco, J. R., Rosenberg, M., and Gross, M.
(1984). The product of Ras is a GTPase and the T24 oncogenic mutant is deficient in this
activity. Nature, 311, 273-275.
Tamkun, J. W., Kahn, R. A., Kissinger, M., Brizuela, B. J., Rulka, C., Scott, M. P., and
Kennison, J. A. (1991). The Arflike gene encodes an essential GTP-binding protein in
Drosophila. Proc. Natl. Acad. Sci., USA, 88, 3120-3124.
Tsai, S. C., Noda, M., Adamik, R., Moss, J., and Vaughan, M. (1987). Enhancement of
choleragen ADP-ribosyltransferase activities by guanyl nucleotides and a 19-kDa
membrane protein. Proc. Natl. Acad. Sci., USA, 84, 5139-5142.
Tsuchiya, M., Price, S. R., Nightingale, M. S., Moss, J., and Vaughan, M. (1989). Tissue and
species distribution of mRNA encoding two ADP-ribosylation factors, 20-kDa guanine
nucleotide binding proteins. Biochemistry, 28, 9668-9673.
Weiss, O., Holden, J., Rulka, C., and Kahn, R. A. (1989). Nucleotide binding and cofactor
activities of purified bovine brain and bacterially expressed ADP-ribosylation factor. J.
Biol. Chem., 264, 21066-21072.
Contributors
Annette Boman, Ph.D./ Department of Biochemistry and Molecular
Biology/ University of Minnesota-Duluth School of Medicine/ 10
University Drive/Duluth, MN 55812/USA/Phone 218 726 7036/Fax
218 726 8014/Email aboman@d.umn.edu
Abstract: A phylogeny of the Arf family of proteins has been constructed using
sequence data available from the complete (or nearly complete) genomes of
six model eukaryotic species; including three animals, two fungi and a protist.
Our analyses reveal distinct groupings of three Arf and ten Arl (Arf-like)
subfamilies. These Arf and Arl subfamilies have arisen by numerous gene
duplications that took place at different times during eukaryotic evolution.
Some apparently young subfamilies are comprised of proteins found only in
animals, while older families include members from all of the eukaryotic
lineages considered. Available functional information for these proteins is
considered in light of their evolutionary relationships.
1. INTRODUCTION
ADP-ribosylation factor(s) (Arf(s)) were first described as, and named after,
a biochemical activity: cofactor in the ADP-ribosylation of Gs by cholera
toxin (Kahn and Gilman, 1984, 1986; Schleifer et al., 1982). The original
cloned cDNAs and their proteins that possess that activity were named
accordingly (Sewell and Kahn, 1988). Unfortunately, that first Arf activity
is now understood to have little or nothing to do with the cellular functions
of Arfs. This disconnect between name and function is even more severe for
the Arf-like (Arl) proteins, which lack Arf activities and were named on the
basis of protein sequence homology (Cavenagh et al., 1994; Clark et al., 1993;
Tamkun et al., 1991). As the size of the Arf family expanded, so did the
number of activities and binding partners found associated with Arfs and
Arls. Other activities emerged that were predicted to be better
1
2 LOGSDON AND KAHN
2. THE FAMILY
4
Proposed Other Accession Locus Gene Length N-terminal
name name(s) number identifier Location (a.a.) Other names sequence
H. sapiens
HsArf1 Arf1 NM_001658/GI:6995997 LocusID: 375 1q42 181 MGNIFANLFKGL
(MmArf2) Arf2 NM_007477/GI:6671570 LocusID: 11841 11 E1(Mm) 181 MGNVFEKLFKSL
HsArf3 Arf3 NM_001659/GI:4502202 LocusID: 377 12q13 181 MGNIFGNLLKSL
HsArf4 Arf4 NM_001660/GI:6995998 LocusID: 378 3p21.2-p21.1 180 MGLTISSLFSRL
HsArf5 Arf5 NM_001662/GI:6995999 LocusID: 381 7q31.3 180 MGLTVSALFSRI
HsArf6 Arf6 NM_001663/GI:6996000 LocusID: 382 7q22.1 175 MGKVLSKIFGNK
HsArl1 Arl1 NM_001177/GI:4755126 LocusID: 400 12q23.3 181 Arfl1 MGGFFSSIFSSL
HsArl2 Arl2 NM_001667/GI:4502228 LocusID: 402 11q13 184 Arfl2 MGLLTILKKMKQ
HsArl3 Arl3 NM_004311/GI:4757773 LocusID: 403 10q23.3 182 Arfl3 MGLLSILRKLKS
HsArl4 Arl4 NM_005738/GI:5031602 LocusID: 10124 7p21-p15.3 200 MGNGLSDQTSILSN
HsArl4B Arl4B NT_033984/XP_166703.1 234 MGNGLSDQTSILSS
HsArl5 Arl5 NM_012097/GI:6912243 LocusID: 26225 2q23.3 179 MGILFTRIWRLF
HsArl5B Arl5B XM_167671/GI:20473688 LocusID: 221079 10p12.33 179 Sim. to Arl5 MGLIFAKLWSLF
HsArl6 Arl6 NM_032146/GI:21314750 LocusID: 84100 3q12.1 186 MGLLDRLSVLLG
HsArl7 Arl7 NM_005737/GI:6552295 LocusID: 10123 2q37.2 192 LAK MGNISSNISAFQ
HsArl8A Arl8A NM_138795/GI:15929963 LocusID: 127829 1q31.3 186 Hypo. Prot BC015408 MIALFNKLLDWF
HsArl8B Arl8B NM_018184/GI:8922600 LocusID: 55207 3p26.1 186 FLJ10702 MLALISRLLDWF
HsArl9 Arf4L/Arl6 NM_001661/GI:4502206 LocusID: 379 17q12-q21 201 Arl6 MGNHLTEMAPTA
HsArl10 Arl10 NM_025047/GI:13376573 LocusID: 80117 3q26.1 192 FLJ22595 MGSLGSKNPQTK
HsArl11 Arl11 NM_138450/GI:27764878 LocusID: 115761 13q14.11 196 MGC17429 MGSVNSRGHKAE
HsArfrp Arp NM_003224/GI:4507448 LocusID: 10139 20q13.3 201 Arfrp1 MYTLLSGLYKYM
HsSar1 Sar1 NM_020150/GI:21361614 LocusID: 56909 10q22.1 198 MSFIFEWIYNGF
HsSara Sara NM_016103/GI:7705826 LocusID: 51128 5q31.1 198 MSFIFDWIYSGF
LOGSDON AND KAHN
23
C. elegans
CeArf1 arf-1 NM_065834/GI:17551729 B0336.2 III 181 MGNVFGSLFKGL
CeArf3 arf-3 NM_068935/GI:17538183 F57H12.1 IV 180 arf-3 MGLTISSLFNRL
CeArf6 arf-6 NM_070610/GI:17538185 Y116A8C.12 IV 175 arf-6 MGKFLSKIFGKK
CeArl1 arl-1 NM_063415/GI:17531196 F54C9.10 II 180 arl-3 MGGVMSYFRGLF
CeArl2 evl-20/arl-2 NM_063378/GI:17532860 F22B5.1 II 184 evl-20 MGFLKILRKQRA
CeArl3 arl-3 NM_064636/GI:17531200 F19H8.3 II 184 arl-3C MGLIDVLKSFKS
CeArl5 arl-5 NM_066777/GI:17551731 ZK632.8 III 178 arl-2 MGLIMAKLFQSW
CeArl6 arl-6 NM_065592/GI:17551733 C38D4.8 III 190 arl-1, arl-query MGFFSSLSSLFG
CeArf arf NM_068841/GI:17538189 F45E4.1 IV 179 arl-6; arf-3 MGLFFSKISSFM
CeArl8 arl-8 NM_070390/GI:17543765 Y57G11C.13 IV 185 MLAMVNKVLDWI
CeArfrp arfrp NM_058693/GI:17510340 Y54E10BR.2 I 191 MYTLSAGIWEKF
CeSar1 sar-1 NM_068181/GI:17544539 ZK180.4 IV 193 MSFLWDWFNGVL
12
Table I (cont.)
D. melanogaster
DmArf1 DmArf79F NM_057607/GI:24668765 Arf79F 3L 182 Darf1, dARFI, CG8385 MGNVFANLFKGL
DmArf2 DmArf102F NM_079892/GI:24638807 Arf102F 4 180 dARFII, ARFII MGLTISSLLTRL
DmArf3 DmArf51F NM_079027/GI:24653826 Arf51F 2R 175 dArf3, ARFIII MGKLLSKIFGNK
DmArl1 DmArf72A NP_524098/GI:24664933 Arf72A 3L 180 arflike, arl, dArl1 MGGVLSYFRGLL
DmArl2 DmArl84F NM_057538/GI:19549394 Arl84F 3R 184 arf-like2, arl2 MGFLTVLKKMRQ
DmArl3 DmCG6560 NM_142738/GI:24648859 CG6560 3R 179 CG6560 MGLLSLLRKLRP
DmArl4 DmCG2219 NP_651905/GI:24638544 CG2219 175 CG2219 MGATMVKPLVKN
DmArl5 DmCG7197 NM_139944/GI:24660780 CG7197 3L 179 CG7197 MGLLLSRLWRMF
DmArl6 DmArl6 NM_137577/GI:24655720 CG7735 2 202 CG7735 MGMLHNLADLIK
DmArl8 DmArl8 NP_649769/GI:21355085 CG7891 3 186 CG7891 MLALINRILEWF
DmArfrp DmArfrp NM_132298/GI:24640728 CG7039 1 200 CG7039 MYTLMHGFYKYM
DmSar1 DmSar1 NP_732717/GI:24648946 CG7073 3 193 CG7073, sar-1 MFIWDWFTGVLG
12
S. cerevisiae
ScArf1 Arf1 P11076/GI:114121 YDL192W IV 181 MGLFASKLFSNL
ScArf2 Arf2 NP_010144/GI:6320064 YDL137W IV 181 MGLYASKLFSNL
ScArf3 Arf3 NP_014737/GI:6324668 YOR094W XV 183 ARL2 MGNSISKVLGKL
ScArl1 Arl1 NP_009723/GI:6319641 YBR164C II 183 MGNIFSSMFDKL
ScArl2 Cin4 NP_013858/GI:6323787 YMR138W XIII 191 GTP1, UGX1 MGLLSIIRKQKL
ScArfrp Arl3 NP_015274/GI:6325206 YPL051W XVI 198 ARL3 MFHLVKGLYNNW
ScSar1 Sar1 NP_015106/GI:6325038 YPL218W XVI 190 MAGWDIFGWFRD
7
The ARF Family Tree
S. pombe
SpArf1 Arf1 P36579 /GI:543843 SPBC4F6.18c II 180 MGLSISKLFQSL
SpArf2 Arf2 Q9Y7Z2 /GI:20137584 SPBC1539.08 II 184 MGNSLFKGFSKP
SpArl2 alp41/Arl2 Q09767 /GI:1168499 SPAC22F3.05c II 186 alp41 MGLLTILRQQKL
SpSar1 Sar1 Q01475 /GI:266990 SPBC31F10.06c II 190 MFIINWFYDALA
4
G. lamblia
GlArf GlArf P26991 /GI:114131 191 MGQGASKIFGKL
GlArl2 Gl4192 197 MGFLSVLRAIKA
GlArl3 GlArlB BAB58895/GI:14275898 149 ArlB ...TILRKLCEEDTS
GlArl Gl7562 168 MGAASSRPARHK
GlArl8/Arfrp GlArlA BAB58894/GI:14275896 157 ArlA ...TTILHQMAYGMT
GlSar1 GlSar1 AY125726/GI:22035408 191 MGFGDWFKSALS
6
5
6 LOGSDON AND KAHN
The Arf proteins have been previously divided into three classes (I, II, III),
based on their gene sequences and organization (Lee et al., 1994a). This
classification is further supported by our analyses. Flies and worms have
single representatives for each of these three classes, while mammals have
either five or six genes (see below), S. cerevisiae has three Arfs, S. pombe
has two and Giardia has only one. The class I and II Arfs, found only
among animals, apparently diverged from a common ancestor more recently
(after the animal-fungal split) than did class III Arfs, which are found in both
animals and fungi. The two yeasts have single representatives for class I/II
and class III (excepting that in S. cerevisiae, a very recent duplication of a
chromosome IV region resulted in two very similar Arf I/II genes, Arf1 and
Arf2). The fact that Arf classes I, II and III form a well-supported group
including representatives in animals, fungi and a single Arf gene from
Giardia supports our conclusion that all Arfs arose from a common ancestor.
The fact that the single Giardia Arf groups (albeit weakly) with class I/II
Arfs, suggests that it represents the class I/II ancestral type (as do Sc Arf 1
and 2). It is also possible that the single Giardia Arf represents the class
I/II/III ancestral type, which would indicate that the I/II vs. III duplication
occurred after the divergence of Giardia, but before the animal-fungal split.
In C. elegans a fourth Arf gene (Ce Arf) has been found. It is very likely a
pseudogene, based upon its proximity to another (highly expressed) gene
and lack of any evidence of its expression. This makes its phylogenetic
placement dubious due to its rapid evolutionary rate (and resulting long
branch on the phylogenetic trees).
The human Arf III class gene, Arf6, has activity as cofactor for cholera
toxin, activation of phospholipase D and rescue of the double arf- null in S.
cerevisiae (Lee et al., 1992; Massenburg et al., 1994). It will be interesting to
see if the class III representatives from flies, worms and yeasts share these
activities. Sc Arf3 has been reported to support cholera toxin activity, albeit
weakly, but it cannot substitute for Arf1 in yeast cells (Lee et al., 1994b).
The ARF Family Tree 7
1 26 47 71
HsArf1 MGNIFANLFK-------------GLFGK-KEMRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YKNIS-FT--VWDVGGQDK
MmArf2 MGNVFEKLFK-------------SLFGK-KEMRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YKNIS-FT--VWDVGGQDK
HsArf3 MGNIFGNLLK-------------SLIGK-KEMRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YKNIS-FT--VWDVGGQDK
DmArf1 MGNVFANLFK-------------GLFGK-KEMRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YKNIS-FT--VWDVGGQDK
CeArf1 MGNVFGSLFK-------------GLFGK-REMRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YKNIS-FT--VWDVGGQDK
SpArf1 MGLSISKLFQ-------------SLFGK-REMRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YRNIS-FT--VWDVGGQDK
HsArf4 MGLTISSLFS-------------RLFGK-KQMRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YKNIC-FT--VWDVGGQDR
HsArf5 MGLTVSALFS-------------RIFGK-KQMRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YKNIC-FT--VWDVGGQDK
DmArf2 MGLTISSLLT-------------RLFGK-KQMRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YKNIC-FT--VWDVGGQDK
CeArf3 MGLTISSLFN-------------RLFGK-RQVRILMVGLDAAGKTTILYKLKLGEIV--------TTIPTIGFNVETVE-----YKNIS-FT--VWDVGGQDK
ScArf1 MGLFASKLFS-------------NLFGN-KEMRILMVGLDGAGKTTVLYKLKLGEVI--------TTIPTIGFNVETVQ-----YKNIS-FT--VWDVGGQDR
ScArf2 MGLYASKLFS-------------NLFGN-KEMRILMVGLDGAGKTTVLYKLKLGEVI--------TTIPTIGFNVETVQ-----YKNIS-FT--VWDVGGQDR
CeArf MGLFFSKISS-------------FMFPN-IECRTLMLGLDGAGKTTILYKLKLNETV--------NTIPTIGFNVETVT-----FQKIT-LT--VWDVGGQKK
GlArf MGQGASKIFG-------------KLFSK-KEVRILMVGLDAAGKTTILYKLMLGEVV--------TTVPTIGFNVETVE-----YKNIN-FT--VWDVGGQDS
HsArf6 MGKVLSKIF-----------------GN-KEMRILMLGLDAAGKTTILYKLKLGQSV--------TTIPTVGFNVETVT-----YKNVK-FN--VWDVGGQDK
DmArf3 MGKLLSKIF-----------------GN-KEMRILMLGLDAAGKTTILYKLKLGQSV--------TTIPTVGFNVETVT-----YKNVK-FN--VWDVGGQDK
CeArf6 MGKFLSKIF-----------------GK-KELRILMLGLDAAGKTTILYKLKLGQSV--------TTIPTVGFNVETVT-----YKNIK-FN--VWDVGGQDK
SpArf2 MGNSLFKGFSKPFS---------RLFSN-KEMRILMLGLDAAGKTTILYKLKLNQSV--------VTIPTVGFNVETVT-----YKNIK-FN--VWDVGGQDK
ScArf3 MGNSISKVLG-------------KLFGS-KEMKILMLGLDKAGKTTILYKLKLNKIK--------TSTPTVGFNVETVT-----YKNVK-FN--MWDVGGQQR
HsArl1 MGGFFSSIFS-------------SLFGT-REMRILILGLDGAGKTTILYRLQVGEVV--------TTIPTIGFNVETVT-----YKNLK-FQ--VWDLGGQTS
DmArl1 MGGVLSY-FR-------------GLLGS-REMRILILGLDGAGKTTILYRLQVGEVV--------TTIPTIGFNVEQVT-----YKNLK-FQ--VWDLGGQTS
CeArl1 MGGVMSY-FR-------------GLFGA-REMRILILGLDGAGKTTILYRLQVGEVV--------TTIPTIGFNVEQVE-----YKNLK-FQ--VWDLGGQTS
ScArl1 MGNIFSSMFD-------------KLWGSNKELRILILGLDGAGKTTILYRLQIGEVV--------TTKPTIGFNVETLS-----YKNLK-LN--VWDLGGQTS
HsArl5 MGILFTRIW--------------RLFNH-QEHKVIIVGLDNAGKTTILYQFSMNEVV--------HTSPTIGSNVEEIV-----INNTR-FL--MWDIGGQES
HsArl5B MGLIFAKLW--------------SLFCN-QEHKVIIVGLDNAGKTTILYQFLMNEVV--------HTSPTIGSNVEEIV-----VKNTH-FL--MWDIGGQES
DmArl5 MGLLLSRLW--------------RMFGN-EEHKLVMVGLDNAGKTTILYQFLMNEVV--------HTSPTIGSNVEEVV-----WRNIH-FL--VWDLGGQQS
CeArl5 MGLIMAKLFQ-------------SWWIG-KKYKIIVVGLDNAGKTTILYNYVTKDQV--------ETKPTIGSNVEEVS-----YRNLD-FV--IWDIGGQES
HsArl4 MGNGLSDQTSILS--------NLPSFQS---FHIVILGLDCAGKTTVLYRLQFNEFV--------NTVPTKGFNTEKIKVTLGNSKTVT-FH--FWDVGGQEK
HsArl4B MGNGLSDQTSILS--------SLPSFQS---FHIVMLGLDCAGKTTVLYRLQFNEFV--------NTVPTKAFNTEKIKVNLRNSKTVT-FH--FGDVGGQEK
HsArl7 MGNISS---------------NISAFQS---LHIVMLGLDSAGKTTVLYRLKFNEFV--------NTVPTIGFNTEKIKLSNGTAKGIS-CH--FWDVGGQEK
HsArl9 MGNHLTEMAPTASS-------FLPHFQA---LHVVVIGLDSAGKTSLLYRLKFKEFV--------QSVPTKGFNTEKIRVPLGGSRGIT-FQ--VWDVGGQEK
DmArl4 MGATMVKPLVKNGNI------LDALPSQ-ATLHVVMLGLDSAGKTTALYRLKFDQYL--------NTVPTIGFNCEKVQCTLGKAKGVH-FL--VWDVGGQEK
HsArl10 MGSLGSKNPQT------------------KQAQVLLLGLDSAGKSTLLYKLKLAKDI--------TTIPTIGFNVEMIEL----ERNLS-LT--VWDVGGQEK
HsArl11 MGSVNSRGHK-------------------AEAQVVMMGLDSAGKTTLLYKLKGHQLV--------ETLPTVGFNVEPLKA----PGHVS-LT--LWDVGGQAP
HsArl2 MGLLTILKKMKQ--------------KE-RELRLLMLGLDNAGKTTILKKFNGEDID--------TISPTLGFNIKTLE-----HRGFK-LN--IWDVGGQKS
DmArl2 MGFLTVLKKMRQ--------------KE-REMRILLLGLDNAGKTTILKRFNGEPID--------TISPTLGFNIKTLE-----HNGYT-LN--MWDVGGQKS
CeArl2 MGFLKILRKQRA--------------RE-REMRILILGLDNAGKTTLMKKFLDEPTD--------TIEPTLGFDIKTVH-----FKDFQ-LN--LWDVGGQKS
SpArl2 MGLLTILRQQKL--------------KE-REVRVLLLGLDNAGKTTILKCLLNEDVN--------EVSPTFGFQIRTLE-----VEGLR-FT--IWDIGGQKT
ScArl2 MGLLSIIRKQKL--------------RD-KEIRCLILGLDNSGKSTIVNKLLPKDEQ-----NNDGIMPTVGFQIHSLM-----IKDVT-IS--LWDIGGQRT
GlArl2 MGFLSVLRAIKA--------------SE-NEARVLVVGLDCSGKTTIVSSLLGKPLT--------EIAPTLGFKISTWR-----PQNTS-MAVALWDVGGQQT
HsArl3 MGLLSILRKLKSA-------------PD-QEVRILLLGLDNAGKTTLLKQLASEDIS--------HITPTQGFNIKSVQS-----QGFK-LN--VWDIGGQRK
DmArl3 MGLLSLLRKLRPN-------------PE-KEARILLLGLDNAGKTTILKQLASEDIT--------TVTPTAGFNIKSVAA-----DGFK-LN--VWDIGGQWK
CeArl3 MGLIDVLKSFKSP-------------SG-REIRILLLGLDNAGKTTILKQLSSEDVQ--------HVTPTKGFNVKTVAA----MGDIR-LN--VWDIGGQRS
GlArl3 TILRKLCEEDTS--------VIMPTQGFNAKTIKG----PKGVS-LN--CWDVGGQKA
HsArl8A MIALFNKLLDW----------FKALFWK-EEMELTLVGLQYSGKTTFVNVIASGQFN-------EDMIPTVGFNMRKIT-----KGNVT-IK--LWDIGGQPR
HsArl8B MLALISRLLDW----------FRSLFWK-EEMELTLVGLQYSGKTTFVNVIASGQFS-------EDMIPTVGFNMRKVT-----KGNVT-IK--IWDIGGQPR
DmArl8 MLALINRILEW----------FKSIFWK-EEMELTLVGLQFSGKTTFVNVIASGQFA-------EDMIPTVGFNMRKIT-----RGNVT-IK--VWDIGGQPR
CeArl8 MLAMVNKVLDW----------IRSLFWK-EEMELTLVGLQNSGKTTFVNVIASGQFT-------EDMIPTVGFNMRKIT-----KGNVT-IK--LWDIGGQPR
GlArfrp TTILHQMAYGMT--------VETIPTMGFTLQTVK-----KGKLE-LD--VWDIGGQSE
HsArfrp MYTLLSGL-------------YKYMFQK-DEYCILILGLDNAGKTTFLEQSKTRFNKNYKGMSLSKITTTVGLNIGTVD-----VGKAR-LM--FWDLGGQEE
DmArfrp MYTLMHGF-------------YKYMTQK-DDYCVVILGLDNAGKTTYLEAAKTTFTRNYKGLNPSKITTTVGLNIGTID-----VQGVR-LN--FWDLGGQQE
CeArfrp MYTLSAGI-------------WEKFFKK-KDYYVVIVGLDNAGKTTFLEQTKSHFVKDYGVLNPSKITATVGLNTGNVE-----LNNTC-LH--FWDLGGQES
ScArfrp MFHLVKGL-------------YNNWNKK-EQYSILILGLDNAGKTTFLETLKKEYSL--AFKALEKIQPTVGQNVATIP-----VDSKQILK--FWDVGGQES
HsArl6 MGLLDRLSV------------LLGL-KK-KEVHVLCLGLDNSGKTTIINKLKPSNAQ------SQNILPTIGFSIEKFK-----SSSLS-FT--VFDMSGQGR
DmArl6 MGMLHNLAD------------LIKI-KK-DKMTILVLGLNNSGKSSIINHFKKSSEQ------TSIVVPTVGFMVEQFYI---GMSGVS-IK--AIDMSGATR
CeArl6 MGFFSSLSS------------LFGL-GK-KDVNIVVVGLDNSGKTTILNQLKTPETR------SQQIVPTVGHVVTNFS-----TQNLS-FH--AFDMAGQMK
GlArl MGAASSRPA-----------------RH-KTAKLLILGRQFSGKSTLINYLKTNSFT--------VVNPTINFTAEKYN---------R-YE--VIDVGGSAE
HsSar1 MSFIFEWIYNG----FSSVLQFLGL-YK-KSGKLVFLGLDNAGKTTLLHMLKDDRLG--------QHVPTLHPTSEELT-----IAGMT-FT--TFDLGGHEQ
HsSara MSFIFDWIYSG----FSSVLQFLGL-YK-KTGKLVFLGLDNAGKTTLLHMLKDDRLG--------QHVPTLHPTSEELT-----IAGMT-FT--TFDLGGHVQ
CeSar1 MSFLWDW--------FNGVLNMLGL-AN-KKGKLVFLGLDNAGKTTLLHMLKDDRIA--------QHVPTLHPTSEQMS-----LGGIS-FT--TYDLGGHAQ
DmSar1 M-FIWDW--------FTGVLGYLGL-WK-KSGKLLFLGLDNAGKTTLLHMLKDDKLA--------QHVPTLHPTSEELS-----IGNMR-FT--TFDLGGHTQ
ScSar1 M-AGWDIFGW-----FRDVLASLGL-WN-KHGKLLFLGLDNAGKTTLLHMLKNDRLA--------TLQPTWHPTSEELA-----IGNIK-FT--TFDLGGHIQ
SpSar1 M-FIINW--------FYDALAMLGL-VN-KHAKMLFLGLDNAGKTTLLHMLKNDRLA--------VMQPTLHPTSEELA-----IGNVR-FT--TFDLGGHQQ
GlSar1 M-GFGDW--------FKSALSFLGL-YK-KKATIVFVGLDNAGKSTLLAMLKNSATT--------TVAPTQQPTSQELV-----MGSIR-FK--TFDLGGHEV
EXCLUDED XXXXXXXXXXXXXXXXXXX X XXXXXXXX XXXXX X XX
Figure 1. Protein alignment of the N-terminal region of the 64 members of the Arf family
described in this chapter. A dash (-) indicates a gap introduced for alignment; white space
indicates that two sequences are incomplete. Numbers above indicate residues in the un-
edited hArf1 and indicate critical residues and/or simply regular spacing. Positions excluded
from the alignment used for phylogenetic analyses (Figure 2) are indicated below.
HsArf1
1 26 47 71 101 126 160 178
MGNIFANGKKEMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKNISFTVWDVGGQDKIRPLWRHYFQNTQGLIFVVDSNDRERVNEAREELMRMLAEDELRDAVLLVFANKQDLPNAMNAAEITDKLGLHSLRHRNWYIQATCATSGDGLYEGLDWLSNQLR
8
MmArf2 ...V.EK..............................................................................................T................V........................Q...........................K
HsArf3 .....G.................................................................................................................................................................A...K
DmArf1 ...V.........................................................................................IG.....................I..........................N...........................K
CeArf1 ...V.GS..R....................................................................................G..............................Q......V..........N.S.........................K
SpArf1 ..LSISK..R..........................................R............................I...........IS..H...Q...N.......L...............................Q..................E...TN.K
HsArf4 ..LTISS...Q............................................C..........R.....K....................IQ.VAD..QK..LV.........L...........AIS.M......Q...N.T..V......Q.T...........E.S
HsArf5 ..LTVSA...Q............................................C......................................Q.SAD..QK..Q.................M....PVS.L......QH..S.T..V......Q.T...D......HE.S
DmArf2 ..LTISS...Q............................................C...................................D.IT..ER..QN..Q......................T...L....R.NQ..N.H.F..S....Q.H..........AE.A
CeArf3 ..LTISS..RQV..............................................................................K..IE.S....HK..N.......T..............T...L.......N..S.Q.........Q.H.............S
ScArf1 ..LFASK.N...........G.....V........VI.............Q...............R..S.....YR..E.V.........S.IG....VMQ...N.....N.AW..........E..S.....E......I.N.P.F.........E......E....S.K
ScArf2 ..LYASK.N...........G.....V........VI.............Q...............R..S.....YR..E.V...I.....S.IG....VMQ...N.....N..W..........E..S.....E......I.N.P.F..S......E......E....N.K
CeArf ..LF.SKPNI.C.T..L...G............N.T.N............TFQK.TL........K...A..KY..P..TT.V.....S.I..IP..K...FSL...P..A.SH.........M...RSP..L.QL.D.G..KN.E.F.CG.N.H..Q......M.VKK.MK
GlArf ..QGASKS...V...................M...V...V...............N..........S........Y...DA..Y.I..A.L..IED.KN..HTL.G.......A...........K..STTDL.ER...QE.KK.D....P...R......Q......DYIF
HsArf6 ..KVLSK.N.......L.................QS......V.......T...VK.N.................YTG.........CA..D.ID...Q..H.IINDR.M...II.I........D..KPH..QE....TRI.D....V.PS............T..TSNYK
DmArf3 ..KLLSK.N.......L.................QS......V.......T...VK.N.................YTG.........CA..D.ID...T..H.IINDR.M...II.I........D..KPH..QE....TRI.D....V.PS........S...I..TSNHK
CeArf6 ..KFLSK....L....L.................QS......V.......T....K.N.................YTG..A....M.AA..D..D...M..H.IINDR.MKE.II.........AD..KPH..Q.....TRI.D....V.PS..ST....H...T...QNCK
SpArf2 ...SLFKSN.......L................NQS.V....V.......T....K.N..................TG.K........A.SN.IS...Q..H.IISDR.M..CL...L.......G.LSP.Q...V.Q.DK.KD.L.NV.P...LT....L...A...QNAK
ScArf3 ...SISK.S...K...L...K............NK.K.ST..V.......T...VK.NM......QRL........PA.TA....I..SA.N.ME..K...YSIIG.K.MENV....W......KD..KPQ.VS.F.E.EN.KNQP.CVIGSN.L..Q..V...S.I..NTN
HsArl1 ..GF.SS.TR.....IL...G........R.QV..V..............T...LK.Q...L...TS...Y..C.YS..DAV.Y....C..D.IGISKS..VA..E.E...K.I.V.......MEQ..TSS.MANS...PA.KD.K.Q.FK.S..K.T..D.AME..VET.K
DmArl1 ..GVLSY.SR.....IL...G........R.QV..V............Q.T...LK.Q...L...TS...Y..C.YS..DAI.Y....A..D.IGISKD..LY..R.E..AG.I.V.L.....MDGC.TV..VHHA...EN.KN.TFQ.FK.S..K.E..DQAM.....T.Q
CeArl1 ..GVMSY.AR.....IL...G........R.QV..V............Q.....LK.Q...L...TS...Y..C.YA..DAI.Y....A..D..GIS.Q..AT..Q....QG...A.L.....IAGCLTET.VYKA...DA..N.TIQ.FK.S.SK.E..DPAM...A...Q
ScArl1 .....SS.S..L...IL...G........R.QI..V...K.........LS...LKLN...L...TS...Y..C.YAD.AAV......T.KD.MST.SK..HL..Q.E..Q..A.........Q.G.LS.S.VSKE.N.VE.KD.S.S.V.SS.IK.E.IT......IDVIK
HsArl5 ..IL.TRNHQ.HKVII....N........QFSMN.V.H.S....S...EIVIN.TR.LM..I...ESL.SS.NT.YT..EFV.V....T....ISVT....YK...HED..K.G..I......VKEC.TV...SQF.K.T.IKDHQ.H...C..LT.E..CQ..E.MMSR.K
HsArl5B ..L...KCNQ.HKVII....N........QFLMN.V.H.S....S...EIVV..TH.LM..I...ESL.SS.NT.YS..EFI.L....I....LAITK...Y....HED..K.AV.I......MKGC.T....SKY.T.S.IKDHP.H..SC..LT.E..CQ..E.MTSRIG
DmArl5 ..LLLSR.NE.HKLV.....N........QFLMN.V.H.S....S...E.VWR..H.L...L...QSL.AA.ST.YT..ELV.M.I..T....LAVT....Y...QHED.SK.S...Y......KGS.S....SRQ.D.T.IKKHQ.H...C..LT.E...Q..E.IVQRIK
CeArl5 ..L.M.KIG.KYK.IV....N........NYVTKDQ.E.K....S...E.S.R.LD.VI..I...ESL.KS.ST.YVQ.DVV.V.I..S.TT.IPIMK.Q.HN..QHED.AR.HI..L.......G...P..VSTQ...QT..A.K.Q.NGC..VK.E..P.A.E.IA.N.-
HsArl4 ...GLSDQS--FH.VIL...C.....V..R.QFN.F.N.V..K...T.KIKS.TVT.HF......E.L....KS.TRC.D.IV.....V.V..ME..KT..HKITRIS.NQGVPV.IV......R.SLSLS..EKL.AMGE.SSTP.HL.P...II....K...EK.HDMII
HsArl4B ...GLSDQS--FH.V.L...C.....V..R.QFN.F.N.V..KA..T.KIKS.TVT.HFG.....E.LM...KS.TRC.D.IL.LM..V.I..ME..KT..HKITRLS.NQGVPV.TV......E.SLSLSG.EKL.ATGE.SSTP.HL.P...II....K...EK.HDMII
HsArl7 ....SS-QS--LH.V.L...S.....V..R..FN.F.N.V......T.KIKA.G..CHF......E.L....KS.SRC.D.I.Y....V.VD.LE..KT..HKVTKFA.NQGTP...I.......KSLPV...EKQ.A..E.IATTYHV.PA..II.E..T..M.K.YEMIL
HsArl9 ...HLTEQA--LHVVVI...S....SL..R..FK.F.QSV..K...T.KIRSRG.T.Q.......E.L.....S.NRR.D..V....AAEA..LE..KV..H.ISRASDNQGVPV..L.....Q.G.LS...VEKR.AVRE.AATLTHV.GCS.VD.L..QQ..ER.YEMIL
DmArl4 ..ATMVKSQATLHVV.L...S.....A..R..FDQYLN.V......C.K.QA.GVH.L.......E.L.....S.TRC.D.IL..I..V.T..ME..KM....TAKCPDNQGVPV.IL.........CG.M.LEKL...NE.--.G....P...IT.E..Q....A.YDMIL
HsArl10 ..SLGSK--.QAQV.LL...S...S.L......AKDI...........MI.ER.L.L........E.M.TV.GC.CE..D..VY....T.KQ.LE.SQRQFEHI.KNEHIKNVPVVLL.....M.G.LT.ED..RMFKVKK.-D....V.PC..LT.E..AQ.FRK.TGFVK
HsArl11 ..SVNSR--A.AQVV.M...S.....L.....GHQL.E.L..V.....PLKPGHV.L.L......APL.AS.KD.LEG.DI.VY.L..T.EA.LP.SAA..TEV.NDPNMAGVPF..L....EA.D.LPLLK.RNR.S.ERFQDHC.ELRGCS.LT.E..P.A.QS.WSL.K
HsArl2 ..LLTILKER.L.L..L...N.......K.FNGED.D.IS..L...IK.L.HRGFKLNI......KSL.SY..N..ES.D...W....A..Q.MQDCQR..QSL.V.ER.AG.T..I........G.LSSNA.REA.E.D.I.SHH.C..GCS.VT.EN.LP.I...LDDIS
DmArl2 ..FLTVLKER.....LL...N.......KRFNGEP.D.IS..L...IK.L.HNGYTLNM......KSL.SY..N..ES.D..VW....A..M.LESCGQ..QVL.Q.ER.AG.T...LC......G.LSSN..KEI.H.EDI-THH.LVAGVS.VT.EK.LSSM...IADIA
CeArl2 ..FLKILRER.....IL...N.....LMK.FLDEPTD.IE..L..DIK..HF.DFQLNL......KSL.SY.KN..ES.DA..W....S....LLQCS...KKL.G.ER.AG.S...L...S...G.IDVNS.AQV.D...I-SHH.K.FSC..L...R.VQAMT..CDDVG
SpArl2 ..LLTILKER.V.V.LL...N.......KC.LNEDVNEVS..F..QIR.L.VEGLR..I..I...KTL.NF.KN..ES.EAI.W....L.DL.LE.C.NT.QEL.V.EK.LFTSI..L...S.VSG.LSSE..SKI.NISKYKSSH.R.FSVS.LT.LNIKDAIS..A.D.K
ScArl2 ..LLSIIRD..I.C.IL...NS..S..VN..LPKDEQGIM..V..QIHSLMI.DVTISL..I...RTL..F.DN..DK..AM.WCI.VSLSM.FD.TLQ..KELINR..N.ECAVI.VL..I..VEDKSELH-RRC.LVEE.KDIRIELVKCSGVT.E.ID----N.RDR.V
GlArl2 ..FLSVLSEN.A.V.V....CS.....VSS.LGKPLTEIA..L..KIS.WRPQ.T.MAL......QT..TY..N..SS.DA..W....T..R.MDTC.KA.SEV.HAER.QGCPVMILC....I.S.LSVE..SAAIT.DA.-N.K.AVLPCS.M.RQ..D.AFS..LSE.L
HsArl3 ..LLSILPDQ.V...LL...N.....L.KQ.ASED.SHIT..Q...IKS.Q-QGFKLN...I...R....Y.KN..E..DI..Y.I..A..K.FE.TGQ..AEL.E.EK.SCVPV.I.......LT.AP.S..AEG.N..TI.D.V.Q..SCS.LT.E.VQD.MN.VCKNVN
DmArl3 ..LLSLLPE..A...LL...N.......KQ.ASED.T.VT..A...IKS.A-DGFKLN...I...W....Y.KN..A..DV..Y.I.CT..T.LP..GS..FE..MDNR.KQVPV.I......M.D..S...VAE.MS.VQ.QG.T.E.K.CT.VD.T..K..M..VCKNMK
CeArl3 ..L.DVLSGR.I...LL...N.......KQ.SSEDVQHVT..K....K..AMGD.RLN...I...RS...Y.SN.YE.IDT....I....KK.FD.MNI..GEL.D.EK..KVPV.I.......VT.ASSE...R..N.DL..D.T.H...CS.LKNE.IND.IT.VASN.K
GlArl3 -------------------------...R..CEEDTSVIM..Q...AK.IKP.GV.LNC......KA..TY.QN.YAG.TC..W...AA.VK.MD.VAL.VSLA.EDCR.AGVPI.........AT.LKPSDLC..I..WA..D.V.H..GCS.LT.E..E..IL.MVSKTD
HsArl8A .IAL.NKW.E..ELTL...QYS....FVNVIAS.QFNDM...V...MRKITKG.VTIKL..I...PRF.SM.ER.CRGVSAIVYM..AA.Q.KIEASKN..HNL.DKPQ.QGIPV..LG..R...G.LDEK.LIE.MN.SAIQD.EICCYSISCKEK.NIDIT.Q..IQHSK
LOGSDON AND KAHN
HsArl8B .LALISRW.E..ELTL...QYS....FVNVIAS.QFSDM...V...MRK.TKG.VTIKI..I...PRF.SM.ER.CRGVNAIVYMI.AA...KIEAS.N..HNL.DKPQ.QGIPV..LG..R.....LDEKQLIE.MN.SAIQD.EICCYSISCKEK.NIDIT.Q..IQHSK
analyses. Protein sequences were aligned and edited to remove non-conserved insertions.
Figure 2. Protein alignment of the 64 members of the Arf family used for the phylogenetic
Lines are shown to delineate between sub-families. A dot (.) indicates identity with the top
The ARF Family Tree 9
Figure 3. Phylogenetic tree of Arf family homologs from six model eukaryotic organisms.
The consensus Bayesian maximum likelihood tree is shown. The tree is based on the
alignment of Arf/Arl protein sequences (64 sequences, 172 aligned amino-acid sites) shown
in Figure 2. The analysis used MrBayes 2.01 (Huelsenbeck and Ronquist, 2001), using a JTT
model with nine gamma-distributed rates for 80400 generations (including 20,000 for burn-
in) and sampling frequency of 1000 generations. The resulting parameter estimates (and their
95% confidence intervals) are: LnL –13164.546 (80.502), alpha 1.585 (0.0261). The numbers
on the branches are the consensus percentages (clade confidences) among the 785 “good”
(post burn-in) trees; bullets represent 99-100%. The scale bar represents amino acid
substitutions per site.
10 LOGSDON AND KAHN
In addition to the three Arf classes, our analysis helps to delineate ten
orthologous groups that collectively form the Arls: Arls1-5, Arl8, Arl9,
Arfrp, and Sar1. Each of these groups is discussed below. For more details
on the biology of Arl proteins, see Chapter 16 by Schurmann and Joost.
2.2.1 Arl1
Single representatives of the Arl1 proteins were found in human, fly, worm,
and S. cerevisiae proteomes. Mammalian Arl1s have previously been shown
to have slightly higher percent identity (~55%) with Arfs than do other Arls
and to share some binding partners (Van Valkenburgh et al., 2001). The
phylogenetic placement of Arl1 as the closest to the Arfs is consistent with
the idea that they are close relatives, both functionally and evolutionarily.
The first of these Arls described was the fly arflike, which is essential in
flies (Tamkun et al., 1991). The lack of Arf activities and essential nature of
the fly Arl1 revealed for the first time that Arls perform essential functions
that can be clearly distinguished from those of Arfs. Arl1 has been localized
to Golgi membranes (Lowe et al., 1996) and expression of dominant activating
or inactivating mutants in mammalian cells results in changes in Golgi
morphology that are highly reminiscent of, but of lesser magnitude than,
those resulting from expression of analogous Arf mutants (Lu et al., 2001;
The ARF Family Tree 11
2.2.2 Arl2
Arl2 proteins were identified in all six organisms included in this study,
including Giardia. This argues for their early origin in eukaryotic evolution.
In mammals, S. cerevisiae (Arl2/CIN4), S. pombe (Arl2/alp41), C. elegans
(Arl2/evl-20), and A. thaliana (Arl2/TITAN5), there is genetic evidence
supporting roles for Arl2 in tubulin assembly and microtubule dynamics
(Antoshechkin and Han, 2002; Bhamidipati et al., 2000; Hoyt et al., 1997;
Hoyt et al., 1990; McElver et al., 2000; Radcliffe et al., 2000). Arl2
mutations result in cytokinesis defects and death in most of these studies,
though Arl2/CIN4 is not essential in S. cerevisiae. A model for Arl2 acting
in tubulin folding has been proposed by Bhamidipati, et al. (Bhamidipati et al.,
2000), based on the evidence for the direct binding of the tubulin-specific
chaperone, cofactor D, by Arl2•GDP.
Based on all of the phylogenetic analyses we have carried out to date, the
Arl2 and Arl3 proteins group strongly together, making it very likely that
they diverged from a common ancestor. Indeed, this must have been an
early event in eukaryotic evolution as Giardia has representatives of each
group. In addition, each of the yeasts in our study appears to have lost one
of the Arl2/Arl3 group proteins. This appears to have been Arl3, though the
long branch lengths (e.g., see Sc Arl2 in Figure 3) make this conclusion
somewhat tenuous. There is also biochemical support for the conclusion that
Arl2 and Arl3 are more closely related to each other than to other Arls. In
particular, guanine nucleotide exchange is much more rapid, proceeds to
higher stoichiometries in vitro, and is independent of lipids or detergents;
properties that are distinct from those of Arfs and Arl1 (Cavenagh et al.,
1994; Clark et al., 1993; Hillig et al., 2000; Sharer and Kahn, 1999).
Structural data explain these differences in divalent metal and nucleotide
binding by Arl2 and Arl3, compared to other members of the Arf family
(Hillig et al., 2000), and further support the conclusion that Arl2 and Arl3 are
more closely related to each other than they are to other Arls.
12 LOGSDON AND KAHN
Figure 4. Schematic phylogenetic tree depicting the relationships between the three Arf and
ten Arl groups. The presence of orthologs of each group in animals (A, in triangle), fungi (F,
in box), or protists (P, in circle) is indicated on the right. In two cases, a Giardia protein
could not be unambiguously assigned between groups so arrows to each are shown with a
question mark.
2.2.3 Arl3
The presence of orthologs of Arl3 in Giardia and the three animals suggest
that the two yeasts have lost the Arl3 gene. Whether this is the result of the
lack of a particular pathway or specific function (e.g., cell motility) in yeast
cannot be determined without more functional data on Arl3. Like Arl2, Arl3
probably is not N-myristoylated. Despite sharing a number of binding
partners (Van Valkenburgh et al., 2001) and biochemical features (Hillig et
al., 2000) with Arl2, Arl3 appears to lack the inferred functions of Arl2 in
tubulin assembly and in mitochondrial localization (C. Snelson, J. Shern, and
R. A. Kahn, unpublished observations).
2.2.4 Arl4
2.2.5 Arl5
Representatives of the Arl5 group were identified in all three animals, with
two closely related paralogs in humans. Wormbase
(http://www.wormbase.org/) reports no phenotype resulting from RNAi of
Ce Arl5, and there is no functional information available on any of these
genes or proteins to date.
2.2.6 Arl6
The Arl6 proteins were found in each of the animal proteomes and that of
Giardia, but in neither fungus. Each of the sequences result from searches
of genomic, cDNA, or EST databases and nothing is known about the
activities or functions in cells of the proteins. The fact that the Giardia Arl6
has three (corresponding to Arf1 residues Asp26, Gln71, and Asn126) and
Drosophila Arl6 has two (Asp26 and Gln71) deviations in sequence at
critical, and otherwise very highly conserved, positions leads us to predict
that novel means of controlling guanine nucleotide binding and hydrolysis
are used by the Arl6 proteins.
2.2.7 Arl8
The human Arl8 sequences were only very recently reported (Pasqualato et
al., 2002) and our analysis identified single orthologs in the fly and worm
proteomes. One of the six Arf family members we have identified in
Giardia groups with Arl8, but in other analyses groups with the Arfrp.
Indeed, a weak, but consistently observed relationship is recovered between
the Arl8 and Arfrp subgroups. No functional or expression data are
available for any Arl8. However, we note (e.g., see Figures 1 and 2) that
each of the Arl8 proteins (and two of the Arl6’s) are the only members of the
Arf family that deviate from the aspartate at residue 26 of Arf1, and that
corresponds to glycine 12 of Ras proteins. This residue is critical to the
hydrolysis of GTP and so its change in Arl8’s may indicate a distinctive
means of hydrolysis or interaction with its GAP(s).
Human Arl10 and Arl11 are described here for the first time as members of
the Arf family, and specifically as possible close relatives of the Arl4 group.
Arl10 and Arl11 are their own closest relatives; their inferred protein
sequences are ~57% identical, and they also share N-terminal spacing (see
Figures 1 and 2). Arl10, Arl11, and DmArl4 were all found from genome
The ARF Family Tree 15
2.2.9 Arfrp
Human and rat orthologs of the Arf-related protein, Arfrp1, were first
described in 1995 by Schurmann, et al. (Schurmann et al., 1995). Orthologs
are present also in D. melanogaster, C. elegans, S. cerevisiae, and, possibly
G. lamblia. This gene appears to have been lost from S. pombe. The genetic
loci and predicted proteins in human, rat, and mouse have been assigned the
name Arfrp1, though the protein has previously been named Arp. Arfrp
proteins all lack the glycine at position 2 and therefore cannot be N-
myristoylated. Arfrps are also unique in that three of the five proteins in our
analysis deviated from the conserved residue, corresponding to proline 41 in
Arf1 (see Figure 1). This proline is critical to the formation of the extra β-
sheet found in Arfs, in comparison to Ras family proteins, and its change
may indicate a novel structure in this critical domain of the GTPase. The
gene has been knocked out in mice and results in embryonic lethality during
gastrulation (Mueller et al., 2002). A much more detailed description of this
and other functional aspects of Arfrp biology are presented in Chapter 16.
2.2.10 Sar1
The Sar proteins share the lowest percent identity to Arfs (e.g. HsArf1 vs.
HsSar1, ~29% identity) or Arls and for that reason are often not included in
descriptions of the Arf family. Alignments with other families of GTPases
(e.g., Ras, Rab, Rho) reveal that Sar proteins are clearly more closely related
to Arfs than these other GTPases. The strongest argument in favor of
including Sar proteins in the Arf family is functional. Sar1 is thought to play
a highly analogous role to those of class I Arfs in the recruitment of coat
proteins to budding vesicles (Barlowe et al., 1993; Kimura et al., 1995; Kuge
et al., 1994; Nakano and Muramatsu, 1989; Nishikawa and Nakano, 1991;
Oka et al., 1991). But while Arfs act at the Golgi/TGN, Sar1 acts at the ER.
Interestingly, the Sar1 proteins have been highly conserved throughout
eukaryotes and Sar1 orthologs are present in each of the six organisms in our
study. Like the Arl8 and Arfrp proteins, Sar1’s lack an N-terminal glycine
and therefore are not N-myristoylated. Additional information on Sar1 can
be found in Chapter 16.
16 LOGSDON AND KAHN
These analyses have revealed some key evolutionary features of the Arf
family. It is important to note that this family is—so far—unique to
eukaryotes, not being found in either Bacteria or Archaea. In contrast, the
fact that many of the Arf family members are found in Giardia, a divergent,
and likely early-diverging, protist (Roger, 1999), emphasizes that the these
proteins are quite ancient features of eukaryotic cells. Our phylogenetic
analyses indicate that the ages of the various subfamilies are quite varied
(Figure 4). The oldest families, which contain animal, fungal, and Giardia
orthologs, include Arf I/II, Arl2 and Sar (and possibly Arfrp). Some
apparently middle-aged families include only animal and fungal members,
such as ArfI/II, ArfIII and Arl1. Young sub-families, which are restricted to
animals, include Arf I, ArfII, Arl 4 and Arl5. The youngest family,
Arf10/11, is restricted only to mammals. These latter groups likely represent
functions unique to animals, including developmental roles (as is known for
Arl4). In addition to estimating the relative ages of each of the subfamilies
by their phylogenetic distribution, we can also make inferences about the
likely loss of particular orthologs from particular subfamilies (assuming that
the genomes in which these genes are not found are indeed complete and/or
that the genes are not so divergent as to not be recognized). These losses
include Arl 1 in S. pombe, Arl4 in C. elegans and Arfrp in S. pombe. The
apparent absence of these orthologs in particular organisms may provide
important clues as to their conserved/dispensable functions in other species.
Finally, we must point out that the phylogenetic sampling used here, while
useful for generally delineating the relationships among these proteins, does
not encompass the breadth of eukaryotic diversity. Additional analyses
including more eukaryotes, notably more protist species and plants, will be
important to further refine the family tree of Arfs.
4. SUMMARY
From the sequencing of genomes we now have a more clear idea of the size
of the Arf family. Members of this family regulate a wide range of essential
cellular processes and they have been performing those functions since the
emergence of eukaryotes. With 23 members of the Arf family in mammals,
and similar numbers of Arf effectors, Arf GEFs, and Arf GAPs (identified to
18 LOGSDON AND KAHN
REFERENCES
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990). Basic local
alignment search tool. J. Mol. Biol., 215, 403-410.
Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman,
D. J. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res., 25, 3389-3402.
Amor, J. C., Horton, J. R., Zhu, X., Wang, Y., Sullards, C., Ringe, D., Cheng, X., and Kahn,
R. A. (2001). Structures of Yeast ARF2 and ARL1. Distinct roles for the N terminus in the
structure and function of Arf family GTPases. J. Biol. Chem., 276, 42477-42484.
Antoshechkin, I., and Han, M. (2002). The C. elegans evl-20 gene is a homolog of the small
GTPase ARL2 and regulates cytoskeleton dynamics during cytokinesis and
morphogenesis. Dev Cell, 2, 579-591.
Barlowe, C., d'Enfert, C., and Schekman, R. (1993). Purification and characterization of
SAR1p, a small GTP-binding protein required for transport vesicle formation from the
endoplasmic reticulum. J. Biol. Chem., 268, 873-879.
Bhamidipati, A., Lewis, S. A., and Cowan, N. J. (2000). ADP ribosylation factor-like protein
2 (Arl2) regulates the interaction of tubulin-folding cofactor D with native tubulin. J Cell
Biol, 149, 1087-1096.
Brown, H. A., Gutowski, S., Moomaw, C. R., Slaughter, C., and Sternweis, P. C. (1993).
ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates
phospholipase D activity [see comments]. Cell, 75, 1137-1144.
Cavenagh, M. M., Breiner, M., Schurmann, A., Rosenwald, A. G., Terui, T., Zhang, C.,
Randazzo, P. A., Adams, M., Joost, H. G., and Kahn, R. A. (1994). ADP-ribosylation
factor (ARF)-like 3, a new member of the ARF family of GTP-binding proteins cloned
from human and rat tissues. J. Biol. Chem., 269, 18937-18942.
Clark, J., Moore, L., Krasinskas, A., Way, J., Battey, J., Tamkun, J., and Kahn, R. A. (1993).
Selective amplification of additional members of the ADP-ribosylation factor (ARF)
family: cloning of additional human and Drosophila ARF-like genes. Proc. Natl. Acad.
Sci., USA, 90, 8952-8956.
Cockcroft, S., Thomas, G. M., Fensome, A., Geny, B., Cunningham, E., Gout, I., Hiles, I.,
Totty, N. F., Truong, O., and Hsuan, J. J. (1994). Phospholipase D: a downstream effector
of ARF in granulocytes. Science, 263, 523-526.
Hanzal-Bayer, M., Renault, L., Roversi, P., Wittinghofer, A., and Hillig, R. C. (2002). The
complex of Arl2-GTP and PDE{delta}: from structure to function. EMBO J., 21, 2095-
2106.
Hillig, R. C., Hanzal-Bayer, M., Linari, M., Becker, J., Wittinghofer, A., and Renault, L.
(2000). Structural and biochemical properties show ARL3-GDP as a distinct GTP binding
protein. Structure Fold Des., 8, 1239-1245.
The ARF Family Tree 19
Hoyt, M. A., Macke, J. P., Roberts, B. T., and Geiser, J. R. (1997). Saccharomyces cerevisiae
PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.
Genetics, 146, 849-857.
Hoyt, M. A., Stearns, T., and Botstein, D. (1990). Chromosome instability mutants of
Saccharomyces cerevisiae that are defective in microtubule-mediated processes. Mol. Cell.
Biol., 10, 223-234.
Huelsenbeck, J. P., and Ronquist, F. (2001). MRBAYES: Bayesian inference of phylogenetic
trees. Bioinformatics, 8,
Jacobs, S., Schilf, C., Fliegert, F., Koling, S., Weber, Y., Schurmann, A., and Joost, H. G.
(1999). ADP-ribosylation factor (ARF)-like 4, 6, and 7 represent a subgroup of the ARF
family characterization by rapid nucleotide exchange and a nuclear localization signal.
FEBS Lett, 456, 384-388.
Kahn, R. A., and Gilman, A. G. (1984). Purification of a protein cofactor required for ADP-
ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera
toxin. J. Biol. Chem., 259, 6228-6234.
Kahn, R. A., and Gilman, A. G. (1986). The protein cofactor necessary for ADP-ribosylation
of Gs by cholera toxin is itself a GTP binding protein. J. Biol. Chem., 261, 7906-7911.
Kahn, R. A., Kern, F. G., Clark, J., Gelmann, E. P., and Rulka, C. (1991). Human ADP-
ribosylation factors. A functionally conserved family of GTP-binding proteins. J. Biol.
Chem., 266, 2606-2614.
Kimura, K., Oka, T., and Nakano, A. (1995). Purification and assay of yeast Sar1p. Methods
Enzymol., 257, 41-49.
Kobayashi, A., Kubota, S., Mori, N., McLaren, M. J., and Inana, G. (2003). Photoreceptor
synaptic protein HRG4 (UNC119) interacts with ARL2 via a putative conserved domain.
FEBS Lett., 534, 26-32.
Kuge, O., Dascher, C., Orci, L., Rowe, T., Amherdt, M., Plutner, H., Ravazzola, M.,
Tanigawa, G., Rothman, J. E., and Balch, W. E. (1994). Sar1 promotes vesicle budding
from the endoplasmic reticulum but not Golgi compartments. J. Cell Biol., 125, 51-65.
Lee, F. J., Huang, C. F., Yu, W. L., Buu, L. M., Lin, C. Y., Huang, M. C., Moss, J., and
Vaughan, M. (1997). Characterization of an ADP-ribosylation factor-like 1 protein in
Saccharomyces cerevisiae. J. Biol. Chem., 272, 30998-31005.
Lee, F. J., Moss, J., and Vaughan, M. (1992). Human and Giardia ADP-ribosylation factors
(ARFs) complement ARF function in Saccharomyces cerevisiae. J. Biol. Chem., 267,
24441-24445.
Lee, F. J., Stevens, L. A., Hall, L. M., Murtagh, J. J., Jr., Kao, Y. L., Moss, J., and Vaughan,
M. (1994a). Characterization of class II and class III ADP-ribosylation factor genes and
proteins in Drosophila melanogaster. J. Biol. Chem., 269, 21555-21560.
Lee, F. J., Stevens, L. A., Kao, Y. L., Moss, J., and Vaughan, M. (1994b). Characterization of
a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae.
J. Biol. Chem., 269, 20931-20937.
Lowe, S. L., Wong, S. H., and Hong, W. (1996). The mammalian ARF-like protein 1 (Arl1) is
associated with the Golgi complex. J Cell Sci, 109, 209-220.
Lu, L., Horstmann, H., Ng, C., and Hong, W. (2001). Regulation of Golgi structure and
function by ARF-like protein 1 (Arl1). J. Cell Sci., 114, 4543-4555.
Massenburg, D., Han, J. S., Liyanage, M., Patton, W. A., Rhee, S. G., Moss, J., and Vaughan,
M. (1994). Activation of rat brain phospholipase D by ADP-ribosylation factors 1,5, and
6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes. Proc.
Natl. Acad. Sci., USA, 91, 11718-11722.
20 LOGSDON AND KAHN
McElver, J., Patton, D., Rumbaugh, M., Liu, C., Yang, L. J., and Meinke, D. (2000). The
TITAN5 gene of Arabidopsis encodes a protein related to the ADP ribosylation factor
family of GTP binding proteins. Plant Cell, 12, 1379-1392.
Mishima, K., Tsuchiya, M., Nightingale, M. S., Moss, J., and Vaughan, M. (1993). ARD 1, a
64-kDa guanine nucleotide-binding protein with a carboxyl-terminal ADP-ribosylation
factor domain. J. Biol. Chem., 268, 8801-8807.
Mueller, A. G., Moser, M., Kluge, R., Leder, S., Blum, M., Buttner, R., Joost, H. G., and
Schurmann, A. (2002). Embryonic lethality caused by apoptosis during gastrulation in
mice lacking the gene of the ADP-ribosylation factor-related protein 1. Mol. Cell Biol., 22,
1488-1494.
Nakano, A., and Muramatsu, M. (1989). A novel GTP-binding protein, Sar1p, is involved in
transport from the endoplasmic reticulum to the Golgi apparatus. J. Cell Biol., 109, 2677-
2691.
Nishikawa, S., and Nakano, A. (1991). The GTP-binding Sar1 protein is localized to the early
compartment of the yeast secretory pathway. Biochim. Biophys. Acta, 1093, 135-143.
Oka, T., Nishikawa, S., and Nakano, A. (1991). Reconstitution of GTP-binding Sar1 protein
function in ER to Golgi transport. J. Cell Biol., 114, 671-679.
Pasqualato, S., Renault, L., and Cherfils, J. (2002). Arf, Arl, Arp, and Sar proteins: a family
of GTP-binding proteins with a structural device for front-back communication. EMBO
Rep.
Radcliffe, P. A., Vardy, L., and Toda, T. (2000). A conserved small GTP-binding protein
Alp41 is essential for the cofactor-dependent biogenesis of microtubules in fission yeast.
FEBS Lett., 468, 84-88.
Randazzo, P. A., and Kahn, R. A. (1995). Myristoylation and ADP-ribosylation factor
function. Methods Enzymo.l, 250, 394-405.
Renault, L., Hanzal-Bayer, M., and Hillig, R. C. (2001). Coexpression, copurification,
crystallization and preliminary X-ray analysis of a complex of ARL2-GTP and PDE delta.
Acta Crystallogr. D.Biol. Crystallogr., 57, 1167-1170.
Roger, A.J. (1999). Reconstructing Early Events in Eukaryotic Evolution. American
Naturalist, 154, S146-S163.
Rosenwald, A. G., Rhodes, M. A., Van Valkenburgh, H., Palanivel, V., Chapman, G., Boman,
A., Zhang, C. J., and Kahn, R. A. (2002). ARL1 and membrane traffic in Saccharomyces
cerevisiae. Yeast, 19, 1039-1056.
Schleifer, L. S., Kahn, R. A., Hanski, E., Northup, J. K., Sternweis, P. C., and Gilman, A. G.
(1982). Requirements for cholera toxin-dependent ADP-ribosylation of the purified
regulatory component of adenylate cyclase. J. Biol. Chem., 257, 20-23.
Schurmann, A., Massmann, S., and Joost, H. G. (1995). ARP is a plasma membrane-
associated Ras-related GTPase with remote similarity to the family of ADP-ribosylation
factors. J. Biol. Chem., 270, 30657-30663.
Sewell, J. L., and Kahn, R. A. (1988). Sequences of the bovine and yeast ADP-ribosylation
factor and comparison to other GTP-binding proteins. Proc. Natl. Acad. Sci., USA, 85,
4620-4624.
Sharer, J. D., and Kahn, R. A. (1999). The ARF-like 2 (ARL2)-binding protein, BART.
Purification, cloning, and initial characterization. J. Biol. Chem., 274, 27553-27561.
Sharer, J. D., Shern, J. F., Van Valkenburgh, H., Wallace, D. C., and Kahn, R. A. (2001).
ARL2 and BART enter mitochondria and bind the adenine nucleotide transporter (ANT).
Mol. Biol. Cell, 2002, 71-83.
Tamkun, J. W., Kahn, R. A., Kissinger, M., Brizuela, B. J., Rulka, C., Scott, M. P., and
Kennison, J. A. (1991). The arflike gene encodes an essential GTP-binding protein in
Drosophila. Proc. Natl. Acad. Sci., USA, 88, 3120-3124.
The ARF Family Tree 21
Van Valkenburgh, H., Shern, J. F., Sharer, J. D., Zhu, X., and Kahn, R. A. (2001). ADP-
ribosylation factors (ARFs) and ARF-like 1 (ARL1) have both specific and shared
effectors: characterizing ARL1-binding proteins. J. Biol. Chem., 276, 22826-22837.
Van Valkenburgh, H. A., and Kahn, R. A. (2002). Coexpression of proteins with methionine
aminopeptidase and/or N-myristoyltransferase in Escherichia coli to increase acylation and
homogeneity of protein preparations. Methods Enzymol., 344, 186-193.
Vitale, N., Moss, J., and Vaughan, M. (1998). Molecular characterization of the GTPase-
activating domain of ADP- ribosylation factor domain protein 1 (ARD1). J. Biol. Chem.,
273, 2553-2560.
Chapter 2
THE GDP/GTP CYCLE OF ARF PROTEINS
Structural and Biochemical Aspects
1. INTRODUCTION
Arf proteins are involved in a large and still expanding number of cellular
processes, all related to their pivotal role as regulators of protein traffic and
membrane dynamics (reviewed in Chavrier and Goud, 1999). These
functions are operated by their ability to switch between an inactive GDP-
bound and an active GTP-bound form, each able to bind selectively to
distinct sets of cellular regulators, while effectors bind only to their GTP-
bound form. In this chapter we will focus on the biochemical and structural
implementation of the GDP/GTP switch, which departs from the classical
switch of other small GTP-binding proteins.
23
24
2 PASQUALATO, RENAULT AND CHERFILS
Although many biochemical studies have preceded the report of the first
crystal structure of Arf in 1994 (Amor et al., 1994), we have chosen to
introduce this chapter by a description of the structural aspects of the
mechanism, as they provide a convenient background for subsequent
discussions. The structure of human Arf1 bound to GDP (Amor et al.,
1994), followed by that of rat Arf1•GDP (identical in sequence) (Greasley et
al., 1995) were first reported. Structure of an activated Arf was then
THE GDP/GTP CYCLE OF ARF PROTEINS 25
3
In the GDP-bound form of both proteins, interactions that wedge the guanine
base, which are provided by an aromatic residue of the switch 1 in Ras, Rho,
Figure 1. The GDP/GTP cycle and the interswitch toggle of full-length human Arf6.
Regions that change their conformation are in dark gray. Switch 1 and 2 regions are defined
here based on the conformational changes between the GDP- and GTP-bound Arf structures,
and therefore differ from their classical definitions in Ras. It should be noted that as the
switch 1, interswitch and switch 2 regions form a continuous switch peptide, their junctions
are arbitrary. In Arf6, switch 1 comprises residues 36-46, the interswitch residues 47-64 and
switch 2 residues 65-80. The flexible N-terminus in Arf6•GTPγS is shown as a dashed line.
D63 from the DxGGQ motif, which blocks the γ-phosphate binding-site in the GDP-bound
form, and the invariant T44 from switch 1, are shown. Hinge glycine residues that allow the
flexibility of switch 1 are indicated by their Cα. The DxGGQxxxRxxW signature is also
shown. Protein Data Bank entries are 1E0S (Arf6•GDP) and 1HFV (Arf6•GTPγS).
and Rab families, originate from a residue from the β6-α5 loop (T161 in
Arf1, K152 in Ran). However, only in Arf is this interaction maintained
throughout the GDP/GTP cycle, whereas in active Ran it is replaced by an
aromatic interaction from the switch 1 (Vetter et al., 1999) equivalent to that
of Ras, Rho and Rab. A +1 shift of the invariant threonine within the
THE GDP/GTP CYCLE OF ARF PROTEINS 27
5
Figure 2. Conformational changes of the nucleotide-binding site along the GDP/GTP cycle.
From top to bottom: Arf1•GDP (PDB entry 1HUR), nucleotide-free Arf1∆17-Gea2-Sec7
complex (gift from J. Goldberg), Arf1∆17•GDP(NH)P (gift from J. Goldberg). Hydrogen
bonds are shown as dotted lines. The carbonyls of A28 and A29 and the Cα of G69 and G70
are shown.
THE GDP/GTP CYCLE OF ARF PROTEINS 29
7
the interswitch, which is shorter in Arf proteins than in other small GTP-
binding proteins, allowing it to be eclipsed in the protein core and form the
hydrophobic binding site for the N-terminal helix in the inactive form. The
second is a conserved sequence signature, wDvGGQxxxRxxW (residues 66-
78 in Arf1, 62-74 in Arf6) that spans the β3 strand of the interswitch and
switch 2. In Arf•GDP, the interswitch and switch 2 are mutually stabilized
by interaction of the tryptophan (W78 in Arf1) with surrounding aromatic
residues, including another tryptophan from the interswitch (W66 in Arf1).
Reorganization of this peptide upon binding of GTP creates a novel network
of hydrogen bonds involving the glycine pair, the arginine and the
tryptophan (G69, G70, R75 and W78 in Arf1) (Figure 3). This structural
transition is probably made possible by the flexibility provided by the
glycine pair, the first one being found only in the Arf family. The large
change in environment of the tryptophan accounts for the increase in
intrinsic fluorescence when GDP is exchanged for GTP (Kahn and Gilman,
1986), which provides a built-in reporter to monitor the kinetics of
spontaneous as well as GEF-catalyzed nucleotide exchange (Antonny et al.,
1997).
THE GDP/GTP CYCLE OF ARF PROTEINS 31
9
We have focused so far on the features that are common to the GDP/GTP
cycles of Arf1 and Arf6, and likely to other Arf proteins as well. This
knowledge is essential to go a step further and identify the specific structural
features beyond the ‘air de famille’ that may explain why Arf1 and Arf6
have distinct cellular functions (reviewed in Chavrier and Goud, 1999, see
Chapter 14) despite having 67% sequence identity and very similar switch 1
and 2 regions. For instance, there is a single V/I change between Arf1 and
Arf6 in the binding interface with the Sec7 domain as established from the
nucleotide-free Arf1/Gea2-Sec7 complex (Goldberg, 1998). However, Arf6
has a family of specific exchange factors, termed EFA6, that are inactive on
Arf1 in vivo and in vitro (Franco et al., 1999; Macia et al., 2001). We have
Figure 4. Arf1 and Arf6 have different GDP-bound conformations. Arf6•GDP is shown in
light gray. Regions of Arf1•GDP that have significant conformational differences to
Arf6•GDP are superimposed in dark gray. The flexible switch 2 region in Arf1•GDP is also
shown.
32
10 PASQUALATO, RENAULT AND CHERFILS
investigated the structural basis for this specificity with the crystallographic
study of the GDP/GTP cycle of human Arf6 and its comparison to that of
Arf1 (Menetrey et al., 2000; Pasqualato et al., 2001).
While the sequence identity between Arf1 and Arf6 predicts that they
should be extremely similar, this study revealed unexpected differences
affecting their GDP-bound forms (Menetrey et al., 2000) (Figure 4). First, if
the N-terminus of Arf6 does form an amphipathic helix that fastens the
retracted interswitch despite being shorter by four residues, the structure
shows that it is the linker to the G protein core that is shortened and has a
different conformation. More surprisingly, switch 1 of Arf6, although
forming the extra β-sheet, is displaced by up to 3-4Å relative to Arf1, and its
switch 2 is less flexible than that of Arf1. Where do these differences come
from, given that Arf1 and Arf6 have almost identical switch regions?
Comparison of Arf6•GDP with Arf1•GDP identifies residues located either
on the remote ends of the switch regions, or in contact with the switch
regions, that are different between Arf1 and Arf6 and could account for their
biochemical and functional specificities. The contribution of these residues
was tested by mutational studies. The crystal structure of Arf6•GDP pointed
to a sequence difference in the vicinity of the nucleotide-binding site (I42 in
Arf1, S38 in Arf6), which positions a conserved glutamate (E54 in Arf1,
E50 in Arf6) in or out of the active site, respectively (Figure 5). Permutation
of these residues was sufficient to switch the kinetics of spontaneous
nucleotide dissociation between N-terminally truncated Arf1 and Arf6
(Menetrey et al., 2000), which is about 15 times faster in Arf6 than in Arf1
(Macia et al., 2001), thus supporting its proposed role in the nucleotide
binding site. A functional role for this residue is further supported by the
inability of the double Arf6-Q37I,S38I mutant to form the actin protrusions
upon treatment with aluminum fluorides in HeLa cells that are characteristic
of wild type Arf6 (Al-Awar et al., 2000). Other residues potentially
involved in stabilizing Arf6•GDP in a conformation different from that of
Arf1•GDP were introduced in Arf1 and tested for their activation by an
unspecific GEF, ARNO, and an Arf6-specific GEF, EFA6 (Macia et al.,
2001). This study showed that ARNO is very robust at activating these
various Arf1 mutants, while mutations targeting separately either switch 1,
the interswitch or switch 2 are not sufficient on their own to gain activation
by EFA6. Thus, although specificity is demonstrated to lie within the G
protein core of Arf and to be fully defined by the Sec7 domain of the GEF,
its structural implementation is likely to result from the combination of
subtle and localized effects. It should be noted that chimeras that paste
entire sub-regions of Arf1 and Arf6 together may, from that point of view,
induce structural effects that are larger than the differences between Arf1
and Arf6 that specify their interactions.
THE GDP/GTP CYCLE OF ARF PROTEINS 33
11
On the other hand, the active structures of Arf1∆17 and Arf6 are
surprisingly similar (Pasqualato et al., 2001). In particular, the switch 1 and
switch 2 regions do not show the discrepancies of the inactive GDP-bound
forms. Altogether, the conformations of the switch regions fully identify the
Figure 5. A structural basis for the different nucleotide-binding properties of Arf1 and Arf6.
Replacement of S38 in Arf6 by I42 in Arf1 modifies the interactions of a conserved glutamate
residue in the nucleotide-binding site.
inactive from the active form of an individual Arf isoform, and their
different conformations in Arf1•GDP and Arf6•GDP can be discriminated
by partners of the inactive form, in particular their GEFs (Menetrey et al.,
2000). On the contrary, as the switch regions have the same conformation
and virtually identical sequences in the active forms of Arf1 and Arf6, they
are expected to be poor contributors to their specific interactions with
effectors (Pasqualato et al., 2001). As a consequence, specific interactions
established by activated Arf must originate from contributions other than the
sole recognition of the switch regions by protein partners. This can be
accounted for by several, non-exclusive hypotheses. One is that regions
other than the switch regions, which feature sequence differences between
Arf1 and Arf6, are necessary for establishing specific interactions. Another
is that specificity is initiated while Arf is still bound to GDP and
subsequently propagates to Arf•GTP-effector complexes. This could be
accomplished by the formation of transient Arf-GEF-effector complexes,
where the identity of the effector would be specified by interactions with
both Arf and the GEF (Pasqualato et al., 2001). Such a concept of
GEF/effector interactions is indeed emerging for another family of small
34
12 PASQUALATO, RENAULT AND CHERFILS
Like other small GTP-binding proteins, the active state of Arfs is terminated
by hydrolysis of the bound GTP. However, spontaneous GTPase activity is
not measurable in Arf proteins (Kahn and Gilman, 1986), for which the
appellation of “GTPases” would therefore be illegitimate. Structural studies
allow us to address this difference with other small GTP-binding proteins,
which have intrinsic GTPase activity. Surprisingly, in the active forms, the
nucleotide binding site and GTP have the classical arrangement found in
other small GTP-binding proteins, including the localization of the catalytic
glutamine (DxGGQ motif, Q71 in Arf1) in the vicinity of the γ-phosphate of
GTP with which it could interact with only minor conformational changes
(Figure 4). Moreover, the wDvGGQxxxRxxW signature, which is also
found in the Gα subunit of heterotrimeric proteins, has the same
conformation in activated Arf1 and Arf6 and in the Gαi•GDP•AlF4 complex
(Coleman et al., 1994). The latter structure mimics the transition state of the
GTPase reaction. One essential difference, however, lies in the replacement
of G42 in the P-loop of Gα, by an aspartate (D26 in Arf1) (Figures 2 and 4).
Superposition of activated Gαi•GDP•AlF4 with structures of activated Arfs
36
14 PASQUALATO, RENAULT AND CHERFILS
suggests that the side chain of this aspartate may hinder the catalytic
glutamine from interacting with and stabilizing the leaving phosphate group.
This aspartate is in fact equivalent to the G12 position of Ras, whose
mutation to valine results in impairment in both spontaneous and GAP-
stimulated GTPase activity (Scheffzek et al., 1997). It is as yet unclear how
the GAP releases this unfavorable contact in Arf, but this observation opens
the possibility that the contribution of the catalytic glutamine may differ
from other small GTP-binding proteins. The crystal structure of the complex
of Arf1∆17•GDP with the catalytic domain of rat Arf GAP1 does not
provide insight into this issue, as the complex features an interface that is
remote from the nucleotide binding site (Goldberg, 1999). This study
proposes that the actual GAP is composed of the GAP domain and the
coatomer, which may provide the interactions that are missing in the GTP
binding site (Goldberg, 1999). At the moment this question is the subject of
an on-going debate as to the existence or not of a classical GAP mechanism
involving the complementation of the active site with an ‘arginine finger’
provided by the Arf GAP (Click et al., 2002; Goldberg, 1999; Szafer et al.,
2000; Szafer et al., 2001).
in the case of the Sec7 domain, while in other systems it is provided by the
G protein itself. In addition, the complex revealed that the P-loop is
distorted such that carbonyls of its main chain (A27 and A28) would conflict
with binding of the α- and β-phosphates of a nucleotide
a double-face adhesive tape, gluing the Sec7 domain to Arf•GDP which has
not yet undertaken the interswitch toggle (Beraud-Dufour et al., 1999).
These studies also suggest that BFA has no direct effect on the
membrane/cytosol partitioning of the trapped Sec7-Arf•GDP complex. This
non-competitive mechanism was also proposed for members of the
p200/BIG family of Arf GEFs, which are likely cellular targets of BFA in
mammalian cells (Mansour et al., 1999). It should be noted that this non-
competitive inhibition mechanism is all the more remarkable in that it targets
a low-affinity complex, yet it is very efficient in the cell (Peyroche et al.,
1999; reviewed in Chardin and McCormick, 1999). It is also very specific,
as it does not target Arf6 in vitro (our unpublished data) nor in vivo (Peters
et al., 1995), and Arf1 is a target for BFA only with certain exchange factors.
These observations make BFA a model inhibitor for GEF-catalyzed
activation of small GTP-binding proteins. Differences in the structures and
flexibility of Arf1•GDP and Arf6•GDP (Menetrey et al., 2000), and in the
flexibility of the Sec7 domains at the residues that determine BFA-
sensitivity (Renault et al., 2002) may contribute to this specificity.
In contrast, the complex of ARNO-K156-Sec7 with Arf•GDP forms only
at low Mg2+ concentration (µM), either in solution with Arf1∆17 or in the
presence of membranes with myr-Arf1, in which case its affinity for
membranes is comparable to that of the nucleotide-free complex (Beraud-
Dufour et al., 1999; Beraud-Dufour et al., 1998). Thus, the E156K mutation
probably traps still another discrete step of the reaction, where the N-
terminal hasp binds to membranes where it is stabilized by the interswitch
toggle, while only the final nucleotide dissociation step is inhibited.
Mutation of the glutamic finger does not interfere with the formation of the
BFA complex (Robineau et al., 2000), reinforcing the idea that the glutamic
finger is not involved until late in the course of the exchange reaction. The
mechanism of the Sec7 domain can thus be separated in (at least) two steps:
a docking step where the Sec7 domain binds to Arf•GDP; and a catalytic
step where the glutamate has a crucial role in dissociating the GDP
nucleotide. Comparison of yeast Gea2-Sec7 in complex with nucleotide-free
human Arf1∆17 (Goldberg, 1998) with its unbound structure (Renault et al.,
2002) shows that a subdomain motion closes the hydrophobic groove upon
binding to Arf, suggesting that Arf•GDP may bind onto the side of the
groove opposite to the glutamic finger at the docking step, while closure of
Sec7 subdomains brings the glutamic finger into the active site at the
catalytic step (Renault et al., 2002).
42
20 PASQUALATO, RENAULT AND CHERFILS
Figure 7. The model for the nucleotide/membrane switch. See text for details of steps 1 to 5.
Gua=guanine base, myr=myristate, E=glutamic finger, D=aspartate from the DxGGQ motif,
Sec7Nt= Sec7 N-terminal domain; Sec7Ct= Sec7 C-terminal domain.
44
22 PASQUALATO, RENAULT AND CHERFILS
5) Finally, entry of GTP, binding first by the guanine base whose binding
site is readily accessible in the nucleotide-free complex, dissociates the GEF
and provides alternative interactions that stabilize the active conformation of
the switch/interswitch machinery. As the interswitch is now firmly
stabilized, the interaction of the N-terminal hasp with membranes becomes
irreversible as long as Arf is bound to GTP.
The model and results discussed so far argue clearly for the need of both
the guanine nucleotide exchange factor and the membrane to perform an
efficient activation of Arf proteins. Notably, both membranes and the Sec7
domain induce conformational changes that drive the activation process. For
these reasons, catalyzed nucleotide exchange towards Arf is composed of
two factors acting in concert, but mostly inactive on their own: a classical
GEF that changes the conformation of the switch regions and builds up the
GTP-binding site, and a membrane co-factor unfastening the N-terminal
hasp. We have recently proposed that this mechanism of front-back
communication by the interswitch toggle is also found in most Arf-like
proteins as well as in Sar1, suggesting that these proteins will also be
activated by a “dual” exchange factor (Pasqualato et al., 2002).
4. ACKNOWLEDGEMENTS
REFERENCES
Al-Awar, O., Radhakrishna, H., Powell, N. N., and Donaldson, J. G. (2000). Separation of
membrane trafficking and actin remodeling functions of ARF6 with an effector domain
mutant. Mol. Cell Biol., 20, 5998-6007.
Amor, J. C., Harrison, D. H., Kahn, R. A., and Ringe, D. (1994). Structure of the human
ADP-ribosylation factor 1 complexed with GDP. Nature, 372, 704-708.
Amor, J. C., Horton, J. R., Zhu, X., Wang, Y., Sullards, C., Ringe, D., Cheng, X., and Kahn,
R. A. (2001). Structures of yeast ARF2 and ARL1: distinct roles for the N terminus in the
structure and function of ARF family GTPases. J. Biol. Chem., 276, 42477-42484.
Antonny, B., Beraud-Dufour, S., Chardin, P., and Chabre, M. (1997). N-terminal hydrophobic
residues of the G-protein ADP-ribosylation factor-1 insert into membrane phospholipids
upon GDP to GTP exchange. Biochemistry, 36, 4675-4684.
Beraud-Dufour, S., Paris, S., Chabre, M., and Antonny, B. (1999). Dual interaction of ADP
ribosylation factor 1 with Sec7 domain and with lipid membranes during catalysis of
guanine nucleotide exchange. J. Biol. Chem., 274, 37629-37636.
THE GDP/GTP CYCLE OF ARF PROTEINS 45
23
Beraud-Dufour, S., Robineau, S., Chardin, P., Paris, S., Chabre, M., Cherfils, J., and Antonny,
B. (1998). A glutamic finger in the guanine nucleotide exchange factor ARNO displaces
Mg2+ and the beta-phosphate to destabilize GDP on ARF1. EMBO J., 17(13), 3651-3659.
Betz, S. F., Schnuchel, A., Wang, H., Olejniczak, E. T., Meadows, R. P., Lipsky, B. P.,
Harris, E. A., Staunton, D. E., and Fesik, S. W. (1998). Solution structure of the cytohesin-
1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1.
Proc. Natl. Acad. Sci., USA, 95, 7909-7914.
Chardin, P., and McCormick, F. (1999). Brefeldin A: the advantage of being uncompetitive.
Cell, 97, 153-155.
Chardin, P., Paris, S., Antonny, B., Robineau, S., Beraud-Dufour, S., Jackson, C. L., and
Chabre, M. (1996). A human exchange factor for ARF contains Sec7- and pleckstrin-
homology domains. Nature, 384, 481-484.
Chavrier, P., and Goud, B. (1999). The role of ARF and Rab GTPases in membrane transport.
Curr. Opin. Cell Biol., 11, 466-475.
Cherfils, J., and Chardin, P. (1999). GEFs: structural basis for their activation of small GTP-
binding proteins. Trends Biochem. Sci., 24, 306-311.
Cherfils, J., Menetrey, J., Mathieu, M., Le Bras, G., Robineau, S., Beraud-Dufour, S.,
Antonny, B., and Chardin, P. (1998). Structure of the Sec7 domain of the Arf exchange
factor ARNO. Nature, 392, 101-105.
Click, E. S., Stearns, T., and Botstein, D. (2002). Systematic Structure-Function Analysis of
the Small GTPase Arf1 in Yeast. Mol. Biol. Cell, 13, 1652-1664.
Coleman, D. E., Berghuis, A. M., Lee, E., Linder, M. E., Gilman, A. G., and Sprang, S. R.
(1994). Structures of active conformations of Gi alpha 1 and the mechanism of GTP
hydrolysis. Science, 265, 1405-1412.
Cullen, P. J., and Chardin, P. (2000). Membrane targeting: what a difference a G makes.
Curr. Biol., 10, R876-878.
Franco, M., Chardin, P., Chabre, M., and Paris, S. (1993). Myristoylation is not required for
GTP-dependent binding of ADP-ribosylation factor ARF1 to phospholipids. J. Biol.
Chem., 268, 24531-24534.
Franco, M., Chardin, P., Chabre, M., and Paris, S. (1995). Myristoylation of ADP-
ribosylation factor 1 facilitates nucleotide exchange at physiological Mg2+ levels. J. Biol.
Chem., 270, 1337-1341.
Franco, M., Chardin, P., Chabre, M., and Paris, S. (1996). Myristoylation-facilitated binding
of the G protein ARF1GDP to membrane phospholipids is required for its activation by a
soluble nucleotide exchange factor. J. Biol. Chem., 271, 1573-1578.
Franco, M., Peters, P. J., Boretto, J., van Donselaar, E., Neri, A., D'Souza-Schorey, C., and
Chavrier, P. (1999). EFA6, a sec7 domain-containing exchange factor for ARF6,
coordinates membrane recycling and actin cytoskeleton organization. EMBO J., 18, 1480-
1491.
Goldberg, J. (1998). Structural basis for activation of ARF GTPase: mechanisms of guanine
nucleotide exchange and GTP-myristoyl switching. Cell, 95, 237-248.
Goldberg, J. (1999). Structural and functional analysis of the ARF1-ARFGAP complex
reveals a role for coatomer in GTP hydrolysis. Cell, 96, 893-902.
Greasley, S. E., Jhoti, H., Teahan, C., Solari, R., Fensome, A., Thomas, G. M., Cockcroft, S.,
and Bax, B. (1995). The structure of rat ADP-ribosylation factor-1 (ARF-1) complexed to
GDP determined from two different crystal forms. Nat. Struct. Biol., 2, 797-806.
Haun, R. S., Tsai, S. C., Adamik, R., Moss, J., and Vaughan, M. (1993). Effect of
myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi. J. Biol.
Chem., 268, 7064-7068.
46
24 PASQUALATO, RENAULT AND CHERFILS
Kahn, R. A. (1991). Fluoride is not an activator of the smaller (20-25 kDa) GTP-binding
proteins. J. Biol. Chem., 266, 15595-15597.
Kahn, R. A., and Gilman, A. G. (1986). The protein cofactor necessary for ADP-ribosylation
of Gs by cholera toxin is itself a GTP binding protein. J. Biol. Chem., 261, 7906-7911.
Kahn, R. A., Goddard, C., and Newkirk, M. (1988). Chemical and immunological
characterization of the 21-kDa ADP-ribosylation factor of adenylate cyclase. J. Biol.
Chem., 263, 8282-8287.
Kahn, R. A., Randazzo, P., Serafini, T., Weiss, O., Rulka, C., Clark, J., Amherdt, M., Roller,
P., Orci, L., and Rothman, J. E. (1992). The amino terminus of ADP-ribosylation factor
(ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of
protein transport. J. Biol. Chem., 267, 13039-13046.
Klausner, R. D., Donaldson, J. G., and Lippincott-Schwartz, J. (1992). Brefeldin A: insights
into the control of membrane traffic and organelle structure. J. Cell Biol., 116, 1071-1080.
Losonczi, J. A., and Prestegard, J. H. (1998). Nuclear magnetic resonance characterization of
the myristoylated, N-terminal fragment of ADP-ribosylation factor 1 in a magnetically
oriented membrane array. Biochemistry, 37, 706-716.
Losonczi, J. A., Tian, F., and Prestegard, J. H. (2000). Nuclear magnetic resonance studies of
the N-terminal fragment of adenosine diphosphate ribosylation factor 1 in micelles and
bicelles: influence of N-myristoylation. Biochemistry, 39, 3804-3816.
Macia, E., Chabre, M., and Franco, M. (2001). Specificities for the small G proteins ARF1
and ARF6 of the guanine nucleotide exchange factors ARNO and EFA6. J. Biol. Chem.,
276, 24925-24930.
Macia, E., Paris, S., and Chabre, M. (2000). Binding of the PH and polybasic C-terminal
domains of ARNO to phosphoinositides and to acidic lipids. Biochemistry, 39, 5893-5901.
Mansour, S. J., Skaug, J., Zhao, X. H., Giordano, J., Scherer, S. W., and Melancon, P. (1999).
p200 ARF-GEP1: a Golgi-localized guanine nucleotide exchange protein whose Sec7
domain is targeted by the drug brefeldin A. Proc. Natl. Acad. Sci., USA, 96, 7968-7973.
Menetrey, J., Macia, E., Pasqualato, S., Franco, M., and Cherfils, J. (2000). Structure of Arf6-
GDP suggests a basis for guanine nucleotide exchange factors specificity. Nat. Struct.
Biol., 7, 466-469.
Mossessova, E., Gulbis, J. M., and Goldberg, J. (1998). Structure of the guanine nucleotide
exchange factor Sec7 domain of human arno and analysis of the interaction with ARF
GTPase. Cell, 92, 415-423.
Paris, S., Beraud-Dufour, S., Robineau, S., Bigay, J., Antonny, B., Chabre, M., and Chardin,
P. (1997). Role of protein-phospholipid interactions in the activation of ARF1 by the
guanine nucleotide exchange factor Arno. J. Biol. Chem., 272, 22221-22226.
Pasqualato, S., Menetrey, J., Franco, M., and Cherfils, J. (2001). The structural GDP/GTP
cycle of human Arf6. EMBO Rep., 2, 234-238.
Pasqualato, S., Renault, L., and Cherfils, J. (2002). Arf, Arl, Arp and Sar proteins: a family of
GTP-binding proteins with a structural device for front-back communication. EMBO Rep.,
3, 1035-1041.
Peters, P. J., Hsu, V. W., Ooi, C. E., Finazzi, D., Teal, S. B., Oorschot, V., Donaldson, J. G.,
and Klausner, R. D. (1995). Overexpression of wild-type and mutant ARF1 and ARF6:
distinct perturbations of nonoverlapping membrane compartments. J. Cell. Biol., 128,
1003-1017.
Peyroche, A., Antonny, B., Robineau, S., Acker, J., Cherfils, J., and Jackson, C. L. (1999).
Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex:
involvement of specific residues of the Sec7 domain. Mol. Cell, 3, 275-285.
THE GDP/GTP CYCLE OF ARF PROTEINS 47
25
Randazzo, P. A., Terui, T., Sturch, S., Fales, H. M., Ferrige, A. G., and Kahn, R. A. (1995).
The myristoylated amino terminus of ADP-ribosylation factor 1 is a phospholipid- and
GTP-sensitive switch. J. Biol. Chem., 270, 14809-14815.
Renault, L., Christova, P., Guibert, B., Pasqualato, S., and Cherfils, J. (2002). Mechanism of
domain closure of Sec7 domains and role in BFA sensitivity. Biochemistry, 41, 3605-
3612.
Renault, L., Kuhlmann, J., Henkel, A., and Wittinghofer, A. (2001). Structural basis for
guanine nucleotide exchange on Ran by the regulator of chromosome condensation
(RCC1). Cell, 105, 245-255.
Robineau, S., Chabre, M., and Antonny, B. (2000). Binding site of brefeldin A at the interface
between the small G protein ADP-ribosylation factor 1 (ARF1) and the nucleotide-
exchange factor Sec7 domain. Proc. Natl. Acad. Sci., USA, 97, 9913-9918.
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmuller, L., Lautwein, A., Schmitz, F., and
Wittinghofer, A. (1997). The Ras-RasGAP complex: structural basis for GTPase
activation and its loss in oncogenic Ras mutants. Science, 277, 333-338.
Scheffzek, K., Klebe, C., Fritz-Wolf, K., Kabsch, W., and Wittinghofer, A. (1995). Crystal
structure of the nuclear Ras-related protein Ran in its GDP-bound form. Nature, 374, 378-
381.
Serafini, T., Orci, L., Amherdt, M., Brunner, M., Kahn, R. A., and Rothman, J. E. (1991).
ADP-ribosylation factor is a subunit of the coat of Golgi-derived COP-coated vesicles: a
novel role for a GTP-binding protein. Cell, 67, 239-253.
Shevell, D. E., Leu, W. M., Gillmor, C. S., Xia, G., Feldmann, K. A., and Chua, N. H. (1994).
EMB30 is essential for normal cell division, cell expansion, and cell adhesion in
Arabidopsis and encodes a protein that has similarity to Sec7. Cell, 77, 1051-1062.
Skippen, A., Jones, D. H., Morgan, C. P., Li, M., and Cockcroft, S. (2002). Mechanism of
ADP ribosylation factor-stimulated phosphatidylinositol 4,5-bisphosphate synthesis in
HL60 cells. J. Biol. Chem., 277, 5823-5831.
Someya, A., Sata, M., Takeda, K., Pacheco-Rodriguez, G., Ferrans, V. J., Moss, J., and
Vaughan, M. (2001). ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-
ribosylation factor 6. Proc. Natl. Acad. Sci., USA, 98, 2413-2418.
Steinmann, T., Geldner, N., Grebe, M., Mangold, S., Jackson, C. L., Paris, S., Galweiler, L.,
Palme, K., and Jurgens, G. (1999). Coordinated polar localization of auxin efflux carrier
PIN1 by GNOM ARF GEF. Science, 286, 316-318.
Szafer, E., Pick, E., Rotman, M., Zuck, S., Huber, I., and Cassel, D. (2000). Role of coatomer
and phospholipids in GTPase-activating protein-dependent hydrolysis of GTP by ADP-
ribosylation factor-1. J. Biol. Chem., 275, 23615-23619.
Szafer, E., Rotman, M., and Cassel, D. (2001). Regulation of GTP hydrolysis on ADP-
ribosylation factor-1 at the Golgi membrane. J. Biol. Chem., 276, 47834-47839.
Vetter, I. R., Arndt, A., Kutay, U., Gorlich, D., and Wittinghofer, A. (1999). Structural view
of the Ran-Importin beta interaction at 2.3 A resolution. Cell, 97, 635-646.
Vetter, I. R., and Wittinghofer, A. (2001). The guanine nucleotide-binding switch in three
dimensions. Science, 294, 1299-1304.
Walker, M. W., Bobak, D. A., Tsai, S. C., Moss, J., and Vaughan, M. (1992). GTP but not
GDP analogues promote association of ADP-ribosylation factors, 20-kDa protein
activators of cholera toxin, with phospholipids and PC-12 cell membranes. J. Biol. Chem.,
267, 3230-3235.
Zerial, M., and McBride, H. (2001). Rab proteins as membrane organizers. Nat. Rev. Mol.
Cell Biol., 2, 107-117.
48
26 PASQUALATO, RENAULT AND CHERFILS
Zhao, L., Helms, J. B., Brunner, J., and Wieland, F. T. (1999). GTP-dependent binding of
ADP-ribosylation factor to coatomer in close proximity to the binding site for dilysine
retrieval motifs and p23. J. Biol. Chem., 274, 14198-14203.
Chapter 3
ARF AND PHOSPHOLIPIDS
Abstract: Arfs have been implicated in remodeling of both biological membranes and
the actin cytoskeleton. In each case, Arf function appears to be integrally
related to lipid metabolism. As regulators of membrane traffic, Arfs bind to
membrane surfaces and affect membrane structure. Effects of Arf on the actin
cytoskeleton may be mediated through acid phospholipids. Examination of
the interactions of Arfs and lipids has revealed complex relationships. Arfs
directly bind lipids. Arfs also bind and activate two enzymes that metabolize
lipids, phospholipase D and phosphatidylinositol 4-phosphate 5-kinase. The
products of these enzymes, phosphatidic acid and phosphatidylinositol 4,5-
bisphosphate, affect both positive and negative regulators of Arfs. Although
precise mechanisms have yet to be defined, regulation of the concentrations of
these signaling lipids appears to mediate at least some effects of Arfs.
1. INTRODUCTION
Gs and Arf. At least part of the effect of the micelles in this reaction is
related to the properties of Arf. Arf•GTP is the cofactor for cholera toxin;
however, Arf•GDP is purified from mammalian tissues. For activity in the
assay, Arf has to exchange GTP for GDP. Exchange of nucleotide on native
Arf is greatly enhanced by lipids. Once exchange does occur, Arf•GTP
binds tightly to and is stabilized by lipid interfaces, where it can function as
a cofactor for cholera toxin (see Chapter 10 for additional details). The basis
of the lipid requirement for nucleotide exchange was uncovered shortly after
the cloning of Arf and identification of N-terminal myristate as a
modification. Arf bound to GTP was found to directly associate with
hydrophobic surfaces through Arf’s N-terminal myristate and -helix.
Arf also interacts with specific phospholipids, the phosphoinositides,
within biological membranes. A cluster of basic amino acids mediates the
binding to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). This specific
interaction, together with the general hydrophobic association of Arf with
lipids, directs Arf binding to target proteins, by both recruiting Arf to
specific surfaces and by affecting the affinity of Arf for effectors. For
instance, acid phospholipids have been found to influence the binding of two
Arf effectors, GGA and Arfaptin, to Arf. Phosphatidic acid (PA), PI(4,5)P2,
and their metabolites have also been found to influence the activity Arf-
directed guanine nucleotide exchange factors (GEFs) and Arf GTPase
activating proteins (GAPs).
Adding complexity to the regulation of Arf by lipids is the ability of Arf
to directly influence the lipid composition of the membranes to which it
binds. Arf activates both phospholipase D (PLD), which hydrolyzes
phosphatidylcholine (PC) to PA, and phosphatidylinositol 4-phosphate 5-
kinase (PIP kinase I), which transfers a phosphate from ATP to
phosphatidylinositol 4-phosphate (PI(4)P) to form PI(4,5)P2 (also see
Chapter 11). The physiological relevance of many of these reactions and
their relationships to one another is yet to be determined.
In this chapter, the literature examining the impact of phospholipids on
Arf function will be discussed followed by some limited speculation about
how these reactions may be related to one another and how the lipids
themselves may mediate the effects of Arf on membrane traffic and the actin
cytoskeleton.
association is greatest for the GTP bound form of the Arf, myrArf•GDP also
associates with membranes (Franco et al., 1996; Beraud-Dufour et al., 1999),
while non-myristoylated Arf•GDP does not. Targeting myrArf•GDP to the
membrane is thought to facilitate interaction with ARNO family exchange
factors that are recruited to membranes through their PH domains (described
below and in Chapters 4-6). A second effect of myristate in GEF-catalyzed
nucleotide exchange is facilitation of the binding of lysines 10, 15 and 16 to
acid phospholipids such as PI(4,5)P2. Chardin and colleagues (Paris et al.,
1997b) found that ARNO catalyzed nucleotide exchange on both
myristoylated and nonmyristoylated Arf1 in the presence of PI(4,5)P2.
Under physiologic conditions of Mg2+ and ionic strength, myristoylated Arf1
was the preferred substrate. Lowering Mg2+ and ionic strength greatly
enhanced the rate of exchange using nonmyristoylated Arf1. The authors
noted that low Mg2+ and salt concentrations favor electrostatic interactions
such as those between acid phospholipids and basic amino acid residues.
Based on these observations, the authors concluded that the electrostatic
binding between acid phospholipids and lysines 10, 15 and 16 of Arf1,
though weak under physiologic conditions, was necessary for activity. The
myristate, by providing a second binding site, would increase the affinity of
Arf for the membrane, thereby driving these otherwise weak electrostatic
interactions. Note that these results are consistent with the reported (Terui et
al., 1994) effect of PI(4,5)P2 to increase nucleotide exchange on Arf1.
4. INTERACTION OF SIGNALING
PHOSPHOLIPIDS WITH ARF AND ITS
REGULATORS
Figure 1. Phospholipid-regulated Arf GEFs and GAPs. (A) Schematic showing the domain
organization of ARNO and EFA6 family Arf GEFs. (B) Amino acid sequences of regions
conferring lipid specificity of ARNO1 and GRP1. (C) Schematic of the Arf GAPs. Ankyrin
repeat, ANK; Arf GAP catalytic domain, Arf GAP; coiled-coil, CC; pleckstrin homology
domain, PH; proline-rich domain, PR; Rho GAP domain, Rho GAP.
To date, fourteen mammalian Arf GAPs have been described (see Chapters
7-9; Cukierman et al., 1995; Premont et al., 1998; Vitale et al., 2000;
Bagrodia et al., 1999; Brown et al., 1998; Premont et al., 2000; Miura et al.,
2002; Krugmann et al., 2002; Nie et al., 2002). The proteins can be divided
into three groups based on structure (Figure 1C). The first subfamily
contains Arf GAP1 and 3. The protein has a catalytic domain, found in all
proteins with GAP activity, comprised of a zinc finger motif. A second
domain targets Arf GAP1 to the Golgi apparatus by binding to ERD2 (Aoe
et al., 1999). A second subfamily contains the GITs (called APAP in the
nomenclature introduced in this volume). Similar to Arf GAP1 in containing
the Arf GAP catalytic domain at the amino terminus, the GITs also have
ARF AND PHOSPHOLIPIDS 57
9
ankyrin (ANK) repeat domains and unique domains involved in targeting the
protein to the plasma membrane. The largest subgroup of Arf GAPs is the
ASAPs, defined by a core of PH, Arf GAP and ANK repeat domains. All
members of this subgroup contain additional domains N-terminal to this
core. Some also have additional domains C-terminal of the core. The lipid
dependence of Arf GAP1, GITs and ASAPs has been examined and are
discussed below.
Arf GAP1 has unique lipid dependence among the Arf GAPs. In the first
studies of Arf GAP1, PI(4,5)P2 was found to have a small but reproducible
effect on activity. Those studies were performed with nonmyristoylated
Arf1 (Randazzo 1997b; Makler et al., 1995). When myrArf1 was used, no
effect of PI(4,5)P2 was seen (Antonny et al., 1997b). The most likely
explanation for these results was that PI(4,5)P2 was recruiting the
nonmyristoylated Arf1 to the hydrophobic surface with which the GAP was
also associated. Myristoylated Arf1, bound to GTP, has a high affinity for
the vesicles and hydrophobic surfaces, and there was no further effect of
adding PI(4,5)P2.
When Antonny and colleagues subsequently re-examined the lipid
requirements of Arf GAP1 (Antonny et al., 1997b), they found that
diacylglyerols (DAG) with monounsaturated acyl groups both increased the
amount of GAP associated with vesicles and stimulated GAP activity. On
examination of the effects of a number of synthetic lipids, the extent of
stimulation was found to correlate with the relative volumes occupied by the
polar head group and the acyl groups. The smaller the head group relative to
the acyl group, the greater the activity. The monounsaturated acyl groups
have a kink that results in a relatively large occupied volume.
Dioleoylglycerol, with no head group and two kinked acyl groups, was the
most effective of the series they examined. Saturated phosphatidylcholine,
with a large head group and tightly packed acyl groups, was inhibitory.
Gcs1p, a yeast homolog of Arf GAP1, was similar in lipid dependency.
Based on this analysis, Cassel and colleagues proposed that Arf GAP1
binding to membranes is driven by hydrophobic contact of the protein with
the acyl groups of the lipids. Large head groups and tight packing of acyl
groups would tend to exclude the protein whereas small head groups and
loosely packed acyl groups would favor interaction with the hydrophobic
part of the protein.
The importance of the activation of Arf GAP1 by DAG was thought to be
related to the function of PLD. The product of PLD, PA, is rapidly
hydrolyzed to ortho-phosphate and DAG. This set of reactions could
58
10 RANDAZZO, NIE, AND HIRSCH
Figure 2. Postulated feedback loop regulating the activation status of Arf1 as a result of
changes in membrane lipids. The direct activation of PLD by Arf•GTP is shown, along with
the product of PLD, PA, being converted to DAG, an activator of Arf GAP1.
The idea that Arf GAPs are a target of lipid signaling is consistent with in
vivo studies in S. cerevisiae (Yanagisawa et al., 2002). Screens for secretory
mutants in yeast had led to the identification of Sec14p, a PI transfer protein
thought to regulate Golgi function by altering the lipid composition of Golgi
membranes (Bankaitis et al., 1989). Deletion of Gcs1, an Arf GAP, was
synthetically lethal with a temperature sensitive mutant of Sec14, sec14-1ts
(Yanagisawa et al., 2002). Similarly, replacement of Gcs1 with Gcs1-K54, a
mutant lacking GAP activity, was synthetically lethal with sec14-1ts. The
defect imposed by loss of Sec14 function can be partially overcome by
mutations (“bypass Sec14p” mutations) in genes that control
phosphatidylcholine or phosphoinositide metabolism. Consistent with Gcs1
functioning downstream of lipid changes mediated by Sec14, deletion of
Gcs1 re-imposed defects in growth and Golgi function in sec14-1ts strains
with “bypass Sec14p” mutations.
4.3.2 GITs
Less is known about the potential regulatory role of lipids for the function of
GITs. In one report, PIP3 stimulated the GAP activity of GIT, using Arf6 as
a substrate (Vitale et al., 2000). However, at least 100 M PIP3 was
required for a relatively modest (2 – 3 fold) stimulation (by comparison, 360
M PA with 45 M PI(4,5)P2 activate ASAP1 10,000 fold (Kam et al.,
2000).
ARF AND PHOSPHOLIPIDS 59
11
4.3.3 ASAPs
activated by PI(3,4)P2 and PI(3,4,5)P3 to a much greater extent than they are
activated by other phosphoinositide isomers (Miura et al., 2002; Krugmann
et al., 2002; personal observation). The contributions of each of the five PH
domains to this activation have not been extensively examined. PH domain
1, counting from the amino terminus, likely confers at least some of the
PI(3,4,5)P3 dependence. PH domain 2 is of particular interest, given the role
of the PH domain of ASAP1 as an allosteric binding site for the PI(4,5)P2-
dependent regulation of GAP activity. The in vitro studies of the AGAPs
have been the most complex to interpret (Nie et al., 2002). The PH domain
is split, with an 80 amino acid insert between the predicted 4 and 5
strands of the structure. Within the first 4 strands, AGAP1 has 9 identities
of the consensus sequence for PI(3,4,5)P3 binding (Lietzke et al., 2000). The
one difference is conservative, lysine in place of an arginine. Consistent
with this level of identity, PI(3,4,5)P3 stimulated this GAP. However, the
required concentrations were relatively high (10 – 50 M) compared to that
seen with ARAP1 (100 nM) and the addition of a second acid phospholipid,
PA, inhibited the PI(3,4,5)P3-dependent activity. PI(4,5)P2, in the presence
of PA, stimulated activity. This effect was specific for PA. Other acid
phospholipids, including phosphatidylserine and PI, were much less
effective in inhibiting PI(3,4,5)P3-dependent GAP activity and synergizing
with PI(4,5)P2.
The distinct phosphoinositide specificities of each Arf GAP and GEF
could allow for the independent regulation of each. For instance, ASAP1,
ACAP1 and ACAP2 have been found in the same cellular sites (Jackson et
al., 2000). Changes in PI(3,5)P2 could contribute to the regulation of
ACAP1 and ACAP2 whereas ASAP1 could be regulated by changes in
PI(4,5)P2. Other mechanisms could provide additional regulation; e.g.,
ASAP1 is dependent on PA and is also a target of other signaling proteins,
such as Src.
5. SYSTEMS OF PHOSPHOINOSITIDE
DEPENDENT REACTIONS
The effect of Arf GAPs on Rho family proteins adds further complexity
to this network of interactions. ARAP1 induces the activation of Cdc42 and
the inactivation of RhoA in NIH 3T3 fibroblasts (Miura et al., 2002).
ARAP1 has a Rho GAP domain and RhoA GAP activity in vitro and in vivo.
Based on the formation of membrane ruffles and filopodia observed when
the proteins are ectopically expressed, other ASAP family members also
appear to be able to activate Cdc42 and/or Rac (P.A. Randazzo, unpublished
observations). Furthermore, GIT family Arf GAPs bind the Rho family
exchange factor called Pix/Cool (Zhao et al., 2000; Turner et al., 1999). Rho
family proteins stimulate PLD and PIP kinase (Sternweis et al., 1997; Chong
et al., 1994). Thus, the effects on the Rho family proteins could generate
additional feedforward and feedback loops.
Figure 3. Proposed system of feedforward and feedback loops impinging on Arf and
regulating phospholipid concentrations. Substrates and products of specific enzymes are
indicated with a solid line and allosteric or regulatory effects with dotted lines. PI3-K, PI 3-
kinase, PI(4)P-5K, PI(4)P 5-kinase.
With the products of the PLD and PIP kinase I reactions synergizing with
Arf and Rho to activate other enzymes, a complex network of feedforward
and feedback loops can be assembled. The distinct phosphoinositide
specificities of GAPs and GEFs could provide further coordination to these
reactions. For instance, a PI(3,4,5)P3-dependent GEF could function with a
62
14 RANDAZZO, NIE, AND HIRSCH
The simplest model for Arf action is that any particular effect (e.g.,
membrane traffic) is mediated by a single effector (e.g., a coat protein). Arf
function in membrane traffic is dependent on the regulated cycle of GTP
binding and hydrolysis. Not only is this cycle integral to Arf function, the
cycle must occur on a time scale that matches the events being regulated.
Therefore, one possible role of the feedforward and feedback loops is to
mediate rapid and precipitous switching of Arf between on and off states.
Lipid metabolites would be particularly suited for these functions as they
could be generated and diffuse rapidly within the membrane at which Arf
works.
PI(4,5)P2 and PA could be Arf effectors, in which case the lipid loops could
be a means of regulating the levels of either or both PI(4,5)P2 and PA.
PI(4,5)P2 and PA regulate a number of events that impact membrane traffic
and actin polymerization and waves of PI(4,5)P2 coincide with phagocytosis,
an Arf6-dependent event (Takenawa and Itoh, 2001; Osborne et al., 2001;
Gillooly et al., 2001; Simonsen et al., 2001; Payrastre et al., 2001; Cremona
and De Camilli, 2001). Evidence supporting the function of PA and
PI(4,5)P2 as Arf effectors has been reviewed elsewhere (Chapter 11 of this
volume and Randazzo et al., 2000). Briefly, either blocking the production
or sequestering the lipids has been found to block Arf-dependent cellular
functions (Honda et al., 1999; Randazzo et al., 2000). Additionally,
overexpressing PIP kinase mimics part of the phenotype seen with the
constitutive activation of Arf6 (Honda et al., 1999; Brown et al., 2001).
Mechanistic details of PA and PI(4,5)P2 function as Arf effectors are
lacking. Two possibilities have been considered (Randazzo et al., 2000).
ARF AND PHOSPHOLIPIDS 63
15
First, the lipids may recruit specific proteins to membranes. For example,
PA might recruit a coat protein or may activate a PIP kinase. PI(4,5)P2 may
activate PLD, directly bind coat proteins or affect coat protein binding by
influencing the association of actin cytoskeletal components with the
membranes. In this “mesh hypothesis”, a membrane microdomain with a
high content of PI(4,5)P2 recruits spectrin, an actin binding protein, which
loosens the actin mesh, allowing coat binding and subsequent vesicle
budding (Godi et al., 1999; Lorra and Huttner, 1999). A second possibility
is that the lipid changes affect the physical properties of the membranes.
The synthesis of PA may, by inducing curvature in the membrane, drive
budding and release of a transport vesicle (Weigert et al., 2000; Weigert et
al., 1999b; Weigert et al., 1999a; Schmidt et al., 1999).
7. CONCLUSION
The role of lipids in Arf function has been examined for over a decade and,
rather than being simplified, more relationships have been discovered among
the proteins and lipids in the Arf pathway. At the same time, the functions
of phosphoinositides and phosphatidic acid have been further defined. This
progress has led to an appreciation of the integral relationship between Arfs
and phospholipids and a number of testable models of the mechanisms by
64
16 RANDAZZO, NIE, AND HIRSCH
which membrane traffic and the actin cytoskeleton are temporally and
spatially regulated.
8. REFERENCES
Aoe, T., Huber, I., Vasudevan, C., Watkins, S. C., Romero, G., Cassel, D., and Hsu, V. W.
(1999). The KDEL receptor regulates a GTPase-activating protein for ADP-ribosylation
factor1 by interacting with its non-catalytic domain. J. Biol. Chem., 274, 20545-20549.
Amor, J. C., Harrison, D. H., Kahn, R. A., and Ringe, D. (1994). Structure of the human
ADP-ribosylation factor-1 complexed with GDP. Nature, 372, 704-708.
Anderson, R. A., Boronenkov, I. V., Doughman, S. D., Kunz, J., and Loijens, J. C. (1999).
Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. J.
Biol. Chem., 274, 9907-9910.
Andreev, J., Simon, J. P., Sabatini, D. D., Kam, J., Plowman, G., Randazzo, P. A., and
Schlessinger, J. (1999). Identification of a new Pyk2 target protein with Arf-GAP activity.
Mol. Cell. Biol., 19, 2338-2350.
Antonny, B., Beraud-Dufour, S., Chardin, P., and Chabre, M. (1997a). N-terminal
hydrophobic residues of the G-protein ADP- ribosylation factor-1 insert into membrane
phospholipids upon GDP to GTP exchange. Biochemistry, 36, 4675-4684.
Antonny, B., Huber, I., Paris, S., Chabre, M., and Cassel, D. (1997b). Activation of ADP-
ribosylation factor 1 GTPase-activating protein by phosphatidylcholine-derived
diacylglycerols. J. Biol. Chem., 272, 30848-30851.
Bagrodia, S., Bailey, D., Lenard, Z., Hart, M., Guan, J., Premont, R., Taylor, S., and Cerione,
R. (1999). A tyrosine-phosphorylated protein that binds to an important regulatory region
on the Cool family of p21-activated kinase-binding proteins. J. Biol. Chem., 274, 22393-
22400.
Bankaitis, V. A., Malehorn, D. E., Emr, S. D., and Greene, R. (1989). The Saccharomyces-
cerevisiae Sec14 gene encodes a cytosolic factor that is required for transport of secretory
proteins from the yeast Golgi complex. J. Cell Biol., 108, 1271-1281.
Beraud-Dufour, S., Paris, S., Chabre, M., and Antonny, B. (1999). Dual interaction of ADP
ribosylation factor 1 with Sec7 domain and with lipid membranes during catalysis of
guanine nucleotide exchange. J. Biol. Chem., 274, 37629-37636.
Bourgoin, S. G., Houle, M. G., Singh, I. N., Harbour, D., Gagnon, S., Morris, A. J., and
Brindley, D. N. (2002). ARNO but not Cytohesin-1 translocation is phosphatidylinositol
3-kinase-dependent in HL-60 cells. J. Leuk. Biol., 71, 718-728.
Brown, F. D., Rozelle, A. L., Yin, H. L., Balla, T., and Donaldson, J. G. (2001).
Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol.,
154, 1007-1017.
Brown, M. T., Andrade, J., Radhakrishna, H., Donaldson, J. G., Cooper, J. A., and Randazzo,
P. A. (1998). ASAP1, a phospholipid-dependent Arf GTPase-activating protein that
associates with and is phosphorylated by Src. Mol. Cell. Biol., 18, 7038-7051.
Chardin, P., Paris, S., Antonny, B., Robineau, S., Beraud-Dufour, S., Jackson, C. L., and
Chabre, M. (1996). A human exchange factor for Arf contains Sec7- and pleckstrin-
homology domains. Nature, 384, 481-484.
Chong, L. D., Traynor-Kaplan, A., Bokoch, G. M., and Schwartz, M. A. (1994). The small
GTP-binding protein-Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in
mammalian-cells. Cell, 79, 507-513.
ARF AND PHOSPHOLIPIDS 65
17
Jackson, C. L. and Casanova, J. E. (2000). Turning on ARF: the Sec7 family of guanine-
nucleotide-exchange factors. Trends Cell Biol., 10, 60-67.
Jackson, T. R., Brown, F. D., Nie, Z. Z., Miura, K., Foroni, L., Sun, J. L., Hsu, V. W.,
Donaldson, J. G., and Randazzo, P. A. (2000). ACAPs are Arf6 GTPase-activating
proteins that function in the cell periphery. J. Cell Biol., 151, 627-638.
Jacques, K. M, Nie, Z., Stauffer, S., Hirsch, D. S., Chen, L.-X., Stanley, K. T., and Randazzo,
P. A. (2002). Arf1dissociates from the clathrin adaptor GGA prior to being inactivated by
Arf GTPase-activating proteins. J. Biol. Chem., 277, 47235-47241.
Jones, D. H., Bax, B., Fensome, A., and Cockcroft, S. (1999). ADP ribosylation factor 1
mutants identify a phospholipase D effector region and reveal that phospholipase D
participates in lysosomal secretion but is not sufficient for recruitment of coatomer I.
Biochem. J., 341, 185-192.
Jones, D. H., Morris, J. B., Morgen, C. P., Kondo, H., Irvine, R. F., and Cockcroft, S. (2000).
Type I phosphatidylinositol 4-phosphate 5-kinase directly interacts with ADP-ribosylation
factor 1 and is responsible for phosphatidylinositol 4,5-bisphosphate synthesis in the Golgi
compartment. J. Biol. Chem., 275, 13962-13966.
Kahn, R. A. and Gilman, A. G. (1984). Purification of a protein cofactor required for ADP-
ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera
toxin. J. Biol. Chem., 259, 6228-6234.
Kahn, R. A. and Gilman, A. G. (1986). The protein cofactor necessary for ADP-ribosylation
of Gs by cholera toxin is itself a GTP binding protein. J. Biol. Chem., 261, 7906-7911.
Kam, J. L., Miura, K., Jackson, T. R., Gruschus, J., Roller, P., Stauffer, S., Clark, J., Aneja,
R., and Randazzo, P. A. (2000). Phosphoinositide-dependent activation of the ADP-
ribosylation factor GTPase-activating protein ASAP1 - evidence for the pleckstrin
homology domain functioning as an allosteric site. J. Biol. Chem., 275, 9653-9663.
Klarlund, J. K., Guilherme, A., Holik, J. J., Virbasius, J. V., Chawla, A., and Czech, M. P.
(1997). Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing
pleckstrin and Sec7 homology domains. Science, 275, 1927-1930.
Klarlund, J. K., Rameh, L. E., Cantley, L. C., Buxton, J. M., Holik, J. J., Sakelis, C., Patki, V.,
Corvera, S., and Czech, M. P. (1998). Regulation of GRP1-catalyzed ADP ribosylation
factor guanine nucleotide exchange by phosphatidylinositol 3,4,5-trisphosphate. J. Biol.
Chem., 273, 1859-1862.
Klarlund, J. K., Tsiaras, W., Holik, J. J., Chawla, A., and Czech, M. P. (2000). Distinct
polyphosphoinositide binding selectivities for pleckstrin homology domains of GRP1-like
proteins based on diglycine versus triglycine motifs. J. Biol. Chem., 275, 32816-32821.
Krugmann, S., Anderson, K. E., Ridley, S. H., Risso, N., McGregor, A., Coadwell, J.,
Davidson, K., Eguinoa, A., Ellson, C. D., Lipp, P., Manifava, M., Ktistakis, N., Painter,
G., Thuring, J. W., Cooper, M. A., Lim, Z. Y., Holmes, A. B., Dove, S. K., Michell, R. H.,
Grewal, A., Nazarian, A., Erdjument-Bromage, H., Tempst, P., Stephens, L. R., and
Hawkins, P. T. (2002). Identification of ARAP3, a novel PI3K effector regulating both Arf
and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell, 9,
95-108.
Lietzke, S. E., Bose, S., Cronin, T., Klarlund, J., Chawla, A., Czech, M. P., and Lambright, D.
G. (2000). Structural basis of 3-phosphoinositide recognition by pleckstrin homology
domains. Mol. Cell, 6, 385-394.
Liscovitch, M., Czarny, M., Fiucci, G., and Tang, X. Q. (2000). Phospholipase D: molecular
and cell biology of a novel gene family. Biochem. J., 345, 401-415.
Lorra, C. and Huttner, W. B. (1999). The mesh hypothesis of Golgi dynamics. Nature Cell
Biol., 1, E113-E115.
ARF AND PHOSPHOLIPIDS 67
19
Makler, V., Cukierman, E., Rotman, M., Admon, A., and Cassel, D. (1995). ADP-ribosylation
factor-directed GTPase-activating protein - purification and partial characterization. J.
Biol. Chem., 270, 5232-5237.
Miura, K., Jacques, K. M., Stauffer, S., Kubosaki, A., Zhu, K. J., Hirsch, D. S., Resau, J.,
Zheng, Y., and Randazzo, P. A. (2002). ARAP1: A point of convergence for Arf and Rho
signaling. Mol. Cell, 9, 109-119.
Moss, J. and Vaughan, M. (2002). Cytohesin-1 in 2001. Arch.Biochem. Biophys., 397, 156-
161.
Nie, Z., Stanley, K. T., Stauffer, S., Jacques, K. M., Hirsch, D. S., Takei, J., and Randazzo, P.
A. (2002). AGAP1: an endosome-associated, phosphoinositide-dependent ADP-
ribosylation factor GTPasae activating protein that affects actin cytoskeleton. J. Biol.
Chem., 277, 48965-48975.
Ogasawara, M., Kim, S. C., Adamik, R., Togawa, A., Ferrans, V. J., Takeda, K., Kirby, M.,
Moss, J., and Vaughan, M. (2000). Similarities in function and gene structure of
Cytohesin-4 and Cytohesin-1, guanine nucleotide-exchange proteins for ADP- ribosylation
factors. J. Biol. Chem., 275, 3221-3230.
Ooi, C. E., Dell'Angelica, E. C., and Bonifacino, J. S. (1998). ADP-ribosylation factor 1
(ARF1) regulates recruitment of the AP-3 adaptor complex to membranes. J. Cell Biol.,
142, 391-402.
Orci, L., Palmer, D. J., Amherdt, M., and Rothman, J. E. (1993). Coated vesicle assembly in
the Golgi requires only coatomer and Arf proteins from the Cytosol. Nature, 364, 732-734.
Osborne, S. L., Meunier, F. A., and Schiavo, G. (2001). Phosphoinositides as key regulators
of synaptic function. Neuron, 32, 9-12.
Pacheco-Rodriguez, G., Meacci, E., Vitale, N., Moss, J., and Vaughan, M. (1998). Guanine
nucleotide exchange on ADP-ribosylation factors catalyzed by Cytohesin-1 and its Sec7
domain. J. Biol. Chem., 273, 26543-26548.
Palmer, D. J., Helms, J. B., Beckers, C. J. M., Orci, L., and Rothman, J. E. (1993). Binding of
coatomer to Golgi membranes requires ADP-ribosylation factor. J. Biol. Chem., 268,
12083-12089.
Paris, S., Antonny, B., Beraud-Dufour, S., Robineau, S., Chabre, M., and Chardin, P. (1997a).
Arf1: interactions with phospholipids and activation by the human exchange factor
ARNO. FASEB J., 11, 3425.
Paris, S., Beraud-Dufour, S., Robineau, S., Bigay, J., Antonny, B., Chabre, M., and Chardin,
P. (1997b). Role of protein-phospholipid interactions in the activation of ARF1 by the
guanine nucleotide exchange factor ARNO. J. Biol. Chem., 272, 22221-22226.
Payrastre, B., Missy, K., Giuriato, S., Bodin, S., Plantavid, M., and Gratacap, M. P. (2001).
Phosphoinositides - key players in cell signaling, in time and space. Cell. Signal., 13, 377-
387.
Premont, R., Claing, A., Vitale, N., Freeman, J., Pitcher, J., Patton, W., Moss, J., Vaughan,
M., and Lefkowitz, R. (1998). β2-Adrenergic Receptor Regulation By GIT1, A G Protein-
Coupled Receptor Kinase-Associated ADP-Ribosylation Factor GTPase-Activating
Protein. Proc. Nat. Acad. Sci., USA, 95, 14082-14087.
Premont, R. T., Claing, A., Vitale, N., Perry, S. J., and Lefkowitz, R. J. (2000). The GIT
family of ADP-ribosylation factor GTPase-activating proteins - functional diversity of
GIT2 through alternative splicing. J. Biol. Chem., 275, 22373-22380.
Randazzo, P. A. (1997a). Functional interaction of ADP-ribosylation factor 1 with
phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem., 272, 7688-7692.
Randazzo, P. A. (1997b) Resolution of two ADP-ribosylation factor 1 GTPase-activating
proteins from rat liver. Biochem. J., 324, 413-419.
68
20 RANDAZZO, NIE, AND HIRSCH
Venkateswarlu, K., Oatey, P. B., Tavare, J. M., and Cullen, P. J. (1998). Insulin-dependent
translocation of ARNO to the plasma membrane of adipocytes requires
phosphatidylinositol 3-kinase. Curr. Biol., 8, 463-466.
Vitale, N., Patton, W. A., Moss, J., Vaughan, M., Lefkowitz, R. J., and Premont, R. T. (2000).
GIT proteins, a novel family of phosphatidylinositol 3,4,5- trisphosphate-stimulated
GTPase-activating proteins for ARF6. J. Biol. Chem., 275, 13901-13906.
Weigert, R., Silletta, M. G., Spano, S., Turacchio, G., Cericola, C., Colanzi, A., Senatore, S.,
Mancini, R., Polishchuk, E. V., Salmona, M., Facchiano, F., Burger, K. N. J., Mironov, A.,
Luini, A., and Corda, D. (1999a). Ctbp/BARS induces fission of Golgi membranes by
acylating lysophosphatidic acid. Nature, 402, 429-433.
Weigert, R., Silletta, M. G., Spano, S., Turacchio, G., Cericola, C., Luini, A., and Corda, D.
(2000). Fission of Golgi membranes is induced by Ctbp/BARS-induced acylation of
lysophosphatidic acid. Biophys. J., 78, 1878.
Weigert, R., Silletta, M. G., Turacchio, G., Spano, S., Burger, K. N. J., Corda, D., and Luini,
A. (1999b). BARS is an acyl-transferase involved in Golgi membrane fission. Mol. Biol.
Cell, 10, 25.
Yanagisawa, L., Marchena, J., Xie, Z., Poon, P., Singer, R., Johnston, G., Randazzo, P., and
Bankaitis, V. (2002). Activity PF specific lipid-regulated Arf GAPs is required for
Sec14p-dependent Golgi secretory function in yeast. Mol. Biol. Cell., 13, 2193-2206
Zhao, Z. S., Manser, E., Loo, T. H., and Lim, L. (2000). Coupling of PAK-interacting
exchange factor PIX to GIT1 promotes focal complex disassembly. Mol. Cell. Biol., 20,
6354-6363.
Zhu, Y. X., Drake, M. T., and Kornfeld, S. (1999). ADP-ribosylation factor 1 dependent
clathrin-coat assembly on synthetic liposomes. Proc. Nat. Acad. Sci., USA, 96, 5013-5018.
Chapter 4
THE SEC7 FAMILY OF ARF GUANINE
NUCLEOTIDE EXCHANGE FACTORS
CATHERINE L. JACKSON
Cell Biology and Metabolism Branch, NICHD, NIH, Bethesda, USA
Abstract: Arf GEFs are all multidomain proteins that likely integrate upstream signals
with the downstream effects of GTPase activation. The presence of a highly
conserved domain, the Sec7 domain, allows prediction of the number of Arf
GEFs in multiple organisms and phylogenetic analyses. The profound effects
of brefeldin A on membrane systems in eukaryotic cells demonstrate that its
targets, the Arf GEFs, are central regulators of organelle structure and
function. Ultrastructural analyses, particularly those coupled to genetic studies
in S. cerevisiae, offer new insights into the roles of Arf GEFs in membrane
dynamics and protein transport.
1. INTRODUCTION
71
72
2 JACKSON
The Arf GEFs began to be identified at the molecular level in 1996 and the
presence of a conserved domain, the Sec7 domain, as that responsible for
GEF activity was soon evident. A genetic approach in budding yeast,
Saccharomyces cerevisiae, identified the first Arf GEF (Peyroche et al.,
1996). In yeast, ARF1 and ARF2 encode functionally indistinguishable Arf
proteins, which in sequence and function are most similar to mammalian
Class I Arfs (see Chapter 1). ARF1 produces 90% of the total Arf protein in
cells, and ARF2 only 10% (Stearns et al., 1990). In a strain deleted for
ARF1 and expressing wild type Arf2p from the ARF2 gene alone, ARF2-N31
was expressed from a low-copy plasmid. This dominant negative phenotype
was conditional: at 37oC, cells expressing the ARF2-N31 allele were viable
but at 23oC, cells expressing the mutant protein failed to grow. A multi-
copy suppressor of the cold-sensitive growth defect was found and named
GEA1 (for Guanine nucleotide Exchange on Arf). There is a second gene
encoding a protein 50% identical to Gea1p, named GEA2. Gea1p and Gea2p
are functionally redundant. Strains carrying a deletion of one or the other
individually have no growth or secretion phenotype, but the double deletion
strain is inviable. To date, no clear differences in function have been
reported. At the time they were identified, the only sequence feature evident
in the Gea1p and Gea2p proteins was the presence of a so-called “Sec7
domain”. This domain was homologous to a region found in the Sec7p
protein. SEC7 was first identified in the screen for secretion mutants carried
out in S. cerevisiae (Novick et al., 1980). Other proteins such as
Arabidopsis thaliana GNOM/Emb30 and mammalian B-2/cytohesin had
also been found to have a Sec7 domain (Sec7d), although its function was
not clear from analysis of these proteins (Liu and Pohajdak, 1992; Shevell et
al., 1994; Zagulski et al., 1995). In collaboration with P. Chardin, we
searched for human proteins containing any sequence similarities to the
Gea1p and Gea2p proteins, and found an EST clone with a Sec7d. The
protein was expressed in E. coli and found to have very potent Arf GEF
activity (Chardin et al., 1996). The protein was named ARNO for ADP-
Ribosylation factor Nucleotide binding site Opener. The only sequence
similarity between ARNO and the Gea proteins was in the Sec7d. This
observation led to the prediction that the Sec7d was responsible for Arf GEF
activity, and indeed the ARNO Sec7d alone (purified from E. coli) had Arf
GEF activity (Chardin et al., 1996). Hence, the Sec7d is the catalytic
domain of the Arf GEFs.
Two other groups were taking different approaches to identify an Arf
GEF at about the same time. A classic biochemical approach aimed at
THE SEC7 FAMILY OF ARF GEFS 73
3
Figure 1. Phylogenetic tree of Arf GEFs from different species. Included are Sec7 domain
proteins from five fully sequenced eukaryotic genomes, and published Sec7 domain
sequences from other organisms. Names of subfamilies are given on the right. Arf GEFs from
closely related organisms to those shown here are not included. See Table 1 for descriptions
of each Arf GEF sequence. Full-length Sec7 domain sequences were used for the analysis,
and the tree was generated using the EMBL European Bioinformatics Institute ClustalW
program at http://www.ebi.ac.uk/clustalw/.
THE SEC7 FAMILY OF ARF GEFS 75
5
A major issue in the Arf GEF field is to determine which Arf substrate(s) are
used by a given GEF in the cell. Arf proteins are divided into three classes: I
(Arf1, 2, 3), II (Arf4, 5), and III (Arf6), based on sequence homology and
function (see Chapter 1). The primary means of assessing substrate
specificity for GEFs is in vitro nucleotide exchange assays. The
Gea/GBF/GNOM and Sec7/BIG Arf GEFs act on class I Arf proteins, as
determined by in vitro exchange assays (Jackson and Casanova, 2000; Moss
and Vaughan, 1998). The full length Gea1p and GNOM proteins use
mammalian class I Arfs as substrates very efficiently (Peyroche et al., 1996;
Steinmann et al., 1999). The in vitro activity of yeast Gea1p on human Arf1
is equivalent to its activity on yeast Arf1p or Arf2p (A. Peyroche and C. L.
Jackson, unpublished observations). However, GBF1 has not yet been
reported to have GEF activity on class I Arfs in vitro, although class I Arfs
76
6 JACKSON
Table 1. Sequence information for the Arf GEFs shown in Figures 1 and 2.
Name Organism Accession number Length
GBF1-Hs Homo sapiens NM_004193 1859
GBF1-Dm Drosophila melanogaster AE003822 2040
GBF1-Ce Caenorhabditis elegans AL032627 1820
Gea1p-Sc Saccharomyces cerevisiae P47102 1408
Gea2p-Sc Saccharomyces cerevisiae P39993 1459
Gea1p-Sp Schizosaccharomyces pombe NP_596613 1462
GNOM-At Arabidopsis thaliana S65571 1451
GNL1-At Arabidopsis thaliana NP_198766 1443
GNL2-At Arabidopsis thaliana NP_197462 1375
BIG1-Hs Homo sapiens Q9Y6D6 1849
BIG2-Hs Homo sapiens Q9Y6D5 1785
BIG1-Dm Drosophila melanogaster AAF53331 1643
BIG1-Ce Caenorhabditis elegans NP_493386 1628
Sec7p-Sc Saccharomyces cerevisiae AAB04031 2009
Sec7p-Pp Pischia pastoris AAK40234 1772
BIG1-Sp Schizosaccharomyces pombe NP_594555 1822
BIG2-Sp Schizosaccharomyces pombe NP_594954 1811
BIG1-At Arabidopsis thaliana NP_195533 1698
BIG2-At Arabidopsis thaliana NP_191645 1793
BIG3-At Arabidopsis thaliana NP_171698 1750
BIG4-At Arabidopsis thaliana NP_195264 1711
BIG5-At Arabidopsis thaliana NP_189916 1669
Sec7-Pt Paramecium tetraurelia AAF36486 1135
Cytohesin1-Hs Homo sapiens Q15438 398
ARNO-Hs Homo sapiens CAA68084 399
GRP1/ARNO3-Hs Homo sapiens NP_004218 399
Cytohesin4-Hs Homo sapiens NP_037517 394
ARNO-Dm Drosophila melanogaster AAF57230 348
ARNO-Ce Caenorhabditis elegans NP_498764 393
EFA6A/PSD-Hs Homo sapiens NP_002770 645
EFA6B/TIC-Hs Homo sapiens NP_036587 1056
EFA6C-Hs Homo sapiens CAB66494 771
EFA6D/KIAA0942-Hs Homo sapiens NP_056125 534
EFA6-Dm Drosophila melanogaster AAF56027 900
EFA6-Ce Caenorhabditis elegans NP_502416 818
BRAG1/KIAA0522-Hs Homo sapiens T00080 1560
ArfGEP100/BRAG2-Hs Homo sapiens NP_055684 841
BRAG3/KIAA 1110-Hs Homo sapiens BAA83062 740
BRAG-Dm Drosophila melanogaster AAF51675 1210
BRAG-Ce Caenorhabditis elegans NP_500420 614
Syt1-Sc Saccharomyces cerevisiae NP_015420 1226
ArfGEF4-Sp Schizosaccharomyces pombe NP_594894 657
ArfGEF5/Yb1060p-Sc Saccharomyces cerevisiae NP_009493 687
ArfGEF5-Sp Schizosaccharomyces pombe NP_594936 942
Ra1F-Lp Legionella pneumophila AAL23711 374
Arf GEF-Pf Plasmodium falciparum Not available 3384
THE SEC7 FAMILY OF ARF GEFS 77
7
are likely to be a substrate for this human GEF in cells (Claude et al., 1999;
Kawamoto et al., 2002). Activity of GBF1 on the class II Arf, Arf5p has
been shown in vitro (Claude et al., 1999). The ARNO/GRP/cytohesin
subfamily of Arf GEFs can act on both class I and class III Arfs in vitro
(Franco et al., 1998; Frank et al., 1998; Macia et al., 2001). An apparent
exception to this rule is cytohesin-4, which has been reported to have no
activity towards Arf6, and which acts preferentially on class I Arfs in vitro
(Ogasawara et al., 2000).
A promising newer approach to the question of substrate specificity uses
pull-downs of Arf•GTP from cell extracts by the Arf effector GGA1, which
binds exclusively to the GTP-bound form of all Arfs (classes I, II and III)
(Boman et al., 2000; Dell'Angelica et al., 2000). This approach was used to
demonstrate that over-expressed ARNO specifically activates Arf6 to
modulate migratory potential and morphology in Madin-Darby canine
kidney (MDCK) cells (Santy and Casanova, 2001). Nakayama and
colleagues used this pull-down approach to demonstrate that BIG2 activates
class I Arfs in cells (Shinotsuka et al., 2002). In the case of the EFA6
family, biochemical and cell biological approaches converge, showing in
both cases that the preferred substrate is Arf6 (Franco et al., 1999; Macia et
al., 2001). ArfGEP100/BRAG2 has highest in vitro activity towards Arf6,
accelerating binding of GTPγS by 12-fold (Someya et al., 2001).
Immunofluorescence analyses indicate that ArfGEP100/BRAG2 and Arf6
co-localize in cells in peripheral areas, strongly supporting the conclusion
that Arf6 is the physiological substrate of this GEF (Someya et al., 2001).
Figure 2 . Phylogenetic trees of the Arf GEFs from A) Homo sapiens B) Drosophila
melanogaster and C) Saccharomyces cerevisiae. See Table 1 for sequence information.
would seem to suggest a more stable state. BFA rapidly blocks transport of
secreted proteins out of the ER-Golgi (Klausner et al., 1992) and trans-Golgi
network (TGN)-endosomal systems, causing fusion of the TGN and
endosome (Hunziker et al., 1992; Lippincott-Schwartz et al., 1991; Reaves
and Banting, 1992; Wood et al., 1991). BFA treatment of particular cell
types also causes tubulation of lysosomes (Lippincott-Schwartz et al., 1991;
Wood and Brown, 1992). Two cell lines, MDCK and PtK1, are resistant to
the effects of BFA at the Golgi, but sensitive to the drug at the
TGN/endosome (Hunziker et al., 1992). This result suggests the existence of
two distinct BFA targets acting at the level of each organelle.
The most rapid effect of BFA is the release of specific peripherally
associated proteins from organelles, notably the Golgi and endosomes
(Boehm et al., 2001; De Matteis and Morrow, 2000; Jackson, 2000). The
first such protein identified was β-COP, a subunit of the COPI coat complex,
which is released from Golgi membranes within 1 minute of BFA treatment
(Donaldson et al., 1990; Presley et al., 2002). Class I Arfs are also rapidly
released from membranes upon BFA treatment (Donaldson et al., 1991;
Presley et al., 2002). GTPγS was found to antagonize the effects of BFA on
the binding of COPI to membranes, suggesting that Arfs might regulate this
rapidly reversible process. This prediction was elegantly verified by the
demonstration that binding of Arf1 to Golgi membranes was a prerequisite
for binding of β-COP, and that only the former step was inhibited by BFA
(Donaldson et al., 1992). Moreover, several groups demonstrated that Golgi
membranes were capable of stimulating guanine nucleotide exchange on
Arf, and that BFA inhibited this GEF activity (Donaldson et al., 1992;
Helms and Rothman, 1992; Randazzo et al., 1993). These results
demonstrated that at least one target of BFA was an Arf GEF or an
associated Golgi protein. Cells expressing the dominant negative mutant
Arf1-N31 had a phenotype indistinguishable from that of BFA-treated cells
(Dascher and Balch, 1994), thus providing further support for the role of Arf
and Arf GEFs in BFA action and COPI binding to Golgi membranes. Arf
controls binding of other coat complexes at the TGN/endosome; including
AP-1/clathrin, AP-3, AP-4 and the GGAs (see Chapters 12 and 13; Boehm
and Bonifacino, 2001; Drake et al., 2000; Liang and Kornfeld, 1997; Ooi et
al., 1998; Robinson and Bonifacino, 2001; Zhu et al., 1998).
The cloning of the Arf GEFs provided an opportunity to test the hypothesis
that these proteins are direct targets of BFA. Surprisingly, although some
80
10 JACKSON
Arf GEFs have in vitro exchange activity sensitive to BFA (Morinaga et al.,
1997; Peyroche et al., 1996), others such as ARNO, have in vitro GEF
activity that is completely resistant to the drug (Chardin et al., 1996). To
determine whether the Sec7d itself is responsible for specifying BFA
resistance/sensitivity, chimeric proteins were constructed. The Sec7ds of the
BFA-sensitive Gea1p and Sec7p GEFs were replaced with that of BFA-
resistant ARNO, and their sensitivity to BFA was determined in vivo. The
chimeras (Gea-ARNO-Gea1p and Sec7-ARNO-Sec7p) were expressed in
cells with chromosomal deletions of the wild type genes, and each
functioned like the endogenous proteins in terms of both growth and
secretion (Peyroche et al., 1999). Even a gea1-∆ gea2-∆ sec7-∆ strain
expressing Gea-ARNO-Gea1p and Sec7-ARNO-Sec7p as the sole copies of
Gea1/2p and Sec7p, respectively, grew normally. However, this strain was
now almost completely resistant to the effects of BFA. Both growth and
secretion in the presence of BFA were comparable to those of the untreated
strain (Peyroche et al., 1999). This result demonstrates that Sec7, Gea1p and
Gea2p are the major targets of BFA in the secretory pathway of yeast, that
the Sec7d itself is responsible for BFA sensitivity or resistance, and that the
cellular toxicity of BFA is directly attributable to its actions on these
proteins in yeast.
Arf binding region. This result might imply that BFA acts as a competitive
inhibitor, binding to the Sec7d and preventing Arf from binding. However,
Figure 3. Alignment of a portion of the Sec7 domains of the human Arf GEFs. Identical
residues are boxed and homologous residues shaded blue. White letters on black background
indicates residues important for determining BFA resistance/sensitivity. The asterisk denotes
the catalytic glutamic acid residue (Béraud-Dufour et al., 1998).
the mechanism of action of this drug turns out to be much more unusual.
BFA does not bind to either Arf or the Sec7d alone, but to a normally very
short-lived reaction intermediate, an Arf•GDP-Sec7d complex (Mansour et
al., 1999; Peyroche et al., 1999; Robineau et al., 2000) (Figure 4). This
Arf•GDP-BFA-Sec7d quaternary complex is relatively stable, with a
dissociation rate (τoff) for BFA of 30 min (Robineau et al., 2000). If BFA
binds to an Arf•GDP-Sec7d protein complex, residues of Arf would be
expected to influence BFA binding. Indeed, B. Antonny and colleagues
identified a mutation in the Switch II region, Arf1-A80, which results in a
decrease in the dissociation rate of BFA from the complex (Robineau et al.,
2000). Another striking feature of the mechanism of action of BFA is the
type of complex stabilized by the drug. The only complex between a small
G protein and its GEF that normally can be isolated is one in which
nucleotide has been lost from the complex. Robineau et al. demonstrate that
BFA does not bind to such a complex (Robineau et al., 2000). The unusual
mechanism of action of BFA provides a paradigm for development of novel
drugs. Instead of the usual search for drugs competing for a given substrate,
THE SEC7 FAMILY OF ARF GEFS 83
13
one could design screens for drugs that block reactions through stabilization
of reaction intermediates (Chardin and McCormick, 1999).
al., 2000). The physiological relevance of this interaction is not known, but
it may represent an important regulatory mechanism. Indeed, interactions
between cyclophilins and regions of proteins involved in their
oligomerization have been previously reported (see Grebe et al., 2000) for
references).
Two-hybrid screens with the Sec7 domains of different Arf GEFs have
identified a surprisingly large number of potential partners. These results
support the idea that the catalytic domain itself is involved in regulatory
interactions. We identified the yeast TGN-localized protein Drs2p as a
direct binding partner of the Sec7d of Gea2p (S. Chantalat and C. L.
Jackson, manuscript in preparation). Drs2p is a 12-transmembrane domain
P-type ATPase that likely functions as an aminophospholipid translocase
(flippase) (Chen et al., 1999). Drs2p co-localizes with Kex2p in a late Golgi
compartment in yeast, and is required for the formation of clathrin-coated
vesicles. There are four other proteins in yeast that are grouped into the
same subfamily of P-type ATPases along with Drs2p, which have distinct
localizations and which function in different transport steps (Hua et al.,
2002).
The region of the Gea2p Sec7d that interacts with Drs2p was mapped by
a reverse two-hybrid approach. Interestingly, the residues identified as
important for the interaction are clustered in the C-terminal portion of the
Sec7d, adjacent to the Arf binding site (C. Jackson, unpublished
observations). This region is quite divergent among different Arf GEFs, and
may represent a region generally used for regulation of Arf GEF activity.
Screens with different Sec7 domains identified a number of partners (E.
Smirnova, S. Chantalat, and C. L. Jackson, unpublished observations) and in
at least two other cases, this same C-terminal portion of the Sec7d was found
to be important for interaction. This C-terminal region is also the region in
which residues affecting BFA resistance/sensitivity were found (Peyroche et
al., 1999). Thus, the C-terminal portion of the Sec7d is important for the
binding of other proteins and likely regulation of Arf GEF activity.
The molecular mechanism of action of BFA indicates that the effects of this
drug on cells is a result not only of failure to activate Arf, but also of
trapping sensitive Arf GEFs in an inactive complex. As described above,
BFA exerts profound effects on both the structure and function of organelles
along the secretory and endocytic pathways. Understanding precisely how
BFA affects traffic has never been easy in the context of the classic models
of intracellular traffic (Griffiths, 2000; Klausner et al., 1992; Sciaky et al.,
1997), and suggests that new ways of understanding membrane dynamics
are needed.
The current unifying principle for all traffic events in eukaryotic cells is the
idea that vesicles carrying cargo bud from a donor compartment membrane,
then target to and fuse with an acceptor compartment. This paradigm is
based on the idea that transport pathways in the cell are divided into distinct
compartments defined by a set of characteristic resident proteins.
Morphological studies based on electron microscopy (EM) of ultra-thin
sections do not provide evidence to contradict this view of transport.
However, thin section EM has significant limitations, which prompted two
86
16 JACKSON
and lipid sorting activity at this level of the organelle (Rambourg et al.,
1987; Robinson and Bonifacino, 2001).
The membranes of the Golgi apparatus are the object of permanent
reorganization, as demonstrated by studies of Golgi structure under
conditions of physiological stimulation and inhibition of secretion. In
prolactin cells of the pituitary gland of lactating rats or acinar cells of the
mammary gland of such animals, the Golgi rapidly breaks down when the
secretion stimulus is removed, and then reforms within minutes of the pups
being returned to their mother for lactation (Clermont et al., 1993;
Rambourg et al., 1993). The results demonstrate that the Golgi apparatus
arises as a result of continual renewal at the cis side, and consumption at the
trans side.
Contrary to what is observed in mammalian cells, the Golgi apparatus of
S. cerevisiae comprises approximately thirty independent units, distributed
seemingly randomly throughout the cytoplasm (Rambourg et al., 2001).
Each unit possesses a structure that is exclusively tubular and in the form of
small tubular networks of polygonal meshes (Rambourg et al., 2001). There
are at least two reasons for the dispersed nature of Golgi elements in S.
cerevisiae, as opposed to mammalian cells (or even other yeasts such as
Pichia pastoris). First, S. cerevisiae lacks the microtubule-dependent system
that carries ER-Golgi transport intermediates to the pericentriolar region
(Huffaker et al., 1988). Second, there are more ER exit sites present in S.
cerevisiae than in other organisms because the former lacks a system that
assembles exit sites together at the level of the ER (Rossanese et al., 1999).
However, despite the differences, the fundamental process of secretion is
highly conserved between S. cerevisiae and higher eukaryotic cells (Duden
and Schekman, 1997; Ferro-Novick and Jahn, 1994; Kaiser and Huffaker,
1992).
Morphological analysis of wild type S. cerevisiae strains reveals that
formation of secretory vesicles/granules occurs by a mechanism remarkably
similar to that in mammalian cells. Nodular swellings resembling secretion
vesicles/granules form at the intersections of polygonal meshes made up of
interconnected tubules (Rambourg et al., 2001). In structures representing
the next stage of development, nodules that have the appearance of fully
formed secretory vesicles are connected by very fine tubes, and are adjacent
to free secretory vesicles (Rambourg et al., 2001). Thus, it is likely that in
yeast, as in mammalian cells (Rambourg and Clermont, 1997), the liberation
of secretion vesicles/granules occurs by rupture of tubular areas and not by
budding from the edges of saccular elements.
88
18 JACKSON
Figure 5. Diagram showing a small section of the Golgi ribbon in cross section (top).
Selected elements are illustrated in the three dimensional depiction shown in the lower panel.
ER, endoplasmic reticulum; CE, cis element; TTN, trans-tubular network; Pg, progranule; g,
granule. Taken with permission from Rambourg et al., 1987.
8. FUTURE DIRECTIONS
This is an exciting time for research in the Arf GEF field. The profound
effects of BFA on membrane systems in eukaryotic cells demonstrate that its
targets, the Arf GEFs, are central regulators of organelle structure and
function. The Arf GEFs are all multidomain proteins that, as is the case for
the Rho family of GEFs, likely integrate upstream signals with the
downstream effects of GTPase activation. Molecular analysis of the Arf
GEFs is just now getting underway, and should soon lead to the
identification of membrane localization determinants, and both positive and
negative regulators of exchange activity.
Analysis of membrane systems both by electron and fluorescence
microscopy leads to the concept that regulated membrane flow is an
essential aspect of membrane dynamics in eukaryotic cells. In vivo analysis
of yeast Arf GEF mutants shows that a specific type of lesion in different
Arf GEFs leads to accumulation of larger-than-normal Golgi structures. In
these cases, the type of structure that accumulates depends on the point in
the secretory pathway that is inhibited by the mutation. It will be interesting
to determine whether these lesions abolish interaction with a particular
protein or membrane partner. A given structure is a manifestation, at a given
time and place, of an underlying dynamic process. The challenge for the
future is to understand this process at the molecular level, and the role of the
Arf GEFs in integrating upstream signals with the generation of dynamic
membrane structures.
THE SEC7 FAMILY OF ARF GEFS 93
23
9. ACKNOWLEDGEMENTS
REFERENCES
Antonny, B., Béraud-Dufour, S., Chardin, P., and Chabre, M. (1997). N-terminal hydrophobic
residues of the G-protein ADP-ribosylation factor-1 insert into membrane phospholipids
upon GDP to GTP exchange. Biochemistry, 36, 4675-4684.
Baumgartner, F., Wiek, S., Paprotka, K., Zauner, S., and Lingelbach, K. (2001). A point
mutation in an unusual Sec7 domain is linked to brefeldin A resistance in a Plasmodium
falciparum line generated by drug selection. Mol. Microbiol., 41, 1151-1158.
Béraud-Dufour, S., Robineau, S., Chardin, P., Paris, S., Chabre, M., Cherfils, J., and Antonny,
B. (1998). A glutamic finger in the guanine nucleotide exchange factor ARNO displaces
Mg2+ and the beta-phosphate to destabilize GDP on ARF1. EMBO J., 17, 3651-3659.
Boehm, M., Aguilar, R. C., and Bonifacino, J. S. (2001). Functional and physical interactions
of the adaptor protein complex AP- 4 with ADP-ribosylation factors (ARFs). EMBO J.,
20, 6265-6276.
Boehm, M., and Bonifacino, J. S. (2001). Adaptins: the final recount. Mol. Biol. Cell, 12,
2907-2920.
Boman, A. L., Zhang, C., Zhu, X., and Kahn, R. A. (2000). A family of ADP-ribosylation
factor effectors that can alter membrane transport through the trans-Golgi. Mol. Biol. Cell,
11, 1241-1255.
Chantalat, S., Courbeyrette, R., Senic-Matuglia, F., Jackson, C. L., Goud, B., and Peyroche,
A. (2003). A novel Golgi membrane protein is a partner of the ARF exchange factors
Gea1p and Gea2p. Mol. Biol. Cell, in press, published March 7, 2003 as
10.1091/mbc.E02-10-0693.
Chardin, P., and McCormick, F. (1999). Brefeldin A: the advantage of being uncompetitive.
Cell, 97, 153-155.
Chardin, P., Paris, S., Antonny, B., Robineau, S., Beraud-Dufour, S., Jackson, C. L., and
Chabre, M. (1996). A human exchange factor for ARF contains Sec7- and pleckstrin-
homology domains. Nature, 384, 481-484.
Chen, C. Y., Ingram, M. F., Rosal, P. H., and Graham, T. R. (1999). Role for Drs2p, a P-type
ATPase and potential aminophospholipid translocase, in yeast late Golgi function. J. Cell
Biol., 147, 1223-1236.
Claude, A., Zhao, B. P., Kuziemsky, C. E., Dahan, S., Berger, S. J., Yan, J. P., Armold, A. D.,
Sullivan, E. M., and Melancon, P. (1999). GBF1: A novel Golgi-associated BFA-resistant
guanine nucleotide exchange factor that displays specificity for ADP-ribosylation factor 5.
J. Cell Biol., 146, 71-84.
Clermont, Y., Xia, L., Rambourg, A., Turner, J. D., and Hermo, L. (1993). Structure of the
Golgi apparatus in stimulated and non-stimulated acinar cells of mammary glands of the
rat. Anat. Rec., 237, 308-317.
Dascher, C., and Balch, W. E. (1994). Dominant inhibitory mutants of ARF1 block
endoplasmic reticulum to Golgi transport and trigger disassembly of the Golgi apparatus.
J. Biol. Chem., 269, 1437-1448.
94
24 JACKSON
De Matteis, M. A., and Morrow, J. S. (2000). Spectrin tethers and mesh in the biosynthetic
pathway. J. Cell Sci., 113, 2331-2343.
Deitz, S. B., Rambourg, A., Kepes, F., and Franzusoff, A. (2000). Sec7p directs the
transitions required for yeast Golgi biogenesis. Traffic, 1, 172-183.
Dell'Angelica, E. C., Puertollano, R., Mullins, C., Aguilar, R. C., Vargas, J. D., Hartnell, L.
M., and Bonifacino, J. S. (2000). GGAs: a family of ADP ribosylation factor-binding
proteins related to adaptors and associated with the Golgi complex. J. Cell Biol., 149, 81-
94.
Derrien, V., Couillault, C., Franco, M., Martineau, S., Montcourrier, P., Houlgatte, R., and
Chavrier, P. (2002). A conserved C-terminal domain of EFA6-family ARF6-guanine
nucleotide exchange factors induces lengthening of microvilli-like membrane protrusions.
J. Cell Sci., 115, 2867-2879.
Doms, R. W., Russ, G., and Yewdell, J. W. (1989). Brefeldin A redistributes resident and
itinerant Golgi proteins to the endoplasmic reticulum. J. Cell Biol., 109, 61-72.
Donaldson, J. G., Cassel, D., Kahn, R. A., and Klausner, R. D. (1992). ADP-ribosylation
factor, a small GTP-binding protein, is required for binding of the coatomer protein beta-
COP to Golgi membranes. Proc. Natl. Acad. Sci., USA, 89, 6408-6412.
Donaldson, J. G., Finazzi, D., and Klausner, R. D. (1992). Brefeldin A inhibits Golgi
membrane-catalyzed exchange of guanine nucleotide onto ARF protein. Nature, 360, 350-
352.
Donaldson, J. G., Kahn, R. A., Lippincott-Schwartz, J., and Klausner, R. D. (1991). Binding
of ARF and beta-COP to Golgi membranes: possible regulation by a trimeric G protein.
Science, 254, 1197-1199.
Donaldson, J. G., Lippincott-Schwartz, J., Bloom, G. S., Kreis, T. E., and Klausner, R. D.
(1990). Dissociation of a 110-kD peripheral membrane protein from the Golgi apparatus is
an early event in brefeldin A action. J. Cell Biol., 111, 2295-2306.
Drake, M. T., Zhu, Y., and Kornfeld, S. (2000). The assembly of AP-3 adaptor complex-
containing clathrin-coated vesicles on synthetic liposomes. Mol. Biol. Cell, 11, 3723-3736.
Duden, R., and Schekman, R. (1997). Insights into Golgi function through mutants in yeast
and animal cells. In E. G. Berger and J. Roth (Eds.), The Golgi apparatus (pp. 219-246).
Basel, Switzerland: Birkhauser Verlag.
Ferro-Novick, S., and Jahn, R. (1994). Vesicle fusion from yeast to man. Nature, 370, 191-
193.
Franco, M., Boretto, J., Robineau, S., Monier, S., Goud, B., Chardin, P., and Chavrier, P.
(1998). ARNO3, a Sec7-domain guanine nucleotide exchange factor for ADP ribosylation
factor 1, is involved in the control of Golgi structure and function. Proc. Natl. Acad. Sci.,
USA, 95, 9926-9931.
Franco, M., Peters, P. J., Boretto, J., van Donselaar, E., Neri, A., D'Souza-Schorey, C., and
Chavrier, P. (1999). EFA6, a sec7 domain-containing exchange factor for ARF6,
coordinates membrane recycling and actin cytoskeleton organization. EMBO J., 18, 1480-
1491.
Frank, S., Upender, S., Hansen, S. H., and Casanova, J. E. (1998). ARNO is a guanine
nucleotide exchange factor for ADP-ribosylation factor 6. J. Biol. Chem., 273, 23-27.
Franzusoff, A., Redding, K., Crosby, J., Fuller, R. S., and Schekman, R. (1991). Localization
of components involved in protein transport and processing through the yeast Golgi
apparatus. J. Cell Biol., 112, 27-37.
Franzusoff, A., and Schekman, R. (1989). Functional compartments of the yeast Golgi
apparatus are defined by the sec7 mutation. EMBO J., 8, 2695-2702.
THE SEC7 FAMILY OF ARF GEFS 95
25
Fujiwara, T., Oda, K., Yokota, S., Takatsuki, A., and Ikehara, Y. (1988). Brefeldin A causes
disassembly of the Golgi complex and accumulation of secretory proteins in the
endoplasmic reticulum. J. Biol. Chem., 263, 18545-18552.
Gaynor, E. C., Chen, C. Y., Emr, S. D., and Graham, T. R. (1998). ARF is required for
maintenance of yeast Golgi and endosome structure and function. Mol. Biol. Cell, 9, 653-
670.
Geldner, N., Friml, J., Stierhof, Y. D., Jurgens, G., and Palme, K. (2001). Auxin transport
inhibitors block PIN1 cycling and vesicle trafficking. Nature, 413, 425-428.
Grebe, M., Gadea, J., Steinmann, T., Kientz, M., Rahfeld, J. U., Salchert, K., Koncz, C., and
Jurgens, G. (2000). A conserved domain of the arabidopsis GNOM protein mediates
subunit interaction and cyclophilin 5 binding. Plant Cell, 12, 343-356.
Griffiths, G. (2000). Gut thoughts on the Golgi complex. Traffic, 1, 738-745.
Helms, J. B., and Rothman, J. E. (1992). Inhibition by brefeldin A of a Golgi membrane
enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature, 360, 352-
354.
Hua, Z., Fatheddin, P., and Graham, T. R. (2002). An essential subfamily of Drs2p-related P-
type ATPases are required for protein trafficking between the Golgi complex and the
endosomal/vacuolar system. Mol. Biol. Cell, 13, 3162-3177. Published July 16, 2002 as
2010.1091/mbc.E2002-2003-0172.
Huffaker, T. C., Thomas, J. H., and Botstein, D. (1988). Diverse effects of beta-tubulin
mutations on microtubule formation and function. J. Cell Biol., 106, 1997-2010.
Hunziker, W., Whitney, J. A., and Mellman, I. (1992). Brefeldin A and the endocytic
pathway. Possible implications for membrane traffic and sorting. FEBS Lett, 307, 93-96.
Jackson, C. L. (2000). Brefeldin A: Revealing the fundamental principles governing
membrane dynamics and protein transport. In H. Hilderson and S. Fuller (Eds.),
Subcellular Biochemistry: Fusion of biological membranes and related problems (Vol. 34,
pp. 233-272). New York: Kluwer Academic/Plenum Publishers.
Jackson, C. L., and Casanova, J. E. (2000). Turning on ARF: the Sec7 family of guanine-
nucleotide-exchange factors. Trends Cell Biol., 10, 60-67.
Jones, S., Jedd, G., Kahn, R. A., Franzusoff, A., Bartolini, F., and Segev, N. (1999). Genetic
interactions in yeast between Ypt GTPases and Arf guanine nucleotide exchangers.
Genetics, 152, 1543-1556.
Julius, D., Schekman, R., and Thorner, J. (1984). Glycosylation and processing of prepro-
alpha-factor through the yeast secretory pathway. Cell, 36, 309-318.
Kaiser, C., and Huffaker, T. (1992). An inside look at a small cell. Yeast Cell Biology
sponsored by Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, August 13-
18, 1991. New Biol., 4, 23-27.
Kawamoto, K., Yoshida, Y., Tamaki, H., Torii, S., Shinotsuka, C., Yamashina, S., and
Nakayama, K. (2002). GBF1, a guanine nucleotide exchange factor for ADP-ribosylation
factors, is localized to the cis-Golgi and involved in membrane association of the COPI
coat. Traffic, 3, 483-495.
Klausner, R. D., Donaldson, J. G., and Lippincott-Schwartz, J. (1992). Brefeldin A: insights
into the control of membrane traffic and organelle structure. J. Cell Biol., 116, 1071-1080.
Liang, J. O., and Kornfeld, S. (1997). Comparative activity of ADP-ribosylation factor family
members in the early steps of coated vesicle formation on rat liver Golgi membranes
[published erratum appears in J. Biol. Chem. 1998 Jan 23;273:2488]. J. Biol. Chem., 272,
4141-4148.
Lippincott-Schwartz, J., Yuan, L., Tipper, C., Amherdt, M., Orci, L., and Klausner, R. D.
(1991). Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general
mechanism for regulating organelle structure and membrane traffic. Cell, 67, 601-616.
96
26 JACKSON
Lippincott-Schwartz, J., Yuan, L. C., Bonifacino, J. S., and Klausner, R. D. (1989). Rapid
redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for
membrane cycling from Golgi to ER. Cell, 56, 801-813.
Liu, L., and Pohajdak, B. (1992). Cloning and sequencing of a human cDNA from cytolytic
NK/T cells with homology to yeast SEC7. Biochim. Biophys. Acta, 1132, 75-78.
Macia, E., Chabre, M., and Franco, M. (2001). Specificities for the small G proteins ARF1
and ARF6 of the guanine nucleotide exchange factors ARNO and EFA6. J. Biol. Chem.,
276, 24925-24930.
Mansour, S. J., Skaug, J., Zhao, X. H., Giordano, J., Scherer, S. W., and Melancon, P. (1999).
p200 ARF-GEP1: a Golgi-localized guanine nucleotide exchange protein whose Sec7
domain is targeted by the drug brefeldin A. Proc. Natl. Acad. Sci., USA, 96, 7968-7973.
Mayer, U., Büttner, G., and Jürgens, G. (1993). Apical-basal pattern formation in the
Arabidopsis embryo: studies on the role of the gnom gene. Development, 117, 149-162.
Misumi, Y., Miki, K., Takatsuki, A., Tamura, G., and Ikehara, Y. (1986). Novel blockade by
brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J.
Biol. Chem., 261, 11398-11403.
Morinaga, N., Moss, J., and Vaughan, M. (1997). Cloning and expression of a cDNA
encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for
ADP-ribosylation factor. Proc. Natl. Acad. Sci., USA, 94, 12926-12931.
Morinaga, N., Tsai, S. C., Moss, J., and Vaughan, M. (1996). Isolation of a brefeldin A-
inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and
ARF3 that contains a Sec7-like domain. Proc. Natl. Acad. Sci., USA, 93, 12856-12860.
Moss, J., and Vaughan, M. (1998). Molecules in the ARF orbit. J. Biol. Chem., 273, 21431-
21434.
Nagai, H., Kagan, J. C., Zhu, X., Kahn, R. A., and Roy, C. R. (2002). A bacterial guanine
nucleotide exchange factor activates ARF on Legionella phagosomes. Science, 295, 679-
682.
Nair, S., Guerra, C., and Satir, P. (1999). A Sec7-related protein in Paramecium. FASEB J.,
13, 1249-1257.
Nishikawa, S., Umemoto, N., Ohsumi, Y., Nakano, A., and Anraku, Y. (1990). Biogenesis of
vacuolar membrane glycoproteins of yeast Saccharomyces cerevisiae. J. Biol. Chem., 265,
7440-7448.
Novick, P., Ferro, S., and Schekman, R. (1981). Order of events in the yeast secretory
pathway. Cell, 25, 461-469.
Novick, P., Field, C., and Schekman, R. (1980). Identification of 23 complementation groups
required for post-translational events in the yeast secretory pathway. Cell, 21, 205-215.
Ogasawara, M., Kim, S. C., Adamik, R., Togawa, A., Ferrans, V. J., Takeda, K., Kirby, M.,
Moss, J., and Vaughan, M. (2000). Similarities in function and gene structure of
cytohesin-4 and cytohesin-1, guanine nucleotide-exchange proteins for ADP-ribosylation
factors. J. Biol. Chem., 275, 3221-3230.
Ooi, C. E., Dell'Angelica, E. C., and Bonifacino, J. S. (1998). ADP-Ribosylation factor 1
(ARF1) regulates recruitment of the AP-3 adaptor complex to membranes. J. Cell Biol.,
142, 391-402.
Peyroche, A., Antonny, B., Robineau, S., Acker, J., Cherfils, J., and Jackson, C. L. (1999).
Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex:
involvement of specific residues of the Sec7 domain. Mol. Cell, 3, 275-285.
Peyroche, A., Courbeyrette, R., Rambourg, A., and Jackson, C. L. (2001). The ARF exchange
factors Gea1p and Gea2p regulate Golgi structure and function in yeast. J. Cell Sci., 114,
2241-2253.
THE SEC7 FAMILY OF ARF GEFS 97
27
Sacher, M., Jiang, Y., Barrowman, J., Scarpa, A., Burston, J., Zhang, L., Schieltz, D., Yates,
J. R., 3rd, Abeliovich, H., and Ferro-Novick, S. (1998). TRAPP, a highly conserved novel
complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J., 17, 2494-
2503.
Santy, L. C., and Casanova, J. E. (2001). Activation of ARF6 by ARNO stimulates epithelial
cell migration through downstream activation of both Rac1 and phospholipase D. J. Cell
Biol., 154, 599-610.
Sata, M., Moss, J., and Vaughan, M. (1999). Structural basis for the inhibitory effect of
brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors. Proc.
Natl. Acad. Sci., USA, 96, 2752-2757.
Sato, K., Nishikawa, S., and Nakano, A. (1995). Membrane protein retrieval from the Golgi
apparatus to the endoplasmic reticulum (ER): characterization of the RER1 gene product
as a component involved in ER localization of Sec12p. Mol. Biol. Cell, 6, 1459-1477.
Sciaky, N., Presley, J., Smith, C., Zaal, K. J., Cole, N., Moreira, J. E., Terasaki, M., Siggia,
E., and Lippincott-Schwartz, J. (1997). Golgi tubule traffic and the effects of brefeldin A
visualized in living cells. J. Cell Biol., 139, 1137-1155.
Segev, N., Mulholland, J., and Botstein, D. (1988). The yeast GTP-binding YPT1 protein and
a mammalian counterpart are associated with the secretion machinery. Cell, 52, 915-924.
Shevell, D. E., Leu, W. M., Gillmor, C. S., Xia, G., Feldmann, K. A., and Chua, N. H. (1994).
EMB30 is essential for normal cell division, cell expansion, and cell adhesion in
Arabidopsis and encodes a protein that has similarity to Sec7. Cell, 77, 1051-1062.
Shinotsuka, C., Yoshida, Y., Kawamoto, K., Takatsu, H., and Nakayama, K. (2002).
Overexpression of an ADP-ribosylation factor-guanine nucleotide exchange factor, BIG2,
uncouples brefeldin A-induced adaptor protein-1 coat dissociation and membrane
tubulation. J. Biol. Chem., 277, 9468-9473.
Someya, A., Sata, M., Takeda, K., Pacheco-Rodriguez, G., Ferrans, V. J., Moss, J., and
Vaughan, M. (2001). ARF-GEP (100), a guanine nucleotide-exchange protein for ADP-
ribosylation factor 6. Proc. Natl. Acad. Sci., USA, 98, 2413-2418.
Spang, A., Herrmann, J. M., Hamamoto, S., and Schekman, R. (2001). The ADP ribosylation
factor-nucleotide exchange factors Gea1p and Gea2p have overlapping, but not redundant
functions in retrograde transport from the Golgi to the endoplasmic reticulum. Mol. Biol.
Cell, 12, 1035-1045.
Stearns, T., Kahn, R. A., Botstein, D., and Hoyt, M. A. (1990). ADP ribosylation factor is an
essential protein in Saccharomyces cerevisiae and is encoded by two genes. Mol. Cell
Biol., 10, 6690-6699.
Steinmann, T., Geldner, N., Grebe, M., Mangold, S., Jackson, C. L., Paris, S., Galweiler, L.,
Palme, K., and Jurgens, G. (1999). Coordinated polar localization of auxin efflux carrier
PIN1 by GNOM ARF GEF. Science, 286, 316-318.
Stevens, T., Esmon, B., and Schekman, R. (1982). Early stages in the yeast secretory pathway
are required for transport of carboxypeptidase Y to the vacuole. Cell, 30, 439-448.
Takatsuki, A., and Tamura, G. (1985). Brefeldin A, a specific inhibitor of intracellular
translocation of vesicular stomatitis virus G protein: intracellular accumulation of high-
mannose type G protein and inhibition of its cell surface expression. Agric. Biol. Chem.,
49, 899-902.
Togawa, A., Morinaga, N., Ogasawara, M., Moss, J., and Vaughan, M. (1999). Purification
and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-
ribosylation factors. J. Biol. Chem., 274, 12308-12315.
Wood, S. A., and Brown, W. J. (1992). The morphology but not the function of endosomes
and lysosomes is altered by brefeldin A. J. Cell Biol., 119, 273-285.
THE SEC7 FAMILY OF ARF GEFS 99
29
Wood, S. A., Park, J. E., and Brown, W. J. (1991). Brefeldin A causes a microtubule-
mediated fusion of the trans-Golgi network and early endosomes. Cell, 67, 591-600.
Yahara, N., Ueda, T., Sato, K., and Nakano, A. (2001). Multiple roles of Arf1 GTPase in the
yeast exocytic and endocytic pathways. Mol. Biol. Cell, 12, 221-238.
Zagulski, M., Babinska, B., Gromadka, R., Migdalski, A., Rytka, J., Sulicka, J., and Herbert,
C. J. (1995). The sequence of 24.3 kb from chromosome X reveals five complete open
reading frames, all of which correspond to new genes, and a tandem insertion of a Ty1
transposon. Yeast, 11, 1179-1186.
Zhu, Y., Traub, L. M., and Kornfeld, S. (1998). ADP-ribosylation factor 1 transiently
activates high-affinity adaptor protein complex AP-1 binding sites on Golgi membranes.
Mol. Biol. Cell, 9, 1323-1337.
Chapter 5
LARGE ARF GEFS OF THE GOLGI COMPLEX
In search of mechanisms for the cellular effects of BFA
Abstract: Class I and class II Arfs localize to the Golgi complex where they activate
lipid-modifying enzymes and also promote the recruitment of several coat
proteins implicated in the sorting of cargo into budding transport vesicles.
Three families of large GEFs spatially and temporally regulate Arf activation
in this organelle. GBF1, a BFA-resistant GEF with specificity for Class II
Arfs in vitro, localizes to cis-compartments of the Golgi and appears to
regulate assembly of the COPI coat. In contrast, BIG1 and BIG2 are BFA-
sensitive GEFs that concentrate on trans-compartments where they control the
recruitment of clathrin adaptor proteins. BRAG1, a representative of the third
family, is confined to early Golgi compartments, but unlike GBF1 displays
broader Arf substrate specificity. These large GEFs are likely multidomain
proteins with complex interactions responsible for regulating activity,
membrane association and possibly the selection of downstream effectors.
Ongoing efforts in several laboratories focus on the identification of partners
for these GEFs.
1. INTRODUCTION
Several years ago, we and others set out to develop a genetic approach to
identify the cellular target(s) of BFA (Yan et al., 1992; Yan et al., 1994).
We generated, by chemical mutagenesis, several mutant lines of Chinese
hamster ovary (CHO) cells resistant to BFA in order to better understand the
effects of this drug on various organelles. These studies led to the isolation
LARGE ARF GEFS OF THE GOLGI COMPLEX 1033
of 24 CHO mutant lines (termed BFY1-24) that can grow in the presence of
BFA concentrations (1-2 µg/ml) 5-10 fold greater than the IC50. These BFY
lines displayed organelle-specific resistance to BFA: whereas the Golgi
complex maintained its appearance and function at high BFA concentrations,
the endosomal system retained sensitivity (Yan et al., 1994). A similar
selection procedure by Nakayama and colleagues led to isolation of several
BFA resistant CHO lines termed BAR1-30 (Torii et al., 1995). In these
mutant cells, COPI showed reduced sensitivity to BFA whereas γ-adaptin
was released at BFA concentrations similar to those effective in the parental
line. These two studies provided direct evidence for the presence of
multiple, organelle-specific targets for BFA. In addition, they demonstrated
that the cytotoxicity of BFA correlated with effects on the COPI coat and the
Golgi complex and not on events associated with the TGN or endo-
lysosomal systems. We concluded that characterization of factors that alter
BFA cytotoxicity would lead to the discovery of proteins involved in
regulation of the COPI coat, and the possible identification of those Arf
GEFs or effectors impacting cell viability.
Two approaches established that BFY cells express wild-type GBF1. First,
we constructed a full-length cDNA for human GBF1 and characterized it
(Mansour et al., 1998). To our surprise, moderate overexpression of the
wild-type protein led to BFA resistance similar to that observed with the
GBF1 recovered from mutant CHO cells (S. Mansour and P. Melançon,
unpublished observation). In parallel, we cloned and sequenced several full-
length cDNAs from a library prepared from the parental CHO line (Zhao et
al., 2002a). Analysis of these GBF1 transcripts revealed no point mutations
but did identify three nucleotide positions (at bp 1010, 1864 and 4479 in the
open reading frame) displaying frequent in-frame deletions or insertions. A
combination of genomic DNA sequencing, RT-PCR and biological assays
demonstrated that (1) the small variations were consistent with the use of
alternative splicing sites, (2) the splice variants were made at similar
frequencies in wild-type and BFA-resistant cells, and, (3) those variants
displayed activity identical to the original GBF1 cDNA (Zhao et al., 2002a).
These results led us to conclude that contrary to expectations, GBF1 was not
mutated in BFY cells and that its isolation in our screen resulted from its
intrinsic ability to induce BFA resistance when overexpressed. Interestingly,
overexpression of the BFA-sensitive Geas similarly induces BFA resistance
(Peyroche et al., 1999). This property appears unique to the GBF1/Gea sub-
family of Arf GEFs: overexpression of BIGs does not reduce BFA
sensitivity (see section 6.2 below) while that of ARNOs actually mimics
BFA and causes dispersal of the COP1 coat (Franco et al., 1998; Monier et
al., 1998).
LARGE ARF GEFS OF THE GOLGI COMPLEX 1055
that GBF1 may cycle between the Golgi complex and the ER. Recent
observations with a new antibody (9D2), raised against a fragment of GBF1,
support the possibility that GBF1 functions on membranes in transit to the
Golgi complex. Contrary to what is observed with most of our sera (e.g., see
Figure 2A), this new antiserum reveals not only the expected juxtanuclear
pattern but also shows a number of peripheral puncta (arrows in Figure 2B).
Figure 2. GBF1 localizes to the Golgi complex (A; 9D5) and peripheral puncta (B; 9D2).
As is the case for large GEFs that regulate other small GTPases, such as
SOS (Hall et al., 2002) and Dbl (Hoffman and Cerione, 2002), GBF1 is
likely to be a multidomain protein with complex interactions responsible for
regulating its membrane association and activity. Unfortunately, with the
exception of the central Sec7d and some proline-rich regions near the C-
terminus, the GBF1 sequence does not contain recognizable protein motifs.
The only other characterized domain regulates dimerization and was
identified through characterization of GNOM. The possibility that GNOM
is a homodimer was first suggested by unusual allelic complementation
between three classes of GNOM alleles (Busch et al., 1996). Subsequent
characterization using a yeast two-hybrid assay confirmed that GNOM is a
homodimer and established that the region responsible for dimerization is
present at the N-terminus (residues 1 to 246), in the region encoded by the
first exon (Grebe et al., 2000). This region is also able to bind cyclophilin-5,
a protein with folding activity that may be important for regulation of
GNOM dimerization and function. This dimerization and cyclophilin-
binding, or DCB domain, is also found in Geas and GBF1 but its function in
these proteins has not been confirmed. However, GBF1 and Geas likely
function as dimers because other well-characterized Arf GEFs such as BIGs
(Yamaji et al., 2000) and ARNOs (Chardin et al., 1996) clearly form dimers.
108
8 MELANÇON, ZHAO, AND LASELL
BLAST searches of the human genome with the GBF1 sequence identified
13 human proteins with a Sec7d, including three previously uncharacterized,
large, putative Arf GEFS encoded by partial human cDNAs (KIAA0522,
KIAA0763 and KIAA1110). Phylogenetic analysis of metazoan Sec7d
proteins encoded by the genomes of H. sapiens (n=13), D. melanogaster
(n=5) and C. elegans (n=5) revealed that these three large proteins define a
fifth subclass of Arf GEFs (see Figure 3). Interestingly, whereas humans
express several members of each subfamily, the D. melanogaster and C.
elegans genomes encode only one member of each of the 5 groups.
Surprisingly, as is also true for ARNOs and EFA6s, the genomes of S.
cerevisiae, S. pombe or A. thaliana do not encode a member of this family.
Furthermore, these Arf GEFs are unique among the large Arf GEFs in
containing a pleckstrin homology (PH) domain, located approximately 55
residues downstream of the Sec7d.
110
10 MELANÇON, ZHAO, AND LASELL
of all three classes of Arfs, but with significantly greater activity towards
Arf6. Furthermore, as expected, this activity was BFA resistant. Previous
work established that the PH domain present in members of the ARNO and
EFA6 families regulates GEF activity by facilitating recruitment to
membranes containing phosphoinositides (Chardin et al., 1996; Macia et al.,
2001; Paris et al., 1997). Surprisingly, varying levels of PS, PIP2 or PIP3
between 0 to 50 µM had no impact on GTP loading by GEP-100/BRAG2 on
either Arf1 or Arf6 (Someya et al., 2001). The authors concluded that the
PH domain does not mediate regulation of GEF activity by
phosphoinositides. However, one should note that all nucleotide exchange
assays were performed with Arfs lacking the essential myristate and used PS
or phosphoinositides bound to BSA rather than as liposomes. Arf activation
is coupled to membrane interaction and assays with full-length Arf are
usually performed in the presence of vesicles (Franco et al., 1993; Paris et
al., 1997). Reactions carried out with non-myristoylated ARFs in absence of
liposomes may therefore not reflect the true specificity of the GEF.
Furthermore, since the authors did not use liposomes doped with varying
levels of phosphoinositides, their results do not exclude regulation of
membrane recruitment by the PH domain.
Figure 4. Endogenous BRAG1 localizes in NRK cells to cis-elements of the Golgi complex
(A), well resolved from trans-elements positive for the clathrin adaptor protein GGA1 (B).
Figure 5. BFA-induced tubules from the TGN contain TGN38 (A) but lack BIG1 (B).
Arf GEF clearly inhibited by BFA and they localize and function within
trans-elements of the Golgi complex. How then can one explain the effects
of BFA on early steps in protein traffic? Although the precise mechanism
remains unclear, several possibilities are discussed here. For example,
BARS-50 is a lysophosphatidate acyl transferase (thus, like phospholipase D
produces phosphatidic acid) that becomes ADP-ribosylated in response to
BFA treatment of cells (Weigert et al., 1999). BARS-50 also promotes
scission of COPI vesicles in in vitro assays (Spano et al., 1999; Weigert et
al., 1999). Thus, BFA-induced ADP-ribosylation of BARS-50 may alter its
enzymatic activity and result in alterations in the lipid composition of the
Golgi stacks and thereby interfere, directly or indirectly, with COPI
recruitment or prevent the release of VTCs from ER exit sites. Changes in
lipid composition could also be responsible for the rapid loss of BRAG1
from Golgi membranes observed after BFA treatment. Some of the effects
of BFA on the Golgi could therefore result not from blocking a cis-acting
GEF but from interfering with its recruitment. We also cannot exclude the
possibility that GBF1 is BFA sensitive, under physiological conditions.
Several lines of evidence established that GBF1 was not the “resistance
factor” originally detected in extracts of BFY1 and BFY2 cells. Comparison
of GBF1 levels in wild-type and mutant cells first confirmed that BFA
resistance did not result from GBF1 overexpression (Claude et al., 1999).
As described in section 3.2 above, subsequent analysis eliminated the
possibility that mutant lines expressed unusual splice forms of GBF1 with
differential effects on BFA sensitivity (Zhao et al., 2002a). These
observations prompted us to examine if a mutation in the Sec7d of BIGs
might be responsible for the reduced BFA-sensitivity of mutant lines.
Sequencing of several RT-PCR products encoding the Sec7d of BIG1 and
BIG2 established that mutant cells expressed wild-type forms of both of
these BFA-sensitive Arf GEFs (personal communication). The nature of the
mutation in our BFY lines therefore remains unknown and open to
investigation. The mechanism responsible for the “natural” BFA resistance
of cell lines such as Ptk1 (Ktistakis et al., 1991) and MDCK (Hunziker et al.,
1991) remains similarly unknown. Clearly the cellular effects of BFA are
more complex than originally anticipated, and further investigation of the
BFY lines may shed new light on regulation of Arf activation in early Golgi
compartments.
116
16 MELANÇON, ZHAO, AND LASELL
The work summarized above provides convincing evidence that the Arf
GEFs that function at the Golgi complex display both substrate preference
and distinct localization. These properties may help define which Arf is
activated where. What remains largely unexplored, however, is the
mechanism(s) that controls the choice of effector targeted by the activated
Arf to elicit a specific cellular response. As discussed in several other
chapters, Arf•GTP promotes not only membrane recruitment of COPI and
the several classes of clathrin adaptor proteins; it also regulates several non-
coat effectors, including the membrane remodeling enzymes phospholipase
D and PI(4)P 5-kinase (Brown et al., 1993; Godi et al., 1999; Roth, 1999), as
well as proteins of poorly defined function such as Arfaptins and Arfophilin
(Kanoh et al., 1997; Shin et al., 1999; Van Valkenburgh et al., 2001;
Williger et al., 1999). By acting as transient molecular scaffolds, the large
Arf GEFs could provide some of the required specificity to direct specific
interactions between GEFs and downstream effectors in a spatially and
temporally regulated manner. Ongoing efforts in several laboratories to
identify partners for Arfs and their regulators will in time test this
hypothesis.
REFERENCES
Antonny, B., and Schekman, R. (2001). ER export: public transportation by the COPII coach.
Curr. Opin. Cell Biol., 13, 438-443.
Bell, A. W., Ward, M. A., Blackstock, W. P., Freeman, H. N., Choudhary, J. S., Lewis, A. P.,
Chotai, D., Fazel, A., Gushue, J. N., Paiement, J., Palcy, S., Chevet, E., Lafreniere-Roula,
M., Solari, R., Thomas, D. Y., Rowley, A., and Bergeron, J. J. (2001). Proteomics
characterization of abundant Golgi membrane proteins. J. Biol. Chem., 276, 5152-5165.
Brown, H. A., Gutowsk, S., Moomaw, R. R., Slaughter, C., and Sternweis, P. C. (1993).
ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates
phospholipase D activity. Cell, 75, 1137-1144.
Busch, M., Mayer, U., and Jürgens, G. (1996). Molecular analysis of the Arabidopsis pattern-
formation gene GNOM: gene structure and intragenic complementation. Molec. Gen.
Genet., 250, 681-691.
Chardin, P., Paris, S., Antonny, B., Robineau, S., Beraud-Dufour, S., Jackson, C. L., and
Chabre, M. (1996). A human exchange factor for ARF contains Sec7- and pleckstrin-
homology domains. Nature, 384, 481-484.
Claude, A., Zhao, B. P., Kuziemsky, C. E., Dahan, S., Berger, S. J., Yan, J. P., Armold, A. D.,
Sullivan, E. M., and Melançon, P. (1999). GBF1: A novel Golgi-associated BFA-resistant
guanine nucleotide exchange factor that displays specificity for ADP-ribosylation factor 5.
J. Cell Biol., 146, 71-84.
LARGE ARF GEFS OF THE GOLGI COMPLEX 117
17
Macia, E., Chabre, M., and Franco, M. (2001). Specificities for the small g proteins arf1 and
arf6 of the guanine nucleotide exchange factors arno and efa6. J. Biol. Chem., 276, 24925-
24930.
Mansour, S. J., Herbrick, J. A., Scherer, S. W., and Melançon, P. (1998). Human GBF1 is a
ubiquitously expressed gene of the sec7 domain family mapping to 10q24 [In Process
Citation]. Genomics, 54, 323-327.
Mansour, S. J., Skaug, J., Zhao, X. H., Giordano, J., Scherer, S. W., and Melançon, P. (1999).
p200 ARF-GEP1: a Golgi-localized guanine nucleotide exchange protein whose Sec7
domain is targeted by the drug brefeldin A. Proc. Natl. Acad. Sci., USA, 96, 7968-7973.
Marsh, B. J., and Howell, K. E. (2002). The mammalian Golgi - complex debates. Nature
Rev. Cell Biol., 3, 789-795.
Monier, S., Chardin, P., Robineau, S., and Goud, B. (1998). Overexpression of the ARF1
exchange factor ARNO inhibits the early secretory pathway and causes the disassembly of
the Golgi complex [In Process Citation]. J. Cell Sci., 111, 3427-3436.
Morinaga, N., Moss, J., and Vaughan, M. (1997). Cloning and expression of a cDNA
encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for
ADP-ribosylation factor. Proc. Natl. Acad. Sci., USA, 94, 12926-12931.
Morinaga, N., Tsai, S. C., Moss, J., and Vaughan, M. (1996). Isolation of a brefeldin A-
inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and
ARF3 that contains a Sec7-like domain. Proc. Natl. Acad. Sci., USA, 93, 12856-12860.
Oprins, A., Duden, R., Kreis, T. E., Geuze, H. J., and Slot, J. W. (1993). Beta-COP localizes
mainly to the cis-Golgi side in exocrine pancreas. J. Cell Biol., 121, 49-59.
Paris, S., Beraud-Dufour, S., Robineau, S., Bigay, J., Antonny, B., Chabre, M., and Chardin,
P. (1997). Role of protein-phospholipid interactions in the activation of ARF1 by the
guanine nucleotide exchange factor Arno. J. Biol. Chem., 272, 22221-22226.
Pelham, H. R., and Rothman, J. E. (2000). The debate about transport in the Golgi – two sides
of the same coin? Cell, 102, 713-719.
Peyroche, A., Antonny, B., Robineau, S., Acker, J., Cherfils, J., and Jackson, C. L. (1999).
Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex:
involvement of specific residues of the Sec7 domain. Mol. Cell, 3, 275-285.
Randazzo, P. A., Yang, Y. C., Rulka, C., and Kahn, R. A. (1993). Activation of ADP-
ribosylation factor by Golgi membranes. J. Biol. Chem., 268, 9555-9563.
Renault, L., Christova, P., Guibert, B., Pasqualato, S., and Cherfils, J. (2002). Mechanism of
domain closure of Sec7 domains and role in BFA sensitivity. Biochemistry, 41, 3605-
3612.
Robinson, M. S., and Bonifacino, J. S. (2001). Adaptor-related proteins. Curr. Opin. Cell
Biol., 13, 444-453.
Roth, M. G., (1999). Lipid regulators of membrane traffic through the Golgi complex. Trends
Cell Biol., 9, 174-179.
Sata, M., Donaldson, J. G., Moss, J., and Vaughan, M. (1998). Brefeldin A-inhibited guanine
nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian
ADP ribosylation factors. Proc. Natl. Acad. Sci., USA, 95, 4204-4208.
Sata, M., Moss, J., and Vaughan, M. (1999). Structural basis for the inhibitory effect of
brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors. Proc.
Natl. Acad. Sci., USA, 96, 2752-2757.
Shin, O. H., Ross, A. H., Mihai, I., and Exton, J. H. (1999). Identification of arfophilin, a
target protein for GTP-bound class II ADP-ribosylation factors. J. Biol. Chem., 274,
36609-36615.
Shinotsuka, C., Waguri, S., Wakasugi, M., Uchiyama, Y., and Nakayama, K. (2002a).
Dominant-negative mutant of BIG2, an ARF-guanine nucleotide exchange factor,
LARGE ARF GEFS OF THE GOLGI COMPLEX 119
19
specifically affects membrane trafficking from the trans-Golgi network through inhibiting
membrane association of AP-1 and GGA coat proteins. Biochem. Biophys. Res. Comm.,
294, 254-260.
Shinotsuka, C., Yoshida, Y., Kawamoto, K., Takatsu, H., and Nakayama, K. (2002b).
Overexpression of an ADP-ribosylation factor-guanine nucleotide exchange factor, BIG2,
uncouples brefeldin A-induced adaptor protein-1 coat dissociation and membrane
tubulation. J. Biol. Chem., 277, 9468-9473.
Someya, A., Sata, M., Takeda, K., Pacheco-Rodriguez, G., Ferrans, V. J., Moss, J., and
Vaughan, M. (2001). ARF-GEP100, a guanine nucleotide-exchange protein for ADP-
ribosylation factor 6. Proc. Natl. Acad. Sci., USA, 98, 2413-2418.
Spang, A. (2002). ARF1 regulatory factors and COPI vesicle formation. Curr. Op. Cell Biol.,
14, 423-27.
Spano, S., Silletta, M. G., Colanzi, A., Alberti, S., Fiucci, G., Valente, C., Fusella, A.,
Salmona, M., Mironov, A., Luini, A., Corda, D., and Spanfo, S. (1999). Molecular cloning
and functional characterization of brefeldin A-ADP- ribosylated substrate. A novel protein
involved in the maintenance of the Golgi structure. [Published erratum appears in J. Biol.
Chem., 274, 25188 (1999).] J. Biol. Chem., 274, 17705-17710.
Steinmann, T., Geldner, N., Grebe, M., Mangold, S., Jackson, C. L., Paris, S., Galweiler. L.,
Palme, K., and Jurgens, G. (1999). Coordinated polar localization of auxin efflux carrier
PIN1 by GNOM ARF GEF. Science, 286, 316-318.
Togawa, A., Morinaga, N., Ogasawara, M., Moss, J., and Vaughan, M. (1999). Purification
and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-
ribosylation factors. J. Biol. Chem., 274, 12308-12315.
Torii, S., Banno, T., Watanabe, T., Ikehara, Y., Murakami, K., and Nakayama, K. (1995).
Cytotoxicity of brefeldin A correlates with its inhibitory effect on membrane binding of
COP coat proteins. J. Biol. Chem., 270, 11574-11580.
Van Valkenburgh, H., Shern, J. F., Sharer, J. D., Zhu, X., and Kahn, R. A. (2001). ADP-
ribosylation factors (ARFs) and ARF-like 1 (ARL1) have both specific and shared
effectors: characterizing ARL1-binding proteins. J. Biol. Chem., 276, 22826-22837.
Weigert, R., Silletta, M. G., Spano, S., Turacchio, G., Cericola, C., Colanzi, A., Senatore, S.,
Mancini, R., Polishchuk, E. V., Salmona, M., Facchiano, F., Burger, K. N., Mironov, A.,
Luini, A., and Corda, D. (1999). CtBP/BARS induces fission of Golgi membranes by
acylating lysophosphatidic acid. Nature, 402, 429-433.
Williger, B. T., Provost, J. J., Ho, W. T., Milstine, J., and Exton, J. H. (1999). Arfaptin 1
forms a complex with ADP-ribosylation factor and inhibits phospholipase D. FEBS Lett.
454, 85-89.
Yamaji, R., Adamik, R., Takeda, K., Togawa, A., Pacheco-Rodriguez, G., Ferrans, V. J.
Moss, J., and Vaughan, M. (2000). Identification and localization of two brefeldin A-
inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a
macromolecular complex. Proc. Natl. Acad. Sci., USA, 97, 2567-2572.
Yan, J. P., Beebe, L., Melançon, P. (1992). Isolation and characterization of Chinese hamster
ovary cell lines resistant to brefeldin A. Mol. Biol. Cell, 3, 118a.
Yan, J. P., Colon, M. E., Beebe, L. A., and Melançon, P. (1994). Isolation and
characterization of mutant CHO cell lines with compartment-specific resistance to
brefeldin A. J. Cell Biol., 126, 65-75.
Yan, J. P., and Melançon, P. (1994). Characterization of a soluble BFA-resistance factor
which regulates association of coatomer to Golgi membranes. FASEB J., 8, 1458.
Zhao, X., Lasell, T. K., and Melançon, P. (2002b). Localization of large ADP-ribosylation
factor-guanine nucleotide exchange factors to different Golgi compartments: evidence for
distinct functions in protein traffic. Mol. Biol. Cell, 13, 119-133.
Chapter 6
BIG1 AND BIG2: BREFELDIN A-INHIBITED
EXCHANGE FACTORS FOR ARFS
Actions of brefeldin A
Abstract: Brefeldin A-inhibited guanine nucleotide exchange factor 1 (BIG1) and BIG2
were purified as components of a ~670 kDa protein complex. BIG1 and BIG2
partially colocalize with the Golgi 58 kDa protein and Ȗ-adaptin, a component
of the AP-1 complex. The distribution of BIG1 in the TGN is distinct from
that of GBF-1, a brefeldin A (BFA)-resistant GEF that was confined to the cis-
Golgi. Recently reported studies implicate BIG2 in the transport of lysosomal
enzymes between the TGN and late endosomes. Recognition that BFA
inhibition of BIG1 and Gea1 is non-competitive was the key to understanding
its mechanism of action. [3H]BFA binding was used to define structural
requirements for the formation of a BFA-Arf-Sec7 domain complex. A
recently published synthesis of structure-function information includes a
valuable model of the Arf-Sec7 domain interaction and the mechanism of BFA
inhibition.
1. INTRODUCTION
121
122
2 PACHECO-RODRIGUEZ, MOSS, AND VAUGHAN
et al., 1996). That protein, p200 (later named BIG1), and a second BFA-
inhibited GEF (p190 or BIG2) were present together in a ~670 kDa complex
(Morinaga et al., 1996; Togawa et al., 1999).
Although many effects of BFA on cells are due to its interference with
Arf activation via GEF inhibition, BFA also alters Golgi structures by
stimulating the ADP-ribosylation of a 50 kDa protein termed BARS, for
BFA-ADP-ribosylated substrate (Spanfó et al., 1999). A 38 kDa
glyceraldehyde-3-phosphate dehydrogenase is also modified by apparently
the same BFA-stimulated ADP-ribosyltransferase. Comparisons of effects
of a number of inhibitors of bacterial ADP-ribosyltransferases revealed
parallel effects of coumarin and quinone class compounds on the ability of
BFA to influence Golgi morphology and to inhibit ADP-ribosylation in
vitro. This result is consistent with the involvement of an ADP-ribosylated
protein in the disruption of Golgi architecture (Weigert et al., 1997). BFA-
induced dissociation of coatomer from Golgi membranes, which results from
its inhibition of Arf activation, was unaffected by prevention of the protein
ADP-ribosylation and the perturbation of Golgi structure (Mironov et al.,
1997). These observations implicated the ADP-ribosylated BARS in Golgi
disintegration, and were consonant with the notion that this effect of BFA
does not result from its inhibition of Arf activation.
With the demonstration that BARS is a lysophosphatidic acid:acyl-CoA
transferase, it was suggested that this activity (or the phosphatidic acid that it
produces) is required for fission of the Golgi tubular
compartments/elements, which in its absence become massively
enlarged/elongated as vesicle formation ceases (Weigert et al., 1999). It is
notable that endophilin, a protein that interacts with dynamin and is essential
for endocytosis, is also a lysophosphatidic acid:acyl-CoA transferase
(Schmidt et al., 1999). Both groups suggested similar mechanisms for the
effects of phosphatidic acid on membrane structure at the site of vesicle
fission. It is of interest that BARS is very similar in structure to CtBP1 and
CtBP2, proteins involved in transcription, which interact with the C-
terminus of the adenovirus transforming protein E1A. As those proteins
were also substrates for BFA-stimulated ADP-ribosylation, it was suggested
that BARS be designated CtBP3, and that dual roles for these proteins in the
nucleus and in Golgi be considered (Spanfó et al., 1999).
The human BIG1 gene was mapped to chromosome 8q13 (Mansour et al.,
1999) and BIG2 to 20q13.13. cDNA clones for bovine BIG1 (Morinaga et
al., 1997), human BIG1 (Togawa et al., 1999; Mansour et al., 1999), and
124
4 PACHECO-RODRIGUEZ, MOSS, AND VAUGHAN
human BIG2 (Togawa et al., 1999; Shinotsuka et al., 2002a) have been
reported, BIG1 and BIG2 proteins and mRNAs are present in many bovine
and human tissues (Morinaga et al., 1997; Togawa et al., 1999; Mansour et
al., 1999).
BIG1 and BIG2 were initially purified together in a ~670 kDa protein
complex (Morinaga et al., 1996). Amino acid sequences of peptides from
BIG1 resembled portions of the yeast Sec7 protein, an Arf GEF involved in
protein secretion (Franzusoff and Schekman, 1989). BIG1 and BIG2 were
later cloned (Morinaga et al., 1997; Togawa et al., 1999; Mansour et al.,
1999; Shinotsuka et al., 2002a), and found to contain Sec7 domains of ~200
amino acids that are 50% identical to the yeast Sec7 domain and 90%
identical to each other. The Sec7 domain of yeast Sec7 synthesized as a
recombinant protein exhibited GEF activity that was inhibited by BFA (Sata
et al., 1998), as did the Sec7 domains of BIG1 (Morinaga et al., 1999), BIG2
(Togawa et al., 1999), and Gea1 (Peyroche et al., 1999). BFA analogues
that had not inhibited the GEF activity of Golgi membranes (Donaldson et
al., 1992) also failed to inhibit the Sec7 domain of yeast Sec7 (Sata et al.,
1998).
Until very recently, the only functional region identified in these
proteins, was the Sec7 domain, initially recognized in the Saccharomyces
cerevisiae Sec7 protein (Achstetter et al., 1988). Sec7 domain proteins, like
Arfs, are ubiquitous in eukaryotes. Structures of the BIG1 and BIG2 Sec7
domains have not been reported, but those for other Sec7 domains are
known, including those for ARNO or cytohesin-2 (Mossesova et al., 1998;
Cherfils et al., 1998), cytohesin-1 (Betz et al., 1998), and Gea2, a BFA-
inhibited GEF from yeast (Goldberg, 1998; Renault et al., 2002). The Sec7
domain is formed by two elements, each composed of five Į-helices, which
contain motifs 1 and 2. These short amino acid sequences are critical for Arf
binding and catalysis of nucleotide exchange. A diagram of the domain
organization of BIG1 is shown in Figure 1. Specific amino acids in a site
formed by apposition of the two motifs appear to interact with
complementary side chains in switch 1 (residues 41-55) and switch 2
(residues 70-80) of Arf (Mossesova et al., 1998; Goldberg, 1998; Betz et al.,
1998; Cherfils et al., 1998; Renault et al., 2002).
BIGS: BFA-SENSITIVE ARF GEFS 1255
Figure 1. Functional domains of BIG1. Mansour et al. (1999) reported that the N-terminal
fragment (residues 1-560) was required for Golgi localization and identified the HUS
(homology upstream of the Sec7 domain) box as important for protein stability. The central
Sec7 domain contains Motifs 1 and 2. Asterisk indicates region that increases GEF activity of
the Sec7 domain 100-fold (Morinaga et al., 1999).
Functions of regions outside the Sec7 domains of BIG1 and BIG2 are, for
the most part, obscure. Arf GEF activity of BIG1(1-885), which lacks the
964 residues C-terminal to the Sec7 domain, was equivalent to that of the
full-length protein, when recombinant proteins synthesized in Sf9 cells were
compared. Additional studies of BIG1(1-885), truncated at the N-terminus,
indicated that removal of amino acids 1-594 (BIG1 (595-885) had no effect,
but an additional truncation of 35 residues (BIG1 (630-885) resulted in the
loss of 99% of the Arf GEF activity (Morinaga et al., 1999).This sequence,
with a predicted pI of 6.30, appears to form a coil, integrated by three helices
that are connected by segments without defined structure, which probably
represent loops. The effect of this segment is consistent with earlier
observations that regions outside the Sec7 domain altered cytohesin Arf GEF
activity (Chardin et al., 1996; Pacheco-Rodriguez et al., 1998). Mansour et
al. (1999) identified a sequence in BIG1 (amino acids 562-
VVDIYVNYDCDLNAANIFERLVNDLSKI-590), which they referred to as
the region of “homology upstream of the Sec7 domain (HUS)” that is also
present in other large GEFs, such as Sec7, GBF1, and EMB30. They
suggested that this sequence, which is identical in BIG1 and BIG2 (Togawa
et al., 1999), could be important for protein folding and stability. The region
N-terminal to it appears to contain a Golgi localization signal. Among five
epitope-tagged BIG1 mutants that were overexpressed in BHK cells, only
the one containing residues 1-560 coincided with the Golgi marker
mannosidase II, as did the full-length BIG1 (Mansour et al., 1999).
Subcellular localization signals have not been recognized in other Arf GEFs
leaving in question the determinants of their subcellular distributions, which
126
6 PACHECO-RODRIGUEZ, MOSS, AND VAUGHAN
lysates using an immobilized fragment of GGA3 could prove very useful for
identifying and quantifying specific intracellular Arf-Arf GEF interactions.
A recent publication compared the crystal structure of the free (without
ligand) Sec7 domain of Gea2 (Renault et al., 2002) with that of Gea2 bound
to nucleotide-free Arf1 that lacks the N-terminal myristate and amino acids
1-17 (Goldberg, 1998). This information dramatically increases our
understanding of the molecular mechanisms of Arf GEF action and its
inhibition by BFA (reviewed in the next section). Renault et al. (Renault et
al., 2002) suggested also that differences among Arf GEFs in the width of
the empty catalytic groove that accommodates the Arf molecule could serve
to discriminate among different structures of the individual Arfs (Amor et
al., 1994; Ménétrey et al., 2000). Additional detailed data of this kind will
surely facilitate identification of the specific roles and interactions of these
molecules.
BIG1 and BIG2 had been purified from bovine brain cytosol as components
of a ~670 kDa complex (Morinaga et al., 1996), and were, to a large extent,
immunoprecipitated together from HepG2 cell cytosol by antibodies specific
for BIG1 or BIG2 (Yamaji et al., 1999). BIG1 and BIG2 were also partially
co-immunoprecipitated from CHAPS-solubilized, microsomal fractions.
After centrifugation of microsomal preparations on a sucrose density
gradient, BIG, BIG2, and ß-COP (one of seven proteins that compose the
COPI coatomer) were recovered only in the 1.15 M/0.85 M sucrose (heavy
Golgi) fraction (Yamaji et al., 1999). By fluorescence microscopy, both
endogenous BIG1 and BIG2 in HepG2 cells were partially colocalized with
the Golgi-specific 58 kDa protein and partially with Ȗ-adaptin, a component
of the AP-1 complex. The distribution of over-expressed BIG2 and
endogenous BIG1, BIG2, and also appeared quite similar in HepG2 and
HeLa cells. After exposure of HepG2 cells to BFA for 10 min with
complete release of ȕ-COP from Golgi structures, both BIG1 and BIG2 were
still Golgi-associated (Yamaji et al., 1999). Mansour, et al. (Mansour et al.,
1999), however, found complete dispersal of over-expressed BIG1 from
Golgi in BHK2 cells incubated for 10 min with BFA, which likely reflects
simply a difference in the time required for BFA inhibition in different cells.
Zhao et al. (2002) reported that endogenous BIG1 in NRK cells was
localized in the TGN. Its concentration in the Golgi compartment was
contrasted with that of GBF1, a 208 kDa, BFA-resistant Arf GEF that
preferentially activates Arf5 (Claude et al., 1999), which was confined to a
128
8 PACHECO-RODRIGUEZ, MOSS, AND VAUGHAN
affecting ȕ-COP. They showed that the adaptor protein GGA1, like Ȗ-
adaptin and BIG2-K738, was dispersed along tubular structures resembling
those seen in BFA-treated cells. These and other observations implicated
BIG2 in transport of lysosomal enzymes between the TGN and late
endosomes (Shinotsuka et al., 2002b).
Earlier conclusions regarding the apparently similar subcellular
distributions of BIG1 and BIG2, both of which appeared to colocalize
partially with both Ȗ-adaptin and coatomer, were undoubtedly due to
insufficiently precise techniques for immunofluorescence microscopy
(Yamaji et al., 1999). They were perhaps accepted with less question than
they might otherwise have been because of the knowledge that BIG1 and
BIG2 had remained associated throughout six steps of purification and were
immunoprecipitated together, both phenomena that demand, now more than
ever, detailed investigation and explanation.
The recognition that BFA inhibition of Gea1 (Peyroche et al., 1999) and
BIG1 (Mansour et al., 1999) is non-competitive was the key to
understanding its mechanism of action. Peyroche et al. (Peyroche et al.,
1999) demonstrated directly that BFA stabilized and thus increased the
amount of a stoichiometric complex containing the Gea1 Sec7 domain and
Arf1-∆17•GDP (lacking the N-terminal myristate and 17 amino acids).
They identified two amino acids in the Sec7 domain that were critical for
BFA inhibition of secretion in the mutant yeast used to test activity of the
recombinant proteins. A chimeric Gea1 containing an ARNO Sec7 domain
was used to demonstrate that replacement of F190 and A191, respectively,
with the residues found in the corresponding position in Gea1 (tyrosine and
serine), resulted in BFA sensitivity and the capacity to form a stable BFA-
Arf•GDP-Sec7 domain complex, each of which was lacking in the parent
molecule (Peyroche et al., 1999). Sata et al. (Sata et al., 1999) showed that
replacement of S198 and P208 in the Sec7 domain of cytohesin-1 (an Arf
GEF very similar to ARNO) with aspartate and methionine, respectively, as
found in the BFA-inhibited BIG1 (p200), made it sensitive to BFA.
Sequences in these regions of BFA-inhibited and BFA-insensitive GEFs are
aligned in Figure 2. In the crystal structure of the ARNO Sec7 domain, these
four amino acid side chains are exposed on the surface, in or near the
hydrophobic groove in which the Arf molecule binds through its switch 1
and switch 2 regions (Mossesova et al., 1998). Specific interactions of
individual amino acids in the two switch regions of Arf with complementary
residues in motifs 1 and 2 of the Sec7 domain were identified in crystal
130
10 PACHECO-RODRIGUEZ, MOSS, AND VAUGHAN
structures of the Gea2 Sec7 domain complex with a mutant Arf1, either
nucleotide-free or bound to Gpp(NH)p, a poorly hydrolysable GTP analogue
(Goldberg, 1998).
Figure 2. Amino acids in the Sec7 domain that influence sensitivity to BFA. Sequences
shown contain Motif 2 (Mossesova et al., 1998), which forms a side of the Arf-binding
groove and includes one pair of residues (**) that modify BFA sensitivity (Peyroche et al.,
1999). The adjacent sequence contains another pair of amino acids that affects BFA
sensitivity, (*) and the boxed position, in which interchanging Q (as in BIG1) with N, (as in
cytohesins), did not affect BFA sensitivity (Sata et al., 1999). Five BFA-sensitive GEFs,
from human (h), yeast (y), and Arabadopsis (a), are shown, along with four BFA-insensitive
cytohesins.
empty Sec7 domain when they are occupied by tyrosine, aspartate, and
methionine (as in BFA-sensitive Arf GEFs) than when occupied by
phenylalanine, serine, and proline (BFA-insensitive). They concluded that
these three positions are important in the flexibility of the Sec7 domain that
is necessary for alternation between the open (empty) and closed (Arf-
bound) conformations of the Arf-binding groove. Both flexibility and the
capacity to form hydrogen bonds may contribute to BFA sensitivity.
Renault et al. (Renault et al., 2002) observed that the specificity of an Arf-
Arf GEF interaction should probably be established by the initial reaction of
the two molecules. They suggested that differences among GEFs in the
width of the empty catalytic groove, which is significantly wider in ARNO
than Gea2, could serve to discriminate among structures of the GDP-bound
forms of individual Arfs (Amor et al., 1994; Ménétrey et al., 2000) in the
switch 1 and switch 2 regions with which they interact.
5. CONCLUSIONS
REFERENCES
Achstetter, T., Franzusoff, A., Field, C., and Schekman, R. (1988). SEC7 encodes an unusual,
high molecular weight protein required for membrane traffic from the yeast Golgi
apparatus. J. Biol. Chem., 263, 11711-11717.
Amor, J. C., Harrison, D. H., Kahn, R. A., and Ringe, D. (1994). Structure of human ADP-
ribosylation factor 1 complexed with GDP. Nature, 372, 704-708.
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., and Elledge, S J. (1996).
SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel
motif, the f-box. Cell, 86, 263-274.
Betz, S. F., Schnuchel, A., Wang, H., Olejniczak, E. T., Meadows, R. P., Lipsky, B. P.,
Harris, E. A. S., Staunton, D. E., and Fesik, S. W. (1998). Solution structure of the
cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP-ribosylation
factor 1. Proc. Natl. Acad. Sci., USA, 95, 7909-7914.
Chardin, P., Paris, S., Antonny, B., Robineau, S., Béraud-Dufour, S., Jackson, C. L., and
Chabre, M. (1996). A human exchange factor for ARF contains Sec7- and pleckstrin-
homology domains. Nature, 384, 481-484.
Cherfils, J., Ménétrey, J., Mathieu, M., LeBrass, G., Robineau, S., Béraud-Dufour, S.,
Antonny, B., and Chardin, P. (1998). Structure of the Sec7 domain of the ARF exchange
factor ARNO. Nature, 392, 101-105.
Claude, A., Zhao, B.-P., Kuziemsky, C. E., Dahan, S., Berger, S. J., Yan, J. P., Arnold, A. D.,
Sullivan, E. M., and Melançon, P. (1999). GBF1: a novel Golgi-associated BFA-resistant
guanine nucleotide exchange factor that displays specificity for ADP-ribosylation factor 5.
J. Cell Biol., 146, 71-84.
Donaldson, J. G., Finazzi, D., and Klausner, R. D. (1992). Brefeldin A inhibits Golgi
membrane-catalyzed exchange of guanine nucleotide into ARF protein. Nature, 360, 350-
352.
Franzusoff, A., and Schekman, R. (1989). Functional compartments of the yeast Golgi
apparatus are defined by the Sec7 mutation. EMBO J., 8, 2695-2702.
Fujiwara, T., Oda, K., Yokota, S., Takatsuki, A., and Ikehara, Y. (1988). Brefeldin A causes
disassembly of the Golgi complex and accumulation of secretory proteins in the
endoplasmic reticulum. J. Biol. Chem., 263, 18545-18552.
Goldberg, J. (1998). Structural basis for activation of ARF GTPase: Mechanisms of guanine
nucleotide exchange and GTP-myristoyl switching. Cell, 95, 237-248.
Helms, J. B., and Rothman, J. E. (1992). Inhibition by brefeldin A of a Golgi membrane
enzyme that catalyzes exchange of guanine nucleotide bound to ARF. Nature, 360, 352-
354.
Ilyin, G. P., Rialland, M., Pigeon, C., and Guguen-Guillouzo, C. (2000). CDNA cloning and
expression analysis of new members of the mammalian f-box protein family. Genomics,
67, 40-47.
Mansour, S. J., Skaug, J., Zhao, X.-H., Giordano, J., Scherer, S. W., and Melancon, P. (1999).
p200 ARF-GEP: a Golgi-localized guanine nucleotide exchange protein whose Sec7
domain is targeted by the drug brefeldin A. Proc. Natl. Acad. Sci., USA, 96, 7968-7973.
Ménétrey, J., Macia, E., Pasqualato, S., Franco, H., and Cherfils, J. (2000). Structure of
ARF6-GDP suggests a basis for guanine nucleotide exchange factors specificity. J. Nat.
Struct. Biol., 7, 466-469.
Mironov, A., Colanzi, A., Silletta, M. G., Fiucci, S., Fusella, A., Polishchuk, R., Mironov, A.,
Jr., DiTullio, G., Weigert, R., Malhotra, V., Corda, D., deMatteis, M. A., and Luini, A.
(1997). Role of NAD+ and ADP-ribosylation in the maintenance of the Golgi structure. J.
Cell Biol., 139, 1109-1118.
134
14 PACHECO-RODRIGUEZ, MOSS, AND VAUGHAN
Mishima, K., Tsuchiya, M., Nightingale, M. S., Moss, J., and Vaughan, M. (1993). ARD1, a
64 kDa guanine nucleotide-binding protein with a carboxyl-terminal ADP-ribosylation
factor domain. J. Biol. Chem., 268, 8801-8807.
Misumi, Y., Misumi, Y., Miki, K., Takatsuki, A., Tamura, G., and Ikehara, Y. (1986). Novel
blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat
hepatocytes. J. Biol. Chem., 261, 11398-11403.
Morinaga, N., Adamik, R., Moss, J., and Vaughan, M. (1999). Brefeldin A inhibited activity
of the Sec7 domain of p200, a mammalian guanine nucleotide-exchange protein for ADP-
ribosylation factors. J. Biol. Chem., 274, 17417-17423.
Morinaga, N., Moss, J., and Vaughan, M. (1997). Cloning and expression of a cDNA
encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for
ADP-ribosylation. Proc. Natl. Acad. Sci., USA, 94, 1226-1231.
Morinaga, N., Tsai, S.-C., Moss, J., and Vaughan, M. (1996). Isolation of a brefeldin A-
inhibited guanine nucleotide-exchange protein for ADP-ribosylation factor (ARF) 1 and
ARF 3 that contains a Sec7-like domain. Proc. Natl. Acad. Sci., USA, 93, 12856-12860.
Mossesova, E., Gulbis, J. M., and Goldberg, J. (1998). Structure of the guanine nucleotide
exchange factor Sec7 domain of human ARNO and analysis of the interaction with ARF
GTPase. Cell, 92, 415-423.
Orci, L., Tagaya, M., Amherdt, M., Perrelet, A., Donaldson, J. G., Lippincott-Schwartz, J.,
Klausner, R. D., and Rothman, J. E. (1991). Brefeldin A, a drug that blocks secretion,
prevents the assembly of non-clathrin-coated buds on Golgi cisternae. Cell, 64, 1183-
1195.
Pacheco-Rodriguez, G., Meacci, E., Vitale, N., Moss, J., and Vaughan, M. (1998). Guanine
nucleotide exchange on ADP-ribosylation factors catalyzed by cytohesin-1 and its Sec7
domain. J. Biol. Chem., 273, 26543-26548.
Palade, G. E. (1975). Intracellular aspects of the process of protein synthesis. Science, 189,
347-358.
Peyroche, A., Antonny, B., Robineau, S., Acker, J., Cherfils, J., and Jackson, C. L. (1999).
Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex:
involvement of specific residues of the Sec7 domain. Mol. Cell., 3, 275-285.
Presley, J. F., Ward, T. H., Pfeifer, A. C., Siggla, E. D., Phair, R. D., Lippincott-Schwartz, J.
(2002). Dissection of COPI and ARF1 dynamics in vivo and role in Golgi membrane
transport. Nature, 417, 187-193.
Renault, L., Christova, P., Guibert, B., Pasqualato, S., and Cherfils, J. (2002). Mechanism of
domain closure of Sec7 domains and role in BFA sensitivity. Biochemistry, 41, 3605-
3612.
Robineau, S., Chabre, M., and Antonny, B. (2000). Binding site of brefeldin A at the interface
between the small G protein ADP-ribosylation factor 1 (ARF1) and the nucleotide-
exchange factor Sec7 domain. Proc. Natl. Acad. Sci., USA, 97, 9913-9918.
Robinson, M. S., and Bonifacino, J. S. (2001). Adaptor-related proteins. Curr. Opin. Cell
Biol., 13, 444-453.
Rothman, J. E. (1994). Mechanisms of intracellular protein transport. Nature, 372, 55-63.
Santy, L. C., and Casanova, J. E. (2001). Activation of ARF6 by ARNO stimulates epithelial
cell migration through downstream activation of both Rac1 and phospholipase D. J. Cell.
Biol., 154, 599-610.
Sata, M., Donaldson, J. G., Moss, J., and Vaughan, M. (1998). Brefeldin A-inhibited guanine
nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian
ADP ribosylation factors. Proc. Natl. Acad. Sci., USA, 95, 4204-4208.
BIGS: BFA-SENSITIVE ARF GEFS 135
15
Sata, M., Moss, J., and Vaughan, M. (1999). Structural basis for the inhibitory effect of
brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors. Proc.
Natl. Acad. Sci., USA, 96, 2752-2757.
Schmidt, T. A., Wolde, M., Thiele, C., Fest, W., Kratz, H., Podtelejnikov, A., Witke, W.,
Hultner, W. B., and Söling, H.-D. (1999). Endophilin 1 mediates synaptic vesicle
formation by transfer of arachidonate to lysophosphatidic acid. Nature, 401, 133-141.
Shinotsuka, C., Waguri, S., Wakasugi, M., Uchiyama, Y., and Nakayama, K., (2002b).
Dominant-negative mutant of BIG2, an ARF-guanine nucleotide exchange factor,
specifically affects membrane trafficking from the trans-Golgi network through inhibiting
membrane association of AP-1 and GGA coat proteins. Biochem. Biophys. Res. Comm.,
294, 254-260.
Shinotsuka, C., Yoshida, Y., Kawamoto, K., Takatsu, H., and Nakayama, K. (2002a).
Overexpression of an ADP-ribosylation factor-guanine nucleotide exchange factor, BIG2,
uncouples brefeldin A-induced adaptor protein-1 coat dissociation and membrane
tubulation. J. Biol. Chem., 277, 9468-9472.
Spanfó, S., Silletta, M. G., Colanzi, A., Alberti, S., Fiucci, G., Valente, C., Fusella, A.,
Salmona, M., Mironov, A., Luini, A., and Corda, D. (1999). Molecular cloning and
functional characterization of brefeldin A-ADP-ribosylated substrate. J. Biol. Chem., 274,
17705-17710.
Spang, A., Matsuoka, K., Hamamoto, S., Schekman, R., and Orci, L. (1998). Coatomer,
ARF1p, and nucleotide are required to bud coat protein complex I-coated vesicles from
large synthetic liposomes. Proc. Natl. Acad. Sci., USA, 95, 11199-11204.
Tamura, G., Ando, K., Suzuki, S., Takatsuki, A., and Arima, K. (1968). Antiviral activity of
brefeldin A and verrucarin A. J. Antibiot., 21, 160-161.
Togawa A., Morinaga, N., Ogasawara, M., Moss, J., and Vaughan, M. (1999). Purification
and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-
ribosylation factors. J. Biol. Chem., 274, 12308-12315.
Tsai, S.-C., Adamik, R., Haun, R. S., Moss, J., and Vaughan, M. (1993). Effects of brefeldin
A and accessory proteins on association of ADP-ribosylation factors 1, 3, and 5 with
Golgi. J. Biol. Chem., 268, 10820-10825.
Vetter, I. R., and Wittinghofer, A. (2001) The guanine nucleotide binding switch in three
dimensions. Science, 294, 1299-1304.
Weigert, A., Colanzi, A., Mironov, R., Buccione, C., Cericola, M. G., Santini, G., Flati, S.,
Fusella, A., Donaldson, J. G., DiGirolamo, M., Corda, D., DeMatteis, M. A., and Luini, A.
(1997). Characterization of chemical inhibitors of brefeldin A-activated mono-ADP-
ribosylation. J. Biol. Chem., 272, 14200-14207.
Weigert, R., Silletta, M. G., Spano, S., Turacchio, G., Cericola, C., Colanzi, A., Sematore, S.,
Mancini, R., Polishchuk, E. V., Salmona, M., Facchiano, F., Burger, K. N. J., Mironov, A.,
Luini, A., and Corda, D. (1999). CtBP/BARS induces fission of Golgi membranes by
acylating lysophosphatidic acid. Nature, 402, 429-433.
Yamaji, R., Adamik, R., Takeda, K., Togawa, A., Pacheco-Rodriguez, G., Ferrans, V. J.,
Moss, J., and Vaughan, M. (1999). Identification and localization of two brefeldin A-
inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a
macromolecular complex. Proc. Natl. Acad. Sci., USA, 97, 2567-2572.
Zhao, X., Lasell, T. K. R., and Melançon, P. (2002). Localization of large ADP-ribosylation
factor-guanine nucleotide exchange factors to different Golgi compartments: evidence for
distinct functions in protein traffic. Mol. Biol. Cell, 13, 119-133.
Chapter 7
ARF GTPASE-ACTIVATING PROTEIN 1
DAN CASSEL
Department of Biology, Technion-Israeli Institute of Technology, Haifa, Israel
Abstract: Regulators of Arf activity include a family of proteins with a shared domain,
the cysteine-rich Arf GAP domain, that is responsible for activating the latent
GTPase activity of Arfs. The first of these to be discovered, Arf GAP1 is the
focus of this chapter. It’s role in the cellular actions of Arfs, particularly
vesicular traffic, and the regulation of Arf GAP1 by other factors, e.g., lipids,
is discussed.
137
138
2 CASSEL
purified and cloned, is then presented. This is the smallest of the many Arf
GAPs found in mammals, is localized to the cytosolic surface of Golgi
membranes, and acts to regulate traffic through this organelle. Where
appropriate, discussions will be extended to Arf GAPs from the yeast S.
cerevisiae that are structurally and/or functionally related to Arf GAP1.
Figure 1. Expression of Arf GAP1 in rat tissues. Tissues were homogenized in isotonic
sucrose in the presence of a cocktail of protease inhibitors, separated by centrifugation
(100,000xg, 1 h) into cytosolic fraction and total membrane fractions, and analyzed by
Western blotting with polyclonal, rabbit anti-Arf GAP1 antibodies.
the X16 “loop” is enriched in neutral and hydrophobic amino acids, reflecting
the fact that this loop is localized in the core of the protein and does not face
the solvent (Goldberg, 1999; Mandiyan et al., 1999). Particularly high
sequence conservation is observed in a 20-25 amino acid stretch that follows
the last cysteine residue of the zinc coordination site. This sequence is
thought to be part of the GAP “catalytic domain” that mediates the
stimulation of GTP hydrolysis on ARFs. In all, the GAP domain includes
approximately 90 residues starting from the last cysteine of the zinc
coordination site (see section 3.3, below). While some short sequence
ARF GTPASE-ACTIVATING PROTEIN 1 1393
elements are conserved between certain subgroups of Arf GAPs in the part
of the catalytic domain that extends beyond the above-mentioned conserved
sequence, sequences in this region are in general quite variable, and do not
show any consensus when all Arf GAPs are compared.
The completed sequence of the human genome has revealed more than 20
genes encoding proteins with an Arf GAP signature. Many of these proteins
have been shown to possess Arf GAP activity. A notable exception is
centaurin-α (Hammonds-Odie et al., 1996), for which no GAP activity could
be demonstrated. Arf GAPs can be divided into five subtypes or
subfamilies, according to similarities in sequence and domain structure (see
Table 1). One type is Arf GAP1, which does not contain any domains found
Table 1: Mammalian Arf GAPs. Notes: 1Size of the longest splice variant (when multiple
variants exist). 2Paxillin does not interact with Git2. 3Absent in ACAPs. 4Defective in
ARAP2. 5Absent in ARAP1. 6Present only in ARAP2. Abbreviations: PH, plekstrin
homology domain; ANK, ankyrin repeats; PrR, proline-rich, SH3-binding domain; SH3, Src-
homology-3 domain; RA, Ras associating/Ral GDS domain; SAM, sterile α motif; RHD,
Rab13 homology domain; GRK, G protein receptor kinase; FA, focal adhesions; ND, not
determined.
Family Size Other Substrate Location Binding Pathways
kD1 Domains Preference Proteins Effected
Arf GAP1 45 - Arf1, 3, 5>6 Golgi KDEL ER-Golgi
receptor traffic
Arf GAP3 57 - ND Peri- ND ND
nuclear
Git1/Cat1 85 ANK Arf1, 3, 5, 6 PM/ GRK, Surface
Git2/Cat2 85 Arf1, 3, 5, 6 Endo- paxilin2, receptor
somes PIX internal-
ization,
integrin
signaling
ASAP1 130 CC, PH, Arf1, 5>6 FA Src, Crk Focal adhe-
Papα/ ANK, Arf1, 5>6 Pyk2, sions,
PAG3 PrR3, SH33 Arf6>1, 5 paxillin Integrin
ACAP1, 2 signaling
ARAP1 PH (x5), Arf1,5>6 Golgi/PM ND Coordi-
ARAP2 RhoGAP, ND ND nation of
ARAP3 ANK, RA4, Arf6 PM Arf and
SAM5, Rho family
RHD6 GTPases
in other proteins besides the Arf GAP domain (Cukierman et al., 1995).
This is also the case for Arf GAP3 (Zhang et al., 2000), a more recently
discovered Arf GAP. Arf GAP1 and Arf GAP3 have orthologs in yeast,
140
4 CASSEL
named Gcs1 and Glo3, respectively (Poon et al., 1999; Poon et al., 1996).
The second subfamily is the Git proteins, including three highly related
members that contain ankyrin repeats, also present in most other Arf GAPs
(Premont et al., 1998; Premont et al., 2000; Turner et al., 1999). Two
additional Arf GAP families, the ASAPs/ACAPs (Andreev et al., 1999;
Brown et al., 1998; Jackson et al., 2000; Kondo et al., 2000) and ARAPs
(Krugmann et al., 2002; Miura et al., 2002) contain PH domain(s) and show
phosphoinositide-dependent Arf GAP activity. Alternative splicing is
common in most Arf GAP genes, adding further to the diversity of the Arf
GAP family of proteins.
The domain structure, substrate specificity, cellular localization and the
general function of Arf GAPs are summarized in Table 1. For detail on
some of these proteins, see subsequent chapters (e.g., Chapters 8 and 9).
3. ARF GAP1
Because Arf GAP1 is thought to function in the COPI system, we will first
briefly introduce this system. For additional details of the role of Arfs in
vesicle coat protein recruitment at Golgi and other membranes, see Chapters
12 and 13. The COPI system functions primarily in the retrograde traffic of
proteins from the Golgi to the endoplasmic reticulum (ER), although there is
evidence for its function in anterograde transport from ER to Golgi as well
(reviewed in (Lippincott-Schwartz et al., 1998; Rothman and Wieland, 1996;
Schekman and Orci, 1996)). The COPI coat (termed coatomer) is a seven-
subunit complex that is recruited en block from cytosol onto Golgi
membrane. Coatomer recruitment is initiated when Arf1 is converted to the
GTP-bound form by the action of a GEF at the Golgi. Subsequently, Golgi-
bound Arf1•GTP acts to recruit coatomer, apparently by direct binding to
coatomer subunits (Eugster et al., 2000; Zhao et al., 1997; Zhao et al., 1999).
Coatomer also interacts with cytoplasmic domains of membrane proteins
bearing the KKXX retrograde transport (sorting) signal, thereby
incorporating this cargo into COPI vesicles (Cosson and Letourneur, 1994;
Letourneur et al., 1994). p23/p24 transmembrane proteins, that are abundant
in the ER-to Golgi shuttle, also interact with coatomer through signals on
their cytoplasmic domain (Dominguez et al., 1998; Fiedler et al., 1996;
Nickel et al., 1997; Sohn et al., 1996). The interaction with coatomer is
likely to function in the recruitment of p23/24 proteins into COPI vesicles,
but the precise function of these proteins remains uncertain. Following its
binding to the Golgi membrane, coatomer is thought to polymerize and
ARF GTPASE-ACTIVATING PROTEIN 1 1415
Arf GAP1 was identified following its purification from rat liver cytosol
(Cukierman et al., 1995; Makler et al., 1995). The purification was
monitored with a GAP assay in which the substrate was myristoylated Arf1
that had been loaded with [γ-32P]GTP in the presence of dimyristoyl-
phosphatidylcholine and cholate. The absence of phosphoinositides in this
assay probably precluded the detection of the phosphoinositide-dependent
Arf GAPs. Purification was greatly facilitated by the finding that GAP
activity could be readily recovered following denaturing conditions,
allowing for a critical purification step in the presence of 8 M urea, and
reverse-phase HPLC in organic solvents. The ability to renature Arf GAP1
by simple dilution with buffer is shared by yeast Arf GAPs Gcs1 and Glo3
(Poon et al., 1999; Poon et al., 1996), and is probably attributable to the zinc
coordination domain, as this domain retains the bound zinc even after
treatment in the presence of 6 M guanidine and 1 mM EDTA (I. Huber and
D. Cassel, unpublished observation). However, this resistance to
denaturants is not a property of all Arf GAPs, possibly because additional
domains that are required for GAP activity (such as the PH domain in
phosphoinositide-dependent GAPs) may not refold under these conditions.
Molecular cloning of the Arf GAP1 cDNA from a rat liver cDNA library
(Cukierman et al., 1995) revealed a protein containing 415 amino acids
(accession NP_659558) (Figure 1). Database entries indicate that the mouse
ortholog of Arf GAP1 (accession XP_130740) contains 414 amino acids,
142
6 CASSEL
whereas two human splice variants encode proteins of 406 (NP_060679) and
414 (AAH28233) amino acids. Sequencing of different rat liver cDNA
library-derived clones has revealed the presence of multiple splice variants
(Cukierman et al., 1995). One variant had an insert containing an early stop
codon, and thus encoded a truncated protein that nevertheless had full Arf
GAP activity when expressed in E. coli, while another variant lacked the
entire zinc finger domain. In this variant the initiating methionine became
out of frame, but translation could be initiated from the second methionine in
the sequence (Met64), resulting in an inactive protein. Additional splice
variants were identified but have not been characterized in detail. Western
blot analysis of different rat tissues and cell lines showed that the long form
(containing 415 amino acids) that we consider the “normal” protein is the
most abundant form expressed. In some cases the expression of smaller
proteins was observed (see Figure 2), but whether these forms are splice
variants or degradation products has not been definitively established.
Attempts to express the full-length Arf GAP1 protein in E. coli were
unsuccessful, whereas fragments containing up to approximately 80% of the
amino terminal sequence could be readily expressed in bacteria (Cukierman
et al., 1995). Amino terminal fragments with full catalytic activity were
employed in numerous studies of the catalytic mechanism (see below).
More recently, full-length Arf GAP1 was successfully expressed in insect
cells using the baculovirus system (Huber et al., 2001; Vitale et al., 2000).
An amino terminal fragment containing the first 257 amino acids of Arf
GAP1 was employed for immunization of rabbits, generating antibodies that
recognized the protein with high affinity and specificity. Western blot
analysis (Figure 2) showed that the protein is ubiquitously expressed in rat
tissues, with the highest levels observed in brain and less in liver and lung.
In all tissues examined, the protein was distributed between cytosol and total
cellular membranes. Comparison to purified, recombinant protein revealed
that Arf GAP1 comprises ~0.004% of liver cytosolic proteins, and is yet less
abundant in most cultured cells.
Use of the antibodies in indirect immunofluorescence showed that Arf
GAP1 distributes between cytosol and the Golgi complex, where it
colocalizes with coatomer. This distribution pattern was observed in normal
rat kidney (NRK) cells (Cukierman et al., 1995) as well as in many other cell
types, including baby hamster kidney (BHK), HeLa and COS-7 cells (E.
Cukierman and D. Cassel, unpublished observations).
When examined in GAP assays in vitro, Arf GAP1 was reported to prefer
Arf1, as compared with Arf6 ((Brown et al., 1998; Vitale et al., 2000) and B.
Antonny and D. Cassel, unpublished observation). The preference for Arf1
over Arf6 may be further increased in vivo, due to the localization of Arf
ARF GTPASE-ACTIVATING PROTEIN 1 1437
GAP1 to Golgi, and the differential distribution of Arf1 and Arf6 to Golgi
and plasma membrane/endosomes, respectively.
Figure 2. (A) The sequence of rat Arf GAP1 is shown with the four cysteines that comprise
the zinc finger (ZF) motif and the essential arginine residue (R50) highlighted. (B) The
domain organization of Arf GAP1 is shown. The N-terminal GAP catalytic domain is
conserved in all known Arf GAPs, whereas the non-catalytic domain is unique to Arf GAP1
and does not contain any motif present in other proteins.
When various amino terminal fragments of Arf GAP1 were tested for in
vitro GAP activity, high activity was observed in proteins containing the first
146 amino acids or more. Substantial, although much lower, activity was
still observed in a mutant protein containing only the first 121 amino acids,
whereas shorter fragments were inactive (Cukierman et al., 1995). These
findings suggested that the minimal GAP catalytic core resides within the
first ~120 amino acids. An essential role of the zinc finger motif was
initially suggested by the finding that mutations in its scaffold cysteines
abolished GAP activity (Cukierman et al., 1995). However, more recent
crystallographic data (Goldberg, 1999) indicated that the 16 amino acid
“loop” of the zinc finger domain is buried within the protein core, and is thus
unlikely to directly participate in catalysis. The loss of activity upon
mutation of the scaffold cysteines is probably the result of unfolding of the
protein upon the destruction of the zinc finger structure that results from the
loss of the chelated zinc atom. That this is indeed the case is suggested by
the decreased solubility of the mutant proteins and their aberrant
chromatographic behavior (D. Cassel, unpublished observations).
Limited proteolysis of the catalytically active Arf GAP1(1-146) resulted
in a fragment consisting of the first 136 amino acids, presumably
representing the complete catalytic core. The crystal structure of the
catalytic core of the Arf GAP domain was solved by Goldberg (Goldberg,
1999) and demonstrated a unique fold, not found in GAPs for other families
of GTPases. In this structure the zinc finger, composed of β strands, is
nested within an array of one β strand and six α helices. Some mechanistic
implications of this structure are discussed below (see also Chapter 2).
GTPases (Nassar et al., 1998; Rittinger et al., 1997; Scheffzek et al., 1997)
showed that the GAPs stimulate GTP hydrolysis in two ways. First, the
GAPs bind to the switch 2 regions of the GTPases, acting to stabilize this
region and to orient the glutamine residue in a position that is optimal for
catalysis. Second, the GAPs possess an “arginine finger” mechanism,
whereby an arginine residue is directly introduced into the active site of the
GTPase. This arginine residue is thought to facilitate GTP hydrolysis by
interacting with the glutamine residue and further orienting it for catalysis,
and by interacting with the phosphate groups of GTP, leading to a decrease
in their effective charge and thereby assisting in the nucleophilic attack of
the water molecule. However, recent studies have indicated that the arginine
finger mechanism does not take place in all GTPases, and is absent in Ran
and Rap GAPs (Brinkmann et al., 2002; Seewald et al., 2002)
The mode of interaction between Arf GAP1 and its substrate has been
studied by Goldberg (Goldberg, 1999), who co-crystallized Arf1•GDP and
the catalytic core of Arf GAP1. The structure revealed multiple interactions
of helix α3 of Arf1 with the GAP catalytic core. A number of interactions
were also observed between the GAP catalytic core and switch 2 of Arf1, but
the significance of these interactions remained unclear as switch 2 undergoes
a significant conformational change upon the GDP-to GTP switch, and
presumably the transition state of the GTPase reaction resembles the GTP
state of Arf1 rather than the GDP state which was used in this study. The
mode of interaction between Arf1 and GAP as observed in the above study
has subsequently been challenged (Click et al., 2002; Mandiyan et al., 1999),
although an alternative model has yet to be presented.
The mechanism that emerged from the structural study by Goldberg
suggested that Arf GAP1 does not contribute an arginine residue to facilitate
catalysis. The single arginine residue in the GAP catalytic core that is
invariant in all known Arf GAPs (Arg50 in Arf GAP1) pointed away from
the protein-protein interface. Additionally, the same study demonstrated that
coatomer greatly stimulated the activity of the catalytic core of GAP. These
findings raised the possibility that coatomer is required to complement the
catalytic activity of GAP, possibly by supplying the arginine residue to the
active site. The effect of coatomer on GAP activity will be further discussed
below. However, site-directed mutagenesis studies by several groups have
shown that the invariant arginine residue in Arf GAPs (always positioned 5
residues from the carboxyl-terminal cysteine of the zinc finger (see Figure
1)) is essential for GAP activity. Even conservative replacements with a
lysine residue completely abolished catalytic activity of Arf GAP1 (Szafer et
al., 2000), and the invariant arginine was also found essential for activity in
other Arf GAPs (Jackson et al., 2000; Mandiyan et al., 1999; Miura et al.,
2002; Randazzo et al., 2000). These findings suggested that this residue
146
10 CASSEL
decay of the GTP state of Arf1 is slow. The effect of external GAPs on GTP
hydrolysis can then be readily measured. Arf GAP1 exhibited high activity
in this assay, but unlike the liposome assay, addition of coatomer
approximately doubled this activity. A similar two-fold effect of coatomer
was observed when using the whole cellular repertoire of Arf GAPs,
represented by coatomer-depleted liver cytosol. Immunodepletion
experiments suggested that although Arf GAP1 contributes significantly to
cytosolic GAP activity, most of the activity in cytosol is mediated by
additional Arf GAPs under these conditions. The identity of these soluble
Arf GAPs is currently unknown.
A different pattern was observed with an Arf GAP from S. cerevisiae.
This organism contains at least 3 Arf GAPs, termed Gcs1, Glo3 and Age2
(Poon et al., 1999; Poon et al., 2001; Poon et al., 1996). When Glo3 was
tested in the Golgi assay, its GAP activity showed large dependency on
coatomer, while in the liposome assay Glo3 activity was low both in the
absence and presence of coatomer (Szafer et al., 2001). These quantitatively
different effects of coatomer on GAP1 and on Glo3 can be rationalized as
follows. The above mentioned studies in Golgi membranes suggest that
coatomer can increase the efficiency of Arf GAP1 stimulation of GTP
hydrolysis in a biological setting. Moreover, evidence for a similar role of a
coat in GTP hydrolysis was recently presented for the COPII system, whose
mechanisms appear to resemble those of the COPI system (Antonny and
Schekman, 2001; Springer et al., 1999). However, unlike in the soluble
system (Goldberg, 1999), a recruitment of GAP to its site of action, either by
binding to membrane lipids (Antonny et al., 1997b) or by interaction with
membrane proteins (Aoe et al., 1997), should provide significant GAP
activity also in the absence of a coat complex, as suggested by our
experiments with liposomes and Golgi membranes. The role of coatomer
would then be to fine-tune the rate of GTP hydrolysis at COPI assembly
sites, a process that could play an important role in cargo sorting (see
below). In the case of Glo3, the large effect of coatomer on GAP activity
might be related to the fact that this protein forms a complex with coatomer
(Eugster et al., 2000), which should bring this GAP into proximity with
Arf1•GTP. Glo3 is not an ortholog of Arf GAP1, and perhaps unlike Arf
GAP1, Glo3 does not interact with membrane lipids, thus explaining its low
activity in the presence of liposomes. The reason for the low activity of
Glo3 with Golgi membranes is less clear; one possible reason might be the
use of a heterologous system consisting of a yeast Arf GAP and a
mammalian Golgi. Future studies should reveal whether the mammalian
ortholog of Glo3 (Arf GAP3) shows a coatomer-dependent GAP activity on
Golgi membranes.
ARF GTPASE-ACTIVATING PROTEIN 1 149
13
p23/24 proteins are abundant membrane proteins that shuttle between the
ER, the ER-Golgi intermediate compartment (ERGIC) and cis-Golgi.
Multiple members of this family are found in hetero-oligomeric complexes
(Emery et al., 2000; Fullekrug et al., 1999; Gommel et al., 1999). They
present short cytoplasmic tails, many of which bind coatomer through a
diphenylalanine (FF) and/or a dibasic motif (Dominguez et al., 1998; Fiedler
et al., 1996; Nickel et al., 1997; Sohn et al., 1996). Recent studies suggest
that some of these tails may act as inhibitors of Arf GAP1 activity. The first
demonstration of this effect came from Goldberg’s study (Goldberg, 2000),
where he showed that a peptide representing the cytoplasmic tail of a p24
protein (with the sequence YLKRFFEVRRVV, termed hp24a) selectively
inhibited coatomer-stimulated activity of the catalytic core of Arf GAP1 in
solution. The peptide had no effect on GAP activity observed in the absence
of coatomer. Several peptides representing cytoplasmic tails of other p24
proteins, as well as p24a variant peptides containing replacements in
residues that are critical for coatomer binding, had no effect of coatomer-
dependent Arf GAP1 activity. Based on these findings, Goldberg suggested
a model for cargo sorting on the basis of GTP hydrolysis on Arf1. In this
model, the interaction of coatomer with cargo (such as the p24 tails)
prevents coatomer stimulation of GAP, resulting in stabilization of
Arf1•GTP. In this way the correct match of cargo, coat complex, and Arf is
“proofread” and specificity in vesicle assembly can be assured. In the
absence of the cargo component, coatomer-dependent Arf GAP activity
rapidly hydrolyzes GTP on Arf1, thereby preventing the formation of COPI
vesicles that lack cargo. Although the effect on GTP hydrolysis was
restricted to p24a, the existence of p24 proteins in hetero-oligomeric
complexes could explain how at least some other members of this family
may be sorted into COPI vesicles.
Recently, Nilsson’s group has reported the results of their studies of the
role of GTP hydrolysis in cargo sorting, using an in vitro assay for vesicle
budding from liver Golgi membranes (Lanoix et al., 1999; Lanoix et al.,
2001). In this system, Golgi enzymes as well as the p23/24 proteins are
sorted into vesicles by a COPI-dependent mechanism, which is in
accordance with the model of Golgi maturation (Bonfanti et al., 1998;
Mironov et al., 2001; Pelham, 2001). Significantly, sorting was observed in
the presence of GTP, but not in the presence of the hydrolysis-resistant GTP
derivative, GTPγS. Several lines of evidence suggested that p23/24 proteins
might be involved in a GTP hydrolysis-dependent sorting event. Addition of
low concentrations of certain p23/24 peptides prevented the sorting of all
Golgi markers examined. The most active peptide was similar to the one
150
14 CASSEL
4. CONCLUSION
REFERENCES
Amor, J. C., Harrison, D. H., Kahn, R. A., and Ringe, D. (1994). Structure of the human
ADP-ribosylation factor 1 complexed with GDP. Nature, 372, 704-708.
Andreev, J., Simon, J. P., Sabatini, D. D., Kam, J., Plowman, G., Randazzo, P. A., and
Schlessinger, J. (1999). Identification of a new Pyk2 target protein with Arf-GAP activity.
Mol. Cell. Biol., 19, 2338-2350.
Andres, D. A., Rhodes, J. D., Meisel, R. L., and Dixon, J. E. (1991). Characterization of the
carboxyl-terminal sequences responsible for protein retention in the endoplasmic
reticulum. J. Biol. Chem., 266, 14277-14282.
Antonny, B., Beraud-Dufour, S., Chardin, P., and Chabre, M. (1997a). N-terminal
hydrophobic residues of the G-protein ADP-ribosylation factor-1 insert into membrane
phospholipids upon GDP to GTP exchange. Biochemistry, 36, 4675-4684.
Antonny, B., Huber, I., Paris, S., Chabre, M., and Cassel, D. (1997b). Activation of ADP-
ribosylation factor 1 GTPase-activating protein by phosphatidylcholine-derived
diacylglycerols. J. Biol. Chem., 272, 30848-30851.
Antonny, B., Madden, D., Hamamoto, S., Orci, L., and Schekman, R. (2001). Dynamics of
the COPII coat with GTP and stable analogues. Nat. Cell. Biol., 3, 531-537.
Antonny, B., and Schekman, R. (2001). ER export: public transportation by the COPII coach.
Curr. Opin. Cell. Biol., 13, 438-443.
Aoe, T., Cukierman, E., Lee, A., Cassel, D., Peters, P. J., and Hsu, V. W. (1997). The KDEL
receptor, ERD2, regulates intracellular traffic by recruiting a GTPase-activating protein for
ARF1. EMBO J., 16, 7305-7316.
Aoe, T., Huber, I., Vasudevan, C., Watkins, S. C., Romero, G., Cassel, D., and Hsu, V. W.
(1999). The KDEL receptor regulates a GTPase-activating protein for ADP- ribosylation
factor 1 by interacting with its non-catalytic domain. J. Biol. Chem., 274, 20545-20549.
ARF GTPASE-ACTIVATING PROTEIN 1 153
17
Aoe, T., Lee, A. J., van Donselaar, E., Peters, P. J., and Hsu, V. W. (1998). Modulation of
intracellular transport by transported proteins: insight from regulation of COPI-mediated
transport. Proc. Natl. Acad. Sci., USA, 95, 1624-1629.
Bonfanti, L., Mironov, A. A., Jr., Martinez-Menarguez, J. A., Martella, O., Fusella, A.,
Baldassarre, M., Buccione, R., Geuze, H. J., Mironov, A. A., and Luini, A. (1998).
Procollagen traverses the Golgi stack without leaving the lumen of cisternae: evidence for
cisternal maturation. Cell, 95, 993-1003.
Brinkmann, T., Daumke, O., Herbrand, U., Kuhlmann, D., Stege, P., Ahmadian, M. R., and
Wittinghofer, A. (2002). Rap-specific GTPase activating protein follows an alternative
mechanism. J. Biol. Chem., 277, 12525-12531.
Brown, M. T., Andrade, J., Radhakrishna, H., Donaldson, J. G., Cooper, J. A., and Randazzo,
P. A. (1998). ASAP1, a phospholipid-dependent Arf GTPase-activating protein that
associates with and is phosphorylated by Src. Mol. Cell. Biol., 18, 7038-7051.
Cherfils, J., Menetrey, J., Mathieu, M., Le Bras, G., Robineau, S., Beraud-Dufour, S.,
Antonny, B., and Chardin, P. (1998). Structure of the Sec7 domain of the Arf exchange
factor ARNO. Nature, 392, 101-105.
Click, E. S., Stearns, T., and Botstein, D. (2002). Systematic Structure-Function Analysis of
the Small GTPase Arf1 in Yeast. Mol. Biol. Cell., 13, 1652-1664.
Cosson, P., and Letourneur, F. (1994). Coatomer interaction with di-lysine endoplasmic
reticulum retention motifs. Science, 263, 1629-1631.
Cukierman, E., Huber, I., Rotman, M., and Cassel, D. (1995). The ARF1 GTPase-activating
protein: zinc finger motif and Golgi complex localization. Science, 270, 1999-2002.
Dominguez, M., Dejgaard, K., Fullekrug, J., Dahan, S., Fazel, A., Paccaud, J. P., Thomas, D.
Y., Bergeron, J. J., and Nilsson, T. (1998). gp25L/emp24/p24 protein family members of
the cis-Golgi network bind both COP I and II coatomer. J. Cell. Biol., 140, 751-765.
Donaldson, J. G., Cassel, D., Kahn, R. A., and Klausner, R. D. (1992a). ADP-ribosylation
factor, a small GTP-binding protein, is required for binding of the coatomer protein beta-
COP to Golgi membranes. Proc. Natl. Acad. Sci., USA, 89, 6408-6412.
Donaldson, J. G., Finazzi, D., and Klausner, R. D. (1992b). Brefeldin A inhibits Golgi
membrane-catalyzed exchange of guanine nucleotide onto ARF protein. Nature, 360, 350-
352.
Donaldson, J. G., and Jackson, C. L. (2000). Regulators and effectors of the ARF GTPases.
Curr. Opin. Cell Biol., 12, 475-482.
Emery, G., Rojo, M., and Gruenberg, J. (2000). Coupled transport of p24 family members. J.
Cell. Sci., 113 ( Pt 13), 2507-2516.
Eugster, A., Frigerio, G., Dale, M., and Duden, R. (2000). COP I domains required for
coatomer integrity, and novel interactions with ARF and ARF-GAP. EMBO J., 19, 3905-
3917.
Fiedler, K., Veit, M., Stamnes, M. A., and Rothman, J. E. (1996). Bimodal interaction of
coatomer with the p24 family of putative cargo receptors. Science, 273, 1396-1399.
Fullekrug, J., Suganuma, T., Tang, B. L., Hong, W., Storrie, B., and Nilsson, T. (1999).
Localization and recycling of gp27 (hp24gamma3): complex formation with other p24
family members. Mol. Biol. Cell, 10, 1939-1955.
Goldberg, J. (1998). Structural basis for activation of ARF GTPase: mechanisms of guanine
nucleotide exchange and GTP-myristoyl switching. Cell, 95, 237-248.
Goldberg, J. (1999). Structural and functional analysis of the ARF1-ARFGAP complex
reveals a role for coatomer in GTP hydrolysis. Cell, 96, 893-902.
Goldberg, J. (2000). Decoding of Sorting Signals by Coatomer through a GTPase Switch in
the COPI Coat complex. Cell, 100, 671-679.
154
18 CASSEL
Gommel, D., Orci, L., Emig, E. M., Hannah, M. J., Ravazzola, M., Nickel, W., Helms, J. B.,
Wieland, F. T., and Sohn, K. (1999). p24 and p23, the major transmembrane proteins of
COPI-coated transport vesicles, form hetero-oligomeric complexes and cycle between the
organelles of the early secretory pathway. FEBS Lett., 447, 179-185.
Hammonds-Odie, L. P., Jackson, T. R., Profit, A. A., Blader, I. J., Turck, C. W., Prestwich,
G. D., and Theibert, A. B. (1996). Identification and cloning of centaurin-alpha. A novel
phosphatidylinositol 3,4,5-trisphosphate-binding protein from rat brain. J. Biol. Chem.,
271, 18859-18868.
Helms, J. B., and Rothman, J. E. (1992). Inhibition by brefeldin A of a Golgi membrane
enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature, 360, 352-
354.
Huber, I., Cukierman, E., Rotman, M., Aoe, T., Hsu, V. W., and Cassel, D. (1998).
Requirement for both the amino-terminal catalytic domain and a non-catalytic domain for
in vivo activity of ADP-ribosylation factor GTPase-activating protein. J. Biol. Chem., 273,
24786-24791.
Huber, I., Rotman, M., Pick, E., Makler, V., Rothem, L., Cukierman, E., and Cassel, D.
(2001). Expression, purification, and properties of ADP-ribosylation factor (ARF) GTPase
activating protein-1. Methods Enzymol., 329, 307-316.
Jackson, T. R., Brown, F. D., Nie, Z., Miura, K., Foroni, L., Sun, J., Hsu, V. W., Donaldson,
J. G., and Randazzo, P. A. (2000). ACAPs are arf6 GTPase-activating proteins that
function in the cell periphery. J. Cell Biol., 151, 627-638.
Kahn, R. A., and Gilman, A. G. (1986). The protein cofactor necessary for ADP-ribosylation
of Gs by cholera toxin is itself a GTP binding protein. J. Biol. Chem., 261, 7906-7911.
Kondo, A., Hashimoto, S., Yano, H., Nagayama, K., Mazaki, Y., and Sabe, H. (2000). A New
Paxillin-binding Protein, PAG3/Papalpha/KIAA0400, Bearing an ADP-Ribosylation
Factor GTPase-activating Protein Activity, Is Involved in Paxillin Recruitment to Focal
Adhesions and Cell Migration. Mol. Biol. Cell, 11, 1315-1327.
Krugmann, S., Anderson, K. E., Ridley, S. H., Risso, N., McGregor, A., Coadwell, J.,
Davidson, K., Eguinoa, A., Ellson, C. D., Lipp, P., Manifava, M., Ktistakis, N., Painter,
G., Thuring, J. W., Cooper, M. A., Lim, Z. Y., Holmes, A. B., Dove, S. K., Michell, R. H.,
Grewal, A., Nazarian, A., Erdjument-Bromage, H., Tempst, P., Stephens, L. R., and
Hawkins, P. T. (2002). Identification of ARAP3, a novel PI3K effector regulating both Arf
and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell, 9,
95-108.
Lanoix, J., Ouwendijk, J., Lin, C. C., Stark, A., Love, H. D., Ostermann, J., and Nilsson, T.
(1999). GTP hydrolysis by arf-1 mediates sorting and concentration of Golgi resident
enzymes into functional COP I vesicles. EMBO J., 18, 4935-4948.
Lanoix, J., Ouwendijk, J., Stark, A., Szafer, E., Cassel, D., Dejgaard, K., Weiss, M., and
Nilsson, T. (2001). Sorting of Golgi resident proteins into different subpopulations of
COPI vesicles: a role for ArfGAP1. J. Cell Biol., 155, 1199-1212.
Letourneur, F., Gaynor, E. C., Hennecke, S., Demolliere, C., Duden, R., Emr, S. D., Riezman,
H., and Cosson, P. (1994). Coatomer is essential for retrieval of dilysine-tagged proteins to
the endoplasmic reticulum. Cell, 79, 1199-1207.
Lippincott-Schwartz, J., Cole, N. B., and Donaldson, J. G. (1998). Building a secretory
apparatus: role of ARF1/COPI in Golgi biogenesis and maintenance. Histochem. Cell
Biol., 109, 449-462.
Liu, X., Zhang, C., Xing, G., Chen, Q., and He, F. (2001). Functional characterization of
novel human ARFGAP3. FEBS Lett., 490, 79-83.
ARF GTPASE-ACTIVATING PROTEIN 1 155
19
Majoul, I., Sohn, K., Wieland, F. T., Pepperkok, R., Pizza, M., Hillemann, J., and Soling, H.
D. (1998). KDEL receptor (Erd2p)-mediated retrograde transport of the cholera toxin A
subunit from the Golgi involves COPI, p23, and the COOH terminus of Erd2p. J. Cell
Biol., 143, 601-612.
Majoul, I., Straub, M., Hell, S. W., Duden, R., and Soling, H. D. (2001). KDEL-cargo
regulates interactions between proteins involved in COPI vesicle traffic: measurements in
living cells using FRET. Dev. Cell, 1, 139-153.
Makler, V., Cukierman, E., Rotman, M., Admon, A., and Cassel, D. (1995). ADP-ribosylation
factor-directed GTPase-activating protein. Purification and partial characterization. J. Biol.
Chem., 270, 5232-5237.
Mandiyan, V., Andreev, J., Schlessinger, J., and Hubbard, S. R. (1999). Crystal structure of
the ARF-GAP domain and ankyrin repeats of PYK2-associated protein beta. Embo J., 18,
6890-6898.
Mazaki, Y., Hashimoto, S., Okawa, K., Tsubouchi, A., Nakamura, K., Yagi, R., Yano, H.,
Kondo, A., Iwamatsu, A., Mizoguchi, A., and Sabe, H. (2001). An ADP-ribosylation
factor GTPase-activating protein Git2-short/KIAA0148 is involved in subcellular
localization of paxillin and actin cytoskeletal organization. Mol. Biol. Cell, 12, 645-662.
Mironov, A. A., Beznoussenko, G. V., Nicoziani, P., Martella, O., Trucco, A., Kweon, H. S.,
Di Giandomenico, D., Polishchuk, R. S., Fusella, A., Lupetti, P., Berger, E. G., Geerts, W.
J., Koster, A. J., Burger, K. N., and Luini, A. (2001). Small cargo proteins and large
aggregates can traverse the Golgi by a common mechanism without leaving the lumen of
cisternae. J. Cell Biol., 155, 1225-1238.
Miura, K., Jacques, K. M., Stauffer, S., Kubosaki, A., Zhu, K., Hirsch, D. S., Resau, J.,
Zheng, Y., and Randazzo, P. A. (2002). ARAP1: a point of convergence for Arf and Rho
signaling. Mol. Cell, 9, 109-119.
Nassar, N., Hoffman, G. R., Manor, D., Clardy, J. C., and Cerione, R. A. (1998). Structures of
Cdc42 bound to the active and catalytically compromised forms of Cdc42GAP. Nat.
Struct. Biol., 5, 1047-1052.
Nickel, W., Sohn, K., Bunning, C., and Wieland, F. T. (1997). p23, a major COPI-vesicle
membrane protein, constitutively cycles through the early secretory pathway. Proc. Natl.
Acad. Sci., USA, 94, 11393-11398.
Orci, L., Stamnes, M., Ravazzola, M., Amherdt, M., Perrelet, A., Sollner, T. H., and
Rothman, J. E. (1997). Bidirectional transport by distinct populations of COPI-coated
vesicles. Cell, 90, 335-349.
Paris, S., Beraud-Dufour, S., Robineau, S., Bigay, J., Antonny, B., Chabre, M., and Chardin,
P. (1997). Role of protein-phospholipid interactions in the activation of ARF1 by the
guanine nucleotide exchange factor Arno. J. Biol. Chem., 272, 22221-22226.
Pelham, H. R. (2001). Traffic through the Golgi apparatus. J. Cell Biol., 155, 1099-1101.
Peyroche, A., Antonny, B., Robineau, S., Acker, J., Cherfils, J., and Jackson, C. L. (1999).
Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex:
involvement of specific residues of the Sec7 domain. Mol. Cell, 3, 275-285.
Poon, P. P., Cassel, D., Spang, A., Rotman, M., Pick, E., Singer, R. A., and Johnston, G. C.
(1999). Retrograde transport from the yeast Golgi is mediated by two ARF GAP proteins
with overlapping function. EMBO J., 18, 555-564.
Poon, P. P., Nothwehr, S. F., Singer, R. A., and Johnston, G. C. (2001). The Gcs1 and Age2
ArfGAP proteins provide overlapping essential function for transport from the yeast trans-
Golgi network. J. Cell Biol., 155, 1239-1250.
156
20 CASSEL
Poon, P. P., Wang, X., Rotman, M., Huber, I., Cukierman, E., Cassel, D., Singer, R. A., and
Johnston, G. C. (1996). Saccharomyces cerevisiae Gcs1 is an ADP-ribosylation factor
GTPase- activating protein. Proc. Natl. Acad. Sci., USA, 93, 10074-10077.
Premont, R. T., Claing, A., Vitale, N., Freeman, J. L., Pitcher, J. A., Patton, W. A., Moss, J.,
Vaughan, M., and Lefkowitz, R. J. (1998). beta2-Adrenergic receptor regulation by GIT1,
a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating
protein. Proc. Natl. Acad. Sci., USA, 95, 14082-14087.
Premont, R. T., Claing, A., Vitale, N., Perry, S. J., and Lefkowitz, R. J. (2000). The GIT
family of ADP-ribosylation factor GTPase-activating proteins. Functional diversity of
GIT2 through alternative splicing. J. Biol. Chem., 275, 22373-22380.
Puertollano, R., Randazzo, P. A., Presley, J. F., Hartnell, L. M., and Bonifacino, J. S. (2001).
The GGAs promote ARF-dependent recruitment of clathrin to the TGN. Cell, 105, 93-102.
Randazzo, P. A., Andrade, J., Miura, K., Brown, M. T., Long, Y. Q., Stauffer, S., Roller, P.,
and Cooper, J. A. (2000). The Arf GTPase-activating protein ASAP1 regulates the actin
cytoskeleton. Proc. Natl. Acad. Sci., USA, 97, 4011-4016.
Rein, U., Andag, U., Duden, R., Schmitt, H. D., and Spang, A. (2002). ARF-GAP-mediated
interaction between the ER-Golgi v-SNAREs and the COPI coat. J. Cell Biol., 157, 395-
404.
Rittinger, K., Walker, P. A., Eccleston, J. F., Smerdon, S. J., and Gamblin, S. J. (1997).
Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a
transition-state analogue. Nature, 389, 758-762.
Rothman, J. E., and Wieland, F. T. (1996). Protein sorting by transport vesicles. Science, 272,
227-234.
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmuller, L., Lautwein, A., Schmitz, F., and
Wittinghofer, A. (1997). The Ras-RasGAP complex: structural basis for GTPase
activation and its loss in oncogenic Ras mutants. Science, 277, 333-338.
Scheffzek, K., Ahmadian, M. R., and Wittinghofer, A. (1998). GTPase-activating proteins:
helping hands to complement an active site. Trends Biochem. Sci., 23, 257-262.
Schekman, R., and Orci, L. (1996). Coat proteins and vesicle budding. Science, 271, 1526-
1533.
Seewald, M. J., Korner, C., Wittinghofer, A., and Vetter, I. R. (2002). RanGAP mediates GTP
hydrolysis without an arginine finger. Nature, 415, 662-666.
Sohn, K., Orci, L., Ravazzola, M., Amherdt, M., Bremser, M., Lottspeich, F., Fiedler, K.,
Helms, J. B., and Wieland, F. T. (1996). A major transmembrane protein of Golgi-derived
COPI-coated vesicles involved in coatomer binding. J. Cell Biol., 135, 1239-1248.
Springer, S., Spang, A., and Schekman, R. (1999). A primer on vesicle budding. Cell, 97,
145-148.
Szafer, E., Pick, E., Rotman, M., Zuck, S., Huber, I., and Cassel, D. (2000). Role of coatomer
and phospholipids in GTPase-activating protein- dependent hydrolysis of GTP by ADP-
ribosylation factor-1. J. Biol. Chem., 275, 23615-23619.
Szafer, E., Rotman, M., and Cassel, D. (2001). Regulation of GTP hydrolysis on ADP-
ribosylation factor-1 at the Golgi membrane. J. Biol. Chem., 276, 47834-47839.
Tanigawa, G., Orci, L., Amherdt, M., Ravazzola, M., Helms, J. B., and Rothman, J. E. (1993).
Hydrolysis of bound GTP by ARF protein triggers uncoating of Golgi- derived COP-
coated vesicles. J. Cell Biol., 123, 1365-1371.
Teal, S. B., Hsu, V. W., Peters, P. J., Klausner, R. D., and Donaldson, J. G. (1994). An
activating mutation in ARF1 stabilizes coatomer binding to Golgi membranes. J. Biol.
Chem., 269, 3135-3138.
ARF GTPASE-ACTIVATING PROTEIN 1 157
21
Turner, C. E., Brown, M. C., Perrotta, J. A., Riedy, M. C., Nikolopoulos, S. N., McDonald, A.
R., Bagrodia, S., Thomas, S., and Leventhal, P. S. (1999). Paxillin LD4 motif binds PAK
and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein: A role in cytoskeletal
remodeling. J. Cell Biol., 145, 851-863.
Vitale, N., Patton, W. A., Moss, J., Vaughan, M., Lefkowitz, R. J., and Premont, R. T. (2000).
GIT proteins, A novel family of phosphatidylinositol 3,4, 5-trisphosphate-stimulated
GTPase-activating proteins for ARF6. J. Biol. Chem., 275, 13901-13906.
Wilson, D. W., Lewis, M. J., and Pelham, H. R. (1993). pH-dependent binding of KDEL to its
receptor in vitro. J. Biol. Chem., 268, 7465-7468.
Yu, S., and M. G. Roth. (2002). Casein kinase-I regulates membrane-binding by ARF GAP1.
Mol. Biol. Cell, 13, 2559-2570.
Zhang, C., Yu, Y., Zhang, S., Liu, M., Xing, G., Wei, H., Bi, J., Liu, X., Zhou, G., Dong, C.,
Hu, Z., Zhang, Y., Luo, L., Wu, C., Zhao, S., and He, F. (2000). Characterization,
chromosomal assignment, and tissue expression of a novel human gene belonging to the
ARF GAP family. Genomics, 63, 400-408.
Zhao, L., Helms, J. B., Brugger, B., Harter, C., Martoglio, B., Graf, R., Brunner, J., and
Wieland, F. T. (1997). Direct and GTP-dependent interaction of ADP ribosylation factor 1
with coatomer subunit beta. Proc. Natl. Acad. Sci., USA, 94, 4418-4423.
Zhao, L., Helms, J. B., Brunner, J., and Wieland, F. T. (1999). GTP-dependent binding of
ADP-ribosylation factor to coatomer in close proximity to the binding site for dilysine
retrieval motifs and p23. J. Biol. Chem., 274, 14198-14203.
Zhu, X., Boman, A. L., Kuai, J., Cieplak, W., and Kahn, R. A. (2000). Effectors increase the
affinity of ADP-ribosylation factor for GTP to increase binding. J. Biol. Chem., 275,
13465-13475.
Chapter 8
GIT PROTEINS: ARF GAPS AND SIGNALING
SCAFFOLDS
Abstract: GIT proteins are GTPase-activating proteins (GAPs) for the ADP-ribosylation
factor (Arf) family of GTPases. The two GIT family members, GIT1 and
GIT2, stimulate GTP hydrolysis on all the known Arf subtypes about equally
well, and this activity is stimulated by PI(3,4,5)P3. As such, GITs are negative
regulators of the cellular functions of Arfs, such as intracellular vesicle traffic
and cytoskeletal rearrangement. In addition, GITs form the core of a large
protein complex involved in integrating signals through multiple pathways,
involving G protein-coupled receptors, receptor tyrosine kinases, integrins,
and at least two classes of small GTP-binding proteins, the Arfs and
Rac/Cdc42, Rho families.
1. INTRODUCTION
GIT proteins are members of the fast-growing family of Arf GAP domain-
containing proteins, which presently has 22 known human members (Figure
1). Based on overall sequence similarity and domain organization, the
members of this family can be divided into two major subgroups that contain
subfamilies with multiple members. We classify these into the smaller
GAPs (Arf GAP1, Arf GAP3/Zfp289, RIP/Hrb, SMAP1/2, centaurin-
α1/α2), and the large, multidomain GAPs (GITs, ASAP1/PAP, ACAPs,
ARAPs, AGAPs). These proteins all share the ~100 amino acid
CX2CX16CX2C zinc finger-containing Arf GAP domain, although several
members have yet to be directly tested for GAP activity. In another
classification scheme, the centaurin subfamily of Arf GAPs has been
proposed for those Arf GAPs also containing ankyrin repeats and PH
domains, and includes two centaurin-α proteins, ASAP1/PAP (centaurin-
β’s), ACAPs (also centaurin-β’s), AGAPs (centaurin-γ’s) and ARAPs
159
160
2 SCHMALZIGAUG AND PREMONT
Figure 1. Mammalian Arf GAP Family Domain Structure. PBS, paxillin binding sequence;
PH, pleckstrin homology domain; Rho GAP, GTPase-activating protein domain for Rho
family small GTPases; SH3 Src homology type 3 domain; Spa2, region of homology with
yeast Spa2p and Sph1p
Over the past few years, GITs have been identified in several distinct
contexts by many laboratories. This has led to a wealth of information about
GITs on the one hand, and to multiple names and a confusing literature on
the other hand.
In short, there are only two GIT genes in humans or mouse, and two
identified GIT sequences from chicken. These sequences have been called
GIT1/Cat-1/p95-APP1 and GIT2/KIAA0148/Cat-2/p95-PKL/p95-APP2.
These are summarized in Table 1.
GITS: ARF GAPS AND SIGNALING SCAFFOLDS 1613
Table 1. GIT protein nomenclature. °Mouse Cat-1 was partially peptide sequenced, but not
cloned or fully sequenced. *PKL was originally reported as being a human cDNA sequence,
but has since been shown to be from chicken and identical to p95-APP2.
GIT1 GIT2 Species Reference
GIT1 Rat Premont et al., 1998
GIT1 GIT2 Human Premont et al., 2000
(Cat-1)º Cat-2 Mouse Bagrodia et al., 1999
PKL Chicken* Turner et al., 1999
p95APP1 Chicken Di Cesare et al., 2000
p95APP2 Chicken Paris et al., 2002
KIAA0148 Human Nagase et al., 1996
The initial discovery of the GIT proteins came from a search for G
protein-coupled receptor kinase 2 (GRK2) interacting proteins. In a yeast
two-hybrid screen, GRK2 was employed as the bait and a rat cDNA library
served as the prey. One positive clone was found to encode the C-terminus
of a previously unknown protein that was named GRK interactor 1, or GIT1
(Premont et al., 1998). The full-length rat GIT1 sequence was found to
contain an N-terminal zinc finger-like motif with similarity to the then
recently identified rat Arf GAP1 GAP domain (Cukierman et al., 1995),
suggesting that it too was a GAP for Arf proteins. Searching DNA databases
for rat GIT1-related sequences revealed two classes of GIT1-related
sequences: the human KIAA0148 sequence encoding a putative protein of
unknown function with high similarity to the first two-thirds of GIT1
(Nagase et al., 1995), and single human and mouse ESTs with similarity to
the extreme C-terminus of GIT1. Reverse transcriptase PCR revealed that
these two sequences were in fact derived from the same alternatively spliced
gene, and then named GIT2 (Premont et al., 2000).
GITs were next found in connection with two small GTPases, Rac1 and
Cdc42, and their effectors, the p21-activated protein kinases (PAKs).
Bagrodia et al. (1999) immunoprecipitated PAK3 from mouse fibroblasts
and co-purified a tyrosine phosphorylated protein of 95 kDa. Analysis of the
protein revealed an indirect binding to PAK3 via the PIX/Cool protein, a
guanine nucleotide exchange factor (GEF) for Rac and Cdc42. Because the
protein directly bound to Cool and was found to be tyrosine phosphorylated,
it was called Cool-associated tyrosine phosphorylated protein 1 or Cat-1.
From the limited peptide sequences obtained from this purified protein, it is
likely mouse GIT1. cDNA cloning based on Cat-1 peptide sequences
yielded the related mouse Cat-2 cDNA, the mouse ortholog of human GIT2
(Bagrodia et al., 1999). Zhao et al. (2000b) used a similar strategy to
identify GIT1 as a binding partner of PIX/Cool and PAK complexes. Both
GIT1 and GIT2 bind to PIX proteins, and indirectly to PAKs (Bagrodia et
al., 1999; Zhao et al., 2000b; Premont et al., 2000). Another study
investigated the link between membrane transport and Rac-mediated actin
162
4 SCHMALZIGAUG AND PREMONT
Human GIT1 and GIT2 proteins are encoded by two genes, located at
chromosome bands 17p11.2 and 12q24.1, respectively (Premont et al.,
2000). The two mouse GIT genes are located on chromosomes 1 and 5 (R.
T. Premont, unpublished observation). No additional GIT-like sequences
were detected in the human or mouse genomes. Chickens also appear to
have two GIT genes (Di Cesare et al., 2000; Paris et al., 2002). To date,
neither GIT gene locus has been associated with any disease. The human
GIT1 gene consists of 20 coding exons distributed over 15 kb. The mouse
GIT1 gene has 19 exons, as there is no intron separating the sequences
equivalent to human exons 13 and 14. The human and mouse GIT2 genes
have an identical structure of 21 coding exons spread over 50 kb. The
location of introns is highly conserved between the two GIT genes, with 18
introns inserted in equivalent positions in the two human and mouse
sequences (R. T. Premont, unpublished observations). In GIT1, an extra
exon is present in a non-conserved part of the C-terminus, and in GIT2, an
additional intron is present within the region encoding the second ankyrin
repeat, and the 21st exon encodes the C-terminal nine amino acids of the
GIT2-short splice variant (see below).
The presence of native GIT1 protein has only been reported for brain and
testes, as well as the HeLa, COS7 and CHOK1 cell lines (Zhao et al., 2000b;
Manabe et al., 2002). The GIT2-short protein has been detected in several
cell lines (U937, HeLa and NIH3T3 cells), with the highest levels in the
immunoderived Jurkat cell line (Mazaki et al., 2001). Neither a
comprehensive study of GIT1 and GIT2 protein expression in various
tissues, nor the identification of most of the multiple predicted GIT2 protein
variants has been reported so far. The main limitation to such a study has
been the lack of specific antibodies able to distinguish between GIT1 and
GIT2. Specific antibodies are crucial because the full-length forms have the
same molecular weight. Antibodies are commercially available from Santa
Cruz Biotechnology and Transduction Laboratories. The GIT1 and GIT2
antibodies from Santa Cruz do not appear to be very avid and give only faint
signals in immunoblots, although they do distinguish recombinant GIT1 and
GIT2. The GIT1 monoclonal antibody from Transduction Labs has good
specificity for GIT1 versus GIT2, but only weakly recognizes endogenous
levels of protein. The PKL monoclonal antibody from Transduction Labs
(raised against chicken GIT2) is fairly avid but not at all specific for
PKL/GIT2 versus GIT1 (R. T. Premont, unpublished observations). Thus,
for example, it remains unclear which GIT protein(s) is present in the Jurkat
T cell line, as detected with the PKL monoclonal antibody (Ku et al., 2001).
In GIT1, the GAP domain was the first functional domain characterized. It
was found by similarity to the two known Arf GAPs at the time, rat Arf
GAP1 and yeast Gcs1. All proteins that have been shown to have Arf GAP
activity share a conserved domain containing a CX2CX16CX2C zinc finger
(Figure 1). A second feature essential for GAP activity is an arginine
residue that has been suggested to serve as the ‘arginine finger’ that
enhances the rate of GTP hydrolysis by several orders of magnitude
(Scheffzyk et al., 1998). Mutation of either of the first two cysteine residues
of the zinc finger abolished GAP activity of Arf GAP1 (Cukierman, et al.,
1995). Mutation of this arginine residue in other Arf GAPs (Arf GAP1,
ASAP1/PAPα, ACAPs, ARAP1) results in ablation of GAP activity
(Mandiyan et al., 1999; Randazzo et al., 2000; Jackson et al., 2000a; Szafer
et al., 2000; Miura et al., 2002).
The GAP domain of GIT1 is located at the very N-terminus of the protein
and contains both the cysteine residues of the zinc finger followed by the
166
8 SCHMALZIGAUG AND PREMONT
essential arginine residue five amino acids downstream of the zinc finger
(Figure 2). The GAP domain of GIT2 has the conserved cysteines and
arginine at the exact same positions as in GIT1 (Premont et al., 2000).
Purified recombinant GIT1 and GIT2 contain stoichiometric amounts of zinc
(Vitale et al., 2000), and the X-ray crystal structure of the GAP domains of
rat Arf GAP1 and human β-PAP show a single zinc atom bound by the four
cysteine residues (Goldberg, 1999; Mandiyan et al., 1999).
Arf GAP1, GIT1 and GIT2 have very similar GAP activities, with GIT1
being slightly more potent than Arf GAP1 and GIT2, using Arf1 as a
substrate (Vitale et al., 2000). GITs promote GTP hydrolysis in all three
subtypes of Arfs with similar efficiency and thus do not show any obvious
enzymatic specificity. In contrast, Arf GAP1 stimulated the GTP hydrolysis
on Arf1-5, but had little effect on Arf6 (Vitale et al., 2000). The distinct
stimulation of Arfs by the different Arf GAP subtypes introduces a level of
specificity within the large GAP family.
The GAP activity of GIT1 is regulated by the phosphatidylinositiol 3,4,5-
trisphosphate (PI(3,4,5)P3) in vitro. The presence of PI(3,4,5)P3 increases
GAP activity of GIT1 3.5-fold and of GIT2 2-fold (Vitale et al., 2000). The
components of the in vitro assay were limited to the Arf1 and GIT proteins
and vesicles carrying PI(3,4,5)P3. Thus, it is likely that the stimulatory
effect of PI(3,4,5)P3 comes from lipid-dependent localization of Arf and GIT
to the vesicles. Stimulation of Arf GAP activity through a direct effect on
the Arf itself by PI(3,4,5)P3 is unlikely, as the GAP activity of Arf GAP1 is
not promoted by PI(3,4,5)P3 under identical assay conditions (Vitale et al.,
2000). However, GIT proteins do not have an obvious PH domain to bind to
PI(3,4,5)P3 (or PIP2) like many other Arf GAPs (Figure 1) (Jackson et al.,
2000b). The mechanism of regulation of the GIT GAP activity by
PI(3,4,5)P3 remains elusive. Perhaps GITs can interact with PI(3,4,5)P3
through sequences distinct from the PH domain, as reported for neurogranin
(Lu et al., 1997). It is interesting to note that various Arf GAPs are
stimulated by distinct sets of phosphoinositides and their metabolites; e.g.
Arf GAP1 activity is stimulated by PIP2 and diacylglycerol, ASAP1, β-PAP
and ACAPs by PIP2, and ARAPs by PI(3,4,5)P3 (Antonny et al., 1997;
Randazzo, 1997, Vitale et al., 2000; Jackson et al., 2000a; Krugmann et al.,
2002, Miura et al., 2002). The regulation of GAPs by distinct
phosphoinositides adds another level of specificity to the regulation of the
Arf GTPases by their GAPs.
The first GAP-dead mutant of GIT1 was made by deleting the 45 N-
terminal residues, including the cysteine residues of the zinc finger and the
conserved arginine residue. GIT1-¨45 failed to activate GTPase activity of
Arf1 (Premont et al., 1998). The single mutation of the conserved arginine
39 (to alanine) abolished the Arf GAP activity of GIT1 and GIT2 as well (R.
GITS: ARF GAPS AND SIGNALING SCAFFOLDS 1679
In the yeast Spa2 and Sph1 proteins, two short, near repeat units that also are
predicted to form a coiled-coil appear to mediate binding to the yeast MEK
proteins Mkk1, Mkk2 and Ste7 (Sheu et al., 1998; Roemer et al., 1998).
GIT1 and GIT2 contain Spa2 homology domains (SHD), consisting of two
30 amino acid near-repeat units separated by 30 residues. This region
appears to be the site by which GITs bind tightly to α- and β-PIX (Zhao et
al., 2000b), guanine nucleotide exchange factors (GEFs) for Rac1/Cdc42 as
well as major binding partners for the Rac1/Cdc42 p21-activated protein
kinases (PAKs) (Manser et al., 1998).
GIT1 fragments containing the SHD bind to β-PIX in protein overlay
assays (Zhao et al., 2000b). The GIT binding site was identified as the C-
terminal region of β-PIX using a variant of β-PIX (p50-Cool1) lacking the
C-terminal 200 residues, which failed to bind (Bagrodia et al., 1999), and in
two-hybrid assays (Premont et al., 2000). The GIT binding site was later
mapped to a 60 residue sequence within the C-terminus of β-PIX by direct
binding in overlay assays (Zhao et al., 2000b). Recently, a valine to alanine
point mutation within this region of β-PIX was reported to decrease GIT1
binding dramatically (Feng et al., 2002). In addition to PIX binding, the
SHD of GIT1 has been reported to interact directly with focal adhesion
168
10 SCHMALZIGAUG AND PREMONT
kinase (FAK) (Zhao et al., 2000b). The direct demonstration that these
SHDs mediate specific protein-protein interactions is currently lacking and
will make an important contribution to our understanding of signaling by
GIT1 and other SHD-containing proteins.
functions, and suggest that other multidomain Arf GAPs might also behave
similarly with their own specific partners.
4.6 Phosphorylation
Deletion of the C-terminal 120 amino acids (including the paxillin binding
site) of GIT1 caused the loss of paxillin binding and localization to focal
adhesions, while C-terminal fragments containing the paxillin-binding site
did localize to focal adhesions (Zhao et al., 2000b; Manabe et al., 2002;
Brown et al., 2002).
The interaction between paxillin and GIT1 is weak compared to the GIT-
PIX interaction, as overexpressed GIT1 can only pull-down a small fraction
of endogenous paxillin (Premont et al., 2000; Zhao et al., 2000b). Paxillin
binds GIT2 weaker than GIT1 (Premont et al., 2000), and the GIT2-short
variant even weaker (Mazaki et al., 2001). The weakness of these
interactions likely results from assays being performed on a mixed
population of cells, in which most cells were not spreading or migrating and
thus did not have GIT/PIX/PAK complexes stably bound to focal adhesions.
Co-expression of GIT1 and β-PIX was reported to enhance paxillin binding
to GIT1 (Zhao et al., 2000b). However, studies in my lab cannot confirm
this enhancing effect of PIX on the GIT-paxillin interaction in the same cell
system (R. T. Premont, unpublished observation). This putative interaction-
enhancing effect of PIX on the GIT-paxillin interaction has not been shown
to lead to enhanced localization to focal adhesions in cells. Thus, the effect
of PIX on GIT localization remains unclear.
Enhanced GIT1 localization to focal adhesions has been shown in three
cases. In the first case, expression of the PAK auto-inhibitory domain
peptide, PAK83-149, led to increased localization of PAK to focal adhesions
(Zhao et al., 2000a). The autoinhibitory domain eliminates PAK
autophosphorylation and prevents full activation (Zhao et al., 1998). The
autoinhibitory domain also enhanced the localization of GIT1 to focal
adhesions (Zhao et al., 2000b). The same effect of the PAK auto-inhibitory
domain was observed with GIT2 in CHO cells (Brown et al., 2002). In
contrast, a constitutively active form of PAK prevented GIT2 localization to
focal adhesions (Brown et al., 2002). These experiments provide evidence
that PAK kinase activity is an important regulator of the localization of GIT
proteins to focal adhesions.
In the other two cases, GIT localization to focal adhesions was stimulated
by constitutively active forms of the GTPases Rac1 (Manabe et al., 2002;
Brown et al., 2002) and Cdc42 (Brown et al., 2002). Constitutively active
Rac1 enhanced GIT1 and GIT2 localization to focal adhesions, while
dominant negative Rac1 had no effect on GIT localization (Manabe et al.,
2002; Brown et al., 2002). In addition, constitutively active Cdc42, but not
RhoA, enhanced GIT2 localization (Brown et al., 2002).
Overall, GIT proteins (in complex with PIX and presumably PAK) are
recruited to paxillin in focal adhesions both as the adhesions are forming and
as they are dissociating. Little GIT (or PIX or PAK) appears associated with
GITS: ARF GAPS AND SIGNALING SCAFFOLDS 173
15
GITs have been found associated with distinct plasma membrane domains.
In chicken embryonic fibroblasts, overexpressed GIT1/p95-APP1 localized
to the plasma membrane at sites of ruffling, along with actin, β1-integrin and
Arf6 (Di Cesare et al., 1999). GIT1 also localized to membrane ruffles in
neuroblastoma cells (Kawachi et al., 2001). Treatments stimulating ruffle
formation localized a C-terminal fragment of GIT1 to the plasma membrane,
where it co-localized with actin (Matafora et al., 2001). In COS7 cells,
GIT1 co-localized with paxillin to the plasma membrane (Zhao et al.,
2000b). GIT1 and a fragment consisting of the paxillin-binding site
localized to membrane ruffles at the leading edge of CHO cells (Manabe et
al., 2002). GIT2-short was found with actin and paxillin at the plasma
membrane (Mazaki et al., 2001).
GIT1 was also found in mobile, punctate structures in the cytosol
(Manabe et al., 2002). Localization to these structures required the presence
of the Spa2 homology domain of GIT1. Using specific markers of
intracellular compartments, these structures were shown to be of neither
endosomal nor Golgi nature. In addition to GIT1, these structures also
contained PIX, PAK and paxillin. In migrating cells, the structures moved
from the cytoplasm towards a pre-existing focal adhesion at the leading edge
of the cells. The reverse movement was found at the retracting side of the
cells, where the GIT1-containing structures moved away from adhesions
towards the cell center (Manabe et al., 2002). The authors conclude that this
represents a transport vesicle carrying GIT/PIX/PAK complexes to and from
sites of focal adhesion assembly and disassembly.
Overexpressed GIT fragments have been found associated with large
cytoplasmic vacuoles that are not seen in untransfected cells. Both N-
terminal and C-terminal fragments of GIT1 containing the SHD can be
found in such structures (Di Cesare et al., 1999). The large vacuoles were
later identified as large Rab11-positive vesicles (Matafora et al., 2001).
Rab11 is a marker for pericentriolar recycling endosomes. Deletion or
inactivation of the GAP domain also induced accumulation of GIT1 to
Rab11-positive structures (Matafora et al., 2001). These findings led to a
174
16 SCHMALZIGAUG AND PREMONT
6. GIT FUNCTIONS
Arf GAPs have been tested and do not alter β2AR sequestration (Claing et
al., 2001), suggesting a unique role for GIT proteins (perhaps through GRK
interaction) in regulating receptor trafficking. Arfs function primarily as
GTP-dependent regulators of vesicular traffic through vesicle coat
recruitment. Arfs are involved in regulating plasma membrane endocytosis,
from experiments in which transferrin receptor traffic is inhibited by Arf6
mutants unable to cycle between the GTP and GDP-bound states (D’Souza-
Schorey et al., 1995). The results with GITs suggested that Arfs, and most
likely Arf6, may be involved in regulating clathrin-coated pit-mediated
internalization of many GPCRs. Direct testing of these Arf6 mutants
revealed that they also inhibited the agonist-dependent sequestration of the
β2AR (Claing et al., 2001). Further, overexpression of the Arf GEF, ARNO,
which activates Arf6 in the cell, led to increased sequestration of the β2AR
(Claing et al., 2001). Thus, it appears that GITs and Arf6 are key regulators
of the recruitment of activated receptors (cargo) to clathrin-coated pits on the
cell surface for their subsequent internalization (see Chapter 15).
Changes in cell shape occur during cell spreading and the formation of
protrusions, and require changes in the cytoskeleton, the formation or
disassembly of focal adhesions and membrane expansion driven by
intracellular vesicle fusion with the leading edge of the cell. Cell spreading
appeared unaffected by GIT1 or a C-terminal fragment consisting of the
coiled-coil domain and the paxillin-binding site, but these same proteins
were found to promote the formation of cell protrusions (Di Cesare et al.,
1999; Manabe et al., 2002). Similarly, GIT2 lacking the PBS2 paxillin
binding region increased cell protrusions (West et al., 2001). However, the
paxillin- and Hic-5-binding fragment GIT1-CT was able to block Hic-5-
induced inhibition of cell spreading (Nishiya et al., 2002). The formation of
protrusions could be prevented by blockade of Rac cycling by dominant
active or negative mutants of Rac (Di Cesare et al., 2000). Co-expression of
178
20 SCHMALZIGAUG AND PREMONT
full-length GIT1 with Arf6 also inhibited cell spreading and caused cells to
retract (Di Cesare et al., 1999). Myristoylated GIT1, and particularly in
combination with β-PIX, induced a severe retraction leading to grossly
elongated cells resembling neurons (Zhao et al., 2000b). Overall, these
studies suggest that GITs are important in regulating a Rac- and PAK-
dependent pathway that requires paxillin-dependent localization, to initiate
cell protrusions. Although cell spreading appears to use the same
mechanisms, it is much less grossly affected by GIT proteins.
6.4 Signaling
PIX and PAK interact with each other but bind paxillin indirectly (Manser et
al., 1998). PKL/GIT2 was then discovered to bind directly to paxillin,
allowing PAK and PIX to indirectly link to paxillin through GITs (Turner et
al., 1999). This GIT/PIX/PAK complex has been found in several situations
and cell lines, and can contain GIT1 or GIT2, α-PIX or β-PIX, and PAK1,
PAK2 or PAK3 (Bagrodia et al., 1999; Premont et al., 2000, Di Cesare et al.,
1999; Ku et al., 2001; Turner et al., 1999). This GIT/PIX/PAK complex can
bind to active Rac1•GTP but not Rac1•GDP (Di Cesare et al., 1999, Paris et
al., 2002). One report, however, suggests that PAK binds directly to paxillin
(Hashimoto et al., 2001), although a mutant of PAK that cannot interact with
PIX also fails to co-immunoprecipitate paxillin (R. T. Premont, unpublished
observation).
The GIT/PIX/PAK complex provides a versatile signaling module to
cells. This complex contains a GAP for Arfs, a GEF for the Rac1/Cdc42
GTPases, and a serine/threonine kinase regulated by Rac1/Cdc42. Activated
Rac1/Cdc42 can also associate with the complex, and the complex can
activate these small GTP-binding proteins. This suggests that recruitment of
this complex to sites within the cell will lead to a local shift from Arf- to
Rac1/Cdc42-dependent pathways, as Arf6 would be deactivated while
Rac1/Cdc42 would be activated. As mentioned earlier, our recent
experiments indicate that GIT and PIX proteins form a tightly associated
oligomeric complex containing multiple GIT and PIX monomers (R. T.
Premont, unpublished observation). This oligomer appears to be at least a
heterotetramer, and may well be far larger. One GIT monomer does not
bind to only one PIX monomer, and the tight association of this oligomeric
GIT–PIX complex suggests that these proteins likely do not dissociate in the
cell but form a stable multiprotein complex. In any case, one clear result of
this oligomeric model is that GIT–PIX complexes should function by
spatially augmenting the activity of the GIT (Arf GAP) and PIX
(Rac1/Cdc42 GEF) proteins through the colocalization of multiple enzyme
GITS: ARF GAPS AND SIGNALING SCAFFOLDS 179
21
7. FUTURE PROSPECTS
GITs have been identified in several distinct cellular contexts. The major
challenge is in understanding how these apparently distinct functions are
integrated. The realization that GIT and PIX proteins are tightly associated
in oligomeric complexes raises many questions about the role of this
association in both what had been thought to be the distinct functions of the
GIT and PIX proteins, and in how this association regulates and integrates
the separate activities of these two GTPase regulators. Further experiments
are necessary to understand the many facets of this complex, including:
defining the structure of the complex, identifying the full set of associated
proteins, understanding the regulation of the localization of the GIT–PIX
complex and its associated proteins, and defining the crosstalk among the
many signaling pathways that intersect within or around this complex.
With regard to regulation of Arf proteins, it seems clear that GITs mainly
regulate Arf6 in the cell. This stems primarily from co-localization, rather
than any enzymatic specificity of the GAP domain for any particular Arf
subtype. The GAP activity is activated in vitro by PI(3,4,5)P3, which is an
intracellular messenger activated by many signaling pathways. The cellular
regulation of GITs by PI(3,4,5)P3 and its role in GIT function in vivo
remains to be shown. It seems clear that GIT and Arf6 are important in
regulating the formation of vesicles containing activated receptors from cell
surface clathrin-coated pits. Whether GITs have other roles in transport
processes is unknown, although recent video microscopy of GIT complexes
shuttling about in cells (Manabe et al., 2002) suggests that this is true.
180
22 SCHMALZIGAUG AND PREMONT
REFERENCES
Antonny, B., Huber, I., Paris, S., Chabre, M., and Cassel, D. (1997). Activation of ADP-
ribosylation factor 1 GTPase-activating protein by phosphatidylcholine-derived
diacylglycerols. J. Biol. Chem., 272, 30848-30851.
Bagrodia, S., Bailey, D., Lenard, Z., Hart, M., Guan, J. L., Premont, R. T., Taylor, S. J., and
Cerione, R. A. (1999). A tyrosine-phosphorylated protein that binds to an important
regulatory region on the Cool family of p21-activated kinase-binding proteins. J. Biol.
Chem., 274, 22393-22400.
Brown, M. C., West, K. A., and Turner, C. E. (2002). Paxillin-dependent paxillin kinase
linker and p21-activated kinase localization to focal adhesions involves a multi-step
activation pathway. Mol. Biol. Cell, 13, 1550-65.
Claing, A., Perry, S. J., Archilio, M., Walker, J. K. L., Albanesi, J. P., Lefkowitz, R. J., and
Premont, R. T. (2000). Multiple endocytic pathways of G protein-coupled receptors
delineated by GIT1 sensitivity. Proc. Natl. Acad. Sci., USA, 97, 1119-24.
Claing, A., Chen, W., Miller, W. E., Vitale, N., Moss, J., Premont, R. T., and Lefkowitz, R. J.
(2001). β-Arrestin-mediated ADP-ribosylation factor 6 activation and β2-adrenergic
receptor endocytosis. J. Biol. Chem., 276, 42509-13.
Cukierman, E., Huber, I., Rotman, M., and Cassel, D. (1995). The ARF1 GTPase-activating
protein: zinc finger motif and Golgi complex localization. Science, 270: 1999-2002.
de Curtis, I. (2001). Cell migration: GAPs between membrane traffic and the cytoskeleton.
EMBO Reports, 2, 277-281
GITS: ARF GAPS AND SIGNALING SCAFFOLDS 181
23
Di Cesare, A., Paris, S., Albertinazzi, C., Dariozzi, S., Andersen, J., Mann, M., Longhi, R.,
and de Curtis, I. (2000). p95-APP1 links membrane transport to Rac-mediated
reorganization of actin. Nature Cell Biol., 2, 521-530.
D’Souza-Schorey, C., Li, G., Colombo, M. I., and Stahl, P. D. (1995). A regulatory role for
ARF6 in receptor-mediated endocytosis. Science, 267, 1175-1178.
Feng, Q., Albeck, J. G., Cerione, R. A., and Yang, W. (2002). Regulation of the Cool/Pix
proteins. J. Biol. Chem., 277, 5644-5650.
Goldberg, J. (1999). Structural and functional analysis of the ARF1-ARFGAP complex
reveals a role for coatomer in GTP hydrolysis. Cell, 96, 893-902.
Hashimoto, S., Tsubouchi, A., Mazaki, Y., and Sabe, H. (2001). Interaction of paxillin with
p21-activated kinase (PAK). J. Biol. Chem., 276, 6037-6045.
Jackson, T. R., Brown, F. D., Nie, Z., Miura, K., Foroni, L., Sun, J., Hsu, V. W., Donaldson,
J. G., and Randazzo, P. A. (2000a). ACAPs are Arf6 GTPase-activating proteins that
function in the cell periphery. J. Cell. Biol., 151, 627-638.
Jackson, T. R., Kearns, B. G., and Theibert, A. B. (2000b). Cytohesins and centaurins:
mediators of PI 3-kinase-regulated Arf signaling. Trends Biochem. Sci., 25, 489-495.
Kawachi, H., Fujikawa, A., Maeda, N., and Noda, M. (2001). Identification of GIT1/Cat-1 as
a substrate molecule of protein tyrosine phosphatase ζ/β by the yeast substrate-trapping
system. Proc. Natl. Acad. Sci., USA, 98, 6593-6598.
Kim, S., Lee, S.-H., and Park, D. (2001). Leucine zipper-mediated homodimerization of the
p21-activated kinase-interacting factor, βPIX. J. Biol. Chem., 276, 10581-10584.
Koh, C.-G., Tan, E.-J., Manser, E., and Lim, L. (2002). The p21-activated kinase PAK is
negatively regulated by POPX1 and POPX2, a pair of serine/threonine phosphatases of the
PP2C family. Current Biol., 12, 317-321.
Krugmann, S., Anderson, K. E., Ridley, S. H., Risso, N., McGregor, A., Coadwell, J.,
Davidson, K., Eguinoa, A., Ellson, C. D., Lipp, P., Manifava, M., Ktistakis, N., Painter,
G., Thuring, J. W., Cooper, M. A., Lim, Z.-Y., Holmes, A. B., Dove, S. K., Michell, R. H.,
Grewal, A., Nazarian, A., Erdjument-Bromage, H., Tempst, P., Stephens, L. R., and
Hawkins, P. T. (2002). Identification of ARAP3, a novel PI3K effector regulating both Arf
and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell, 9,
95-108.
Ku, G. M., Yablonski, D., Manser, E., Lim, L., and Weiss, A. (2001). A PAK1-PIX-PKL
complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT. EMBO
J., 20, 457-465.
Lefkowitz, R.J. (1998). G protein-coupled receptors. J. Biol. Chem., 273, 18677-18680.
Lefkowitz, R. J. (2000). The superfamily of heptahelical receptors. Nature Cell Biol., 2,
E133-E136.
Lu, P.J., and Chen, C.S. (1997). Selective recognition of phosphatidylinositol 3,4,5-
trisphosphate by a synthetic peptide. J. Biol. Chem., 272, 466-472.
Manabe, R., Kovalenko, M., Webb, D., and Horwitz, A. R. (2002). GIT1 functions in a
motile, multi-molecular signaling complex that regulates protrusive activity and cell
migration. J. Cell Sci., 115, 1497-1510.
Mandiyan, V., Andreev, J., Schlessinger, J., and Hubbard, S. R. (1999). Crystal structure of
the ARF-GAP domain and ankyrin repeats of PYK2-associated protein beta. EMBO J., 18,
6890-6898.
Manser, E., Loo, T.-H., Koh, C.-G., Zhao, Z.-S., Chen, X.-Q., Tan, L., Tan, I., Leung, T., and
Lim, L. (1998). PAK kinases are directly coupled to the PIX family of nucleotide
exchange factors. Mol. Cell, 1, 183-192.
Matafora, V., Paris, S., Dariozzi, S., and de Curtis, I. (2001). Molecular mechanisms
regulating the subcellular localization of p95-APP1 between the endosomal recycling
182
24 SCHMALZIGAUG AND PREMONT
compartment and sites of actin organization at the cell surface. J. Cell Sci., 114, 4509-
4520.
Mazaki, Y., Hashimoto, S., Okawa, K., Tsubouchi, A., Nakamura, K., Yagi, R., Yano, H.,
Kondo, A., Iwamatsu, A., Mizoguchi, A., and Sabe, H. (2001). An ADP-ribosylation
factor GTPase-activating protein GIT2-short/KIAA0148 is involved in subcellular
localization of paxillin and actin cytoskeletal organization. Mol. Biol. Cell, 12, 645-662.
McCarty, J. H. (1998). The Nck SH2/SH3 adaptor protein: a regulator of multiple
intracellular signal transduction events. BioEssays, 20, 913-921.
Meng, K., Rodriguez-Pena, A., Dimitrov, T., Chen, W., Yamin, M., Noda, M., and Deuel,
T.F. (2000). Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through
inactivation of the intrinsic catalytic activity of the receptor-type protein phosphatase β/ζ.
Proc. Natl. Acad. Sci., USA, 97, 2603-2608.
Miura, K., Jacques, K. M., Stauffer, S., Kubosaki, A., Zhu, K., Hirsch, D. S., Resau, J.,
Zheng, Y., and Randazzo, P. A. (2002). ARAP1: a point of convergence for Arf and Rho
signaling. Mol. Cell, 9, 109-119.
Nagase, T., Seki, N., Tanaka, A., Ishikawa, K., and Nomura, N. (1995). Prediction of the
coding sequences of unidentified human genes. DNA Res., 2, 167-174.
Nishiya, N., Shirai, T., Suzuki, W. and Nose, K. (2002). Hic-5 interacts with GIT1 with a
different binding mode from paxillin. J. Biochem., 132, 279-289.
Norman, J. C., Jones, D., Barry, S. T., Holt, M. R., Cockcroft, S., and Critchley, D. R. (1998).
ARF1 mediates paxillin recruitment to focal adhesions and potentiates Rho-stimulated
stress fiber formation in intact and permeabilized Swiss 3T3 fibroblasts. J. Cell Biol., 143,
1981-1995.
Paris, S., Za, L., Sporchia, B., and de Curtis, I. (2002). Analysis of the subcellular distribution
of avian p95-APP2, an ARF-GAP orthologous to mammalian paxillin kinase linker. Int. J.
Biochem. Cell Biol., 34, 826-837.
Pierce, K. L., Premont, R. T., and Lefkowitz, R. J. (2002). Seven-transmembrane receptors.
Nature Rev. Mol. Cell Biol., 3, 639-650.
Pitcher, J. A., Friedman, N. J. and Lefkowitz, R. J. (1998). G protein-coupled receptor
kinases. Ann. Rev. Biochem., 67, 653-692.
Premont, R. T., Claing, A., Vitale, N., Freeman, J. L. R., Pitcher, J. A., Patton, W. A., Moss,
J., Vaughan, M., and Lefkowitz, R. J. (1998). β2-Adrenergic receptor regulation by GIT1,
a G protein-coupled receptor kinase-associated ADP-ribosylation factor GTPase-activating
protein. Proc. Natl. Acad. Sci., USA, 95, 14082-14087.
Premont, R. T., Claing, A., Vitale, N., Perry, S. J., and Lefkowitz, R. J. (2000). The GIT
family of ADP-ribosylation factor GTPase-activating proteins. J. Biol. Chem., 275, 22373-
22380.
Randazzo, P. A. (1997). Resolution of two ADP-ribosylation factor 1 GTPase-activating
proteins from rat liver. Biochem. J., 324, 413-419.
Randazzo, P. A., Andrade, J., Miura, K., Brown, M. T., Long, Y.-Q., Stauffer, S., Roller, P.,
and Cooper, J. A. (2000). The Arf GTPase-activating protein ASAP1 regulates the actin
cytoskeleton. Proc. Natl. Acad. Sci., USA, 97, 4011-4016.
Roemer, T., Vallier, L., Sheu Y.J., and Snyder, M. (1998). The Spa2-related protein, Sph1p,
is important for polarized growth in yeast. J. Cell. Sci., 111, 479-494.
Scheffzek, K., Ahmadian, M. R., and Wittinghofer, A. (1998). GTPase-activating proteins:
helping hands to complement an active site. Trends Biochem. Sci., 23, 257-262.
Sheu, Y. J., Santos, B., Fortin, N., Costigan, C., and Snyder, M. (1998). Spa2p interacts with
cell polarity proteins and signaling components involved in yeast morphogenesis. Mol.
Cell Biol., 18, 4053-4069.
GITS: ARF GAPS AND SIGNALING SCAFFOLDS 183
25
Szafer, E., Pick, E., Rotman, M., Zuck, S., Huber, I., and Cassel, D. (2000). Role of coatomer
and phospholipids in GTPase-activating protein-dependent hydrolysis of GTP by ADP-
ribosylation factor-1. J. Biol. Chem., 275, 23615-23619.
Tumbarello, D. A., Brown, M. C., and Turner, C. E. (2002). The paxillin LD motifs. FEBS
Lett., 513, 114-118.
Turner, C. E., Brown, M. C., Perrotta, J. A., Riedy, M. C., Nikolopoulos, S. N., McDonald, A.
R., Bagrodia, S., Thomas, S., and Leventhal, P. S. (1999). Paxillin LD4 motif binds PAK
and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein. J. Cell Biol., 145, 851-
863.
Turner, C. E., West, K. A., and Brown, M. C. (2001). Paxillin-ARF GAP signaling and the
cytoskeleton. Current Opin. Cell Biol., 13, 593-599.
Vitale, N., Patton, W. A., Moss, J., Vaughan, M., Lefkowitz, R. J., and Premont, R. T. (2000).
GIT proteins, a novel family of phosphatidylinositol 3,4,5-trisphosphate-stimulated
GTPase-activating proteins for ARF6. J. Biol. Chem., 275, 13901-13906.
Webb, D. J., Parsons, J. T., and Horwitz, A. F. (2002). Adhesion assembly, disassembly and
turnover in migrating cells - over and over and over again. Nature Cell Biol., 4, E97-100.
West, K. A., Zhang, H., Brown, M. C., Nikolopoulos, S. N., Riedy, M. C., Horwitz, A. R.,
and Turner, C. E. (2001). The LD4 motif of paxillin regulates cell spreading and motility
through interaction with paxillin kinase linker. J. Cell Biol., 154, 161-176.
Yoshii, S., Tanaka, M., Otsuki, Y., Wang, D.-Y., Guo, R.-J., Zhu, Y., Takeda, R., Hanai, H.,
Kaneko, E., and Sugimura, H. (1999). αPIX nucleotide exchange factor is activated by
interaction with phosphatidylinositol 3-kinase. Oncogene, 18, 5680-5690.
Zhao, Z.-S., Manser, E., Chen, X.-Q., Chong, C., Leung, T., and Lim, L. (1998) A conserved
negative regulatory region in αPAK. Mol. Cell. Biol., 18, 2153-2163.
Zhao, Z.-S., Manser, E., and Lim, L. (2000a) Interaction between PAK and Nck. Mol. Cell.
Biol., 20, 3906-3917.
Zhao, Z.-S., Manser, E., Loo, T.-H., and Lim, L. (2000b). Coupling of PAK-interacting
exchange factor PIX to GIT1 promotes focal complex disassembly. Mol. Cell. Biol., 20,
6354-6363.
Chapter 9
PAXILLIN-ASSOCIATED ARF GAPS
Their Isoform Specificities and Roles in Coordination
HISATAKA SABE
Department of Molecular Biology, Osaka Bioscience Institute, Osaka, Japan
1. INTRODUCTION
In this chapter, PAG1 is called APAP2, and PAG2 and PAG3 are called
AMAP1 and AMAP2, respectively, following the proposed unified naming
of ArfGAPs. Other ArfGAPs are also called accordingly.
Figure 1. Arf GAP proteins in human genome. The class I and class II paxillin-associated
Arf GAPs are indicated on the right, with the paxillin-binding regions underlined.
may interact with the N-terminus of Arfs or with the PH domains of the Arf
GAPs, when present (see Chapter 3 for details).
Biochemical assays were also performed in vivo. Mammalian cells,
overexpressing epitope-tagged Arfs and Arf GAPs were labeled with
radioactive orthophosphate. Tagged Arfs were subsequently pulled-down
and bound radiolabeled nucleotides analysed by thin layer chromatography.
With this assay, AMAP1 again appeared to exhibit GAP activity for Arf1,
but not for Arf6 (Furman et al., 2002).
Biochemical assays have verified the presence of Arf GAP activity in every
paxillin-associated Arf GAP. However, in vitro GAP assays often show
relatively broad specificity that can be contradictory to results obtained from
in vivo studies (e.g., see Settleman et al., 1992 for p190RhoGAP; Ridley et
al., 1993 for rhoGAP-C). Moreover, given the known abilities of other
proteins (e.g., COPI, see below) or lipids (see Chapter 3) to dramatically
alter Arf GAP activities and the potential loss of specificity inherent in the
use of purified proteins, it seems to be important to define Arf GAP
activities and specificities in a cellular context whenever possible. Of
course, the value of such data from intact cells must be weighed against the
dangers of using modified and overexpressed proteins. In this section I
describe several cell biological approaches to assay Arf GAP activities for
the paxillin binding Arf GAPs. The in vivo specificity of these Arf GAPs
was verified using mutants within the GAP domains (Cukierman et al.,
1995) as negative controls in each experiment.
A cell based approach to assaying the GAP activity for Arf1 involved
analyzing the subcellular localization of β-COP, a subunit of the COPI coat
that is involved in shuttling of vesicles between the Golgi and ER
compartments. Activated Arf1 specifically recruits COPI to the appropriate
intracellular membrane. Thus, β-COP can be an excellent marker for the
intracellular activity of Arf1; it is diffusely redistributed in the cytosol when
Arf1 is inactivated (Peters et al., 1995; Ooi et al., 1998). This redistribution
is specific to Arf1, and is not seen by inactivation of Arf5 or Arf6.
Overexpression of APAP2-short caused the redistribution of β-COP in
fibroblasts (Mazaki et al., 2001). This redistribution was suppressed by co-
expression of the GTP hydrolysis-deficient form of Arf1, Arf1-L67. On the
other hand, overexpression of AMAP2 did not exert such an effect on β-
COP (Andreev et al., 1999; Kondo et al., 2000).
A second cell biological assay involved analysis of the GAP activity for
Arf6. The class III Arf, Arf6, but not class I or II Arfs, is involved in Fcγ
receptor-mediated phagocytosis in macrophage cells (Zhang et al., 1998).
PAXILLIN-ASSOCIATED ARF-GAPS 1917
The results described above from biochemical and cell biological assays are
not consistent with each other. One of the critical questions is why AMAP2
does not exhibit GAP activity for Arf6 when measured in vitro, although it
acts as an efficient GAP for Arf6 in vivo. This issue is discussed further
below.
Protein pull-down assays have demonstrated that the GEF domains of
several GEF proteins, such as intersectin, can selectively and stably bind to
their substrate GTPases in their GDP bound forms (Hart et al., 1994;
Hussain et al., 2001). In the case of the GAP proteins, on the other hand,
assessment of their substrates by a similar method has not been applicable,
because the binding sites for the GAPs and effectors on Ras family GTPases
have been shown to largely overlap (Goldberg, 1999), which may result in
large areas of their GAP binding domains being occluded by effectors, and
therefore unavailable for being pulled-down efficiently by exogenously
expressed GAP domains. Moreover, GTP bound to GTPases may quickly
be hydrolysed upon binding to their GAPs in vivo so that GAPs cannot bind
stably to the GTPases. However, it has been proposed that the binding sites
for the GAPs and coatomers or other effectors do not overlap in Arf1
(Goldberg, 1999). These observations may explain the success in the use of
pull-down assays with at least one Arf GAP and Arfs. AMAP2 was found to
PAXILLIN-ASSOCIATED ARF-GAPS 1939
bind stably to wild type Arf6 in vivo, but not to other Arfs, in cells
overexpressing all of these proteins (S. Hashimoto and H. Sabe, unpublished
observation). The presence of divalent cations did not affect the binding.
Moreover, the Arf GAP domain of AMAP2 selectively bound Arf6-L67, but
not Arf6-N27 in vitro. Consistent with this, AMAP2 was efficiently
recruited to the plasma membrane by activated Arf6, but not by other Arfs,
and both proteins colocalize stably at the plasma membrane of these
transfected cells (S. Hashimoto and H. Sabe, unpublished observation).
Therefore, it is conceivable that this 'non-catalytic' and stable binding of
AMAP2 to Arf6 prevents AMAP2 from exhibiting efficient catalytic activity
against Arf6, when measured using the above mentioned biochemical
method.
The fact that AMAP2 can bind stably to Arf6•GTP without hydrolyzing the
GTP appears to be consistent and analogous to a current model for the
interaction of Arf GAP1 with Arf1. Arf1 is the best studied of the Arf
isoforms, and may provide some insight into the mechanism of regulation of
the other Arf isoforms. Arf1 mediates transport between the ER and Golgi
by employing coat protein complexes, such as COPI (Roth, 1999). GAP
molecules for Arf1 are found as components of a priming complex induced
by Arf1-GTP in the COPI system (Schekman and Orci, 1996). The GTPase
activity of other small GTPases, such as Ras and Rho, is accelerated
dramatically upon binding to their cognate GAPs. With these protein
complexes, the ‘arginine finger’ model has been proposed, in which the
corresponding GAP supplies a critical arginine, which hydrogen bonds to the
γ-phosphate of GTP and stabilizes the transition state (Scheffzek et al.,
1998). In contrast to this model, Goldberg (1999) has proposed that
Arf1/ArfGAP1 constitutes only part of the usual protein-binding interface,
and that the key residue(s) required for maximal rates of GTP hydrolysis,
like the 'arginine finger' in the case of other GAPs, may not be provided by
ArfGAP1. Rather, further association with the coatomer and/or
accumulation of the coatomer with the Arf1/ArfGAP1 complex may be
required for the maximal catalytic activity of the Arf1/ArfGAP1 complex.
This model may explain why ArfGAP1 by itself does not function as an
efficient catalytic GAP upon binding to Arf1•GTP (Roth, 1999; Springer et
al., 1999). It should be noted, however, that there are several reports
apparently contradictory to this model, which suggest that the coatomer may
simply aid the productive association of Arf and ArfGAP (Mandiyan et al.,
1999; Szafer et al., 2000; Eugster, et al., 2000). Nevertheless, a recent
194
10 SABE
The paxillin-associated Arf GAPs of the APAP group, Git1, Git2, and Git2-
short, are orthologs of murine Cat-1 and Cat-2 and their splice variants,
identified as Cool/Pix binding proteins (Bagrodia and Cerione, 1999).
Cool/Pix proteins were identified as binding to Pak (p21-activated
serine/threonine kinase; Manser et al., 1998; Bagrodia et al., 1998); a kinase
activated by GTP-bound Cdc42 or Rac1 (Manser et al., 1994). Binding of
Cool/Pix to Pak also activates its kinase activity, either by cooperating with
the binding of activated Cdc42 or Rac or by altering Pak conformation
directly. There are several isoforms of Cool/Pix proteins, p50Cool-1,
p85Cool-1/βPix and Cool-2/αPix, and all contain the Dbl-homology (DH)
domain that can activate Rho family members by stimulating guanine
nucleotide exchange (Bagrodia and Cerione, 1999). p85Cool-1/βPix
increases GTP binding to Rac but not Cdc42 (Manser et al., 1998) and Cool-
2/αPix may increase the levels of GTP-bound Cdc42 (Daniels et al., 1999).
On the other hand, in vitro measurements of Cool/Pix-catalyzed GDP release
from small GTPases have failed to detect any exchange activity (Bagrodia et
al., 1998), suggesting that additional factors may be required for this
exchange activity (Bagrodia and Cerione, 1999).
Chicken APAP2, p95PKL, was identified as a paxillin-binding protein at
the same time that Cat proteins and Cool/Pix proteins were identified, and
was originally proposed to be a protein kinase-linker (PKL). p95PKL plays
a role in connecting paxillin to Pak through Pix: i.e., paxillin binds to
p95PKL, p95PKL to Pix, and Pix to Pak in a linear configuration (Turner et
al., 1999). APAP2 and its short isoform in other species also bind to both
Cool-2/αPix and p85Cool-1/βPix (Premont et al., 2000; Hashimoto et al.,
2001; Mazaki et al., 2001). Given that the binding of Pix to Pak activates its
196
12 SABE
kinase activity, the above model implies that the connection of Pak with
paxillin may be activated together with activation of the kinase activity of
Pak. Paxillin can associate with both the kinase-inactive and the Cdc42-
activated forms of Pak3 in vivo, in which the kinase activities were assayed
by phosphorylation of myelin basic protein in vitro (Hashimoto et al., 2001).
Nck, an adaptor protein, binds directly to Pak1 to link Pak1 to growth factor
receptors (Galisteo et al., 1996; Bockoch et al., 1996; Lu et al., 1997; Zhao
et al., 2000). Nck binding to Pak1 had no stimulatory effect on Pak1 kinase
activity, and it did not alter the ability of Pak1 to be stimulated by activated
Rac or Cdc42. Pak1 can phosphorylate Nck. Hashimoto, et al. (2001) have
shown that the biochemical properties of the binding of paxillin to Pak are
similar to those ascribed to Nck: paxillin can bind directly to Pak without
affecting its kinase activity, and can be phosphorylated by Pak3. Moreover,
paxillin and Nck exhibit comparable affinities and bind competitively to
Pak3. Therefore, paxillin appears to function as a template linking integrin
to Pak, as Nck links growth factors to Pak (Hashimoto et al., 2001).
Therefore, there seem to be at least two different ways in which paxillin and
Pak can associate: one is through the aid of APAP2 , in which Paks may be
activated by binding to Pix, and the other is direct, in which Paks can either
remain inactive or be activated by Cdc42 or Rac1.
Chicken APAP2 and paxillin colocalize to focal adhesions, and are
connected to stress fibers, at the edges of CHO.K1 fibroblast cells (Turner et
al., 1999; Brown et al., 2002). On the other hand, human APAP2-short
primarily localize to perinuclear areas in 3Y1 and NIH3T3 fibroblasts,
largely overlapping with paxillin as well as β-COP (Mazaki et al., 2001).
However, AMAP2-short does not accumulate at focal adhesions in 3Y1 and
NIH3T3 fibroblasts, while a fraction colocalizes with paxillin at focal
complexes of lamellipodia (Mazaki et al., 2001). The cell morphology
induced by overexpression of Git2-short is similar to that induced by active
Rac1, exhibiting active membrane ruffles with concomitant substantial loss
of actin stress fibers and focal adhesions (Mazaki et al., 2001). Consistently,
rat p78Pix, a homolog of human p85Cool-1/βPix, and paxillin colocalize to
Cdc42 and Rac1-induced focal complexes in HeLa cells (Manser et al.,
1998). In CHO.K1 cells, on the other hand, APAP2 was recruited to focal
adhesions connected to stress fibers, by the expression of activated Cdc42
and Rac1, but not RhoA (Brown et al., 2002). These data suggest that focal
adhesions may be regulated differently in CHO.K1 cells compared to 3Y1 or
NIH3T3 cells. Accumulation of APAP1 to adhesion-like structures, which
apparently resemble focal adhesions, was also observed in REF52 fibroblast
cells (Manabe et al., 2002). It has also been shown that paxillin plays a role
in recruiting APAP2 and Pak to focal adhesions in CHO.K1 cells (Brown et
al., 2002). On the other hand, it is yet to be clarified as to whether APAP1
PAXILLIN-ASSOCIATED ARF-GAPS 197
13
4. PROSPECT
In this chapter, we have focused on the Arf GAPs that bind paxillin, and
described their isoform specificity and roles in cytoskeletal remodeling and
membrane remodeling. The latter two are coordinately regulated during
integrin-mediated cell adhesion, migration and intracellular signaling. An
important distinction that emerges from the results described is that the
paxillin binding Arf GAPs fall into two groups. One, the APAPs, has
specificity for class I Arfs (e.g., Arf1) and cellular roles in membrane traffic
and ruffling at the leading edge of motile cells. The other, the AMAPs, is
active on Arf6 in cell-based Arf GAP assays and coordinates effects on
endocytosis and recycling at the plasma membrane and on membrane
protrusions in motile cells (see Figure 2).
Migrating cells secrete proteins, such as cytokines and membrane
metalloproteases, at the leading edges of cells. The APAPs, exhibiting a
GAP activity for Arf1, localize both at the cell periphery and perinuclear
areas, and bind Pix proteins, that contain Rac/Cdc42 GEF activity and bind
Paks. Arf1 plays important roles in the secretion of newly synthesized
proteins, and Cdc42 and Rac1 are important in polarity and membrane
transport. I speculate that these Arf GAPs may be able to influence the
determination of the cell polarity or movements, as mentioned earlier.
Moreover, Cdc42 and Rac1 appear to be activated at the perinuclear areas, in
addition to the cell periphery (Stowers et al., 1995; Erickson et al., 1996;
Kroschewski et al., 1999; Wu et al., 2000; Kraynov et al., 2000; Del Pozo et
al., 2001; Ridley, 2001). It will thus be interesting to explore whether the
APAPs, as well as their interaction with Pix or Pak, are involved in the
perinuclear activation of Cdc42 and Rac1. Possible relationships between
the perinuclear activation of Cdc42 and Rac1, and activity of Arf1 may also
provide interesting results.
PAXILLIN-ASSOCIATED ARF-GAPS 201
17
Figure 2. Biochemical circuitry of paxillin-associated Arf GAP proteins. See text for details.
movement. The AMAP Arf GAPs remain excellent tools to explore these
issues.
Paxillin is found at all subcellular areas where the APAPs and AMAPs
exist. Paxillin is tyrosine phosphorylated in most of these areas, and linked
to the regulation of Rho-family GTPases (Nakamura et al., 2000; Tsubouchi
et al., 2002). Binding of paxillin to these Arf GAPs may be necessary for
the recruitment of paxillin to certain subcellular areas where paxillin is
subsequently phosphorylated and acts as an adaptor linking the upstream
signals to the activities of Rho GTPases. This model, however, also needs
further experimental scrutiny. Lastly, paxillin-binding Arf GAPs are all
tyrosine phosphorylated (Andreev et al., 1999; Bagrodia et al., 1999), though
the biological significance of tyrosine phosphorylation awaits description.
Although the discussion in this chapter has been restricted to those Arf
GAP that were identified by their binding to paxillin, most of the other Arf
GAPs also have multiple protein interaction modules and are thus likely to
act to coordinate multiple signaling events. Arfs are found in all eukaryotes.
Hence, Arf GAPs are great targets for the analysis of the principles of
intracellular multifactorial processes, where membranes have been employed
as primordial superintendents of cell function, perhaps from the very
beginning of the existence of eukaryotes on this planet (http://smart.embl-
heidelberg.de/smart/do_annotation.pl?DOMAIN=Arf&BLAST=DUMMY&
EVOLUTION=Show#Evolution).
REFERENCES
Aderem, A., and Underhill, D. M. (1999). Mechanisms of phagocytosis in macrophages.
Annu. Rev. Immunol., 17, 593-623.
Aggeler, J., and Werb, Z. (1982). Initial events during phagocytosis by macrophages viewed
from outside and inside the cell: membrane-particle interactions and clathrin. J. Cell Biol.,
94, 613-623.
Al-Awar, O., Radhakrishna, H., Powell, N. N., and Donaldson, J. G. (2000). Separation of
membrane trafficking and actin remodeling functions of ARF6 with an effector domain
mutant. Mol. Cell. Biol., 20, 5998-6007.
Allen, L. H., and Aderem, A. (1996). Molecular definition of distinct cytoskeletal structures
involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J. Exp.
Med., 184, 627-637.
Andreev, J., Simon, J., Sabatini, D. D., Kam, J., Plowman, G., Randazzo, P.A., and
Schlessinger, J. (1999). Identification of a new Pyk2 target protein with Arf-GAP activity.
Mol. Cell. Biol., 19, 2338-2350.
Bajno, L., Peng, X. R., Schreiber, A. D., Moore, H. P., Trimble, W. S., and Grinstein, S.
(2000). Focal exocytosis of VAMP3-containing vesicles at sites of phagosome formation.
J. Cell Biol., 149, 697-706.
Bagrodia, S., Taylor, S. J., Jordon, K. A., Van Aelst, L.,and Cerione, R. A. (1998). A novel
regulator of p21-activated kinases. J. Biol. Chem., 273, 23633-23636.
PAXILLIN-ASSOCIATED ARF-GAPS 203
19
Bagrodia, S., Bailey, D., Lenard, Z., Hart, M., Guan, J. L., Premont, R. T., Taylor, S. J., and
Cerione, R. A. (1999). A tyrosine-phosphorylated protein that binds to an important
regulatory region on the cool family of p21-activated kinase-binding proteins. J. Biol.
Chem., 274, 22393-22400.
Bagrodia, S., and Cerione, R. A. (1999). Pak to the future. Trends Cell Biol., 9, 350-355.
Bockoch, G. M., Wang, Y., Bohl, B. P., Sells, M. A., Quilliam, L. A., and Knaus, U. G.
(1996). Interaction of the Nck adapter protein with p21-activated kinase (PAK1). J. Biol.
Chem., 271, 25746-25749.
Borisy, G. G., and Svitkina, T. M. (2000). Actin machinery: pushing the envelope. Curr.
Opin. Cell Biol., 12, 104-112.
Boshans, R. L., Szanto, S., van Aelst, L., and D'Souza-Schorey, C. (2000). ADP-ribosylation
factor 6 regulates actin cytoskeleton remodeling in coordination with Rac1 and RhoA.
Mol. Cell Biol., 20, 3685-3694
Bretscher, M. S. (1996). Getting membrane flow and the cytoskeleton to cooperate in moving
cells. Cell, 87, 601-606.
Bretscher, M. S. (1989). Endocytosis and recycling of the fibronectin receptor in CHO cells.
EMBO J., 8, 1341-1348.
Bretscher, M. S. (1992). Circulating integrins: α5β1, α6β4 and Mac-1, but not α3β1, α4β1 or
LFA-1. EMBO J., 11, 405-410.
Brown, M. T., Andrade, J., Radhakrishna, H., Donaldson, J. G., Cooper, J. A., and Randazzo,
P. A. (1998). ASAP1, a phospholipid-dependent arf GTPase-activating protein that
associates with and is phosphorylated by Src. Mol. Cell Biol., 18, 7038-7051.
Brown, F. D., Rozelle, A. L., Yin, H. L., Bella, T., and Donaldson, J. G. (2001).
Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol.,
154, 1007-1017.
Brown, M. C., West, K. A., and Turner, C. E. (2002). Paxillin-dependent Paxillin Kinase
Linker and p21-Activated Kinase Localization to Focal Adhesions Involves a Multistep
Activation Pathway. Mol. Biol. Cell, 13, 1550-1565.
Cavenagh, M. M., Whitney, J. A., Carrol, K., Zhang, C. -J., Boman, A. L., Rosenwald, A.G.,
Mellman, I., and Kahn, R. A. (1996). Intracellular distribution of Arf proteins in
mammalian cells. Arf6 is uniquely localized to the plasma membrane. J. Biol. Chem., 271,
21767-21774.
Chardin, P., and McCormick, F. (1999). Brefeldin A: the advantage of being uncompetitive.
Cell, 97, 153-155.
Corbett, K. D., and Alber, T. (2001). The many faces of Ras: recognition of small GTP-
binding proteins. Trends Biochem. Sci., 26, 710-716.
Cox, D., Tseng, C. C., Bjekic, G., and Greenberg, S. (1999). A requirement for
phosphatidylinositol 3-kinase in pseudopod extension. J. Biol. Chem., 274, 1240-1247.
Cukierman, E., Huber, I., Rotman, M., and Cassel. D. (1995). The ARF1 GTPase-activating
protein: zinc finger motif and Golgi complex localization. Science, 270, 1999-2002.
Daniels, R. H., Zenke, F. T. and Bokoch, G. M. (1999). αPix stimulates p21-activated kinase
activity through exchange factor-dependent and -independent mechanisms. J. Biol. Chem.,
274, 6047-6050.
de Curtis, I. (2001) Cell migration : GAPs between membrane traffic and the cytoskeleton.
EMBO R., 2, 277-281.
Del Pozo, M. A., Kiosses, W. B., Alderson, N. B., Meller, N., Hahn, K. M., and Schwartz, M.
A. (2002). Integrins regulate GTP-Rac localized effector interactions through dissociation
of Rho-GDI. Nature Cell Biol., 4, 232-239.
204
20 SABE
Di Cesare, A., Paris, S., Albertinazzi, C., Dariozzi, S., Andersen, J., Mann, M., Longhi, R.,
and de Curtis, I. (2000). p95-APP1 links membrane transport to Rac-mediated
reorganization of actin. Nat. Cell Biol., 2, 521-530.
D'Souza-Schorey, C., Li, G., Colombo, M. I, and Stahl, P. D. (1995). A reglatory role for
ARF6 in receptor-mediated endocytosis. Science, 267, 1175-1178.
D'Souza-Schorey, C., van Donselaar, E., Hsu, V. W., Yang, C., Stahl, P. D., and Peters, P. J.
(1998). ARF6 targets recycling vesicles to the plasma membrane: insights from an
ultrastructural investigation. J. Cell Biol., 140, 603-616.
Erickson, J. W., Zhang, C., Kahn, R. A., Evans, T., and Cerione, R. A. (1996). Mammalian
Cdc42 is a brefeldin A-sensitive component of the Golgi apparatus. J. Biol. Chem., 271,
26850-26854.
Eugster, A., Frigerio, G., Dale, M., and Duden, R. (2000). COP I domains required for
coatomer integrity, and novel interactions with ARF and ARF-GAP. EMBO J., 19, 3905-
3917.
Furman, C., Short, S. M., Subramanian, R. R., Zetter, B. R., and Roberts, T. M. (2002). DEF-
1/ASAP1 is a GTPase-activating protein (GAP) for ARF1 that enhances cell motility
through a GAP-dependent mechanism. J. Biol. Chem., 277, 7962-7969.
Galisteo,M. L., Chernoff, J., Su, Y.C., Skolnik, E. Y., and Schlessinger, J. (1996). The
adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1.
J. Biol. Chem., 271, 20997-21000.
Goldberg, J. (1999). Structural and functional analysis of the ARF1-ARFGAP complex
reveals a role for coatomer in GTP hydrolysis. Cell, 96, 893-902.
Greenberg, S., Chang, P., and Silverstein, S. C. (1994). Tyrosine phosphorylation of the γ
subunit of Fcγ receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in
macrophages. J. Biol. Chem., 269, 3897-3902.
Greenberg, S. (1999). Molecular components of phagocytosis. J. Leukoc. Biol., 66, 712-717.
Hart, M. J., Eva, A., Zangrilli, D., Aaronson, S. A., Evans, T., Cerione, R. A., and Zheng, Y.
(1994). Cellular transformation and guanine nucleotide exchange activity are catalyzed by
a common domain on the dbl oncogene product. J. Biol. Chem., 269, 62-65.
Hashimoto, S., Tsubouchi, A., Mazaki, Y., and Sabe, H. (2001). Interaction of paxillin with
p21-activated Kinase (PAK). Association of paxillin α with the kinase-inactive and the
Cdc42-activated forms of PAK3. J. Biol. Chem., 278, 6037-6045.
Hussain, N. K., Jenna, S., Glogauer, M., Quinn, C. C., Wasiak, S., Guipponi, M.,
Antonarakis, S. E., Kay, B. K., Stossel, T. P., Lamarche-Vane, N., and McPherson, P. S.
(2001). Endocytic protein intersectin-l regulates actin assembly via Cdc42 and N-WASP.
Nat. Cell Biol., 3, 927-932.
Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell, 110, 673-
687.
Kahn, R. A., and Gilman, A. G. (1986). The protein cofactor necessary for ADP-ribosylation
of Gs by cholera toxin is itself a GTP binding protein. J. Biol. Chem., 261, 7906-7911.
King, F. J., Hu, E., Harris, D.F., Sarraf, P., Spiegelman, B. M., and Roberts, T. M. (1999).
DEF-1, a novel Src SH3 binding protein that promotes adipogenesis in fibroblastic cell
lines. Mol. Cell. Biol., 19, 2330-2337.
Kondo, A., Hashimoto, S., Yano, H., Nagayama, K., Mazaki, Y., and Sabe, H. (2000). A new
paxillin-binding protein, PAG3/Papalpha/KIAA0400, bearing an ADP-ribosylation factor
GTPase-activating protein activity, is involved in paxillin recruitment to focal adhesions
and cell migration. Mol. Biol. Cell, 11,1315-1327.
Kraynov, V. S., Chamberlain, C., Bokoch, G. M., Schwartz, M. A., Slabaugh, S., and Hahn,
K. M. (2000). Localized Rac activation dynamics visualized in living cells. Science, 290,
333-337.
PAXILLIN-ASSOCIATED ARF-GAPS 205
21
Kroschewski, R., Hall, A., and Mellman, I. (1999). Cdc42 controls secretory and endocytic
transport to the basolateral plasma membrane of MDCK cells. Nature Cell Biol., 1, 8-13.
Lawson, M. A., and Maxfield, F. R. (1995). Ca(2+)- and calcineurin-dependent recycling of
an integrin to the front of migrating neutrophils. Nature, 377, 75-79.
Laukaitis, C. M., Webb, D. J., Donais, K., and Horwitz, A. F. (2001). Differential dynamics
of α5 integrin, paxillin, and α-actinin during formation and disassembly of adhesions in
migrating cells. J. Cell Biol., 153, 1427-1440.
Lu, W., Katz, S., Gupta, R., and Mayer, B. J. (1997). Activation of Pak by membrane
localization mediated by an SH3 domain from the adaptor protein Nck. Curr. Biol., 7, 85-
94.
Manabe, R., Kovalenko, M., Webb, D. J.,and Horwitz, A. R. (2002). GIT1 functions in a
motile, multi-molecular signaling complex that regulates protrusive activity and cell
migration. J. Cell Sci., 115, 1497-1510.
Mandiyan, V., Andreev, J., Schlessinger, J., and Hubbard, S. R. (1999). Crystal structure of
the ARF-GAP domain and ankyrin repeats of PYK2-associated protein beta. EMBO J., 18,
6890-6898.
Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S., and Lim, L. (1994). A brain serine/
threonine ptotein kinase activated by Cdc42 and Rac1. Nature, 367, 40-46.
Manser, E., Loo, T. H., Koh, C. G., Zhao, Z. S., Chen, X. Q., Tan, L., Tan, I., Leung, T., and
Lim, L. (1998). PAK kinases are directly coupled to the PIX family of nucleotide
exchange factors. Mol. Cell, 1, 183-192.
Mazaki, Y., Hashimoto, S., and Sabe, H. (1997). Monocyte cells and cancer cells express
novel paxillin isoforms with different binding properties to focal adhesion proteins. J.
Biol. Chem., 272, 7437-7444.
Mazaki, Y., Uchida, H., Hino, O., Hashimoto, S., and Sabe, H. (1998). Paxillin isoforms in
mouse. Lack of the γ isoform and developmentally specific beta isoform expression. J.
Biol. Chem., 273, 22435-22441.
Mazaki, Y., Hashimoto, S., Okawa, K., Nakamura, K., Yagi, R., Yano, H., Kondo, A.,
Iwamatsu, A., Mizoguchi, A., and Sabe, H. (2001). An ADP-ribosylation factor GTPase-
activating protein Git2-short/KIAA0148 is involved in subcellular localization of paxillin
and actin cytoskeletal organization. Mol. Biol. Cell. 12, 645-662.
Mitchison, T. J., and Cramer, L. P. (1996). Actin-Based Cell Motility and Cell Locomotion.
Cell, 84, 371-379.
Miyamoto, S., Akiyama, S. K., and Yamada, K. M. (1995a). Synergistic roles for receptor
occupancy and aggregation in integrin transmembrane function. Science, 267, 883-885.
Miyamoto, S., Teramoto, H., Coso, O. A., Gutkind, J. S., Burbelo, P. D., Akiyama, S. K., and
Yamada, K. M. (1995b). Integrin function: molecular hierarchies of cytoskeletal and
signaling molecules. J. Cell Biol., 131, 791-805.
Nakamura, K., Yano, H., Uchida, H., Hashimoto, S., and Sabe, H. (2000). Tyrosine
phosphorylation of paxillin α is involved in temporospatial regulation of paxillin-
containing focal adhesion formation and F-actin organization in motile cells. J. Biol.
Chem., 275, 27155-27164.
Nakashima, S., Morinaka, K., Koyama, S., Ikeda, M., Kishida, M., Okawa, K., Iwamatsu, A.,
Kishida, S., and Kikuchi, A. (1999). Small G protein Ral and its downstream molecules
regulate endocytosis of EGF and insulin receptors. EMBO J., 18, 3629-4362.
Norman, J. C., Jones, D., Barry, S. T., Holt, M. R., Cockcroft, S., and Critchley, D.R. (1998).
ARF1 mediates paxillin recruitment to focal adhesions and potentiates Rho-stimulated
stress fiber formation in intact and permeabilized Swiss 3T3 fibroblasts. J. Cell Biol., 143,
1981-1995.
206
22 SABE
Szafer, E., Pick, E., Rotman, M., Zuck, S., Huber, I., and Cassel, D. (2000). Role of coatomer
and phospholipids in GTPase-activating protein-dependent hydrolysis of GTP by ADP-
ribosylation factor-1. J. Biol. Chem., 275, 23615-23619.
Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., Schaefer, E., Yano, H., and Sabe, H.
(2002). Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in
cell adhesion nd migration. J. Cell Biol., 159, 673-683.
Turner, C. E., Brown, M. C., Perrotta, J. A., Riedy, M. C., Nikolopoulos, S. N., McDonald, A.
R., Bagrodia, S., Thomas, S., and Leventhal, P. S. (1999). Paxillin LD4 motif binds PAK
and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein: A role in cytoskeletal
remodeling. J. Cell Biol., 145, 851-863.
Turner, C. E. (2000). Paxillin and focal adhesion signalling. Nature Cell Biol., 2, E231-E236.
Uchida, H., Kondo, A., Yoshimura, Y., Mazaki, Y., and Sabe, H. (2001).
PAG3/Papα/KIAA0400, a GTPase-activating protein for ADP-ribosylation factor (ARF),
regulates ARF6 in Fcγ receptor-mediated phagocytosis of macrophages. J. Exp. Med., 193,
955-966.
Vitale, N., Patton, W. A., Moss, J., Vaughan, M., Lefkowitz, R. J., and Premont, R. T. (2000).
GIT proteins, A novel family of phosphatidylinositol 3,4, 5-trisphosphate-stimulated
GTPase-activating proteins for ARF6. J. Biol. Chem., 275, 13901-13906.
Wu, W. J., Erickson, J. W., Lin, R., and Cerione, R. A. (2000). The gamma-subunit of the
coatomer complex binds Cdc42 to mediate transformation. Nature, 405, 800-804.
Zhang, Q., Cox, D., Tseng, C.C., Donaldson, J.G., and Greenberg, S.(1998). A requirement
for ARF6 in Fcγ receptor-mediated phagocytosis in macrophages. J. Biol. Chem., 273,
19977-19981.
Zhao, Z. S., Manser, E., Loo, T. H., and Lim, L. (2000). Coupling of PAK-interacting
exchange factor PIX to GIT1 promotes focal complex disassembly. Mol. Cell. Biol., 20,
6354-6363.
Chapter 10
ACTIVATION OF CHOLERA TOXIN AND E.
COLI HEAT-LABILE ENTEROTOXIN (LT) BY
ARF
Abstract: Cholera (CT) and heat labile E. coli (LT) enterotoxins are members of the AB5
family of bacterial toxins that contain one catalytically active A subunit
associated with a complex of five B subunits. The B subunits of CT and LT
bind the receptor, ganglioside GM1, at the cell surface as a required first step
in entry of the holotoxin into target cells. The A subunit is processed into the
catalytic A1 and linker A2 segments. The holotoxin-receptor complex is
internalized and transported to the endoplasmic reticulum before release of the
active A1 protein into the cytosol. The ADP-ribosyltransferase activity of A1
is a critical determinant of toxin potency. When bound to GTP, all Arfs are
allosteric activators of CT in vitro. The importance of such interactions in the
intoxication of cells is, however, less clear. Recent reports suggest possibilities
for clinically effective prevention of CT action by interference at the critical
initial step of binding to the GM1 receptor or by inhibition of CTA1 ADP-
ribosyltransferase activity in intestinal mucosa cells.
1. INTRODUCTION
209
210
2 PACHECO-RODRIGUEZ, MORINAGA, NODA, MOSS, AND VAUGHAN
CT and LT are members of the AB5 family of bacterial toxins that contain
one catalytically active A subunit associated with a complex of five B
subunits. The latter are responsible for toxin binding to specific receptors on
the cell surface and the subsequent entry of toxin into the cell. In a given
toxin, the five B subunits may or may not be identical, but all bind to
glycoproteins or ganglioside oligosaccharides. In particular, CT and LT
each have a single type of B subunit and the pentamer associates with the
monosialoganglioside GM1 (galactosyl-N-acetylgalactosaminyl-[N-
acetylneuraminyl]-galactosylglucosylceramide), the oligosaccharide of
which is responsible for toxin binding. A subunits of the AB5 toxins can
have different enzymatic activities, although several of them are mono-ADP-
ribosyltransferases (reviewed by Merritt and Hol, 1995). CT and LT are
very similar in structure (ca. 80% amino acid sequence identity in both A
and B subunits) and function, including enzymatic properties, ganglioside
specificity, and immunoreactivity. However, they differ significantly in
toxicity for human cells (Rodighiero et al., 1999). Systematic comparison of
the effects of chimeric CT/LT molecules on secretion of Cl¯ ion by human
T84 epithelial cells grown in culture demonstrated that differences in the
receptor binding B subunits, or in the catalytic A1 fragment were not
responsible for the differences in toxicity. However, when the holotoxins
were bound to GM1 the ability of CT to withstand denaturation by acid or
urea was greater than that of LT. This was accounted for by sequence
differences in a ten-residue segment of the A2 fragments. Stability of the
holotoxin-receptor complex as it is internalized and transported to the
ACTIVATION OF CT AND LT BY ARF 2113
intracellular site where release of A1 will have the greatest toxicity is critical
to toxin potency (Rodighiero et al., 1999).
Figure 1. Structure of LT (reproduced by permission from Merritt and Hol, 1995). In LT, the
A subunit is positioned above a ring of five identical B subunits with the A2 domain
extending through the center of the B pentamer. In this image, the catalytic A1 subunit is at
the top and connected to the pentameric B subunit ring (bottom) by the long alpha helix that
comprises most of the A2 subunit.
The crystal structure of LT was first reported in 1991 (Sixma et al., 1991)
and that of the CTB complex, with GM1 oligosaccharide bound, in 1994
(Merritt et al., 1994). Information from these and other structural studies is
all consistent with a model in which the B pentamer that binds GM1 on the
cell surface forms a circular base on which the single A subunit rests, with
its C-terminal 5 kDa A2 segment extending into the B subunit ring (see
212
4 PACHECO-RODRIGUEZ, MORINAGA, NODA, MOSS, AND VAUGHAN
Figure 1). The KDEL (RDEL in LT) sequence at the C-terminus marks the
toxin for transport to the endoplasmic reticulum (Lencer et al., 1995).
Additional critical sequence in A2 is that required for appropriate release of
active A1 from the A2 fragment. Proteolytic cleavage (nicking) of the
holotoxin at R192 can occur even before toxin entry into the cell, but the A1
and A2 fragments remain covalently linked until reduction of the single
disulfide bond between them releases A1. This is probably catalyzed by a
protein disulfide isomerase in the endoplasmic reticulum (Moss et al., 1980;
Orlandi, 1997; Tsai et al., 2001).
In the mono-ADP-ribosyltransferase reaction catalyzed by CT or LT, the
ADP-ribose moiety of NAD is transferred to a specific arginine in an
acceptor protein (Moss and Vaughan, 1977; Moss and Richardson, 1978).
These toxins also catalyze a reaction (NAD glycohydrolase) in which water
serves as the ADP-ribose acceptor (Moss et al., 1976). Both activities are
intrinsic to the A1 fragment of CT (Moss et al., 1979a). In addition, CTA
can ADP-ribosylate itself (auto-ADP-ribosylation) and Arf (Tsai et al.,
1988). In the stereospecific reaction catalyzed by CT, the Į-anomer of
ADP-ribosylarginine is produced from ȕNAD+ (Moss et al., 1979b). The
major ADP-ribose acceptor in CT- and LT-catalyzed reactions in eukaryotic
cells is GĮs, but in vitro, CT and LT can use several guanidinium compounds
as ADP-ribose acceptors. Agmatine is one of those used in a simple assay
(Moss and Vaughan, 1977) for quantification of CT ADP-ribosyltransferase
activity (and that of other transferases that use arginine as an ADP-ribose
acceptor).
Ganglioside GM1 is the cell surface binding site/receptor for the B subunit
pentamer through which CT or LT is internalized (Fishman et al., 1978). CT
bound also to GM1 oligosaccharide that had been covalently attached to
proteins on the cell surface (neoganglioproteins), but was not internalized,
indicating that the toxin-GM1 interaction contributes to intoxication beyond
the initial cell-surface binding (Pacuszka and Fishman, 1992). It also
suggests that toxin internalization should be evaluated along with cell
binding to assess the biological relevance of the interaction (Pacuszka and
Fishman, 1992). The CT receptor, GM1, appears to be concentrated in
caveolae or lipid rafts (Tran et al., 1987). The toxin was localized at non-
clathrin-coated invaginations of fibroblast membranes by electron
microscopy (Tran et al., 1987). In the intestine, CT binds to and is
internalized via ganglioside GM1 on the apical membrane of the mucosal
ACTIVATION OF CT AND LT BY ARF 2135
cells. Cell polarity may be, in fact, an essential property of a CT (or LT)
target cell in vivo, although many studies of toxin action are performed in
non-polarized cells, e.g., CHO cells, that are also susceptible to CT
(Morinaga et al., 2001). In intestinal mucosa cells, it is the GĮs subunit
located on the basolateral membrane that is the main CT substrate. Covalent
modification of GĮs and the resulting essentially irreversible activation of
adenylyl cyclase leads to sustained elevation of cellular cAMP content,
efflux of Na+ and water into the intestinal lumen, and eventual dehydration
of the host.
The complex of CT with GM1 ganglioside is internalized by receptor-
mediated endocytosis, which is selective, regulated, and carried out via
either clathrin-coated or non-clathrin-coated invaginations of the plasma
membrane (e.g., caveolae and lipid rafts). Clathrin-coated pits are lined on
the cytoplasmic surface with light and heavy clathrin chains plus the adaptor
proteins required for assembly of the clathrin coat (for review see Higgins
and McMahon, 2002). The process includes: 1) binding and localization of
the ligand (toxin)-receptor complex in a nascent clathrin-coated vesicle, and,
2) accumulation of other specific molecules to complete vesicle formation.
Caveolae are flask-shaped invaginations of the plasma membrane
characterized by their size (50-100 nm), morphology, and biochemical
constituents, which include cholesterol, sphingomyelin, and ceramide among
other lipids (Anderson, 1998). Protein components include caveolin,
glycosylphosphatidylinositol-anchored proteins, and receptors (Anderson,
1998). Lipid rafts or caveolae appear to be the main site of holotoxin entry,
although access to some cells can occur via clathrin-coated pits or non-
clathrin-coated invaginations. The site of entry can depend on the cell type,
as was shown by studies of the Caco-2, HeLa, and BHK cell lines
(Torgersen et al., 2001). CT-induced morphological changes of CHO cells
were not affected by over-expression of dynamin, but were suppressed
significantly by over-expression of the mutant dynamin in which K44 is
replaced by alanine, resulting in an impaired capacity to hydrolyze GTP
(personal communication, N. Morinaga). Dynamin functions in
internalization via caveolae (Henley et al., 1998; Oh et al., 1998). As
chlorpromazine, an inhibitor of clathrin-dependent endocytosis (Sofer and
Futerman, 1995; Orlandi and Fishman, 1998), did not affect CT-induced
cAMP accumulation in CHO cells, the entry of CT into those cells may be
via caveolae. The mutant of Eps15, a component of clathrin-coated pits,
should clarify which is involved. Independent of the membrane site of
receptor interaction or mechanism of internalization, specific binding of
CTB is the critical initial step in CT action. It represents, therefore, an
important potential site for intervention with drugs that could prevent the
CT-GM1 interaction (Merritt et al., 2002).
214
6 PACHECO-RODRIGUEZ, MORINAGA, NODA, MOSS, AND VAUGHAN
concluded by Kassis et al. (1982), CTA1 (or LTA1) may not, in fact,
accumulate in the Golgi of intoxicated cells. As the multiple actions of BFA
become better understood, it may be useful in answering some of these kinds
of questions, just as it continues to be useful in elucidating mechanisms of
intracellular vesicular transport (Presley et al., 2002).
In their early experiments, Kahn and Gilman (1986) had demonstrated that
Arf activation of CT-catalyzed ADP-ribosylation of GĮs was dependent on
GTP, and quantification of GTP binding to Arf can often be a more
convenient measure of Arf activation than is measurement of the activated
Arf by its effects on an enzyme activity. Low stoichiometry of GTPȖS
binding to Arf in vitro has been found in many laboratories, and it is known
that the assay conditions, notably Mg2+ concentration and the presence of
specific phospholipids or detergents are of major importance (reviewed in
Moss and Vaughan, 1998). A dramatic effect of recombinant LTA1 on the
stoichiometry of GTPȖS binding to recombinant Arf3 was reported by Zhu
et al. (2000). They observed that LTA1, LTA, and CTA had similar effects;
those of POR1∆N, GGA1, and MKLP1, were analogous but smaller. The
authors interpreted their findings as evidence that these proteins acted as Arf
effectors, which interacted with inactive Arf, to increase its affinity for GTP,
resulting in the formation of stoichiometric effector-Arf•GTP complexes.
For several years, it had seemed plausible that the mechanism by which
Arf activates CT (or LT) might also be the mechanism employed for Arf
activation of its endogenous effectors. It is difficult, however, to compare
quantitatively Arf activity in vitro with its physiological actions in a cell.
Perhaps the most obvious reason is that Arf function in the cell requires the
continuing alternation between GTP- and GDP-bound forms that must be
constantly regulated (temporally and spatially) by the proteins that modulate
GDP release and GTP binding and hydrolysis in response to diverse signals
and molecular interactions. This Arf activity (or its absence) can be
observed or inferred (e.g., in effects of BFA on Golgi morphology). Unlike
a difference in catalytic rate, however, it is not readily quantified.
Following reports that Arf1 and Arf3 activate phospholipase D (PLD) in
animal cells (Brown et al., 1993; Cockcroft et al., 1994), an Arf-activated
PLD in rat brain extract was separated from an oleate-dependent PLD and
shown to be activated by recombinant Arf5 (class II) and Arf6 (class III), as
well as by class I Arfs (Massenburg et al., 1994). It appeared that a
quantitative comparison of Arf effects on the activities of the partially
218
10 PACHECO-RODRIGUEZ, MORINAGA, NODA, MOSS, AND VAUGHAN
purified PLD and the pure CTA1 protein might permit identification of
elements of the Arf structure that are responsible for activation of the two
enzymes. Experiments were facilitated by the production of recombinant
chimeric proteins in which segments of the human Arf1 and Arl1 proteins
were exchanged (Zhang et al., 1995). These two proteins are, overall 53%
identical in amino acid sequence (181 residues), but Arl1 is deficient in Arf
activity, as defined by the usual criteria of 1) ability to stimulate cholera
toxin ADP-ribosyltransferase activity, and, 2) to rescue yeast bearing the
lethal double mutation of both arf1 and arf2 genes (Moss and Vaughan,
1995). On assay of the chimeric molecules, the protein containing the first
73 amino acids of Arf1 (and the remainder of Arl1) activated PLD to the
same extent as did Arf1, but failed to activate the toxin. The latter was
activated by the reciprocal chimera containing Arf sequence in positions 74-
181 and the first 73 amino acids of Arl1. Positions 37-55 in Arf correspond
to the “effector loop” in Ras and Ras-related proteins, through which the 20
kDa GTPases produce many of their effects (Vetter and Wittinghofer, 2001).
Thus, the mechanism of Arf activation of the ADP-ribosyltransferase
activity of the toxin seems unlike that of its phospholipase D activation and
at least some of its actions in cells (Zhang et al., 1995). These observations
do not, of course, rule out the possibility that Arf stimulation of CTA1 and
LTA1 activity proceeds by a mechanism that is employed by the GTPase for
other, as yet unrecognized, biological purposes.
6. CONCLUSIONS
galactoside moieties, which interacts in a 1:1 molar ratio with the AB5
holotoxin.
Inhibition of ADP-ribosyltransferase activity is another potentially
efficacious approach. On investigation of herbal medications from several
countries, it was determined that kampo formulations, or the gallate
compounds that they contain, can effectively prevent or reduce the diarrheal
effects of CT. The gallate derivatives inhibited ADP-ribosyltransferase
activity of CT in vitro, when agmatine was used as a model substrate. They
also inhibited the diarrheogenic activity of CT in an ileal loop model of in
vivo action on the intestine (Oi et al., 2002), consistent with a significant role
for this activity in disease. Thus, study of the mechanisms of action of CT
and LT, their cell surface binding and entry into cells, as well as activation
of GĮs by ADP-ribosylation can continue to provide clinically useful
information.
REFERENCES
Anderson, R. G. W. (1998). The caveolae membrane system. Annu. Rev. Biochem., 67, 199-
225.
Botstein, D., Segev, N., Stearns, T., Hoyt, M. A., Holden, J., and Kahn, R. A. (1988). Diverse
biological functions of small GTP-binding proteins in yeast. Cold Spring Harbor Symp.
Quant. Biol., 53, 629-636.
Brown, H. A., Gutowski, S., Moomaw, C. R., Slaughter, C., and Sternweis, P. C. (1993).
ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates
phospholipase D. Cell, 75, 1137-1144.
Cockcroft, S., Thomas, G. M. H., Fensome, A., Geny, B., Cunningham, E., Gout, I., Hiles, I.,
Totty, N. F., Truong, O., and Hsuan, J. J. (1994). Phospholipase D: a downstream effector
of Arf in granulocytes. Science, 263, 523-526.
Fishman, P. H. (1982). Internalization and degradation of cholera toxin by cultured cells:
relationship to toxin action. J. Cell. Biol., 93, 860-865.
Fishman, P. H., Moss, J., and Osborne, J. C. Jr. (1978). Interaction of choleragen with the
oligosaccharide of ganglioside GM1: evidence for multiple oligosaccharide binding sites.
Biochemistry, 17, 711-716.
Henley, J. R., Krueger, E. W. A., Oswald, B. J., and McNiven, M. A. (1998). Dynamin-
mediated internalization of caveolae. J. Cell Biol., 141, 85-99.
Higgins, M. K., and McMahon, H. T. (2002). Snap-shots of clathrin-mediated endocytosis.
Trends Biochem. Sci., 27, 257-263.
Kahn, R. A., and Gilman, A. G. (1984). Purification of a protein cofactor required for ADP-
ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera
toxin. J. Biol. Chem., 259, 6228-6234.
Kahn, R. A., and Gilman, A. G. (1986). The protein cofactor necessary for ADP-ribosylation
of Gs by cholera toxin is itself a GTP-binding protein. J. Biol. Chem., 261, 7906-7911.
Kassis, S., Hagmann, J., Fishman, P. H., Chang, P. P., and Moss, J. (1982). Mechanism of
action of cholera toxin on intact cells. Generation of A1 peptide and activation of
adenylate cyclase. J. Biol. Chem., 257, 12148-12152.
220
12 PACHECO-RODRIGUEZ, MORINAGA, NODA, MOSS, AND VAUGHAN
Lencer, W. I., Constable C., Moe, S., Jobling, M. G., Webb, H. M., Ruston, S., Madara, J. L.,
Hirst, T. R., and Holmes, R. K. (1995). Targeting of cholera toxin and Escherichia coli
heat-labile toxin in polarized epithelia: Role of COOH-terminal KDEL. J. Cell. Biol., 131,
951-962.
Lencer, W. I., Constable, C., Moe, S., Rufo, P. A., Wolf, A., Jobling, M. G., Ruston, S. P.,
Madara, J. L., Holmes, R. K., and Hirst, T. R. (1997). Proteolytic activation of cholera
toxin and Escherichia coli heat-labile toxin by entry into host epithelial cells. Signal
transduction by a protease-resistant toxin variant. J. Biol. Chem., 272, 15562-15568.
Massenburg, D., Han, J.-S., Liyanage, M., Patton, W. A., Rhee, S. G., Moss, J., and Vaughan,
M. (1994). Activation of rat brain phospholipase D by ADP-ribosylation factors, 1,5, and
6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes. Proc.
Natl. Acad. Sci., USA, 91, 11718-11722.
Merritt, E. A., and Hol, W. G. J. (1995). AB5 toxins. Curr. Opin. Struct. Biol., 5, 165-171.
Merritt, E. A., Zhang, Z., Pickens, J. C., Ahn, M., Hol, W. G. J., and Fan, E. (2002).
Characterization and crystal structure of a high-affinity pentavalent receptor-binding
inhibitor for cholera toxin and E. coli heat-labile enterotoxin. J. Am. Chem. Soc., 124,
8818-8824.
Merritt, E. A., Sarfaty, S., Van den Akker, F., L’hoir, C., Martial, J. A., and Hol, W. G. J.
(1994). Crystal structure of cholera toxin B-pentamer bound to receptor GM1
pentasaccharide. Prot. Sci., 3, 166-175.
Morinaga, N., Kaihou, Y., Vitale, N., Moss, J., and Noda, M. (2001). Involvement of ADP-
ribosylation factor 1 in cholera toxin-induced morphological changes of Chinese hamster
ovary cells. J. Biol. Chem., 276, 22838-22843.
Moss, J., Manganiello, V. C., and Vaughan, M. (1976). Hydrolysis of nicotinamide adenine
dinucleotide by choleragen and it’s a protomer: possible role in the activation of adenylate
cyclase. Proc. Natl. Acad. Sci., USA, 73, 4424-4427.
Moss, J., and Richardson, S. H. (1978). Activation of adenylate cyclase by heat-labile
Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that
of choleragen. J. Clin. Invest., 62, 281-285.
Moss, J., Stanley, S. J., and Lin, M. C. (1979b). NAD glycohydrolase and ADP-
ribosyltransferase activities are intrinsic to the A1 peptide to choleragen. J. Biol. Chem.,
254, 11993-11996.
Moss, J., Stanley, S. J., Morin, J. E., and Dixon, J. E. (1980). Activation of choleragen by
thiol: protein disulfide oxidoreductase. J. Biol. Chem., 255, 11085-11087.
Moss, J., Stanley, S. J., and Oppenheimer, N. J. (1979a). Substrate specificity and partial
purification of a stereospecific NAD- and guanidine-dependent ADP-ribosyltransferase
from avian erythrocytes. J. Biol. Chem., 254, 8891-8894.
Moss, J., and Vaughan, M. (1977). Mechanism of action of choleragen. Evidence for ADP-
ribosyltransferase activity with arginine as an acceptor. J. Biol. Chem., 252, 2455-2457.
Moss, J., and Vaughan, M. (1995). Structure and function of Arf proteins: Activators of
cholera toxin and critical components of intracellular vesicular transport processes. J. Biol.
Chem., 270, 21431-21434.
Moss, J., and Vaughan, M. (1998). Molecules in the Arf orbit. J. Biol. Chem., 273, 12327-
12330.
Noda, M., Tsai, S.-C., Adamik, R., Moss, J., and Vaughan, M. (1990). Mechanism of cholera
toxin activation by a guanine nucleotide-dependent 19 kDa protein. Biochim. Biophys.
Acta, 1034, 195-199.
ACTIVATION OF CT AND LT BY ARF 221
13
Oh, P., McIntosh, D. P., and Schnitzer, J. E. (1998). Dynamin at the neck of caveolae
mediates their budding to form transport vesicles by GTP-driven fission from the plasma
membrane of endothelium. J. Cell Biol., 141, 101-114.
Oi, H., Matsuura, D., Miyake, M., Ueno, M., Takai, I., Yamamoto, T., Kubo, M., Moss, J.,
and Noda, M. (2002). Identification in traditional herbal medications and confirmation by
synthesis of factors that inhibit cholera toxin-induced fluid accumulation. Proc. Natl.
Acad. Sci., USA, 99, 3042-3046.
Orlandi, P. A. (1997). Protein-disulfide isomerase-mediated reduction of the A subunit of
cholera toxin in a human intestinal cell line. J. Biol. Chem., 272, 4591-4599.
Orlandi, P. A., Curran, P. K., and Fishman, P. H. (1993). Brefeldin A blocks the response of
cultured cells to cholera toxin. J. Biol. Chem., 268, 12010-12016.
Orlandi, P. A., and Fishman, P. H. (1998). Filipin-dependent inhibition of cholera toxin:
evidence for toxin internalization and activation through caveolae-like domains. J. Cell
Biol. 141, 905-915.
Pacuszka, T., and Fishman, P. H. (1992). Intoxication of cultured cells by cholera toxin:
evidence for different pathways when bound to ganglioside GM1 or neoganglioproteins.
Biochemistry, 31, 4773-4778.
Palade, G. E. (1975). Intracellular aspects of the process of protein synthesis. Science, 189,
347-358.
Peterson, J. W., and Ochoa, L. G. (1989). Role of prostaglandins and cAMP in the secretory
effects of cholera toxin. Science, 245, 857-859.
Presley, J. F., Ward, T. H., Pfeifer, A. C., Siggla, E. D., Phair, R. D., and Lippincott-
Schwartz, J. (2002). Dissection of COPI and Arf1 dynamics in vivo and role in Golgi
membrane transport. Nature, 417, 187-193.
Rodighiero, C., Aman, A. T., Kenny, M. J., Moss, J., Lencer, W. I., and Hirst, T. R. (1999).
Structural basis for the differential toxicity of cholera toxin and Escherichia coli heat-
labile enterotoxin. J. Biol. Chem., 274, 3962-3969.
Schmitz, A., Herrgen, H., Winkeler, A., and Herzog, V. (2000). Cholera toxin is exported
from microsomes by the Sec61p complex. J. Cell Biol., 140, 1203-1212.
Sixma, T. K., Pronk, S. E., Kalk, K., Wartna, E. S., Van Zanten, B. A. M., Withold, B., and
Hol, W. G. J. (1991). Crystal structure of a cholera toxin-related heat-labile enterotoxin
from E. coli. Nature, 351, 371-377.
Sofer, A., and Futerman, A. H. (1995). Cationic amphiphilic drugs inhibit the internalization
of cholera toxin to the Golgi apparatus and the subsequent elevation of cyclic AMP. J.
Biol. Chem., 270, 12117-12122.
Torgersen, M. L., Skretting, G., Van Deurs, B., Sandvig, K. (2001). Internalization of cholera
toxin by different endocytic mechanism. J. Cell Sci., 114, 3737-3747.
Tran, D., Carpenter, J. L., Sawano, F., Gorden, P., and Orci, L. (1987). Ligands internalized
through coated or non-coated invaginations follow a common intracellular pathway. Proc.
Natl. Acad. Sci., USA, 84, 7957-7961.
Tsai, S.-C., Noda, M., Adamik, R., Chang, P., Chen, H.-G., Moss, J., and Vaughan, M.
(1988). Stimulation of choleragen enzymatic activities by GTP and two soluble proteins
purified from bovine brain. J. Biol. Chem., 263, 1768-1772.
Tsai, B., Rodighiero, C., Lencer, W. I., and Rapoport, T. A. (2001). Protein disulfide
isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell, 104, 937-
948.
Vetter, J. R., and Wittinghofer, A. (2001). The guanine nucleotide-binding switch in three
dimensions. Science, 294, 1299-1304.
222
14 PACHECO-RODRIGUEZ, MORINAGA, NODA, MOSS, AND VAUGHAN
Weigert, R., Silletta, M. G., Spano, S., Turrachio, G., Cericola, C., Conzi, A., Senatore, S.,
Mancini, R., Polishchuk, E. V., Salmona, M., Facchiang, F., Burger, K. N. J., Miranov, A.,
Luini, A., and Corda, D. (1999). CtBP/BARS induces fission of Golgi membranes by
acylating lysophosphatidic acid. Nature, 402, 429-433.
Zhang, G.-F., Patton, W. A., Lee, F.-J. S., Liyanage, M., Han, J.-S., Rhee, S. G., Moss, J., and
Vaughan, M. (1995). Different Arf domains are required for the activation of cholera toxin
and phospholipase D. J. Biol. Chem., 270, 21-24.
Zhu, X., Boman, A. L., Kuai, J., Cieplak, W., and Kahn, R. A. (2000). Effectors increase the
affinity of ADP-ribosylation factor for GTP to increase binding. J. Biol. Chem., 275,
13465-13475.
Zhu, X., and Kahn, R. A. (2001). The Escherichia coli heat-labile toxin binds to Golgi
membranes and alters Golgi and cell morphologies using ADP-ribosylation factor-
dependent processes. J. Biol. Chem., 276, 25014-25021.
Chapter 11
PHOSPHOLIPASE D, ARFAPTINS AND
ARFOPHILIN
JOHN H. EXTON
Department of Molecular Physiology, Biophysics and Pharmacology, Howard Hughes
Medical Institute, Vanderbilt University, Nashville, USA n
1. PHOSPHOLIPASE D
223
224
2 EXTON
unmodified forms (Massenburg et al., 1994; Brown et al., 1995; Tsai et al.,
1998). No large differences were observed in the potency or efficacy of
different Arf members to activate PLD in vitro (Massenburg et al., 1994;
Brown, 1995; Tsai et al., 1998). As noted for all other stimulators of PLD,
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) was required for the effect
of Arf on the enzyme.
Cloning studies have revealed the existence of two mammalian isozymes
of PLD (PLD1 and PLD2), each of which exist as splice variants. These
isozymes have four conserved sequences (I-IV) and sequences I and IV each
contain the highly conserved HKD motif (Exton, 2002). Searches of the
human genome database have not revealed other PLD isozymes. PLD1 is
strongly stimulated by Arfs 1 and 3 in vitro (Hammond et al., 1995, 1997;
Min et al., 1998; Sung et al., 1999b) whereas PLD2 shows little or no
response (Colley et al., 1997; Kodaki and Yamashita, 1997; Lopez et al.,
1998; Sung et al., 1999a). Marked synergism is observed between Arf and
RhoA or protein kinase C in the activation of PLD1 or partially purified
brain PLD (Hammond et al., 1997; Singer et al., 1996). The site at which
Arf interacts with PLD1 has not been defined, but deletional mutagenesis of
the first 325 amino acids of the N-terminus indicates that the site is not
contained within this sequence (Sung et al., 1999b; Park et al., 1998).
Surprisingly, deletion of the first 308 amino acids of PLD2 decreases the
basal activity of the enzyme, but renders it highly responsive to Arfs 1 and 5
in vitro (Sung et al., 1999a). This suggests that the N-terminus may block
binding of Arf or otherwise interfere with its ability to stimulate catalysis.
This observation, plus the finding that PLD2 does show a weak response to
Arf1 in vitro (Kodaki and Yamashita, 1997; Lopez et al., 1998; Sung et al.,
1999a), suggests that this PLD isozyme could mediate part of the action of
Arfs on PLD.
The domain in Arf1 that interacts with PLD has been defined (Zhang et
al., 1995; Jones et al., 1999). Initial work with chimeric proteins constructed
between Arf1 and the structurally related, but inactive, protein ARL1
indicated that the first 73 amino acids at the N-terminus of Arf1 were
required for activation of PLD (Zhang et al., 1995). The region comprising
residues 35-94 was shown in another study to be required for PLD1
activation and AP-1 recruitment, but not for Arf1 activation by a Golgi-
associated GEF (Liang et al., 1997). A later study utilized substitution and
deletion mutagenesis and knowledge of the crystal structure of Arf1 to map
the PLD interaction site to the α2 helix, part of the β2 strand and the N-
terminal helix and its ensuing loop (Jones et al., 1999). Mutants that showed
increased or decreased ability to activate PLD produced similar effects on
secretion in HL60 cells (Jones et al., 1999). However, another study
utilizing selective mutations showed that amino acid residues (I49T, F51Y)
PHOSPHOLIPASE D, ARFAPTINS AND ARFOPHILIN 225
3
in the switch I region of Arf3 were required for PLD activation, but only one
of these (F51Y) was needed to promote vesiculation of Golgi (Kuai, et al.,
2000).
The mechanism by which Arf activates PLD is unclear. In in vitro
experiments, recombinant Arf1 can activate recombinant PLD1 in the
presence of GTPγS and PI(4,5)P2, which is included in the PLD assay
mixture (Hammond et al., 1995; Min et al., 1998). Because PI(4,5)P2 is
required for PLD activity (Brown et al., 1993; Hammond et al., 1995; Min et
al., 1998; Sciorra et al., 1999), it is difficult to explore the role of this lipid in
the action of Arf on the enzyme. As stated above, no interaction site for Arf
on PLD has been defined, although binding of PI(4,5)P2 to the enzyme has
been demonstrated (Sciorra et al., 1999; Hodgkin, et al., 2000). The binding
of PI(4,5)P2 to Arf1 has been demonstrated and shown to increase nucleotide
exchange (Randazzo, 1997; Terui et al., 1994). The binding promotes the
interaction of Arf1 with an Arf GAP (Randazzo and Kahn, 1994) and with
the Arf GEF ARNO (Paris et al., 1997), and this may be true for PLD. As
discussed below, indirect effects of Arf family members on PLD isozymes in
vivo are also likely.
A role for Arf in the regulation of PLD in vivo is not as well defined as the
roles of protein kinase C and Rho family members. Early experiments
showed that depletion of the cytosol of HL-60 cells through detergent
permeabilization caused loss of GTPγS-stimulated PLD activity, which
could be restored by addition of brain cytosol (Geny et al., 1993). The
restorative agent was subsequently shown to be Arf (Cockcroft et al., 1994).
A similar role for Arf in the regulation of PLD in permeabilized neutrophils,
mast cells and HEK cells has been reported (Rumenapp et al., 1995, 1997;
Fensome et al., 1998; Way, et al., 2000). In the studies with neutrophils and
mast cells, Arf also restored the response to FMLP (Fensome et al., 1998) or
antigen (Way, et al., 2000). In other studies, addition of Arf1 or Arf6 to
permeabilized A10 vascular smooth muscle cells or Rat 1 fibroblasts did not
restore the activation of PLD by GTPγS, but restored the ability of
angiotensin II, PDGF or PMA to activate the enzyme (Shome et al., 1998;,
2000). However, these results have not been observed in all cells (Glenn et
al., 1998). Transfection of wild type or constitutively active forms of Arf3
does not activate PLD1 in COS-7 cells (Park et al., 1997), but this may be
due to mislocalization of the expressed proteins or disruption of the Golgi.
Isolated Golgi fractions possess Arf-stimulated PLD activity (Provost et al.,
1996; Ktistakis et al., 1995, 1996), and PLD1 has been localized to the
226
4 EXTON
transport between the endoplasmic reticulum and Golgi, and the block could
be reversed by addition of PA (Bi et al., 1997).
In permeabilized GH3 pituitary cells, purified PLD was observed to
stimulate secretory vesicle budding from the trans Golgi, whereas this was
inhibited by primary butanol (Chen et al., 1997). Generation of PA through
the combined action of phospholipase C and diacylglycerol kinase also
stimulated vesicle budding (Siddhanta and Shields, 1998). Treatment of
GH3 cells with primary butanol reduced transport from the endoplasmic
reticulum and the Golgi, and also inhibited hormone secretion (Siddhanta et
al., 2000). There was an associated decrease in PI(4,5)P2 synthesis by Golgi
membranes and disassembly and fragmentation of the Golgi (Siddhanta et
al., 2000). Exogenous PLD has also been shown to recruit AP-2 adaptors
onto plasma membranes and thus mimic the effects of GTPγS plus Arf
(West et al., 1997). This suggests a role for PLD in vesicle traffic at other
cellular sites. Although it has been assumed that the effects of PLD on
vesicle traffic are due to the effects of PA per se, they may be due to
changes in PI(4,5)P2. PA has been reported to stimulate Type I PIP kinase
(Skippen et al., 2002; Jenkins et al., 1994; Moritz et al., 1992; Ren et al.,
1996) and there is much evidence that PI(4,5)P2 is required for traffic at
several cellular sites (Skippen et al., 2002; Martin, 1998,, 2001; Simonsen et
al., 2001).
There is other evidence implicating a role for PLD in exocytosis. This
has mainly relied on the ability of primary alcohols to inhibit secretion from
many cell types (for references, see Cockcroft, 1996, and, Jones et al., 1999).
However, it must be recognized that these reagents may not be specific for
PLD when used in intact cells. However, exogenous PLD stimulates
secretion in many cell types (Cockcroft, 1996) and permeabilization of cells
to release Arf decreases GTPγS-stimulated PLD activity and exocytosis,
both of which can be restored by adding Arf (Jones et al., 1999). Additional
evidence for a role of PLD in exocytosis comes from studies of the effects of
overexpressed wild type and catalytically inactive PLD1 in PC12 cells.
These active and inactive enzymes stimulated and inhibited secretion,
respectively (Vitale et al., 2001). On the other hand, wild type and inactive
PLD2 were without effect. Ceramide is known to inhibit the stimulation of
PLD by PMA and agonists in several cell types (Exton, 2002) and Arf may
possibly be involved. Addition of C2 ceramide to HL-60 cells inhibits
membrane translocation of Arf and PLD activation induced by FMLP
(Abousalham et al., 1997). In chromaffin cells, C2 ceramide inhibits both
PLD activity and catecholamine release (Vitale et al., 2001).
In contrast to the preceding evidence supporting a role of Arf-stimulated
PLD in membrane traffic at the Golgi and in exocytosis, there are findings
that do not support this hypothesis. For example, measurements of PA
PHOSPHOLIPASE D, ARFAPTINS AND ARFOPHILIN 229
7
levels in Golgi during budding of COPI coated vesicles indicated that this
lipid declined rather than increased (Abousalham et al., 1997). Another
study examined the effects of mutations in Arf3 on PLD activity and the
recruitment of COPI to Golgi membranes (Kuai et al., 2000) and observed a
poor correlation. Similarly, an N-terminally deleted form of Arf1 was found
to be without effect on Arf-stimulated PLD activity, but competed with Arf1
to prevent COPI binding to Golgi membranes (Jones et al., 1999). In
another study, exogenous PLD was observed to recruit AP-2 adaptors onto
the plasma membrane, but was unable to recruit AP-1 adaptors onto the trans
Golgi network (West et al., 1997). In summary, it seems very unlikely that
PLD alone mediates the effects of Arf on vesicle traffic at various sites.
However, it probably plays a supporting role through the generation of
PI(4,5)P2 and perhaps other lipids.
2. ARFAPTINS
action of this Arf mutant on the cholera toxin activity (Tsai et al., 1998).
The corresponding experiments could not be conducted with PLD, because
the Arf mutant was unable to activate this enzyme. These data imply the
existence of an Arfaptin 1 binding site at the N-terminus of Arf1. In studies
of guanine nucleotide binding and release from Arf3, Arfaptin 1 was found
to increase the binding of GTPγS and GDP, but the effects were not large
and may have been due to stabilization of Arf (Tsai et al., 1998). The
release of GTPγS from Arf3 was also only slightly altered by Arfaptin 1.
When tested in the presence of a guanine nucleotide exchange factor, only
slight effects of Arfaptin 1 were observed on GTPγS or GDP binding (Tsai
et al., 1998). These results indicate that Arfaptin 1 has little intrinsic GEF
activity and does not modify the action of GEFs on Arf. The possible effects
of Arfaptin 1 on the inactivation of Arf by GTPase-activating proteins were
not examined.
In binding studies of the interaction of Arfaptin 1 with Arf3, deletional
mutagenesis of Arfaptin 1 indicated that sequences in both the N-and C-
termini were involved (Williger et al., 1999). Both were required for the
inhibitory effect of Arfaptin 1 on Arf3 stimulation of PLD1 (Williger et al.,
1999). Arfaptin 1 was also shown to associate with a 'high speed' fraction
containing Golgi membranes in a GTPγS- and Arf3-dependent manner
(Williger et al., 1999). The functional consequences of the effects of
Arfaptin 1 on Arf interactions with PLD in Golgi were explored in NIH 3T3
cells overexpressing Arfaptin 1 (Williger et al., 1999). In these cells, the
activation of PLD by PMA was suppressed and there was a slowing of
vesicular traffic through the Golgi, as measured by the glycosylation of
vesicular stomatitis virus (Williger et al., 1999). Consistent with an earlier
report (Tsai et al., 1998), Arfaptin inhibited the effect of Arf3 on PLD
activity in Golgi membranes.
3. ARFOPHILIN
REFERENCES
Abousalham, A., Loissis, C., O’Brien, L., and Brindley, D. N. (1997). Cell-permeable
ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and
RhoA. J. Biol. Chem., 272, 1069-1075.
Al-Awar, O., Radhakrishna, H., Powell, N. N., and Donaldson, J. G. (2000). Separation of
membrane trafficking and actin remodeling functions of Arf6 with an effector domain
mutant. Mol. Cell. Biol., 20, 5998-6007.
Anderson, R. A., Boronenkov, I. V., Doughman, S. D., Kunz, J., and Loijens, J. C. (1999).
Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. J.
Biol. Chem., 274, 9907-9910.
Andresen, B. T., Jackson, E. K., and Romero, G. G. (2001). Angiotensin II signaling to
phospholipase D in renal microvascular smooth muscle cells in SHR. Hepatology, 37,
635-639.
Bi, K., Roth, M. G., and Ktistakis, N. T. (1997). Phosphatidic acid formation by
phospholipase D is required for transport from the endoplasmic reticulum to the Golgi
complex. Curr. Biol., 7, 301-307.
Bourgoin, S., Harbour, D., Desmarais, Y., Takai, Y., and Beaulieu, A. (1995). Low molecular
weight GTP-binding proteins in HL-60 granulocytes. J. Biol. Chem., 270, 3172-3178.
Brown, F. D., Thomas, N., Saqib, K. M., Clark, J. M., Powner, D., Thompson, N. T., Solari,
R., and Wakelam, M. J. O. (1998). Phospholipase D1 localizes to secretory granules and
lysosomes and is plasma membrane translocated on cellular stimulation. Curr. Biol., 8,
835-838.
Brown, H. A., Gutowski, S., Kahn, R. A., and Sternweis, P. C. (1995). Partial purification and
characterization of Arf-sensitive phospholipase D from porcine brain. J. Biol. Chem., 270,
14935-14943.
Brown, H. A., Gutowski, S., Moomaw, C. R., Slaughter, C., and Sternweis, P. C. (1993).
ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates
phospholipase D activity. Cell, 75, 1137-1144.
Caumont, A.-S., Galas, M.-C., Vitale, N., Aunis, D., and Bader, M.-F. (1998). Regulated
exocytosis in chromaffin cells. Translocation of Arf6 stimulates a plasma membrane-
associated phospholipase D. J. Biol. Chem., 273, 1373-1379.
Caumont, A.-S., Vitale, N., Gensse, M., Galas, M-C, Casanova, J. E., and Bader, M.-F.
(2000). Identification of a plasma membrane-associated guanine nucleotide exchange
factor for Arf6 in chromaffin cells. Possible role in the regulated exocytotic pathway. J.
Biol. Chem., 275, 15637-15644.
Cavenagh, M. M., Whitney, J. A., Carroll, K., Zhang, C.-J., Bowman, A.L., Rosenwald, A.
G., Mellman, I., and Kahn, R. A. (1996). Intracellular distribution of Arf proteins in
mammalian cells. Arf6 is uniquely localized to the plasma membrane. J. Biol. Chem.,
271, 21767-21774.
Chen, Y.-G., Siddhanta, A., Austin, C. D., Hammond, S. M., Sung, T.-C., Frohman, M. A.,
Morris, A. J., and Shields, D. (1997). Phospholipase D stimulates release of nascent
secretory vesicles from the trans-Golgi network. J. Cell Biol. 138, 495-504
Cherfils, J. (2001). Structural mimicry of DH domains by Arfaptin suggests a model for the
recognition of Rac-GDP by its guanine nucleotide exchange factor. FEBS Lett., 507, 280-
284.
Cockcroft, S. (1996). Arf-regulated phospholipase D: a potential role in membrane traffic.
Chem. Physics Lipids, 80, 59-80.
236
14 EXTON
Cockcroft, S., Thomas, G. M. H., Fensome, A., Geny, B., Cunningham, E., Gout, I., Hiles, I.,
Totty, N. F., Truong, O., and Hsuan, J. J. (1994). Phospholipase D: a downstream effector
of Arf in granulocytes. Science, 263, 523-526.
Colley, W. C., Sung, T.-C., Roll, R., Jenco, J., Hammond, S. M., Altshuller, Y., Bar-Sagi, D.,
Morris, A. J., and Frohman, M. A. (1997). Phospholipase D2, a distinct phospholipase D
isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr.
Biol., 7, 191-20
D’Souza-Schorey, C., Li, G., Colombo, M. I., and Stahl, P. D. (1995). A regulatory role for
Arf6 in receptor-mediated endocytosis. Science, 267, 1175-1178.
D’Souza-Schorey, C., Boshans, R. L., McDonought, M., Stahl, P. D., and Van Aelst, L.
(1997). A role for POR1, a Rac1-interacting protein, in Arf6-mediated cytoskeletal
rearrangements. EMBO J., 16, 5445-5454.
Exton, J. H. (2002). Phospholipase D – structure, regulation and function. In S. G. Amara, E.
Bamberg, M. P. Blaustein, H. Grunick, R. J. Gottingen, W. J. Lederer, A. Miyajima, H.
Murer, N. Pfanner, G. Schultz, M. Schweiger (Eds.), Reviews of physiology, biochemistry
and pharmacology (pp. 1-94). Berlin, Heidelberg: Springer-Verlag.
Fensome, A., Whatmore, J., Morgan, C., Jones, D., and Cockcroft, S. (1998). ADP-
ribosylation factor and Rho proteins mediate fMLP-dependent activation of phospholipase
D in human neutrophils. J. Biol. Chem., 273, 13157-13164.
Franco, M., Peters, P. J., Boretton, J., van Donselaar, E., Neri, A., D’Souza-Schorey, C., and
Chavrier, P. (1999). EFA6 a Sec7 domain-containing exchange factor for Arf6 coordinates
membrane recycling and actin cytoskeleton organization. EMBO J., 18, 1480-1491.
Freyberg, Z., Sweeney, D., Siddhanta, A., Bourgoin, S., Frohman, M., and Shields, D. (2001).
Intracellular localization of phospholipase D1 in mammalian cells. Mol. Biol. Cell, 12,
943-955.
Gaschet, J., and Hsu, V. W. (1999). Distribution of Arf6 between membrane and cytosol is
regulated by its GTPase cycle. J. Biol. Chem., 274, 20040-20045.
Geny, B., Fensome, A., and Cockcroft, S. (1993). Rat brain cytosol contains a factor which
reconstitutes guanine-nucleotide-binding-protein-regulated phospholipase–D activation in
HL 60 cells previously permeabilized with streptolysin O. Eur. J. Biochem., 215, 389-396.
Glenn, D. E., Thomas, G. M. H., O’Sullivan, A. J., and Burgoyne, R. D. (1998). Examination
of the role of ADP-ribosylation factor and phospholipase D activation in regulated
exocytosis in Chromaffin and PC12 cells. J. Neurochem., 71, 2023-2033.
Godi, A., Pertile, P., Meyers, R., Marra, P., DiTullio, G., Iurisci, C., Luini, A., Corda, D., and
DeMatteis, M. A. (1999). Arf mediates recruitment of PtdIns-4-OH kinase-β and
stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat. Cell Biol., 1, 280-287.
Gress, T. M., Muller-Pillasch, F., Geng, M., Zimmerhackl, F., Zehetner, G., Friess, H.,
Buchler, M., Adler, G., and Lehrach, H. (1996). A pancreatic cancer-specific expression
profile. Oncogene, 13, 1819-1830.
Guillemain, I., and Exton, J. H. (1997). Effects of brefeldin A on phosphatidylcholine
phospholipase D and inositol phospholipid metabolism in HL-60 cells. Eur. J. Biochem.,
249, 812-819.
Hammond, S. M., Altshuller, Y. M., Sung, T.-C., Rudge, S. A., Rose, K., Engebrecht, J. A.,
Morris, A. J., and Frohman, M. A. (1995). Human ADP-ribosylation factor-activated
phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene
family. J. Biol. Chem., 270, 29640-29643.
Hammond, S. M., Jenco, J. M., Nakashima, S., Cadwallader, K., Gu, Q.-m., Cook, S.,
Nozawa, Y., Prestwich, G. D., Frohman, M. A., and Morris, A. J. (1997). Characterization
of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes
PHOSPHOLIPASE D, ARFAPTINS AND ARFOPHILIN 237
15
Lamarche, N., Tapon, N., Stowers, L., Burbelo, P. D., Aspenstrom, P., Bridge, T., Chant, J.,
and Hall, A. (1996). Rac and Cdc42 induce actin polymerization and G1 cell cycle
progression independently of p65pAK and the JNK/SAPK MAP kinase cascade. Cell, 87,
519-529.
Liang, J. O., Sung, T.-C., Morris, A. J., Frohman, M.A., and Kornfeld, S. (1997). Different
domains of mammalian ADP-ribosylation factor 1 mediate interaction with selected target
proteins. J. Biol. Chem., 272, 33001-33008.
Lopez, I., Arnold, R. S., and Lambeth, J. D. (1998). Cloning and initial characterization of a
human phospholipase D (hPLD2). J. Biol. Chem., 273, 12846-12852.
Martin, A., Brown, F. D., Hodgkin, M. N., Bradwell, A. J., Cook, S. J., and Hart, M. (1996).
Activation of phospholipase D and phosphatidylinositol 4-phosphate 5-kinase in HL60
membranes is mediated by endogenous Arf but not Rho. J. Biol. Chem., 271, 17397-
17403.
Martin, T. F. J. (1998). Phosphoinositide lipids as signaling molecules: common themes for
signal transduction, cytoskeletal regulation, and membrane trafficking. Annu. Rev. Cell
Dev. Biol., 14, 231-264.
Martin, T. F. J. (2001). PI(4,5)P2 regulation of surface membrane traffic. Curr. Opin. Cell
Biol., 13, 493-499.
Massenburg, D., Han, J.-S., Liyanage, M., Patton, W. A., Rhee, S. G., Moss, J., and Vaughan,
M. (1994). Activation of rat brain phospholipase D by ADP-ribosylation factors 1, 5, and
6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes. Proc.
Natl. Acad. Sci., USA, 91, 11718-11722.
Meacci, E., Vasta, V., Moorman, J. P., Bobak, D. A., Bruni, P., Moss, J., and Vaughan, M.
(1999). Effect of Rho and ADP-ribosylation factor GTPases on phospholipase D activity
in intact human adenocarcinoma A549 cells. J. Biol. Chem., 274, 18605-18612.
Min, D. S., Park, S.-K, and Exton, J. H. (1998). Characterization of a rat brain phospholipase
D isozyme. J. Biol. Chem., 273, 7044-7051.
Mitchell, R., McCulloch, D., Lutz, E., Johnson, M., MacKenzie, C., Fennell, M., Fink, G.,
Zhou, W., and Sealfon, S. C. (1998). Rhodopsin-family receptors associate with small G
proteins to activate phospholipase D. Nature, 392, 411-414.
Moritz, A., DeGraan, P. N. E., Gispen, W. H., and Wirz, K. W. A. (1992). Phosphatidic acid
is a specific activator of phosphatidylinositol-4-phosphate kinase. J. Biol. Chem., 267,
7207-7210.
Moss, J., and Vaughan, M. (1998). Molecules in the Arf orbit. J. Biol. Chem., 273, 21431-
21434.
Paris, S., Beraud-Dufour, S., Robineau, S., Bigay, J., Antonny, B., Chabre, M., and Chardin,
P. (1997). Role of protein-phospholipid interactions in the activation of Arf1 by the
guanine nucleotide exchange factor Arno. J. Biol. Chem., 272, 22221-22226.
Park, S.-K., Min, D. S., and Exton, J. H. (1998). Definition of the protein kinase C interaction
site of phospholipase D. Biochem. Biophys. Res. Comm., 244, 364-367.
Park, S.-K., Provost, J. J., Bae, C. D., Ho, W.-T., and Exton, J. H. (1997). Cloning and
characterization of phospholipase D from rat brain. J. Biol. Chem., 272, 29263-29271.
Peters, P. J., Ning, K., Palacios, F., Boshans, R. L., Kazanstev, A., Thompson, L. M.,
Woodman, B., Bates, G. P., and D’Souza-Schorey, C. (2002). Arfaptin 2 regulates the
aggregation of mutant huntingtin protein. Nature Cell Biol., 4, 240-245.
Provost, J. J., Fudge, J., Israelit, S., Siddiqi, A. R., and Exton, J. H. (1996). Tissue-specific
distribution and subcellular distribution of phospholipase D in rat: evidence for distinct
RhoA- and ADP-ribosylation factor (Arf)-regulated isoenzymes. Biochem. J., 319, 285-
291.
PHOSPHOLIPASE D, ARFAPTINS AND ARFOPHILIN 239
17
Sung, T.-C., Zhang, Y., Morris, A. J., and Frohman, M. A. (1999b). Structural analysis of
human phospholipase D1. J. Biol. Chem., 274, 3659-3666.
Takeya, R., Takeshige, K., and Sumimoto, H. (2000). Interaction of the PDZ domain of
human PICK1 with class 1 ADP-ribosylation factors. Biochem. Biophys. Res. Comm., 267,
149-155.
Tarricone, C., Xiao, B., Justin, N., Walker, P. A., Rittinger, K., Gamblin, S. J., and Smnerdon,
S. J. (2001). The structural basis of Arfaptin-mediated cross talk between Rac and Arf
signaling pathways. Nature, 411, 215-219.
Terui, T., Kahn, R. A., and Randazzo, P. A. (1994) Effects of acid phospholipids on
nucleotide exchange properties of ADP-ribosylation factor 1. Evidence for specific
interaction with phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem., 269, 28130-28135.
Tsai, S.-C., Adamik, R., Hong, J.-X., Moss, J., Vaughan, M., Kanoh, H., and Exton, J. H.
(1998). Effects of Arfaptin 1 on guanine nucleotide-dependent activation of phospholipase
D and cholera toxin by ADP-ribosylation factor. J. Biol. Chem., 273, 20697-20701.
Van Aelst, L., Joneson, T., and Bar-Sagi, D. (1996). Identification of a novel Rac1-interacting
protein involved in membrane ruffling. EMBO J., 15, 3778-3786.
Vitale, N., Caumont, A-S, Chasserot-Golaz, S., Du, G., Wu, S., Sciorra, V. A., Morris, A. J.,
Frohman, M. A., and Bader, M-F. (2001) Phospholipase D1: a key factor for the
exocytotic machinery in neuroendocrine cells. EMBO J., 20, 2424-2434.
Way, G., O’Luanaigh, N., and Cockcroft, S. (2000). Activation of ecovytosis by cross-linking
of the IgE receptor is dependent on ADP-ribosylation factor 1-regulated phopholipase D in
RBL-2H3 mast cells: evidence that the mechanism of activation is via regulation of
phosphatidylinositol 4,5-bisphosphate synthesis. Biochem. J., 345, 63-70.
West, M. A., Bright, N. A., and Robinson, M. S. (1997). The role of ADP-ribosylation factor
and phospholipase D in adaptor recruitment. J. Cell Biol., 138, 1239-1254,
Whatmore, J., Morgan, C. P., Cunningham, E., Collison, K. S., Willison, K. R., and
Cockcroft, S. (1996) ADP-ribosylation factor 1-regulated phospholipase D activity is
localized at the plasma membrane and intracellular organelles in HL60 cell. Biochem. J.,
320, 785-794.
Williger, B.-T., Osterman, J., and Exton, J. H. (1999). Arfaptin 1, an Arf-binding protein,
inhibits phospholipase D and endoplasmic reticulum/Golgi protein transport. FEBS Lett.,
443, 197-200.
Williger, B.-T., Provost, J. J., Ho, W.-T., Milstine, J., and Exton, J. H. (1999). Arfaptin 1
forms a complex with ADP-ribosylation factor and inhibits phospholipase D. FEBS Lett.,
454, 85-89.
Yang, C. Z., Heimberg, H., D’Souza-Schorey, C., Mueckler, M. M., and Stahl, P. D. (1998).
Subcellular distribution and differential expression of endogenous ADP-ribosylation factor
6 in mammalian cells. J. Biol. Chem., 273, 4006-4011.
Zhang, G.-F., Patton, W. A., Lee, F.-J. L., Liyanage, M., Han, J.-S., Rhee, S.G., Moss, J., and
Vaughan, M. (1995). Different Arf domains are required for the activation of cholera toxin
and phospholipase D. J. Biol. Chem., 270, 21-24.
Chapter 12
COAT PROTEINS
Abstract: A major cellular function of Arfs is the regulation of membrane traffic. Many
studies, using several independent approaches, have shown that activated Arfs
directly recruit coat complexes to membranes. These coats sort cargo and
facilitate vesicle formation. Three classes of Arf-dependent coat proteins or
complexes have been described so far, including COPs, adaptins, and GGAs.
This chapter focuses on aspects of Arf-dependent coat proteins and complexes.
We will discuss the binding between Arfs and coats, with an emphasis on
COPI and GGAs, as well as the localization and function of each coat.
There are currently three different classes of Arf-dependent adaptors that act
in the biogenesis of vesicles and sorting of their cargo: the tetrameric
adaptins (APs), heptameric coatomers (COPs), and monomeric GGAs
(Golgi-localized, γ-adaptin ear homology domain, Arf-binding). Each class
has more than one member in mammals with at least four APs, two COP
complexes, and three GGAs.
2.3 GGAs
The GGAs are a recently identified family of Arf effectors that are
monomeric, clathrin-binding adaptors (for review, see Boman, 2001). Three
GGAs are present in mammalian cells: GGA1, GGA2, and GGA3. Two are
present in S. cerevisiae (Gga1p and Gga2p), and D. melanogaster, C.
elegans, and S. pombe genomes each have at least one GGA gene. GGA
proteins have four domains (Figure 1) that possess many or all the functions
N C
VHS GAT hinge ear
Figure 1. Schematic of GGA domain structure.
Figure 2. Sites of action of each coat protein. COPs function in the early secretory pathway,
mediating transport between the ER, cis-Golgi network (CGN), and Golgi. APs and GGAs
function in later pathways, primarily between TGN, endosomes, and plasma membrane.
However, the specific pathways mediated by each coat are still being debated.
COPI localizes to the Golgi apparatus, and can be seen distributing mainly to
the cis side, including the cis-Golgi network (CGN) (Oprins et al., 1993).
Though COPI has been extensively studied, the role of this coat complex is
still being debated. The debate can be divided into two categories: one
debating the very existence of COPI (and COPII) as a coat for vesicles, the
other what type of cargo goes into COPI vesicles. Though each issue is far
from settled, there is good biochemical, morphological, and functional
evidence in support of COPI vesicles. However, COPI is also implicated in
other processes such as tubulation of membranes (e.g., such as that seen
upon removal of the coat) and regulation (with Arf) of lipid modifying
enzymes, and the sorting process itself. The issue of cargo sorting is also far
from settled. For a long time, it was assumed that anterograde cargo was the
main cargo of COPI vesicles. There is now growing evidence that COPI
vesicles recycle Golgi resident proteins. Whether recycling is the sole
248
8 BOMAN AND NILSSON
function of COPI vesicles remains to be seen (for a recent review, see Storrie
and Nilsson, 2002).
COPII localizes to the endoplasmic reticulum (ER) and functions in ER
exit (Barlowe et al., 1994). As with COPI, COPII components have been
implicated in sorting through direct association to cytoplasmic domains of
both newly synthesized proteins as well as to resident proteins that shuttle
between the ER and the Golgi apparatus (e.g., p24 proteins). One of the
COPII components, Sec13, has also been localized close to the cis side of
the Golgi apparatus in mammalian cells (Tang et al., 1997), raising the
possibility of a functional link between COPII and COPI. There is less
controversy regarding the role of COPII vesicles though important questions
remain. For example, large supra-molecular structures (e.g., collagen and
some viruses) too large to fit in the typical 60nm COPII vesicle can still
leave the ER. Does this occur with the help of COPII and if so, how?
4. INTRAMOLECULAR INTERACTIONS
BETWEEN ARFS AND COATS
Several experiments have been performed to identify the region of Arf that
binds to coats and vice versa. The similarities and differences reveal
interesting mechanistic insights into coat recruitment.
The crystal structure of Arf contains two flexible switch regions, comparable
to switch I and II of Ras (see Chapter 2). These regions have different
conformations in the GDP-bound versus GTP-bound states, suggesting that
they are effector binding regions. Using directed and random mutagenesis
approaches, these switch regions were found to be important for coat
binding.
In a directed approach, three residues in switch I of Arf1 were mutated to
allow photo-activated cross-linking to neighboring residues. In the presence
of membranes and GTP, residues Ile46 and Ile49 were cross-linked to COPI
(Zhao et al., 1999). Under the same conditions, residue Val43 was not
specifically cross-linked (Zhao et al., 1999). Similarly, Ile46 was cross-
linked to AP-1 and AP-3 (Austin et al., 2002; Austin et al., 2000). These
data suggest that switch I is in close proximity to COPI, AP-1, and AP-3 at
membrane surfaces. Notably, the Ile46 cross-linking experiments did not
identify GGAs or AP-2 (Austin et al., 2002).
In a random approach to define effector-binding sites on human Arf3,
reverse two-hybrid screening showed that switch I and switch II are each
important for binding to different effectors (Kuai et al., 2000). Several
mutations were identified that eliminated binding to one effector yet retained
binding to other effectors. Two mutations in switch I were found to
eliminate binding to GGA1: I49T and F51Y (Kuai et al., 2000). These
mutants were later shown to fail to interact with the GAT domain of GGA3,
as expected (Puertollano et al., 2001). In contrast, several mutations in
250
10 BOMAN AND NILSSON
switch II had no effect on GGA binding. These data suggest that switch I is
essential for binding to GGA proteins. In the absence of direct binding tests
with COPI, these mutants were also tested for recruitment of COPI to Golgi
membranes. Interestingly, the switch II mutations were much more impaired
in COPI recruitment to Golgi membranes than were the switch I mutations
(Kuai et al., 2000), suggesting that switch II is essential for COPI
recruitment. This suggested that the binding sites for GGAs and COPI/APs
are distinct, though perhaps overlapping.
The binding site for Arf GAP includes switch II, as determined by x-ray
crystallography. The activity of Arf GAP1 is enhanced by a factor of at least
a thousand by COPI. However, this effect has only been observed in
solution using truncated Arf GAP1 and Arf1 devoid of its N-terminal
domain (Goldberg, 1999; Szafer et al., 2000; Szafer et al., 2001). Thus, the
possibility of a stimulatory role of coatomer is open and additional
experiments, preferably including some in vivo, are required. In contrast,
binding and activity of Arf GAP1 is reduced by GGAs (Puertollano et al.,
2001). These data suggest that COPI binds predominantly to switch I and
GGAs bind to switch II. But such a conclusion is inconsistent with the
mutational analyses. The potential differences between the cross-linking,
GAP, and mutant analyses have not yet been resolved, and will likely require
structure determinations of the protein complexes and additional data.
The binding site for Arf on each coat has been mapped to different extents,
with the most detailed analysis performed on GGA proteins. There is no
apparent homology between coats in the Arf-binding regions. Perhaps the
structures are conserved, but the linear sequence is not.
The binding site on GGA proteins was mapped by truncation analysis to
a highly conserved domain corresponding to residues 170-280 in GGA1
(Boman et al., 2000; Zhdankina et al., 2001). This region lies in a domain
that has been named the Arf-Binding Domain (ABD), GGA and TOM1
(GAT) domain, or GGA Homology (GGAH) domain (Boman et al., 2002;
Dell'Angelica et al., 2000; Takatsu et al., 2002). There appears to be
consensus to use the term GAT in the future. A cluster of residues within
this domain (180-200 of GGA1) is extremely conserved between all yeast
and human GGAs. Point mutations within this region of human and yeast
GGA proteins eliminate binding to Arf (Boman et al., 2000; Puertollano et
al., 2001; Takatsu et al., 2002). In human GGAs, these mutations abolish
membrane association, showing that Arf recruits GGAs to the late Golgi.
Interestingly, in yeast these mutations have minor effects on function and no
effect on localization, suggesting that interactions with proteins other than
COAT PROTEINS 251
11
Shiba et al., 2002). These models show that 12 residues in two α helices (α6
and α8) are involved in the interaction (Shiba et al., 2002). Only three of
these residues are conserved in yeast Gga1 and Gga2, none of which make
contact with the dileucine motif. Consistent with this, human GGAs bind to
yeast Vps10p tail (Dennes et al., 2002), but yeast Ggas do not (A. Boman,
unpublished observation). These data suggest that yeast Gga proteins bind
cargo with a different motif than reported for human GGA proteins.
However, the VHS domain of yeast Gga proteins is required for localization
and function, strongly suggesting that this domain binds to cargo or other
important regulatory proteins (Boman et al., 2002). The VHS and GAT
domains of yeast Ggas work synergistically for Golgi localization,
suggesting that Arf activation will lead to efficient cargo packaging by Gga
proteins. We speculate that Arf binding to yeast or human GGAs may allow
kinases or phosphatases to act on GGA proteins, thus regulating cargo
binding.
It is still unclear how long Arf and coats remain associated with vesicles
in vivo. Based on early experiments with GTPγS, it was proposed that
hydrolysis of GTP on Arf triggered uncoating, just prior to vesicle fusion.
More recent data show that vesicles formed with GTP do not retain their
coats, suggesting that GTP hydrolysis occurs during or shortly after coat
recruitment (Lanoix et al., 1999). Unlike COP and AP complexes, GGA
proteins are not stabilized on membranes by GTPγS (A. Boman, unpublished
observations), nor are they cross-linked to Arf (Austin et al., 2002). These
data suggest that distinct mechanisms are involved in vesicle formation by
each of the different coat proteins.
5. FUTURE QUESTIONS
REFERENCES
Austin, C., Hinners, I., and Tooze, S. A. (2000). Direct and GTP-dependent interaction of
ADP-ribosylation factor 1 with clathrin adaptor protein AP-1 on immature secretory
granules. J. Biol. Chem., 275, 21862-21869.
Austin, C., Boehm, M., and Tooze, S. A. (2002). Site-specific cross-linking reveals a
differential direct interaction of class 1, 2, and 3 ADP-ribosylation factors with adaptor
protein complexes 1 and 3. Biochemistry, 41, 4669-4677.
Balch, W. E., Kahn, R. A., and Schwaninger, R. (1992). ADP-ribosylation factor is required
for vesicular trafficking between the endoplasmic reticulum and the cis-Golgi
compartment. J. Biol. Chem., 267, 13053-13061.
Barlowe, C., d'Enfert, C., and Schekman, R. (1993). Purification and characterization of
SAR1p, a small GTP-binding protein required for transport vesicle formation from the
endoplasmic reticulum. J. Biol. Chem., 268, 873-879.
Barlowe, C., Orci, L., Yeung, T., Hosobuchi, M., Hamamoto, S., Salama, N., Rexach, M. F.,
Ravazzola, M., Amherdt, M., and Schekman, R. (1994). COPII: a membrane coat formed
by Sec proteins that drive vesicle budding from the endoplasmic reticulum. Cell, 77, 895-
907.
Beckers, C. J., and Balch, W. E. (1989). Calcium GTP: essential components in vesicular
trafficking between the endoplasmic reticulum and Golgi apparatus. J. Cell Biol., 108,
1245-1256.
Blumstein, J., Faundez, V., Nakatsu, F., Saito, T., Ohno, H., and Kelly, R. B. (2001). The
neuronal form of adaptor protein-3 is required for synaptic vesicle formation from
endosomes. J. Neurosci., 21, 8034-8042.
Boehm, M., Aguilar, R. C., and Bonifacino, J. S. (2001). Functional and physical interactions
of the adaptor protein complex AP- 4 with ADP-ribosylation factors (Arfs). EMBO J., 20,
6265-6276.
Boman, A. L., Taylor, T. C., Melancon, P., and Wilson, K. L. (1992). A role for ADP-
ribosylation factor in nuclear vesicle dynamics. Nature, 358, 512-514.
Boman, A. L., Zhang, C., Zhu, X., and Kahn, R. A. (2000). A family of ADP-ribosylation
factor effectors that can alter membrane transport through the trans-Golgi. Mol. Biol. Cell,
11, 1241-1255.
Boman, A. L. (2001). GGA proteins: new players in the sorting game. J. Cell Science, 114,
3413-3418.
Boman, A. L., Salo, P. D., Hauglund, M. J., Strand, N. L., Rensink, S. J., and Zhdankina, O.
(2002). Arf interaction is not sufficient for yeast Gga function or localization. Mol. Biol.
Cell, 13, 3078-3095.
Cosson, P., and Letourneur, F. (1994). Coatomer interaction with di-lysine endoplasmic
reticulum retention motifs. Science, 263, 1629-1631.
Cosson, P., and Letourneur, F. (1997). Coatomer (COPI)-coated vesicles: role in intracellular
transport and protein sorting. Curr. Opin. Cell Biol., 9, 484-487.
Costaguta, G., Stefan, C. J., Bensen, E. S., Emr, S. D., and Payne, G. S. (2001). Yeast gga
coat proteins function with clathrin in golgi to endosome transport. Mol. Biol. Cell, 12,
1885-1896.
Cowles, C. R., Odorizzi, G., Payne, G. S., and Emr, S. D. (1997). The AP-3 adaptor complex
is essential for cargo-selective transport to the yeast vacuole. Cell, 91, 109-118.
Dell'Angelica, E. C., Ohno, H., Ooi, C. E., Rabinovich, E., Roche, K. W., and Bonifacino, J.
S. (1997). AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO J.,
16, 917-928.
254
14 BOMAN AND NILSSON
Misra, S., Puertollano, R., Kato, Y., Bonifacino, J. S., and Hurley, J. H. (2002). Structural
basis for acidic-cluster-dileucine sorting-signal recognition by VHS domains. Nature, 415,
933-937.
Ooi, C. E., Dell'Angelica, E. C., and Bonifacino, J. S. (1998). ADP-Ribosylation factor 1
(Arf1) regulates recruitment of the AP-3 adaptor complex to membranes. J. Cell Biol.,
142, 391-402.
Oprins, A., Duden, R., Kreis, T. E., Geuze, H. J., and Slot, J. W. (1993). Beta-COP localizes
mainly to the cis-Golgi side in exocrine pancreas. J. Cell Biol., 121, 45-59.
Orci, L., Glick, B. S., and Rothman, J. E. (1986). A new type of coated vesicular carrier that
appears not to contain clathrin: its possible role in protein transport within the Golgi
stack. Cell, 46, 171-184.
Orci, L., Malhotra, V., Amherdt, M., Serafini, T., and Rothman, J. E. (1989). Dissection of a
single round of vesicular transport: sequential intermediates for intercisternal movement in
the Golgi stack. Cell, 56, 357-368.
Osterman, J., Orci, L., Tani, K., Amherdt, M., Ravazzola, M., Elazar, Z., and Rothman, J. E.
(1993). Stepwise assembly of functionally active transport vesicles. Cell, 75, 1015-1025.
Pepperkok, R., Whitney, J. A., Gomez, M., and Kreis, T. E. (2000). COPI vesicles
accumulating in the presence of a GTP restricted arf1 mutant are depleted of anterograde
and retrograde cargo. J. Cell Sci., 113, 135-144.
Poussu, A., Lohi, O., and Lehto, V. P. (2000). Vear, a novel Golgi-associated protein with
VHS and gamma-adaptin "Ear" domains. J. Biol. Chem., 275, 7176-7183.
Puertollano, R., Randazzo, P. A., Presley, J. F., Hartnell, L. M., and Bonifacino, J. S. (2001).
The ggas promote arf-dependent recruitment of clathrin to the tgn. Cell, 105, 93-102.
Radhakrishna, H., Klausner, R. D., and Donaldson, J. G. (1996). Aluminum fluoride
stimulates surface protrusions in cells overexpressing the Arf6 GTPase. J. Cell Biol., 134,
935-947.
Robinson, M. S., and Kreis, T. E. (1992). Recruitment of coat proteins onto Golgi membranes
in intact and permeabilized cells: effects of brefeldin A and G protein activators. Cell, 69,
129-138.
Roth, T. F., and Porter, K. R. (1964). Yolk protein uptake in the oocyte of the mosquito Aedes
aegypti. J. Cell Biol., 20, 313-332.
Seaman, M. N., Sowerby, P. J., and Robinson, M. S. (1996). Cytosolic and membrane-
associated proteins involved in the recruitment of AP-1 adaptors onto the trans-Golgi
network. J. Biol. Chem., 271, 25446-25451.
Serafini, T., Orci, L., Amherdt, M., Brunner, M., Kahn, R. A., and Rothman, J. E. (1991).
ADP-ribosylation factor is a subunit of the coat of Golgi-derived COP-coated vesicles: a
novel role for a GTP-binding protein. Cell, 67, 239-253.
Shiba, T., Takatsu, H., Nogi, T., Matsugaki, N., Kawasaki, M., Igarashi, N., Suzuki, M., Kato,
R., Earnest, T., Nakayama, K., and Wakatsuki, S. (2002). Structural basis for recognition
of acidic-cluster dileucine sequence by GGA1. Nature, 415, 937-941.
Simpson, F., Bright, N. A., West, M. A., Newman, L. S., Darnell, R. B., and Robinson, M. S.
(1996). A novel adaptor-related protein complex. J. Cell. Biol., 133, 749-760.
Simpson, F., Peden, A. A., Christopoulou, L., and Robinson, M. S. (1997). Characterization
of the adaptor-related protein complex, AP-3. J. Cell Biol., 137, 835-845.
Springer, S., Spang, A., and Schekman, R. (1991). A primer on vesicle budding. Cell, 97,
145-148.
Stamnes, M. A., and Rothman, J. E. (1993). The binding of AP-1 clathrin adaptor particles to
Golgi membranes requires ADP-ribosylation factor, a small GTP-binding protein. Cell,
73, 999-1005.
256
16 BOMAN AND NILSSON
Stearns, T., Kahn, R. A., Botstein, D., and Hoyt, M. A. (1990). ADP ribosylation factor is an
essential protein in Saccharomyces cerevisiae and is encoded by two genes. Mol. Cell.
Biol., 10, 6690-6699.
Stearns, T., Willingham, M. C., Botstein, D., and Kahn, R. A. (1990). ADP-ribosylation
factor is functionally and physically associated with the Golgi complex. Proc. Natl. Acad.
Sci., USA, 87, 1238-1242.
Stepp, J. D., Pellicena-Palle, A., Hamilton, S., Kirchhausen, T., and Lemmon, S. K. (1995). A
late Golgi sorting function for Saccharomyces cerevisiae Apm1p, but not for Apm2p, a
second yeast clathrin AP medium chain-related protein. Mol. Biol. Cell, 6, 41-58.
Stepp, J. D., Huang, K., and Lemmon, S. K. (1997). The yeast adaptor protein complex, AP-
3, is essential for the efficient delivery of alkaline phosphatase by the alternate pathway to
the vacuole. J. Cell Biol., 139, 1761-1774.
Storrie, B., and Nilsson, T. (2002). The Golgi apparatus: balancing new with old. Traffic, 3
521-529.
Szafer, E., Pick, E., Rotman, M., Zuck, S., Huber, I., and Cassel, D. (2000). Role of coatomer
and phospholipids in GTPase-activating protein-dependent hydrolysis of GTP by ADP-
ribosylation factor-1. J. Biol. Chem., 275, 23615-23619.
Szafer, E., Rotman, M., and Cassel, D. (2001). Regulation of GTP hydrolysis on ADP-
ribosylation factor-1 at the Golgi membrane. J. Biol. Chem., 276, 47834-47839.
Takatsu, H., Yoshino, K., and Nakayama, K. (2000). Adaptor gamma ear homology domain
conserved in gamma-adaptin and GGA proteins that interact with gamma-synergin.
Biochem. Biophys. Res. Comm., 271, 719-725.
Takatsu, H., Yoshino, K., Toda, K., and Nakayama, K. (2002). GGAproteins associate with
Golgi membranes through interaction between their GGAH domains and ADP-
ribosylation factors. Biochem. J., 365, 369-78.
Tang, B. L., Peter, F., Krijnse-Locker, J., Low, S. H., Griffiths, G., and Hong, W. (1997).
The mammalian homolog of yeast Sec13p is enriched in the intermediate compartment
and is essential for protein transport from the endoplasmic reticulum to the Golgi
apparatus. Mol. Cell. Biol., 17, 256-266.
Taylor, T. C., Kahn, R. A., and Melancon, P. (1992). Two distinct members of the ADP-
ribosylation factor family of GTP-binding proteins regulate cell-free intra-Golgi transport.
Cell, 70, 69-79.
Traub, L. M., Ostrom, J. A., and Kornfeld, S. (1993). Biochemical dissection of AP-1
recruitment onto Golgi membranes. J. Cell Biol., 123, 561-573.
Waters, M. G., Serafini, T., and Rothman, J. E. (1991). 'Coatomer': a cytosolic protein
complex containing subunits of non-clathrin-coated Golgi transport vesicles. Nature, 349,
248-251.
West, M. A., Bright, N. A., and Robinson, M. S. (1997). The role of ADP-ribosylation factor
and phospholipase D in adaptor recruitment. J. Cell Biol., 138, 1239-1254.
Yeung, B. G., Phan, H. L., and Payne, G. S. (1999). Adaptor complex-independent clathrin
function in yeast. Mol. Biol. Cell, 10, 3643-3659.
Zhang, C. J., Rosenwald, A. G., Willingham, M. C., Skuntz, S., Clark, J., and Kahn, R. A.
(1994). Expression of a dominant allele of human Arf1 inhibits membrane traffic in vivo.
J. Cell Biol., 124, 289-300.
Zhao, L., Helms, J. B., Brunner, J., and Wieland, F. T. (1999). GTP-dependent binding of
ADP-ribosylation factor to coatomer in close proximity to the binding site for dilysine
retrieval motifs and p23. J. Biol. Chem., 274, 14198-14203.
Zhdankina, O., Strand, N. L., Redmond, J. M., and Boman, A. L. (2001). Yeast GGA proteins
interact with GTP-bound Arf and facilitate transport through the Golgi. Yeast, 18, 1-18.
COAT PROTEINS 257
17
Zhu, X., Boman, A. L., Kuai, J., Cieplak, W., and Kahn, R. A. (2000). Effectors increase the
affinity of GTP to Arf and lead to increased binding. J. Biol. Chem., 275, 13465-13475.
Chapter 13
HETEROTETRAMERIC COAT PROTEIN-ARF
INTERACTIONS
Abstract: The mechanisms by which COPI and the heterotetrameric adaptor complexes
interact with Arf are analyzed from a comparative evolutionary perspective.
Phylogenetic, biochemical, and structural analyses support a common ancestry
of the heterotetrameric adaptors and COPI. Consistent with a structural
conservation between COPI and adaptors, the functional interactions between
Arf and adaptors possess similarities with the way COPI and Arf associate.
However, these interactions have become increasingly complex and appear to
have reached a summit with the adaptor AP-2. A common theme across
different carrier-forming machines is the requirement of interacting networks
of functionally diverse Arf effectors to recruit adaptor complexes to
membranes.
1. INTRODUCTION
with regard to the coats and their interaction with Arf that could be
obligatory properties of the network.
Figure 2. The pair of dimers model for the assembly of the heterotetrameric coat complexes.
Diagram represents a putative evolutionary sequence for the formation of heterotetramers
from a set of dimers (see Figure 1). The putative proto-dimer pair has been inferred from the
hierarchy of subunit interactions obtained for COPI as well as the adaptor complexes (see
text). Diagram of the canonical heterotetramer structure was derived from the crystal
structure of the AP-2 core complex (Collins et al., 2002).
the small ζ-COP subunit (Eugster et al., 2000; Faulstich et al., 1996; Takatsu
et al., 2001). Triple-hybrid analysis has further shown that ζ-COP acts as a
bridge between the β and γ subunits because negligible interaction occurs
between β and γ-COP in the absence of ζ-COP (Takatsu et al., 2001). This
hierarchy of contacts detected by yeast hybrid analysis can also be
biochemically defined, as it is possible to disassemble purified coatomer into
stable β−δ and γ−ζ sub-complexes (Pavel et al., 1998). In particular, the
isolated β−δ sub-complex is functional, as this isolated sub-complex can be
recruited to membranes in an Arf1•GTP-dependent manner (Pavel et al.,
1998). As we will see, the β subunit of the COPI F-subcomplex is involved
in Arf1 recognition. These results suggest that the most primitive interaction
between Arf1 and a coat occurred between the GTPase and a β−δ dimer.
This molecular analysis is supportive of the phylogenetic model proposed by
Schledzewski, et al. (Schledzewski et al., 1999), who suggested that the
primordial COPI precursor emerged by the fusion of two proto-dimers (see
Figure 2).
Does adaptor subunit organization fit the proto-dimer model? The
crystal structure of the AP-2 adaptor core complex (Collins et al., 2002),
which phylogenetic studies indicate is the most recent heterotetramer
addition to the tetrameric adaptor family (Lewin and Mellman, 1998;
Schledzewski et al., 1999; Boehm and Bonifacino, 2001), has provided
insight into this question. The core of AP-2 is organized as a rectangular
structure with its outside flanked by curved α and β2 chains. Nestled in the
elbow of α and β2 are the σ2 and the N-terminus of the µ2 subunits,
respectively. Each pair, α−σ2 and β2-µ2, forms a tight heterodimer, which
creates a flat platform where the C-terminal end of µ2 sits. Remarkably, the
crystal structure of σ2 and the N-terminal end of µ2 are almost identical
(Collins et al., 2002) (see Figure 2). Also, the large subunits α and β2 share
substantial structural homology (Collins et al., 2002). These results are in
agreement with the phylogenetic prediction that the large subunits as well as
the σ and µ-type chain originated by gene duplication from common
ancestor genes that encoded a primitive dimer (Lewin and Mellman, 1998;
Schledzewski et al., 1999; Boehm and Bonifacino, 2001).
Genetic and biochemical evidence regarding other tetrameric adaptors
also support a “proto-dimer” model”. Two-hybrid analysis has revealed the
existence of preferential dimer associations within AP-1 (Takatsu et al.,
2001; Page and Robinson, 1995; Aguilar et al., 1997), AP-3 (Peden et al.,
2002) and AP-4 (Takatsu et al., 2001; Hirst et al., 1999), in addition to AP-2
(Page and Robinson, 1995). Stable AP-3 dimers are also found in vivo.
Naturally occurring AP-3 mutations in mice, either in δ or β3A subunits,
lead to degradation of the non-mutated subunits to different extents
(Kantheti et al., 1998; Feng et al., 1999; Dell’Angelica et al., 1999a; Zhen et
264
6 STYERS AND FAUNDEZ
With the exception of Arf6 (Cavenagh et al., 1996), all Arfs cycle between
the cytosol and membranes, depending upon whether GDP or GTP is bound,
respectively (Moss and Vaughan, 1998). Cycling of Arf between cytosol
and membranes brings its effectors in close proximity to membranes.
Among those effectors are COPI and other adaptors. These coat complexes
cycle between membrane-bound and cytosolic states in a mechanism that is
functionally linked to the Arf GTPase cycle.
Three non-exclusive models have been proposed that differ in the nature
of the Arf effector. These models include the hypotheses that:
a) Arfs interact directly with COPI and other adaptor complexes (Zhao et
al., 1997).
b) Arfs interact with or modify a putative docking site, inducing a change
that would allow the docking site to bind the coat molecule (Zhu et al.,
1998). The docking site could be either a lipid (Arneson et al., 1999) and/or
a protein (Zhu et al., 1998).
c) Arfs interact with lipid modifying effectors that create membrane
microdomains favorable for adaptor binding (Ktistakis et al., 1996).
It is likely that in a single cell, different membranes organize networks of
Arf effectors that build vesiculation machines that differ in the extent that
TETRAMERIC COAT PROTEIN-ARF INTERACTIONS 2657
The first indication that Arf was involved in the recruitment of adaptors to
membranes came from the use of the fungal metabolite brefeldin A (BFA),
an inhibitor of some Arf GEFs (Klausner et al., 1992; Jackson and
Casanova, 2000). Shortly after drug treatment COPI (Klausner et al., 1992;
Lippincott-Schwartz et al., 1991; Orci et al., 1991); AP-1 (Seaman et al.,
1993; Robinson and Kreis, 1992), AP-3 (Simpson et al., 1996; Dell’Angelica
et al., 1997; Ooi, et al., 1998) and AP-4 (Hirst et al., 1999; Dell’Angelica, et
al., 1999b) are redistributed to the cytosol. Similar effects can be triggered
using Arf mutants that mimic the GDP-bound state of the GTPase (Hirst et
al., 1999; Ooi et al., 1998). Demonstration of direct binding between coat
molecules and Arf1 was first obtained in an in vitro reconstituted Golgi
membrane system (Zhao et al., 1997; Zhao, et al., 1999). Purified COPI can
be recruited to Golgi membranes by in vitro transcribed-translated-Arf1.
Using tRNA loaded with photo-reactive amino acids it is possible to label
selected positions on in vitro transcribed-translated Arf1. Loading the
GTPase with a photo-reactive phenylalanine in position 82 leads to a cross-
linked product with β-COP (Zhao et al., 1997). In contrast, Arf1 loaded
with photo-reactive residues either at position 46 or 49 forms cross-linked
products with each large coatomer subunit, β-COP and γ-COP (Zhao et al.,
1999). The GTP•Arf1-COPI interaction has been confirmed for the β-COP
subunit using two-hybrid analysis (Eugster et al., 2000). The exact regions
in the β-COP and γ-COP subunits where Arf1 binds are presently not
known. However, if we draw a parallel between the AP-2 core crystal
structure and COPI, these results suggest that Arf1 is wedged in the interface
of the two large COPI subunits in close proximity to the membrane (see
Figure 3).
In light of the structural conservation observed between COPI and the
tetrameric adaptors, a likely prediction is that Arf1 labeled on positions 46,
49 or 82 should be cross-linked to the large subunits of the adaptor
complexes known to be recruited by Arf1. Immature secretory granules
purified from adrenomedullary cells recruit AP-1 and AP-3 in a GTP•Arf-
dependent fashion (Dittie et al., 1996). In this in vitro adaptor recruitment
system, photoreactive Arf1•GTP or Arf5•GTP, labeled at position 46, can
be cross-linked to the AP-1 complex (Austin et al., 2000; Austin et al.,
2002). Immunoprecipitation with β1 and γ antibodies has confirmed that the
266
8 STYERS AND FAUNDEZ
large subunits of the AP-1 complex interact with Arf1. Moreover, removing
the ear domains of both large subunits by controlled proteolysis does not
abrogate the formation of β1/γ-Arf1 cross-linked products (Austin et al.,
2002). These results suggest that the membrane-facing region of AP-1,
composed of the amino-terminal part of β1 and γ, interacts with Arf1.
Similar results have been obtained with AP-3, although the identity of the
high molecular weight cross-linked products could not be defined by
immunoprecipitation with β3 or δ antibodies. However, native
immunoprecipitation with antibodies against the small σ3 subunit brings
down Arf1 cross-linked to polypeptides that correspond to the molecular
weight of the large AP-3 subunits (Austin et al., 2002).
Figure 3. Proposed molecular interactions of the ARF GTPases with heterotetrameric coats.
See text for details.
A major indication that other factors are required to define the binding of an
adaptor to membranes has come from the reconstitution of Arf-dependent
coat recruitment onto protein-free synthetic membranes. AP-1 and clathrin
can be recruited to liposomes with a similar efficiency to that achieved on
natural membranes, such as Golgi-enriched fractions (Zhu et al., 2001a; Zhu
et al., 1999a). However, AP-1 recruitment to Golgi membranes requires
cytosolic factors other than Arf1 fractions (Zhu et al., 2001a; Zhu et al.,
1999a; Seaman et al., 1996). Moreover, the AP-1-liposome interaction is
significantly influenced by the liposome lipid composition. Acidic
phospholipids, such as phosphatidic acid or phosphatidylinositides (PIs),
notably increase the adaptor recruitment to liposomes (Zhu et al., 1999a).
Phosphatidic acid is generated from phosphatidylcholine by phospholipase D
(PLD). This enzyme is an Arf effector (Brown et al., 1993; Cockcroft et al.,
1994) that is found in association with the Golgi complex, to which it is
recruited by a GTP•Arf-dependent mechanism (Ktistakis et al., 1995;
Freyberg et al., 2001). In addition, PI-4-kinase β is recruited to the Golgi
complex by an Arf-1 dependent mechanism and once on the membrane it
stimulates the production of PI(4,5)P2 (Godi et al., 1999). Thus, it is likely
that lipid-modifying enzymes, recruited to membranes by Arf-dependent
mechanisms, control the dynamics of the Golgi complex (Sweeney et al.,
2002) by creating membrane microdomains favorable for adaptor and coat
recruitment.
AP-1 and AP-3 recruitment to liposomes differ in the specificity of lipids
required. AP-3 recruitment to synthetic liposomes occurs irrespective of the
presence of acidic phospholipid (Drake et al., 2000). Moreover, AP-3, but
not AP-1 or AP-2, can be recruited to synaptic vesicles in an Arf1-dependent
manner (Faundez et al., 1998). Interestingly, synaptic vesicles do not
possess detectable levels of PIs (Micheva et al., 2001). Additionally, the
ATP-requirement to recruit AP-3 to membranes can be completely replaced
by ATPγS (Faundez and Kelly, 2000), a poor substrate for lipid modifying
enzymes (Hay and Martin, 1992). In this regard, AP-3 is closely related to
COPI, which can also be recruited to synthetic liposomes irrespective of the
presence of acidic phospholipids (Spang et al., 1998; Bremser et al., 1999).
These observations agree with the close evolutionary relationship between
AP-3 and COPI (Scheldzewski et al., 1999; Boehm and Bonifacino, 2001).
In addition, they suggest that the interaction of adaptors with acidic
TETRAMERIC COAT PROTEIN-ARF INTERACTIONS 269
11
Early indications that GTPases could modulate AP-2 came from studies
using perforated cells and cell-free assays (Seaman et al., 1993; West et al.,
1997). AP-2 can be recruited to a variety of membranes by mechanisms that
differ in their nucleotide requirement (Arneson et al., 1999; Zhang et al.,
1994; Traub et al., 1996). The best characterized example is the AP-2
recruitment to synaptic membrane preparations (Takei et al., 1996). In this
system, AP-2 binding to membranes requires ATP and is stimulated by the
addition of GTPγS. GTPγS-dependent AP-2 recruitment to membranes has
been initially regarded as dependent on the GTPase dynamin. However, as
we will discuss, it could reflect the involvement of other GTPases.
If PIP2 lipids are involved in the recruitment of AP-2, then a critical
regulatory step is likely to reside in the localized synthesis of PIP2. Among
those proteins responsible to control PIP2 levels, for this discussion we will
concentrate on the enzymes that regulate AP-2/clathrin recruitment. PIP-5-
kinase Iγ (Wenk et al., 2001) and the class II PI 3-kinase C2α (Gaidarov et
al., 2001) control the production of different PIP2’s at the plasma membrane.
Both enzymes are necessary to recruit AP-2 to either liposomes or
membranes. As expected, the effects of the PIP-5-phosphatase
(synaptojanin I) and the PIP 5-kinase (PIP kinase Iγ) are antagonistic with
regard to AP-2 recruitment to membranes (Wenk et al., 2001).
TETRAMERIC COAT PROTEIN-ARF INTERACTIONS 271
13
receptor traffic, can bind Arf6•GDP and ARNO, forming a complex that
catalyzes the exchange of GDP for GTP (Claing et al., 2001). Because β-
arrestin possesses binding sites for AP-2 (Laporte et al., 2000; Miller and
Lefkowitz, 2001) as well as PIP2 (Gaidarov and Keen, 1999) it is possible
that β-arrestin brings together Arf6 and AP-2 in a PIP2 membrane patch.
Alternatively, AP-2 may interact with the by-product of an Arf-effector
interaction, such as PIP2, which is generated by activating a PIP 5-kinase. In
either case, the nature of the interaction is indirect. As previously discussed
for COPI, AP-1, AP-3 and AP-4, it is likely that Arf is wedged between the
membrane facing regions of the two large subunits of the heterotetrameric
coat complexes. Instead, in AP-2, α-adaptin and the µ2 subunit, by virtue of
tight binding to PI(4,5)P2, dock AP-2 to membrane lipids, likely obliterating
an Arf-binding pocket. PI(4,5)P2 binds to Arfs with affinities on the order of
-5 -7
10 M (Randazzo, 1997) whereas it binds α-adaptin with a KD of 10 M
(Gaidarov and Keen, 1999). Thus, it is unlikely that an Arf molecule could
co-exist with AP-2 on membrane patches rich in AP-2 and PI(4,5)P2. The
-7
simultaneous binding of arrestin to AP-2 and PI(4,5)P2 (KD=10 M) could
provide a selective means to generate clathrin-coated vesicles preferentially
enriched in β-adrenergic receptors.
4. MUTUALISM IN ARF-EFFECTOR
INTERACTIONS INVOLVED IN MEMBRANE
CARRIER BIOGENESIS
the recent description that β-arrestin can bind Arf6•GDP and induce the
GDP-GTP exchange (Claing et al., 2001). These results suggest the
counterintuitive idea that an adaptor (arrestin) could arrive at the membrane
first and then activate the GTPase (Zhu et al., 2000).
If Arf activation is the primary input to a branched network with
feedback regulation, it is not unreasonable to expect that even after
shutdown of Arf function, other network components (Arf-activated
effectors or membrane cargo) could maintain the network functional status
(such as an adaptor bound to membranes). We predict that the kinetic
parameters that govern the activation or membrane recruitment of Arf as
well as distinct effectors should become independent, as the initial Arf input
is disseminated in the network. Indeed, in vivo Arf1 and COPI membrane
association at the Golgi complex obey different kinetic and thermodynamic
parameters; indicating that Arf and coat recruitment to membranes can be
dissociated (Presley et al., 2002). Simultaneous in vivo analysis of the
dynamics of Arfs and their effectors on membranes will provide the
evidence required to test the mutualism model.
The interactions between Arf and adaptors have become increasingly
disparate over time and appear to have reached a summit with the adaptor
AP-2. This divergence may have been selected as the cell-cell
communication and intracellular traffic demands have progressively
increased from a free-living unicellular organism to a multi-cellular
organism comprised of highly specialized cells and tissues. However, the
common theme across different levels of complexity in carrier forming
machines is the formation of networks that interact in a mutualistic manner.
5. ACKNOWLEDGEMENT
This work was supported by grants from the Basil O’Connor March of
Dimes Foundation, The Melanoma Research Foundation, and the Emory
University URC. M. L. Styers is a member of the Biochemistry, Cell and
Developmental Biology Graduate program from the Graduate Division of
Biomedical Sciences, Emory University School of Medicine.
REFERENCES
Aguilar, R. C., Boehm, M., Gorshkova, I., Crouch, R. J., Tomita, K., Saito, T., Ohno, H., and
Bonifacino, J. S. (2001). Signal-binding specificity of the mu4 subunit of the adaptor
protein complex AP-4. J. Biol. Chem., 276, 13145-13152.
TETRAMERIC COAT PROTEIN-ARF INTERACTIONS 275
17
Aguilar, R. C., Ohno, H., Roche, K. W., and Bonifacino, J. S. (1997). Functional domain
mapping of the clathrin-associated adaptor medium chains mu1 and mu2. J. Biol. Chem.,
272, 27160-27166.
Altschuler, Y., Liu, S., Katz, L., Tang, K., Hardy, S., Brodsky, F., Apodaca, G., and Mostov,
K. (1999). ADP-ribosylation factor 6 and endocytosis at the apical surface of Madin-
Darby canine kidney cells. J. Cell Biol., 147, 7-12.
Arneson, L. S., Kunz, J., Anderson, R. A., and Traub, L. M. (1999). Coupled inositide
phosphorylation and phospholipase D activation initiates clathrin-coat assembly on
lysosomes. J. Biol. Chem., 274, 17794-17805.
Ashery, U., Koch, H., Scheuss, V., Brose, N., and Rettig, J. (1999). A presynaptic role for the
ADP ribosylation factor (ARF)-specific GDP/GTP exchange factor msec7-1. Proc. Natl.
Acad. Sci., USA, 96, 1094-1099.
Austin, C., Boehm, M., and Tooze, S. A. (2002). Site-specific cross-linking reveals a
differential direct interaction of class 1, 2, and 3 ADP-ribosylation factors with adaptor
protein complexes 1 and 3. Biochemistry, 41, 4669-4677.
Austin, C., Hinners, I., and Tooze, S. A. (2000). Direct and GTP-dependent interaction of
ADP-ribosylation factor 1 with clathrin adaptor protein AP-1 on immature secretory
granules. J. Biol. Chem., 275, 21862-21869.
Boehm, M., Aguilar, R. C., and Bonifacino, J. S. (2001). Functional and physical interactions
of the adaptor protein complex AP- 4 with ADP-ribosylation factors (ARFs). EMBO J.,
20, 6265-6276.
Boehm, M., and Bonifacino, J. S. (2001). Adaptins: the final recount. Mol. Biol. Cell, 12,
2907-2920.
Bremser, M., Nickel, W., Schweikert, M., Ravazzola, M., Amherdt, M., Hughes, C. A.,
Sollner, T. H., Rothman, J. E., and Wieland, F. T. (1999). Coupling of coat assembly and
vesicle budding to packaging of putative cargo receptors. Cell, 96, 495-506.
Brodin, L., Low, P., and Shupliakov, O. (2000). Sequential steps in clathrin-mediated
synaptic vesicle endocytosis. Curr. Opin. Neurobiol., 10, 312-320.
Brown, H. A., Gutowski, S., Moomaw, C. R., Slaughter, C., and Sternweis, P. C. (1993).
ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates
phospholipase D activity. Cell, 75, 1137-1144.
Cao, T. T., Mays, R. W., and von Zastrow, M. (1998). Regulated endocytosis of G-protein-
coupled receptors by a biochemically and functionally distinct subpopulation of clathrin-
coated pits. J. Biol. Chem., 273, 24592-24602.
Cavenagh, M. M., Whitney, J. A., Carroll, K., Zhang, C., Boman, A. L., Rosenwald, A. G.,
Mellman, I., and Kahn, R. A. (1996). Intracellular distribution of Arf proteins in
mammalian cells. Arf6 is uniquely localized to the plasma membrane. J. Biol. Chem., 271,
21767-21774.
Chen, Y. A., and Scheller, R. H. (2001). SNARE-mediated membrane fusion. Nat. Rev. Mol.
Cell Biol., 2, 98-106.
Chow, V. T., Sakharkar, M. K., Lim, D. P., and Yeo, W. M. (2001). Phylogenetic
relationships of the seven coat protein subunits of the coatomer complex, and comparative
sequence analysis of murine xenin and proxenin. Biochem. Genet., 39, 201-211.
Claing, A., Chen, W., Miller, W. E., Vitale, N., Moss, J., Premont, R. T., and Lefkowitz, R. J.
(2001). beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-
adrenergic receptor endocytosis. J. Biol. Chem., 276, 42509-42513.
Cockcroft, S., Thomas, G. M., Fensome, A., Geny, B., Cunningham, E., Gout, I., Hiles, I.,
Totty, N. F., Truong, O., and Hsuan, J. J. (1994). Phospholipase D: a downstream effector
of ARF in granulocytes. Science, 263, 523-526.
276
18 STYERS AND FAUNDEZ
Collins, B. M., McCoy, A. J., Kent, H. M., Evans, P. R., and Owen, D. J. (2002). Molecular
architecture and functional model of the endocytic AP2 complex. Cell, 109, 523-535.
Cremona, O., Di Paolo, G., Wenk, M. R., Luthi, A., Kim, W. T., Takei, K., Daniell, L.,
Nemoto, Y., Shears, S. B., Flavell, R. A., McCormick, D. A., and De Camilli, P. (1999).
Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell, 99, 179-
188.
Dell'Angelica, E. C., Mullins, C., and Bonifacino, J. S. (1999b). AP-4, a novel protein
complex related to clathrin adaptors. J. Biol. Chem., 274, 7278-7285.
Dell'Angelica, E. C., Ohno, H., Ooi, C. E., Rabinovich, E., Roche, K. W., and Bonifacino, J.
S. (1997). AP-3: an adaptor-like protein complex with ubiquitous expression. EMBO J.,
16, 917-928.
Dell'Angelica, E. C., Shotelersuk, V., Aguilar, R. C., Gahl, W. A., and Bonifacino, J. S.
(1999a). Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to
mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell, 3, 11-21.
Dittie, A. S., Hajibagheri, N., and Tooze, S. A. (1996). The AP-1 adaptor complex binds to
immature secretory granules from PC12 cells, and is regulated by ADP-ribosylation factor.
J. Cell Biol., 132, 523-536.
Drake, M. T., Zhu, Y., and Kornfeld, S. (2000). The assembly of AP-3 adaptor complex-
containing clathrin-coated vesicles on synthetic liposomes. Mol. Biol. Cell, 11, 3723-3736.
D'Souza-Schorey, C., Li, G., Colombo, M. I., and Stahl, P. D. (1995). A regulatory role for
ARF6 in receptor-mediated endocytosis. Science, 267, 1175-1178.
Eugster, A., Frigerio, G., Dale, M., and Duden, R. (2000). COP I domains required for
coatomer integrity, and novel interactions with ARF and ARF-GAP. EMBO J., 19, 3905-
3917.
Faulstich, D., Auerbach, S., Orci, L., Ravazzola, M., Wegchingel, S., Lottspeich, F.,
Stenbeck, G., Harter, C., Wieland, F. T., and Tschochner, H. (1996). Architecture of
coatomer: molecular characterization of delta-COP and protein interactions within the
complex. J. Cell Biol., 135, 53-61.
Faundez, V., Horng, J. T., and Kelly, R. B. (1998). A function for the AP3 coat complex in
synaptic vesicle formation from endosomes. Cell, 93, 423-432.
Faundez, V. V., and Kelly, R. B. (2000). The AP-3 complex required for endosomal synaptic
vesicle biogenesis is associated with a casein kinase Ialpha-like isoform. Mol. Biol. Cell,
11, 2591-2604.
Feng, L., Seymour, A. B., Jiang, S., To, A., Peden, A. A., Novak, E. K., Zhen, L., Rusiniak,
M. E., Eicher, E. M., Robinson, M. S., Gorin, M. B., and Swank, R. T. (1999). The beta3A
subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse
hypopigmentation mutant pearl, a model for Hermansky- Pudlak syndrome and night
blindness. Hum. Mol. Genet., 8, 323-330.
Freyberg, Z., Sweeney, D., Siddhanta, A., Bourgoin, S., Frohman, M., and Shields, D. (2001).
Intracellular localization of phospholipase D1 in mammalian cells. Mol. Biol. Cell, 12,
943-955.
Gad, H., Ringstad, N., Low, P., Kjaerulff, O., Gustafsson, J., Wenk, M., Di Paolo, G.,
Nemoto, Y., Crun, J., Ellisman, M. H., De Camilli, P., Shupliakov, O., and Brodin, L.
(2000). Fission and uncoating of synaptic clathrin-coated vesicles are perturbed by
disruption of interactions with the SH3 domain of endophilin. Neuron, 27, 301-312.
Gaidarov, I., and Keen, J. H. (1999). Phosphoinositide-AP-2 interactions required for
targeting to plasma membrane clathrin-coated pits. J. Cell Biol., 146, 755-764.
TETRAMERIC COAT PROTEIN-ARF INTERACTIONS 277
19
Gaidarov, I., Smith, M. E., Domin, J., and Keen, J. H. (2001). The class II phosphoinositide
3-kinase C2alpha is activated by clathrin and regulates clathrin-mediated membrane
trafficking. Mol. Cell, 7, 443-449.
Glickman, J. N., Conibear, E., and Pearse, B. M. (1989). Specificity of binding of clathrin
adaptors to signals on the mannose-6- phosphate/insulin-like growth factor II receptor.
EMBO J., 8, 1041-1047.
Godi, A., Pertile, P., Meyers, R., Marra, P., Di Tullio, G., Iurisci, C., Luini, A., Corda, D., and
De Matteis, M. A. (1999). ARF mediates recruitment of PtdIns-4-OH kinase-beta and
stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex. Nat. Cell Biol., 1, 280-287.
Hannah, M. J., Schmidt, A. A., and Huttner, W. B. (1999). Synaptic vesicle biogenesis. Annu.
Rev. Cell Dev. Biol., 15, 733-798.
Harris, T. W., Hartwieg, E., Horvitz, H. R., and Jorgensen, E. M. (2000). Mutations in
synaptojanin disrupt synaptic vesicle recycling. J. Cell Biol., 150, 589-600.
Haucke, V., Wenk, M. R., Chapman, E. R., Farsad, K., and De Camilli, P. (2000). Dual
interaction of synaptotagmin with mu2- and alpha-adaptin facilitates clathrin-coated pit
nucleation. EMBO J., 19, 6011-6019.
Hay, J. C., and Martin, T. F. (1992). Resolution of regulated secretion into sequential
MgATP-dependent and calcium-dependent stages mediated by distinct cytosolic proteins.
J. Cell Biol., 119, 139-151.
Hirst, J., Bright, N. A., Rous, B., and Robinson, M. S. (1999). Characterization of a fourth
adaptor-related protein complex. Mol. Biol. Cell, 10, 2787-2802.
Honda, A., Nogami, M., Yokozeki, T., Yamazaki, M., Nakamura, H., Watanabe, H.,
Kawamoto, K., Nakayama, K., Morris, A. J., Frohman, M. A., and Kanaho, Y. (1999).
Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G
protein ARF6 in membrane ruffle formation. Cell, 99, 521-532.
Jackson, C. L., and Casanova, J. E. (2000). Turning on ARF: the Sec7 family of guanine-
nucleotide-exchange factors. Trends Cell Biol., 10, 60-67. _00001699 _00001699.
Jones, D. H., Morris, J. B., Morgan, C. P., Kondo, H., Irvine, R. F., and Cockcroft, S. (2000).
Type I phosphatidylinositol 4-phosphate 5-kinase directly interacts with ADP-ribosylation
factor 1 and is responsible for phosphatidylinositol 4,5-bisphosphate synthesis in the golgi
compartment. J. Biol. Chem., 275, 13962-13966.
Jost, M., Simpson, F., Kavran, J. M., Lemmon, M. A., and Schmid, S. L. (1998).
Phosphatidylinositol-4,5-bisphosphate is required for endocytic coated vesicle formation.
Curr. Biol., 8, 1399-1402.
Kantheti, P., Qiao, X., Diaz, M. E., Peden, A. A., Meyer, G. E., Carskadon, S. L., Kapfhamer,
D., Sufalko, D., Robinson, M. S., Noebels, J. L., and Burmeister, M. (1998). Mutation in
AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in
platelets, melanosomes, and synaptic vesicles. Neuron, 21, 111-122.
Keen, J. H. (1990). Clathrin and associated assembly and disassembly proteins. Annu. Rev.
Biochem., 59, 415-438.
Kirchhausen, T. (2000). Three ways to make a vesicle. Nat Rev Mol Cell Biol, 1, 187-198.
Klausner, R. D., Donaldson, J. G., and Lippincott-Schwartz, J. (1992). Brefeldin A: insights
into the control of membrane traffic and organelle structure. J. Cell Biol., 116, 1071-1080.
Ktistakis, N. T., Brown, H. A., Sternweis, P. C., and Roth, M. G. (1995). Phospholipase D is
present on Golgi-enriched membranes and its activation by ADP ribosylation factor is
sensitive to brefeldin A. Proc. Natl. Acad. Sci., USA, 92, 4952-4956.
Ktistakis, N. T., Brown, H. A., Waters, M. G., Sternweis, P. C., and Roth, M. G. (1996).
Evidence that phospholipase D mediates ADP ribosylation factor- dependent formation of
Golgi coated vesicles. J. Cell Biol., 134, 295-306.
278
20 STYERS AND FAUNDEZ
Laporte, S. A., Oakley, R. H., Holt, J. A., Barak, L. S., and Caron, M. G. (2000). The
interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-
adrenergic receptor into clathrin-coated pits. J. Biol. Chem., 275, 23120-23126.
Le Borgne, R., and Hoflack, B. (1997). Mannose 6-phosphate receptors regulate the
formation of clathrin-coated vesicles in the TGN. J. Cell Biol., 137, 335-345.
Lewin, D. A., and Mellman, I. (1998). Sorting out adaptors. Biochim. Biophys. Acta, 1401,
129-145.
Lippincott-Schwartz, J., Roberts, T. H., and Hirschberg, K. (2000). Secretory protein
trafficking and organelle dynamics in living cells. Annu. Rev. Cell Dev. Biol., 16, 557-589.
Lippincott-Schwartz, J., Yuan, L., Tipper, C., Amherdt, M., Orci, L., and Klausner, R. D.
(1991). Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general
mechanism for regulating organelle structure and membrane traffic. Cell, 67, 601-616.
Lowe, M., and Kreis, T. E. (1998). Regulation of membrane traffic in animal cells by COPI.
Biochim. Biophys. Acta, 1404, 53-66.
McPherson, P. S., Garcia, E. P., Slepnev, V. I., David, C., Zhang, X., Grabs, D., Sossin, W.
S., Bauerfeind, R., Nemoto, Y., and De Camilli, P. (1996). A presynaptic inositol-5-
phosphatase. Nature, 379, 353-357.
Micheva, K. D., Holz, R. W., and Smith, S. J. (2001). Regulation of presynaptic
phosphatidylinositol 4,5-biphosphate by neuronal activity. J. Cell Biol., 154, 355-368.
Miller, W. E., and Lefkowitz, R. J. (2001). Expanding roles for beta-arrestins as scaffolds and
adapters in GPCR signaling and trafficking. Curr. Opin. Cell Biol., 13, 139-145.
Moss, J., and Vaughan, M. (1998). Molecules in the ARF orbit. J. Biol. Chem., 273, 21431-
21434.
Ohno, H., Stewart, J., Fournier, M. C., Bosshart, H., Rhee, I., Miyatake, S., Saito, T.,
Gallusser, A., Kirchhausen, T., and Bonifacino, J. S. (1995). Interaction of tyrosine-based
sorting signals with clathrin-associated proteins. Science, 269, 1872-1875.
Ooi, C. E., Dell'Angelica, E. C., and Bonifacino, J. S. (1998). ADP-Ribosylation factor 1
(ARF1) regulates recruitment of the AP-3 adaptor complex to membranes. J. Cell Biol.,
142, 391-402.
Orci, L., Tagaya, M., Amherdt, M., Perrelet, A., Donaldson, J. G., Lippincott-Schwartz, J.,
Klausner, R. D., and Rothman, J. E. (1991). Brefeldin A, a drug that blocks secretion,
prevents the assembly of non- clathrin-coated buds on Golgi cisternae. Cell, 64, 1183-
1195.
Page, L. J., and Robinson, M. S. (1995). Targeting signals and subunit interactions in coated
vesicle adaptor complexes. J. Cell Biol., 131, 619-630.
Palade, G. (1975). Intracellular aspects of the process of protein synthesis. Science, 189, 347-
358.
Pavel, J., Harter, C., and Wieland, F. T. (1998). Reversible dissociation of coatomer:
functional characterization of a beta/delta-coat protein subcomplex. Proc. Natl. Acad. Sci.,
USA, 95, 2140-2145.
Pearse, B. M. (1985). Assembly of the mannose-6-phosphate receptor into reconstituted
clathrin coats. EMBO J., 4, 2457-2460.
Pearse, B. M. (1988). Receptors compete for adaptors found in plasma membrane coated pits.
EMBO J., 7, 3331-3336.
Pearse, B. M. (1989). Characterization of coated-vesicle adaptors: their reassembly with
clathrin and with recycling receptors. Methods Cell Biol., 31, 229-246.
Pearse, B. M., and Robinson, M. S. (1990). Clathrin, adaptors, and sorting. Annu. Rev. Cell
Biol., 6, 151-171.
TETRAMERIC COAT PROTEIN-ARF INTERACTIONS 279
21
Peden, A. A., Rudge, R. E., Lui, W. W., and Robinson, M. S. (2002). Assembly and function
of AP-3 complexes in cells expressing mutant subunits. J. Cell Biol., 156, 327-336.
Powelka, A. M., and Buckley, K. M. (2001). Expression of ARF6 mutants in neuroendocrine
cells suggests a role for ARF6 in synaptic vesicle biogenesis. FEBS Lett., 501, 47-50.
Prasad, S. V., Laporte, S. A., Chamberlain, D., Caron, M. G., Barak, L., and Rockman, H. A.
(2002). Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-
2 recruitment to the receptor/beta-arrestin complex. J. Cell Biol., 158, 563-575.
Presley, J. F., Ward, T. H., Pfeifer, A. C., Siggia, E. D., Phair, R. D., and Lippincott-
Schwartz, J. (2002). Dissection of COPI and Arf1 dynamics in vivo and role in Golgi
membrane transport. Nature, 417, 187-193.
Puertollano, R., Aguilar, R. C., Gorshkova, I., Crouch, R. J., and Bonifacino, J. S. (2001).
Sorting of mannose 6-phosphate receptors mediated by the GGAs. Science, 292, 1712-
1716.
Randazzo, P. A. (1997). Functional interaction of ADP-ribosylation factor 1 with
phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem., 272, 7688-7692.
Robinson, M. S., and Kreis, T. E. (1992). Recruitment of coat proteins onto Golgi membranes
in intact and permeabilized cells: effects of brefeldin A and G protein activators. Cell, 69,
129-138.
Rohde, G., Wenzel, D., and Haucke, V. (2002). A phosphatidylinositol (4,5)-bisphosphate
binding site within mu2- adaptin regulates clathrin-mediated endocytosis. J. Cell Biol.,
158, 209-214.
Santini, F., and Keen, J. H. (1996). Endocytosis of activated receptors and clathrin-coated pit
formation: deciphering the chicken or egg relationship. J. Cell Biol., 132, 1025-1036.
Santini, F., Marks, M. S., and Keen, J. H. (1998). Endocytic clathrin-coated pit formation is
independent of receptor internalization signal levels. Mol. Biol. Cell, 9, 1177-1194.
Schledzewski, K., Brinkmann, H., and Mendel, R. R. (1999). Phylogenetic analysis of
components of the eukaryotic vesicle transport system reveals a common origin of adaptor
protein complexes 1, 2, and 3 and the F subcomplex of the coatomer COPI. J. Mol. Evol.,
48, 770-778.
Seaman, M. N., Ball, C. L., and Robinson, M. S. (1993). Targeting and mistargeting of
plasma membrane adaptors in vitro. J. Cell Biol., 123, 1093-1105.
Seaman, M. N., Sowerby, P. J., and Robinson, M. S. (1996). Cytosolic and membrane-
associated proteins involved in the recruitment of AP-1 adaptors onto the trans-Golgi
network. J. Biol. Chem., 271, 25446-25451.
Shen, Y., Xu, L., and Foster, D. A. (2001). Role for phospholipase D in receptor-mediated
endocytosis. Mol. Cell Biol., 21, 595-602.
Shupliakov, O., Low, P., Grabs, D., Gad, H., Chen, H., David, C., Takei, K., De Camilli, P.,
and Brodin, L. (1997). Synaptic vesicle endocytosis impaired by disruption of dynamin-
SH3 domain interactions. Science, 276, 259-263.
Simpson, F., Bright, N. A., West, M. A., Newman, L. S., Darnell, R. B., and Robinson, M. S.
(1996). A novel adaptor-related protein complex. J. Cell Biol., 133, 749-760.
Spang, A., Matsuoka, K., Hamamoto, S., Schekman, R., and Orci, L. (1998). Coatomer,
Arf1p, and nucleotide are required to bud coat protein complex I-coated vesicles from
large synthetic liposomes. Proc. Natl. Acad. Sci., USA, 95, 11199-11204.
Springer, S., Spang, A., and Schekman, R. (1999). A primer on vesicle budding. Cell, 97,
145-148.
Stimson, D. T., and Ramaswami, M. (1999). Vesicle recycling at the Drosophila
neuromuscular junction. Int. Rev. Neurobiol., 43, 163-189.
280
22 STYERS AND FAUNDEZ
Sweeney, D. A., Siddhanta, A., and Shields, D. (2002). Fragmentation and re-assembly of the
Golgi apparatus in vitro. A requirement for phosphatidic acid and phosphatidylinositol
4,5- bisphosphate synthesis. J. Biol. Chem., 277, 3030-3039.
Takatsu, H., Futatsumori, M., Yoshino, K., Yoshida, Y., Shin, H. W., and Nakayama, K.
(2001). Similar subunit interactions contribute to assembly of clathrin adaptor complexes
and COPI complex: analysis using yeast three-hybrid system. Biochem. Biophys. Res.
Commun., 284, 1083-1089.
Takei, K., Haucke, V., Slepnev, V., Farsad, K., Salazar, M., Chen, H., and De Camilli, P.
(1998). Generation of coated intermediates of clathrin-mediated endocytosis on protein-
free liposomes. Cell, 94, 131-141.
Takei, K., Mundigl, O., Daniell, L., and De Camilli, P. (1996). The synaptic vesicle cycle: a
single vesicle budding step involving clathrin and dynamin. J. Cell Biol., 133, 1237-1250.
Traub, L. M., Bannykh, S. I., Rodel, J. E., Aridor, M., Balch, W. E., and Kornfeld, S. (1996).
AP-2-containing clathrin coats assemble on mature lysosomes. J. Cell Biol., 135, 1801-
1814.
Ullrich, B., Li, C., Zhang, J. Z., McMahon, H., Anderson, R. G., Geppert, M., and Sudhof, T.
C. (1994). Functional properties of multiple synaptotagmins in brain. Neuron, 13, 1281-
1291.
von Poser, C., Zhang, J. Z., Mineo, C., Ding, W., Ying, Y., Sudhof, T. C., and Anderson, R.
G. (2000). Synaptotagmin regulation of coated pit assembly. J. Biol. Chem., 275, 30916-
30924.
Wenk, M. R., Pellegrini, L., Klenchin, V. A., Di Paolo, G., Chang, S., Daniell, L., Arioka, M.,
Martin, T. F., and De Camilli, P. (2001). PIP kinase Igamma is the major PI(4,5)P(2)
synthesizing enzyme at the synapse. Neuron, 32, 79-88.
West, M. A., Bright, N. A., and Robinson, M. S. (1997). The role of ADP-ribosylation factor
and phospholipase D in adaptor recruitment. J. Cell Biol., 138, 1239-1254.
Wickner, W., and Haas, A. (2000). Yeast homotypic vacuole fusion: a window on organelle
trafficking mechanisms. Annu. Rev. Biochem., 69, 247-275.
Zhang, J. Z., Davletov, B. A., Sudhof, T. C., and Anderson, R. G. (1994). Synaptotagmin I is
a high affinity receptor for clathrin AP-2: implications for membrane recycling. Cell, 78,
751-760.
Zhao, L., Helms, J. B., Brugger, B., Harter, C., Martoglio, B., Graf, R., Brunner, J., and
Wieland, F. T. (1997). Direct and GTP-dependent interaction of ADP ribosylation factor 1
with coatomer subunit beta. Proc. Natl. Acad. Sci., USA, 94, 4418-4423.
Zhao, L., Helms, J. B., Brunner, J., and Wieland, F. T. (1999). GTP-dependent binding of
ADP-ribosylation factor to coatomer in close proximity to the binding site for dilysine
retrieval motifs and p23. J. Biol. Chem., 274, 14198-14203.
Zhen, L., Jiang, S., Feng, L., Bright, N. A., Peden, A. A., Seymour, A. B., Novak, E. K.,
Elliott, R., Gorin, M. B., Robinson, M. S., and Swank, R. T. (1999). Abnormal expression
and subcellular distribution of subunit proteins of the AP-3 adaptor complex lead to
platelet storage pool deficiency in the pearl mouse. Blood, 94, 146-155.
Zhu, X., Boman, A. L., Kuai, J., Cieplak, W., and Kahn, R. A. (2000). Effectors increase the
affinity of ADP-ribosylation factor for GTP to increase binding. J. Biol. Chem., 275,
13465-13475.
Zhu, Y., Doray, B., Poussu, A., Lehto, V. P., and Kornfeld, S. (2001b). Binding of GGA2 to
the lysosomal enzyme sorting motif of the mannose 6- phosphate receptor. Science, 292,
1716-1718.
TETRAMERIC COAT PROTEIN-ARF INTERACTIONS 281
23
Zhu, Y., Drake, M. T., and Kornfeld, S. (1999a). ADP-ribosylation factor 1 dependent
clathrin-coat assembly on synthetic liposomes. Proc. Natl. Acad. Sci., USA, 96, 5013-
5018.
Zhu, Y., Drake, M. T., and Kornfeld, S. (2001a). Adaptor protein 1-dependent clathrin coat
assembly on synthetic liposomes and Golgi membranes. Methods Enzymol., 329, 379-387.
Zhu, Y., Traub, L. M., and Kornfeld, S. (1998). ADP-ribosylation factor 1 transiently
activates high-affinity adaptor protein complex AP-1 binding sites on Golgi membranes.
Mol. Biol. Cell, 9, 1323-1337.
Zhu, Y., Traub, L. M., and Kornfeld, S. (1999b). High-affinity binding of the AP-1 adaptor
complex to trans-golgi network membranes devoid of mannose 6-phosphate receptors.
Mol. Biol. Cell, 10, 537-549.
Chapter 14
ARF6
JAMES E. CASANOVA
Department of Cell Biology, University of Virginia Health Sciences Center, Charlottesville,
USA
Abstract: Arf6 is the sole representative of the class III Arfs and is the most divergent
(both structurally and functionally) of the Arfs. Its localization to the plasma
membrane and endosomal system also distinguishes it from the other five
Arfs. Both the localization of Arf6 and its functional roles in endocytosis,
secretion, and desensitization of G-protein coupled receptors exhibit cell type-
specificity, making comparative studies difficult and often confusing. Finally,
models for Arf6 in actin organization and phospholipid signaling are
discussed.
1. INTRODUCTION
2. BIOCHEMICAL PROPERTIES
As noted above, human Arf6 is 68% identical to human Arf1, yet the two
proteins differ in important ways. First, the pI of Arf6 is significantly higher
than that of Arf1 (8.5 vs 5.9; Maranda et al., 2001) and modeling of surface
electrostatic potential indicates that it has an overall cationic appearance
(Amor et al., 2001). In particular, the region of the protein surrounding and
including the N-terminal helix is strongly basic, while in Arf1 the primarily
basic helix is surrounded by an acidic ring or “cushion” (Amor et al., 2001).
The strong cationic character of Arf6 may promote electrostatic interactions
with acidic head groups of membrane lipids, contributing to its observed
higher affinity for membranes even in the GDP-bound state. A second key
difference is the presence of a four-residue deletion near the N terminus of
Arf6 relative to Arf1. Crystal structures indicate that this deletion shortens
the loop between the N-terminal helix and the first beta strand, resulting in
subtle changes in the nature of the nucleotide-binding pocket (Menetrey et
al., 2000). In Arf1, E54 helps coordinate the bound Mg++ ion, while in Arf6,
the corresponding residue, E50, instead forms a hydrogen bond with S38,
thus weakening the interaction with Mg++ (Menetrey et al., 2000). The
overall effect of these changes is that Arf6 exhibits a higher rate of
spontaneous nucleotide exchange, particularly in the presence of acidic
lipids (Terui et al., 1994).
As mentioned above, the effector-interacting domains of Arf6 are
virtually identical with those of the other Arfs, and it is therefore not
surprising that, so far, all of the effectors that have been described for Arf6
also interact with at least one other Arf. Because effectors are discussed in
detail in the preceding chapters, we will describe them here only in the
specific context of Arf6 function.
3. LOCALIZATION
4. FUNCTIONS
4.1 Endocytosis
Figure 1. Alternative models for the role of Arf6 in GLUT4 transport. In model A, ligation of
endothelin receptors activates Arf6 through a PI3-kinase independent mechanism (possibly
EFA6) and this stimulates the recycling of GLUT4 transporter via a constitutive recycling
pathway. Insulin mediated signaling stimulates translocation of both GLUT4 and GLUT1 via
a distinct, insulin sensitive pathway that does not require Arf6 function. The same results
could also be explained by model B, in which expression of Arf6-N27 leads to selective
sequestration of endothelin receptors within the recycling endosomal compartment, reducing
the number of receptors at the cell surface.
290
8 CASANOVA
suggests that recruitment of such Arf GAPs to sites of Arf6 activation could
lead directly to the down regulation of Rho.
As mentioned above, in many cell types activation of Arf6 also leads to
the formation of flat, actin-rich structures resembling lamellipodia. Motile
cells extend lamellipodia in the direction of movement, and inhibition of this
process dramatically slows cell motility (Ridley et al., 1999). Membrane
ruffling and lamellipodial extensions can be induced by a variety of
extracellular signals including growth factors (PDGF, EGF, HGF, CSF-1,
insulin), integrin ligation, and a number of G-protein coupled receptor
agonists (e.g., bombesin) through signaling pathways coupled to the
activation of Rac. Initial evidence of crosstalk between Arf and Rac came
from the discovery that the two GTPases share a common effector,
POR1/Arfaptin2 (D'Souza-Schorey et al., 1997; see Chapter 11). Although
the function of this protein is not well understood, D’Souza-Schorey et al.
showed that POR1 mutants interfered with actin remodeling induced by
either activated Rac1 or Arf6-L67, suggesting that these two proteins operate
on parallel pathways to modulate actin dynamics. However,
POR1/Arfaptin2 interacts with Arf1 as well as Arf6, and exhibits a striking
localization to the Golgi rather than the plasma membrane (Kanoh et al.,
1997). While it remains possible that a fraction of POR1/Arfaptin2
functions in the cell periphery to modulate cytoskeleton assembly, it seems
more likely that its primary function is at the Golgi, and the inhibitory
effects of mutant expression on lamellipodial extension are due to
mislocalization of the overexpressed constructs.
Further evidence of crosstalk between Rac and Arf6 is provided by the
observation that Arf6-N27 inhibits membrane ruffling in response to EGF
(Honda et al., 1999), bombesin (Boshans et al., 2000) or CSF-1 (Zhang et
al., 1999). In macrophages, Arf6-N27 dramatically inhibits Fcγ-mediated
phagocytosis (Zhang et al., 1998), a process also known to require activation
of both Rac and Cdc42. Similarly, activation of Arf6 by expression of the
exchange factor EFA6 induces membrane ruffling that is inhibited by co-
expression of dominant negative Rac1-N17 (Franco et al., 1999).
Furthermore, expression of the Arf GEF ARNO in MDCK cells is sufficient
to induce a dramatic morphological transition from a cuboidal, stationary
phenotype to a flattened, motile phenotype with pronounced lamellipodia
(Santy and Casanova, 2001). This transition was accompanied by the
activation of both endogenous Arf6 and Rac1. As in the case of EFA6-
induced ruffling (Franco et al., 1999), lamellipodia did not form in the
presence of dominant inhibitory Rac1-N17, suggesting that Rac lies
downstream of Arf6 in a GTPase signaling pathway.
How might Arf6 activation lead to activation of Rac? One model that has
gained favor in recent years is that Arf6 regulates the translocation of an
ARF6 295
13
context, a basal level of PI(4,5)P2 is necessary to bring PLD together with its
substrate. Therefore, determining whether PI(4,5)P2 is serving solely to
recruit PLD or is truly required as a downstream effector necessitates careful
experimental design. Recently, Cockroft and coworkers used an Arf1
mutant that can activate PI(4P)5K but not PLD (Arf1-R52), to demonstrate
that 45% of the Arf-stimulated PI(4,5)P2 synthesis in HL-60 cells was
dependent on PLD activity, whereas the remaining 55% was PLD-
independent (Skippen et al., 2002). Thus, a significant fraction of PI(4,5)P2
can be generated by a pathway that does not require new PA synthesis.
5. SUMMARY
REFERENCES
Altschuler, Y., Liu, S., Katz, L., Tang, K., Hardy, S., Brodsky, F., Apodaca, G., and Mostov,
K. (1999). ADP-ribosylation factor 6 and endocytosis at the apical surface of Madin-
Darby canine kidney cells. J. Cell Biol., 147, 7-12.
Amor, J. C., Horton, J. R., Zhu, X., Wang, Y., Sullards, C., Ringe, D., Cheng, X., and Kahn,
R. A. (2001). Structures of yeast Arf2 and ARL1: distinct roles for the N terminus in the
structure and function of Arf family GTPases. J. Biol. Chem., 276, 42477-42484.
Bose, A., Cherniack, A. D., Langille, S. E., Nicoloro, S. M., Buxton, J. M., Park, J. G.,
Chawla, A., and Czech, M. P. (2001). G(alpha)11 signaling through Arf6 regulates F-actin
mobilization and GLUT4 glucose transporter translocation to the plasma membrane. Mol.
Cell Biol., 21, 5262-5275.
Boshans, R. L., Szanto, S., van Aelst, L., and D'Souza-Schorey, C. (2000). ADP-ribosylation
factor 6 regulates actin cytoskeleton remodeling in coordination with Rac1 and RhoA.
Mol. Cell Biol., 20, 3685-3694.
Brown, F. D., Rozelle, A. L., Yin, H. L., Balla, T., and Donaldson, J. G. (2001).
Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol.,
154, 1007-1018.
Brown, F. D., Thompson, N., Saqib, K. M., Clark, J. M., Powner, D., Thompson, N. T.,
Solari, R., and Wakelam, M. J. (1998). Phospholipase D1 localizes to secretory granules
and lysosomes and is plasma-membrane translocated on cellular stimulation. Curr. Biol.,
8, 835-838.
Caumont, A. S., Galas, M. C., Vitale, N., Aunis, D., and Bader, M. F. (1998). Regulated
exocytosis in chromaffin cells. Translocation of Arf6 stimulates a plasma membrane-
associated phospholipase D. J. Biol. Chem., 273, 1373-1379.
Caumont, A. S., Vitale, N., Gensse, M., Galas, M. C., Casanova, J. E., and Bader, M. F.
(2000). Identification of a plasma membrane-associated guanine nucleotide exchange
factor for Arf6 in chromaffin cells. Possible role in the regulated exocytotic pathway. J.
Biol. Chem., 275, 15637-15644.
300
18 CASANOVA
D'Souza-Schorey, C., Boshans, R. L., McDonough, M., Stahl, P. D., and Van Aelst, L.
(1997). A role for POR1, a Rac1-interacting protein, in Arf6-mediated cytoskeletal
rearrangements. EMBO J., 16, 5445-5454.
D'Souza-Schorey, C., Li, G., Colombo, M. I., and Stahl, P. D. (1995). A regulatory role for
Arf6 in receptor-mediated endocytosis. Science, 267, 1175-1178.
D'Souza-Schorey, C., van Donselaar, E., Hsu, V. W., Yang, C., Stahl, P. D., and Peters, P. J.
(1998). Arf6 targets recycling vesicles to the plasma membrane: insights from an
ultrastructural investigation. J. Cell Biol., 140, 603-616.
Del Pozo, M. A., Kiosses, W. B., Alderson, N. B., Meller, N., Hahn, K. M., and Schwartz, M.
A. (2002). Integrins regulate GTP-Rac localized effector interactions through dissociation
of Rho-GDI. Nat. Cell Biol., 4, 232-239.
Franco, M., Peters, P. J., Boretto, J., van Donselaar, E., Neri, A., D'Souza-Schorey, C., and
Chavrier, P. (1999). EFA6, a sec7 domain-containing exchange factor for Arf6,
coordinates membrane recycling and actin cytoskeleton organization. EMBO J., 18, 1480-
1491.
Frank, S. R., Hatfield, J. C., and Casanova, J. E. (1998). Remodeling of the actin cytoskeleton
is coordinately regulated by protein kinase C and the ADP-ribosylation factor nucleotide
exchange factor ARNO. Mol. Biol. Cell, 9, 3133-3146.
Gottlieb, T. A., Ivanov, I. E., Adesnik, M., and Sabatini, D. D. (1993). Actin microfilaments
play a critical role in endocytosis at the apical but not the basolateral surface of polarized
epithelial cells. J. Cell Biol., 120, 695-710.
Honda, A., Nogami, M., Yokozeki, T., Yamazaki, M., Nakamura, H., Watanabe, H.,
Kawamoto, K., Nakayama, K., Morris, A. J., Frohman, M. A., and Kanaho, Y. (1999).
Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G
protein Arf6 in membrane ruffle formation. Cell, 99, 521-532.
Jackson, C. L., and Casanova, J. E. (2000). Turning on Arf: the Sec7 family of guanine-
nucleotide-exchange factors. Trends Cell Biol., 10, 60-67.
Kanoh, H., Williger, B. T., and Exton, J. H. (1997). Arfaptin 1, a putative cytosolic target
protein of ADP-ribosylation factor, is recruited to Golgi membranes. J. Biol. Chem., 272,
5421-5429.
Krugmann, S., Anderson, K. E., Ridley, S. H., Risso, N., McGregor, A., Coadwell, J.,
Davidson, K., Eguinoa, A., Ellson, C. D., Lipp, P., Manifava, M., Ktistakis, N., Painter,
G., Thuring, J. W., Cooper, M. A., Lim, Z. Y., Holmes, A. B., Dove, S. K., Michell, R. H.,
Grewal, A., Nazarian, A., Erdjument-Bromage, H., Tempst, P., Stephens, L. R., and
Hawkins, P. T. (2002). Identification of ARAP3, a novel PI3K effector regulating both Arf
and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell, 9,
95-108.
Langille, S. E., Patki, V., Klarlund, J. K., Buxton, J. M., Holik, J. J., Chawla, A., Corvera, S.,
Czech, M. P. (1999). ADP-ribosylation factor 6 as a target of guanine nucleotide exchange
factor GRP1. J. Biol. Chem., 274, 27099-27104.
Lawrence, J. T., and Birnbaum, M. J. (2001). ADP-ribosylation factor 6 delineates separate
pathways used by endothelin 1 and insulin for stimulating glucose uptake in 3T3-L1
adipocytes. Mol. Cell Biol., 21, 5276-5285.
Liscovitch, M., Czarny, M., Fiucci, G., and Tang, X. (2000). Phospholipase D: molecular and
cell biology of a novel gene family. Biochem. J., 345, 401-415.
Londono, I., Marshansky, V., Bourgoin, S., Vinay, P., and Bendayan, M. (1999). Expression
and distribution of adenosine diphosphate-ribosylation factors in the rat kidney. Kidney
Int., 55, 1407-1416.
ARF6 301
19
Manser, E., Loo, T. H., Koh, C. G., Zhao, Z. S., Chen, X. Q., Tan, L., Tan, I., Leung, T., and
Lim, L. (1998). PAK kinases are directly coupled to the PIX family of nucleotide
exchange factors. Mol. Cell, 1, 183-192.
Maranda, B., Brown, D., Bourgoin, S., Casanova, J. E., Vinay, P., Ausiello, D. A., and
Marshansky, V. (2001). Intra-endosomal pH-sensitive recruitment of the Arf-nucleotide
exchange factor ARNO and Arf6 from cytoplasm to proximal tubule endosomes. J. Biol.
Chem., 276, 18540-18550.
Mayor, S., Presley, J. F., and Maxfield, F. R. (1993). Sorting of membrane components from
endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J.
Cell Biol., 121, 1257-1269.
Menetrey, J., Macia, E., Pasqualato, S., Franco, M., and Cherfils, J. (2000). Structure of Arf6-
GDP suggests a basis for guanine nucleotide exchange factors specificity. Nat. Struct.
Biol., 7, 466-469.
Millar, C. A., Powell, K. A., Hickson, G. R., Bader, M. F., and Gould, G. W. (1999).
Evidence for a role for ADP-ribosylation factor 6 in insulin-stimulated glucose
transporter-4 (GLUT4) trafficking in 3T3-L1 adipocytes. J. Biol. Chem., 274, 17619-
17625.
Miura, K., Jacques, K. M., Stauffer, S., Kubosaki, A., Zhu, K., Hirsch, D. S., Resau, J.,
Zheng, Y., and Randazzo, P. A. (2002). ARAP1: a point of convergence for Arf and Rho
signaling. Mol. Cell, 9, 109-119.
Mukherjee, S., Gurevich, V. V., Jones, J. C., Casanova, J. E., Frank, S. R., Maizels, E. T.,
Bader, M. F., Kahn, R. A., Palczewski, K., Aktories, K., and Hunzicker-Dunn, M. (2000).
The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin
release necessary for luteinizing hormone/choriogonadotropin receptor desensitization.
Proc. Natl. Acad. Sci., USA, 97, 5901-5906.
Palacios, F., Price, L., Schweitzer, J., Collard, J. G., and D'Souza-Schorey, C. (2001). An
essential role for Arf6-regulated membrane traffic in adherens junction turnover and
epithelial cell migration. EMBO J., 20, 4973-4986.
Perry, S. J., and Lefkowitz, R. J. (2002). Arresting developments in heptahelical receptor
signaling and regulation. Trends Cell Biol., 12, 130-138.
Pessin, J. E., Thurmond, D. C., Elmendorf, J. S., Coker, K. J., and Okada, S. (1999).
Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location!
Location! J. Biol. Chem., 274, 2593-2596.
Peters, P. J., Gao, M., Gaschet, J., Ambach, A., van Donselaar, E., Traverse, J. F., Bos, E.,
Wolffe, E. J., and Hsu, V. W. (2001). Characterization of coated vesicles that participate in
endocytic recycling. Traffic, 2, 885-895.
Peters, P. J., Hsu, V. W., Ooi, C. E., Finazzi, D., Teal, S. B., Oorschot, V., Donaldson, J. G.,
and Klausner, R. D. (1995). Overexpression of wild-type and mutant Arf1 and Arf6:
distinct perturbations of non-overlapping membrane compartments. J. Cell Biol., 128,
1003-1017.
Powner, D. J., Hodgkin, M. N., and Wakelam, M. J. (2002). Antigen-stimulated activation of
phospholipase D1b by Rac1, Arf6, and PKC-alpha in RBL-2H3 Cells. Mol. Biol. Cell, 13,
1252-12562.
Radhakrishna, H., Al-Awar, O., Khachikian, Z., and Donaldson, J. G. (1999). Arf6
requirement for Rac ruffling suggests a role for membrane trafficking in cortical actin
rearrangements. J. Cell Sci., 112, 855-866.
Radhakrishna, H., and Donaldson, J. G. (1997). ADP-ribosylation factor 6 regulates a novel
plasma membrane recycling pathway. J. Cell Biol., 139, 49-61.
302
20 CASANOVA
Zhang, Q., Cox, D., Tseng, C. C., Donaldson, J. G., and Greenberg, S. (1998). A requirement
for Arf6 in Fc-gamma receptor-mediated phagocytosis in macrophages. J. Biol. Chem.,
273, 19977-19981.
Chapter 15
A ROLE FOR ARF6 IN G PROTEIN-COUPLED
RECEPTOR DESENSITIZATION
MARY HUNZICKER-DUNN
Department of Cell and Molecular Biology, Northwestern University Medical Schoo1,
Chicago, USA
Abstract: In addition to its roles in changes in the actin cytoskeleton and lipid
metabolism at the plasma membrane, recent results suggest that Arf6 also
participates in desensitization and internalization of G-protein-coupled
receptors. The evidence to support this novel function for Arf6 is reviewed in
this chapter.
1. INTRODUCTION
With more than 1,000 GPCRs and less than 20 G proteins, there is a clear
need for regulation of the temporal aspects of G protein mediated signaling
or simply alternative mechanisms of signal termination. Homologous
desensitization is the phenomenon in which exposure to agonist produces a
state in which reduced responses are observed upon subsequent challenge by
agonist. This type of desensitization can result from covalent modifications
to the receptor (e.g., phosphorylation), changes in the binding partners of the
receptor (e.g., Arrestins), or changes in the location of the receptor
(internalization).
Most agonist-bound GPCRs require GRK-catalyzed phosphorylation of
the receptor in order to achieve high-affinity Arrestin binding (Krupnick and
Benovic, 1998). The family of Arrestins consists of the visual Arrestins
(Arrestin1 in rod cells and Arrestin4 in cone cells) and the ubiquitous
ROLE OF ARF6 IN GPCR DESENSITIZATION 3073
charged Glu in most other receptors (Schulz et al., 2000). Although the
other glycoprotein hormone receptors are believed to require GRK-catalyzed
phosphorylation to bind Arrestins for desensitization (Iacovelli et al., 1996;
Troispoux et al., 2000), it is possible that the presence of this Asp residue in
their 3i loops, as with the LHR, may allow them to bind Arrestin for
desensitization in a phosphorylation-independent manner.
For Arrestin2 to promote LHR desensitization it should bind only to
active and not to inactive receptor. Moreover, the Arrestin2 binding site at
Asp-564 in the 3i loop is not expected to be accessible in the inactive
receptor conformation. Under conditions in which neither receptor nor
Arrestin is overexpressed, Arrestin2 preferentially co-immunoprecipitated
with agonist-bound LHR (Mukherjee et al., 1999a; Mukherjee et al., 2000).
Because the presence of Arrestin2 in LHR-enriched membranes is
independent of agonist and interacts only with agonist-bound LHR,
Arrestin2 must be bound at a site distinct from the LHR, when the receptor
is not active (as shown in Figure 1, panel A). Moreover, there must be a
mechanism that stimulates the “undocking” of Arrestin2 so it is available to
bind to agonist-bound receptor. A clue to the regulation of the Arrestin2
undocking mechanism was revealed by the demonstration that the pool of
Arrestin2 present in the plasma membrane-enriched fraction requires GTP to
be released and effect the desensitization of LHRs.
Figure 1. Proposed model depicting LHR desensitization: the LHR promotes the activation
of ARF6, leading to cessation of LHR coupling to Gs and adenylyl cyclase. (A) The inactive
receptor and key proteins detected by immunoblot or activity assays in ovarian follicle plasma
membrane are shown. (B) Agonist binding promotes a conformational change in the LHR,
resulting in activation of Gs and adenylyl cyclase (AC). Dashed arrows represent the directed
movements of ARNO to bind the NPXXY motif in TM7 of the LHR with consequent
activation of ARF6. This, in turn, releases Arrestin2, allowing its binding to the 3i loop of the
LHR and effecting desensitization. The large dot in the 3i peptide represents Asp-564. (C)
The desensitized LHR is shown with Arrestin2 bound to the 3i loop, ARNO bound to TM 7,
and Gs uncoupled and returned to its basal state.
312
8 HUNZICKER-DUNN
Arf6 activation. Arrestin2 is released from its membrane docking site only
in response to (a) Arf6 activation by ARNO, in the presence of 1 µM GTP,
(b) high concentrations of GTP that override the GEF requirement and
activate all GTPases, or (c) LHR activation by agonist. Thus, the release of
Arrestin2 is regulated and specific for reagents that activate Arf6.
Moreover, sufficient Arrestin2 is retained in a membrane fraction to achieve
complete LHR desensitization under cell-free conditions. These results
suggest that the Arrestin available for receptor desensitization in cells may
be limiting under some circumstances. Indeed, there is evidence to support
this hypothesis in intact cells. In COS-7 cells in which a constitutively
active parathyroid hormone receptor was expressed and coupled to Gs, the
overexpression of Arrestin3 was required to reduce cAMP production by this
receptor (Ferrari and Bisello, 2001). Even more compelling is the report that
internalization of the β2-AR in stably transfected HEK293 cells was reduced
>65% by activation of the V2 vasopressin receptor coexpressed in the same
cells, an effect that was reversed by overexpression of Arrestin2 and
Arrestin3 (Klein et al., 2001).
Does the Arrestin2 that is not localized at the plasma membrane by Arf6
participate in LHR desensitization in intact cells? We do not know.
Subcellular fractionation of ovarian granulosa cells revealed that the
majority of immunoreactive Arrestin2, in contrast to Arf6 (Mukherjee et al.,
2000), was detected in a soluble fraction (S. Mukherjee, unpublished
observation). Perhaps this soluble Arrestin has additional functions. For
example, Arrestin2 binds to cytosolic Disheveled proteins, which lie
downstream of the Frizzled receptor in the Wnt pathway (Chen et al., 2001).
It is also not known if the Arrestin present in the soluble fraction of
untransfected cells is docked at specific cellular locations, perhaps bound
(directly or indirectly) to other Arfs, or if it is diffusely distributed
throughout the cell. In one of the few studies in which the distribution of
endogenous Arrestins was evaluated by immunofluorescence, both non-
visual Arrestins were found distributed in a punctate pattern throughout the
interior of RBL-2H3 cells (a rat mast cell line) (Santini et al., 2000),
consistent with the existence of specific Arrestin binding sites.
Does Arf6 sequester Arrestin in cells other than ovarian follicular cells?
And does GPCR activation universally promote the undocking of Arrestin
from an Arf6-dependent binding site, or is this pathway unique to the ovary
and the LHR? We do not yet know the complete answer to these questions.
However, the findings that LHR artificially expressed in kidney cells can
activate a pathway that leads to Arf6 activation and Arrestin2-dependent
LHR desensitization, shows that the GPCR-dependent Arf6 activation
pathway to undock Arrestin is not restricted to ovarian cells (Mukherjee et
al., 2002). Additional studies are required to ascertain whether or not other
316
12 HUNZICKER-DUNN
5. SUMMARY
Taken together these data support a novel function for Arf6 in Arrestin-
dependent GPCR desensitization and internalization. The key features of the
role of Arf6 in receptor desensitization are as follows. In the resting state
318
14 HUNZICKER-DUNN
6. ACKNOWLEDGMENTS
REFERENCES
Abdulaev, N. G., and Ridge, K. D. (1998). Light-induced exposure of the cytoplasmic end of
transmembrane helix seven in rhodopsin. Proc. Natl. Acad. Sci., USA, 95, 12854-12859.
Abell, A. N. and Segaloff, D. L. (1997). Evidence for the direct involvement of
transmembrane region 6 and the lutropin/choriogonadotropin receptor in activating Gs. J.
Biol. Chem., 272, 14586-14591.
Altenbach, C., Cai, K., Khorana, H. G., and Hubbell, W. L. (1999). Structural features and
light-dependent changes in the sequence 306-322 extending from helix VII to the
palmitoylation sites in rhodopsin: a site-directed spin-labeling study. Biochemistry, 38,
7931-7937.
Anderson, W. B. and Jaworski, C. J. (1979). Isoproterenol-induced desensitization of
adenylate cyclase responsiveness in a cell-free system. J. Biol. Chem., 254, 4596-4601.
Austin, C., Boehm, M., and Tooze, S. A. (2002). Site-specific cross-linking reveals a
differential direct interaction of class 1, 2, and 3 ADP-ribosylation factors with adaptor
protein complexes 1 and 3. Biochemistry, 41, 4669-4677.
Ballesteros, J. A., Jensen, A. D., Liapakis, G., Rasmussen, S. G., Shi, L., Gether, U., and
Javitch, J. A. (2001). Activation of the beta 2-adrenergic receptor involves disruption of an
ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol.
Chem., 276, 29171-29177.
Barak, L. S., Ferguson, S. S., Zhang, J., and Caron, M. G. (1997). A beta-arrestin/green
fluorescent protein biosensor for detecting a G protein-coupled receptor activation. J. Biol.
Chem., 272, 27497-27500.
Barak, L. S., Warabi, K., Feng, X., Caron, M. G., and Kwatra, M. M. (1999). Real-time
visualization of the cellular redistribution of G protein-coupled receptor kinase 2 and beta-
arrestin 2 during homologous desensitization of the substance P receptor. J. Biol. Chem.,
274, 7565-7569.
Bennett, T. A., Maestas, D. C., and Prossnitz, E. R. (2000). Arrestin binding to the G protein-
coupled N-formyl peptode receptor is regulated by the conserved "DRY" sequence. J.
Biol. Chem., 275, 24590-24594.
Bhatnagar, A., Willins, D. L., Gray, J. A., Woods, J., Benovic, J. L., and Roth, B. L. (2001).
The dynamin-dependent, arrestin-independent Internalization of 5-hydroxytryptamine 2A
(5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A
receptors during endocytosis. J. Biol. Chem., 276, 8269-8277.
Bockaert, J., Hunzicker-Dunn, M., and Birnbaumer, L. (1976). Hormone-stimulated
desensitization of hormone-dependent adenylyl cyclase. J. Biol. Chem., 251, 2653-2663.
Bohn, L. M., Gainetdinov, R. R., Lin, F. T., Lefkowitz, R. J., and Caron, M. G. (2000). Mu-
opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not
dependence. Nature, 408, 720-723.
Brown, F. D., Rozelle, A. L., Yin, H. L., Balla, T., and Donaldson, J. G. (2001).
Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell. Biol.,
154, 1007-1017.
Carmen, C. V. and Benovic, J. L. (1999). G-protein-coupled receptors: turn-ons and turn-offs.
Curr. Opin. Neurobiol., 8, 335-344.
Caumont, A.-S., Galas, M.-C., Vitale, N., Aunis, D., and Bader, M.-F. (1998). Regulated
exocytosis in chromaffin cells.Translocation of ARF6 stimulates a plasma membrane-
associated phosphlipase D. J. Biol. Chem., 273, 1373-1379.
320
16 HUNZICKER-DUNN
Cavenagh, M. M., Whitney, J. A., Carroll, K., Zhang, C., Boman, A. L., Rosenwald, A. G.,
Mellman, I., and Kahn, R. A. (1996). Intracellular distribution of Arf proteins in
mammalian cells. J. Biol. Chem., 271, 21767-21774.
Celver, J., Vishnivetskiy, S. A., Chavkin, C., and Gurevich, V. V. (2002). Conservation of the
phosphate-sensitive elements in the arrestin family of proteins. J. Biol. Chem., 277, 9043-
9048.
Chen, W., Hu, L. A., Semenov, M. V., Yanagawa, S., Kikuchi, A., Lefkowitz, R. J., and
Miller, W. E. (2001). β-Arrestin1 modulates lymphoid enhancer factor transcriptional
activity through interaction with phosphorylated dishevelled proteins. Proc. Natl. Acad.
Sci., USA, 98, 14889-14894.
Cheng, Z.-J., Yu, Q.-M., Wu, Y.-L., Ma, L., and Pei, G. (1998). Selective interference of β-
arrestin 1 with κ and δ but not µ opiod receptor/G protein coupling. J. Biol. Chem., 273,
24328-24333.
Claing, A., Chen, W., Miller, W. E., Vitale, N., Moss, J., Premont, R. T., and Lefkowitz, R. J.
(2001). β arrestin-mediated ARF6 activation and β2-adrenergic receptor endocytosis. J.
Biol. Chem. 276, 42509-42513.
Claing, A., Laporte, S. A., Caron, M. G., and Lefkowitz, R. J. (2002). Endocytosis of G
protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin
proteins. Prog. Neurobiol., 66, 61-79.
Conner, D. A., Mathier, M. A., Mortensen, R. M., Christe, M., Vatner, S. F., Seidman, C. E.,
and Seidman, J. G. (1997). β-Arrestin1 knockout mice appear normal but demonstrate
altered cardiac responses to β-adrenergic stimulation. Circ. Res., 81, 1021-1026.
D'Souza-Schorey, C., van Donselaar, E., Hsu, V. W., Yang, C., Stahl, P. D., and Peters, P. J.
(1998). ARF6 targets recycling vesicles to the plasma membrane: insights from an
ultrastructural investigation. J. Cell Biol., 140, 603-616.
Drake, M. T., Zhu, Y., and Kornfeld, S. (2000). The assembly of AP-3 adaptor complex-
containing clathrin-coated vesicles on synthetic liposomes. Mol. Biol. Cell, 11, 3723-3736.
Dulin, N. O., Niu, J., Browning, D. D., Ye, R. D., and Voyno-Yasenetskaya, T. (2001). Cyclic
AMP-independent Activation of Protein Kinase A by Vasoactive Peptides. J. Biol. Chem.,
276, 20827-20830.
Ekstrom, R. C., Carney, E. M., Lamm, M. L. G., and Hunzicker-Dunn, M. (1992). Reversal of
the desensitized state of pig ovarian follicular human choriogonadotropin-sensitive
adenylylcyclase by guanosine 5'-0-(2-thiodiphosphate). J. Biol. Chem., 267, 22183-22189.
Ekstrom, R. C. and Hunzicker-Dunn, M. (1989). Homologous desensitization of ovarian
luteinizing hormone/human chorionic gonadotropin-responsive adenylyl cyclase is
dependent upon GTP. Endocrinology, 124, 956-963.
Ekstrom, R. C. and Hunzicker-Dunn, M. (1990). Opposing effects of ethanol on pig ovarian
adenylyl cyclase desensitized by human choriogonadotropin or isoproterenol.
Endocrinology. 127, 2578-2586.
Evans, N. A., Groarke, D. A., Warrack, J., Greenwood, C. J., Dodgson, K., Milligan, G., and
Wilson, S. (2001). Visualizing differences in ligand-induced beta-arrestin-GFP
interactions and trafficking between three recently characterized G protein-coupled
receptors. J. Neurochem., 77, 476-485.
Ezra, E. and Salomon, Y. (1980). Mechanism of desensitization of adenylate cyclase by
lutropin. J. Biol. Chem., 255, 653-658.
Ezra, E. and Salomon, Y. (1981). Mechanism of desensitization of adenylate cyclase by
lutropin. J. Biol. Chem., 256, 5377-5382.
Ferguson, S. S. G. (2001). Evolving concepts in G protein-coupled receptor endocytosis: the
role in receptor desensitization and signaling. Pharm. Rev., 53, 1-24.
ROLE OF ARF6 IN GPCR DESENSITIZATION 321
17
Ferguson, S. S. G., Barak, L. S., Zhang, J., and Caron, M. G. (1996). G-protein-coupled
receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can. J.
Physiol. Pharmacol., 74, 1094-1110.
Ferrari, S. L. and Bisello, A. (2001). Cellular distribution of constitutively active mutant
parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic
adenosine 3',5'-monophosphate signaling by β-arrestin2. Mol. Endo., 15, 149-163.
Franco, M., Peters, P. J., Boretto, J., van Donselaar, E., Neri, A., D'Souza-Schorey, C., and
Chavrier, P. (1999). EFA6, a sec7 domain-containing exchange factor for ARF6,
coordinates membrane recycling and actin cytoskeleton organization. EMBO J., 18, 1480-
1491.
Frank, S. R., Hatfield, J. C., and Casanova, J. E. (1998). Remodeling of the actin cytoskeleton
is coordinately regulated by protein kinase C and the ADP-ribosylation factor nucleotide
exchange factor ARNO. Mol. Biol. Cell, 9, 3133-3146.
Galas, M.-C., Helms, J. B., Vitale, N., Thierse, D., Aunis, D., and Bader, M.-F. (1997).
Regulated exocytosis in chromaffin cells. A potential role for a secretory granule-
associated ARF6 protein. J. Biol. Chem., 272, 2788-2793.
Godi, A., Pertile, P., Meyers, R., Marra, P., Di Tullio, G., Iurisci, C., Luini, A., Corda, D., and
De Matteis, M. A. (1999). ARF mediates recruitment of Ptdins-4-OH kinase-β and
stimulates synthesis of Ptdins(4,5)P2 on the golgi complex. Nature Cell Biol., 1, 280-287.
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W.,
Keen, J. H., and Benovic, J. L. (1996). β-arrestin acts as a clathrin adaptor in endocytosis
of the β2-adrenergic receptor. Nature, 383, 447-450.
Gurevich, V. V. and Benovic, J. L. (1993). Visual arrestin interaction with rhodopsin. J. Biol.
Chem., 268, 11628-11638.
Gurevich, V. V., Dion, S. B., Onorato, J. J., Ptasienski, J., Kim, C. M., Sterne-Marr, M.,
Hosey, M. M., and Benovic, J. L. (1995). Arrestin interactions with G protein-coupled
receptors. J. Biol. Chem., 270, 720-731.
Honda, A., Nogami, M., Yokozeki, T., Yamazaki, M., Nakamura, H., Watanabe, H.,
Kawamoto, K., Nakayama, K., Morris, A. J., Frohman, M. A., and Kanaho, Y. (1999).
Phosphatidylinositol 4-phosphate 4-kinase alpha is a downstream effector of the small G
protein ARF6 in membrane ruffle formation. Cell, 99, 521-532.
Hunzicker-Dunn, M. (1981). Rabbit follicular adenylyl cyclase activity. II. Gonadotropin-
induced desensitization in granulosa cells and follicle shells. Biol. Repro., 24, 279-286.
Iacovelli, L., Franchetti, R., Masini, N. M., and DeBlasi, A. (1996). GRK2 and β−arrestin1 as
negative regulators of thyrotropin receptor-stimulated response. Mol. Endo., 10, 1138-
1146.
Jackson, C. L. and Casanova, J. E. (2000). Turning on ARF: the Sec7 family of guanine-
nucleotide-exchange factors. Trends Cell Biol., 10, 60-67.
Kahn, R. A., Randazzo, P., Serafini, T., Weiss, O., Rulka, C., Clark, J., Amherdt, M., Roller,
P., Orci, L., and Rothman, J. E. (1992). The amino terminus of ADP-ribosylation factor
(ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of
protein transport. J. Biol. Chem., 267, 13039-13046.
Klein, U., Muller, C., Chu, P., Birnbaumer, M., and von Zastrow, M. (2001). Heterologous
inhibition of G protein-coupled receptor endocytosis mediated by receptor-specific
trafficking of beta-arrestins. J. Biol. Chem., 276, 17442-17447.
Knospe, V., Donoso, L. A., Banga, J. P., Yue, S., Kasp, E., and Gregerson, D. S. (1988).
Epitope mapping of bovine retinal S-antigen with monoclonal antibodies. Eye Res., 7,
1137-1147.
322
18 HUNZICKER-DUNN
Kohout, T. A., Lin, F. T., Perry, S. J., Conner, D. A., and Lefkowitz, R. J. (2001). β-Arrestin
1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc. Natl.
Acad. Sci., 98, 1601-1606.
Kovoor, A., Celvert, J., Abdryashitov, R. I., Chavkin, C., and Gurevich, V. V. (1999).
Targeted construction of phosphorylation-independent beta-arrestin mutants with
constitutive activity in cells. J. Biol. Chem., 274, 6831-6834.
Krupnick, J. G. and Benovic, J. L. (1998). The role of receptor kinases and arrestins in G
protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol., 38, 289-319.
Lamm, M. L. G., Ekstrom, R. C., Maizels, E. T., Rajagopalan, R. M., and Hunzicker-Dunn,
M. (1994). The effect of protein kinases on desensitization of the porcine follicular
membrane luteinizing hormone/chorionic gonadotropin-sensitive adenylyl cyclase.
Endocrinology, 134, 1745-1754.
Lamm, M. L. G. and Hunzicker-Dunn, M. (1994). Phosphorylation-independent
desensitization of the luteinizing hormone/chorionic gonadotropin receptor in porcine
follicular membranes. Mol. Endo., 8, 1537-1546.
Laporte, S. A., Oakley, R. H., Holt, J. A., Barak, L. S., and Caron, M. G. (2000). The
interaction of β-arrestin with the AP-2 adaptor is required for clustring of β2-adrenergic
receptor into clathrin-coated pits. J. Biol. Chem., 275, 23120-23126.
Laporte, S. A., Oakley, R., Zhang, J., Holt, J. A., Ferguson, S. S. G., Caron, M. G., and Barak,
L. S. (1999). The β2-adrenergic receptor/β arrestin complex recruits the clathrin adaptor
AP-2 during endocytosis. Proc. Natl. Acad. Sci., USA, 96, 3712-3717.
Lenhard, J. M., Kahn, R. A., and Stahl, P. D. (1992). Evidence for ADP-ribosylation factor
(ARF) as a regulator of in vitro endosome-endosome fusion. J. Biol. Chem., 267, 13047-
13052.
Lohse, M. J., Andexinger, S., Pitcher, J., Trukawinski, S., Codina, J., Faure, J.-P., Caron, M.
G., and Lefkowitz, R. J. (1992). Receptor-specific desensitization with purified proteins. J.
Biol. Chem., 267, 8558-8564.
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., and Lefkowitz, R. J. (1990). β-arrestin:
a protein that regulates β-adrenergic receptor function. Science, 248, 1547-1550.
Marsh, J. M., Mills, T. M., and Lemaire, W. J. (1973). Preovulatory changes in the synthesis
of cyclic AMP by rabbit Graafian follicles. Biochem. Biophys. Acta, 304, 197-202.
Min, L., Galet, C., and Ascoli, M. (2001). The association of arrestin-3 with the human
lutropin/choriogonadotropin receptor depends mostly on receptor activation rather than on
receptor phosphorylation. J. Biol. Chem., 277, 702-710.
Mukherjee, S., Casanova, J. E., and Hunzicker-Dunn, M. (2001). Desensitization of the
luteinizing hormone/choriogonadotropin receptor in ovarian follicular membranes is
inhibited by catalytically inactive ARNO. J. Biol. Chem., 276, 6524-6528.
Mukherjee, S., Gurevich, V. V., Jones, J. C. R., Casanova, J. E., Frank, S. R., Maizels, E. T.,
Bader, M.-F., Kahn, R. A., Palczewski, K., Aktories, K., and Hunzicker-Dunn, M. (2000).
The ADP ribosylation factor nucleotide exchange factor ARNO promotes β-arrestin
release necessary for luteinizing hormone/choriogonadotropin receptor desensitization.
Proc. Natl. Acad. Sci., USA, 97, 5901-5906.
Mukherjee, S., Gurevich, V. V., Preninger, A., Hamm, H. E., Bader, M. F., Fazleabas, A. T.,
Birnbaumer, L., and Hunzicker-Dunn, M. (2002). Aspartic acid 564 in the third
cytoplasmic loop of luteinizing hormone/choriogonadotropin receptor is crucial for
phosphorylation-independent interaction with arrestin2. J. Biol. Chem., 277, 17916-17927.
Mukherjee, S., Palczewski, K., Gurevich, V. V., Benovic, J. L., Banga, J. P., and Hunzicker-
Dunn, M. (1999a). A direct role for arrestins in desensitization of the luteinizing
ROLE OF ARF6 IN GPCR DESENSITIZATION 323
19
Santini, F., Penn, R. B., Gagnon, A. W., Benovic, J. L., and Keen, J. H. (2000). Selective
recruitment of arrestin-3 to clathrin coated pits upon stimulation of G protein-coupled
receptors. J. Cell. Sci., 113, 2463-2470.
Schulz, A., Bruns, K., Henklein, P., Krause, G., Schubert, M., Gudermann, T., Wray, V.,
Schultz, G., and Schoneberg, T. (2000). Requirement of specific intrahelical interactions
for stabilizing the inactive conformation of glycoprotein hormone receptors. J. Biol.
Chem., 275, 37860-37869.
Shenker, A. (2002). Activating mutations of the lutropin/choriogonadotropin receptor in
precocious puberty. Receptors Channels, 8, 3-18.
Troispoux, C., Guillou, F. E. J.-M., Firsov, D., Iacovelli, L., DeBlasi, A., Combarnous, Y.,
and Reiter, E. (2000). Involvement of G protein-coupled receptor kinases and arrrestins in
desensitization to follicle sitmulating hromone action. Mol. Endo., 13, 1599-1614.
Wang, Z., Liu, X., and Ascoli, M. (1997). Phosphorylation of the lutropin/choriogonadotropin
receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of
the bound hormone. Mol. Endo., 11, 183-192.
Zhu, X., Gudermann, T., Birnbaumer, M., and Birnbaumer, L. (1993). A luteinizing hormone
receptor with a severely truncated cytoplasmic tail (LHR-ct628) desensitizes to the same
degree as the full-length receptor. J. Biol. Chem., 268, 1723-1728.
Zhu, Y., Drake, M. T., and Kornfeld, S. (1999). ADP-ribosylation factor 1 dependent clathrin-
coat assembly on synthetic liposomes. Proc. Natl. Acad. Sci., USA, 96, 5013-5018.
Chapter 16
ARF-LIKE PROTEINS
Abstract: At least 10 different proteins have homology to members of the Arf family but
each lacks activities that define “true” Arfs. In addition, the percent identity
between these 10 proteins, when aligned with Arfs or to each other, is lower
(typically 40-60%) than that between Arfs (greater than 65% identity). A
summary of current information on each is presented below. Despite
extensive conservation of structure between Arfs and Arls, the Arls represent a
much more functionally divergent collection of GTPases, with apparent roles
in vesicle traffic (Arl1, Sar1), microtubule organization (Arl2, Arl3),
spermatogenesis (Arl4), and differentiation (Arfrp1). However, the overlap in
binding partners between functionally distinct Arls suggests that Arfs and Arls
are likely to have a complex web of overlapping and distinct functions.
1. INTRODUCTION
These data lead to the conclusion that Arfs and Arls lack a functional
overlap, except for their role as GTPase-operated molecular switches. In
addition, there appears to be little functional overlap between Arls, as
reflected by a considerable heterogeneity of their expression in tissues and of
their subcellular distribution. Some Arls appear to be involved in the
regulation of protein and/or vesicle transport between cell organelles (Arl1,
Arl4, Sar1) or in the regulation of enzymatic activities controlling these
processes (Arfrp1). Furthermore, the physiological functions of the different
family members, in as far as they are known, appear to be quite diverse (e.g.,
Arl4, spermatogenesis; Arfrp1, differentiation of mesoderm during
embryogenesis).
2. ARL1
Arl1 is the closest relative to the Arfs, appears to have some functional
similarities to the Arfs, and should rather be considered an atypical Arl
protein. Although the subcellular localization and several interaction
partners of Arl1 were identified in the past, the exact role of Arl1 is still
unknown.
Figure 1. Dendrogram of the Arf family. The human proteins were aligned with the
CLUSTAL program. Bars denote the classes I-III of Arfs and the Arl4 subgroup. All
mammalian Arl proteins are highly conserved (97% to 99% identity between human, mouse,
rat and bovine).
Like most Arf proteins, Arl1 is associated with the Golgi complex. Lowe et
al. (1996) detected endogenous Arl1 in the perinuclear region of normal rat
kidney (NRK) cells by indirect immunofluorescence, co-localized with the
Golgi markers p28 (a cis-Golgi protein) and mannosidase II. The same
subcellular localization was found in other cell lines. Furthermore, treatment
of cells with nocodazole, a microtubule depolymerizing drug that causes
fragmentation of the Golgi complex, dispersed Arl1 labeling into many
328
4 SCHÜRMANN AND JOOST
punctate structures throughout the cell. A similar pattern was observed for
both Golgi markers p28 and mannosidase II (Lowe et al., 1996).
A different pattern of cellular redistribution was observed for Arl1 and
mannosidase II when brefeldin A was used to disrupt the Golgi structures.
After short treatment (2 min) with brefeldin A, the labeling pattern of Arl1
and mannosidase II was unaffected. After 5 min of brefeldin A-treatment,
mannosidase II was detected in tubulovesicular extensions. Arl1 labeling
did not colocalize with these structures, but was detected in the cytosol.
After 30 min of brefeldin A treatment, Arl1 was completely redistributed to
the cytosol, whereas mannosidase II was transferred into an extensive
reticular network.
The observed response of Arl1 to brefeldin A differs from those of Arf
and COPI (β-COP), components of non-clathrin-coated transport vesicles.
Arf and COPI redistributed into the cytosol faster (within 2 min) than Arl1.
This suggests that the effect of brefeldin A on Arl1 may be indirect or
secondary, as compared to Arfs. As is the case for Arfs, brefeldin A could
block guanine nucleotide exchange via interaction with a brefeldin A-
sensitive, Arl1-specific exchange factor (GEF). If the normal turnover rate
of Arl1 cycling on and off Golgi membranes is slower than that of Arfs, then
the inhibition of this GEF could cause the delayed release of Arl1 from the
Golgi (Lowe et al., 1996). Alternatively, brefeldin A may affect Arl1
indirectly. For example, inhibition of an Arf-specific GEF by brefeldin A
leads to the fast redistribution of Arf1 into the cytosol. Subsequently, the
lack of Arf1 within Golgi membranes could result (via an unknown
mechanism) in the release of Arl1 into the cytosol, suggesting that Arf1 is
acting upstream of Arl1. Somewhat different results were obtained by van
Valkenburgh et al. (2001). They found that epitope tagged Arl1 (Arl1-myc)
was released from the Golgi with similar kinetics to endogenous Arfs. This
discrepancy may result from the use of epitope tagging or overexpression of
the GTPase. There is now extensive evidence that either approach can
produce data that differ from the location or behavior of endogenous
GTPases, particularly for members of the Arf family. Unfortunately, the
levels of expression of Arl1 are typically low and make studies of
endogenous protein more difficult than for Arfs. We should probably
consider tentative any conclusions based solely on results obtained with
overexpressed and or epitope tagged proteins.
Additional evidence that the subcellular distribution of Arf1 and Arl1 is
regulated independently was obtained with aluminum fluoride. AlF
activates heterotrimeric G-proteins and reverses the effects of brefeldin A on
COPI, mannosidase II, and Rab6, but not that on TGN38. When NRK cells
were preincubated with AlF for 20 min prior to addition of brefeldin A, both
Arl1 and COPI were more tightly associated with the Golgi complex (Lowe
ARF-LIKE PROTEINS 3295
In order to test whether Arl1 and Arf1 have overlapping functions, van
Valkenburgh et al. (2001) analyzed the interaction of known Arf-binding
proteins with Arl1. Of these, Arfaptin2 (also termed POR1, see Chapter 11
for details) and mitotic kinesin-like protein-1 (MKLP1) exhibited GTP-
dependent binding with Arl1. Furthermore, Arfaptin2 increased the
stoichiometry of GTP binding to Arl1 (van Valkenburgh et al., 2001).
Arfaptin2 was previously identified as an effector of Rac (D’Souza-Schorey
et al., 1997; Kanoh et al., 1997), and has been proposed to be a mediator of
cross talk between Arf proteins and Rac. Arfaptin2 binds specifically to
GTP-bound Arf1 and Arf6, and binds to Rac•GTP and Rac•GDP with
similar affinities (Tarricone et al., 2001). The C-terminal domain of MKLP1
binds to all activated Arf isoforms (Boman et al., 1999) and also to Arl1, but
not to Arl2 or Arl3 (van Valkenburgh et al., 2001). MKLP1 is present in
central spindles and midbodies of mammalian cells, and is thought to be
involved in the re-organization of membranes during the terminal phase of
cytokinesis (Kuriyama et al., 2002).
In a two-hybrid screen performed with the GTPase-defective mutants of
Arl1-3, van Valkenburgh et al. (2001) identified PDEδ and HRG4 as GTP-
dependent binding proteins. In addition, the authors identified Golgin-245 to
bind to Arl1-L71 and Arl3-L71 (see Figure 2). Golgins are Golgi-associated
proteins with antigenic potency in autoimmune diseases. The 245 kDa
protein Golgin-245 contains a coiled-coil domain and is peripherally
associated with the cis-Golgi. Golgin-245 comprises a C-terminal GRIP-
domain that is believed to direct associated proteins to the Golgi apparatus.
Arl1 and the GRIP domain of Golgin-245 are co-localized when expressed
in NRK cells. In contrast to Arl1, binding of the GRIP-domain to the Golgi
was not disrupted by brefeldin A, suggesting that this domain can bind the
Golgi independently of Arl1.
SCOCO (Short Coiled-Coil; see Figure 2) is another binding protein of
Arl1-L71 that colocalizes with Arl1 in the Golgi. The function of SCOCO is
still unknown (van Valkenburgh et al., 2001). Its 82 amino acid residues are
predicted to fold almost completely into a coiled-coil structure. SCOCO
message was widely distributed in human tissues with the highest levels
ARF-LIKE PROTEINS 3317
detected in brain, heart, and skeletal muscle. The protein was found
associated with the Golgi apparatus and the plasma membrane. Like Arl1,
the binding of SCOCO to the Golgi was rapidly reversed by brefeldin A.
Purified SCOCO had no detectable GTPase activating protein (GAP)
activity for Arl1.
Figure 2. Specific and shared binding partners of Arfs, Arls and Arfrp1 are shown. Arf
family members are shown in boxes (center), with binding partners that are shared by
multiple members shown above them and those specific to the Arfs or an Arl, shown below.
3. ARL2
Figure 3. Model depicting the diversity in localization and actions of Arl proteins in (1) the
biogenesis of microtubules (Arl2; Bhamidipati et al., 2000; R. A. Kahn, unpublished
observations), (2) mitochondrial adenine nucleotide transport (Arl2; Sharer et al., 2002), (3)
nuclear transport (Arl4; Jacobs et al., 1999), (4) vesicle budding from the endoplasmic
reticulum (Sar1; Springer et al., 1999), membrane traffic through the Golgi (Arl1), and
nuclear localization of Arl4, Arl6/Arf4L and Arl7. (C, D, E = cofactors C, cofactor D and
cofactor E).
ARF-LIKE PROTEINS 3339
Arl3 (Cavenagh et al., 1994) exhibits 43% identity with Arf1. The GTPase
is expressed in most tissues, with elevated mRNA levels detected in several
human tumor cell lines. Recombinant Arl3 binds guanine nucleotides but
lacks intrinsic GTPase activity (Cavenagh et al., 1994). However, Arl3
exhibits an unusually low affinity for guanine nucleotides, with a KD of 24
nM for mant-GDP and 48 µM for mant-GTP (Linari et al., 1999a). The
Arl3•GTP, but not the Arl3•GDP binds the δ subunit of the cGMP
ARF-LIKE PROTEINS 335
11
5. ARL4
Arl4, Arl6/Arf4-like and Arl7 represent a subgroup of the Arl proteins that
share sequence similarities and the presence of C-terminal nuclear
localization signals (NLSs). Arl4 is highly expressed in testis and is
involved in the differentiation of spermatocytes. It has been suggested that
Arl4 is involved in the regulation of nuclear protein transport during cell
division or differentiation.
336
12 SCHÜRMANN AND JOOST
6. ARL5
Arl5 was identified by PCR cloning on the basis of its sequence similarity
with members of the Arf family (Breiner et al., 1996). Arl5 exhibits 48.2%
and 49.2% identity with Arf1 and Arl1, respectively, and is mainly
expressed in brain, thymus and intestine. No other information (e.g.,
subcellular localization, nucleotide binding properties, function) is yet
available.
7. ARL6/ARF4L
Arl6, also named Arf4-like protein (Arf4L; Smith et al., 1995; accession
number L38490), exhibits the highest similarity to Arl4 (61%) and Arl7
(59%) (Jacobs et al., 1999). Arl6/Arf4L binds guanine nucleotides rapidly
and in a Mg2+-dependent manner. The exchange rate of Arl6/Arf4-like
protein alone was considerably higher than that of Arf1 in the presence of its
exchange factor Sec7-2/ARNO. Like its close relatives Arl4 and Arl7,
Arl6/Arf4L contains an NLS in its C-terminus, suggesting that it too is
located within the nucleus (Jacobs et al., 1999).
Unfortunately, a different Arl has also been named Arl6 (accession
number AF031903). The amino acid sequence of this GTPase is 41%
identical with that of Arf1 (and only 34% identical to Arl6/Arf4L). Its
cDNA was identified by differential display (Ingley et al., 1999). The gene
338
14 SCHÜRMANN AND JOOST
exhibits an expression pattern that is unique within the Arf and Arl family,
with highest mRNA levels present in brain and kidney. In addition, this
Arl6 transcript is up regulated during erythropoietin-induced differentiation
of erythroid cells and down regulated during interleukin 6-induced
macrophage differentiation, suggesting that it plays a role in hematopoietic
development. The protein was found mainly in the cytoplasm (Ingley et al.,
1999). Stimulation of cells with GTPγS produced an increase in membrane
association, indicating that the protein may cycle between the cytoplasm and
membranes in a GTP-dependent manner. A yeast two-hybrid screen and co-
immunoprecipitation revealed that Arl6 interacts with Sec61β, a subunit of
the core component of the ER translocon (Ingley et al., 1999).
Arl7 was cloned by Jacobs et al. (1999), and shown to be a close relative of
Arl4 (71% identical amino acids) and Arl6/Arf4L (59% identical amino
acids). The C-terminal NLS of Arl7 targets a GFP fusion protein to the
nucleus of transfected COS-7 cells. Like Arl4 and Arl6/Arf4L, Arl7 binds
GTPγS rapidly and in a Mg2+-dependent manner. Arl7 mRNA expression
was highest in brain, with lower levels seen in spleen, thymus, esophagus,
stomach, intestine and uterus (Jacobs et al., 1999).
Arfrp1 exhibits the lowest similarity to Arf proteins and several differences
to Arf and Arl proteins. It inhibits activation of phospholipase D (PLD) as a
result of its interaction with an Arf-specific activator (cytohesin 1, an Arf
GEF). Because deletion of the Arfrp1 gene resulted in marked defects in
early gastrulation, it was speculated that Arfrp1 is involved in adhesion-
dependent morphogenesis, cytoskeletal reorganization, or development of
cell polarity, occurring during this stage of embryogenesis.
proteins that distinguish it from other members of the Arf family; Arfrp1 can
hydrolyze GTP in the absence of a GAP (0.093 min-1), and it lacks the site
for N-myristoylation (glycine 2). Arfrp1 was detected in the plasma
membrane and was absent from the cytosol (Schürmann et al., 1995) of 3T3-
L1 cells. The mechanism of this tight attachment to membranes is unknown.
Arfrp1 appears to be involved in a pathway that can inhibit Arf activities,
e.g., activation of PLD (Schürmann et al., 1999). In a two-hybrid screen
designed to identity proteins interacting with Arfrp1, a partial sequence
encoding the N-terminus and most of the Sec7 domain of the Arf-specific
guanine nucleotide exchange factor cytohesin 1 was isolated. The
interaction between Arfrp1 and the Sec7 domain was GTP-dependent and
resulted in the inhibition of the Arf/Sec7-dependent activation of PLD in a
system of isolated membranes. In addition, transfection of HEK-293 cells
with a constitutively active mutant of Arfrp1 inhibited the stimulation of
PLD by the muscarinic acetylcholine receptor-3, and the translocation of Arf
from the cytosol to membranes.
The closest relative of Arfrp1 in yeast is a protein with 43% identity that
has been identified by Huang et al. (1999) and designated ScArl3 (see
Chapter 1). Like ScArl1 and ScArf3, ScArl3 is not essential for cell
viability. However, disruption of ScArl3 resulted in cold-sensitive growth.
At the permissive temperature (37°C), maturation of vacuolar proteins was
retarded and, at the non-permissive temperature (15°C), impairment in fluid
phase endocytosis was observed. Unlike mammalian Arfrp1, ScArl3 was
detected in the cytosol and in part associated with the ER-nuclear envelope
structure, suggesting that the GTPase is involved in the regulation of
vesicular transport pathways (Huang et al., 1999).
The murine Arfrp1 gene spans approximately 7 kb and contains 8 exons.
The proximal 5’-flanking regions of mouse and human Arfrp1 lack a TATA
box and a CAAT box, are highly GC rich and contain potential transcription
factor binding sites. Sequence analysis of human Arfrp1 showed that its 5’-
flanking region contains the first exon of another gene (DJ583P15.3,
ensemble data base) on the opposite strand. Promoter analysis revealed that
the intergenic region between both genes (54 bp) exhibits bi-directional
promoter activity. However, deletion analysis demonstrated that
transcription of both genes is regulated by different cis-elements.
Mutational analysis and electrophoretic mobility shift assays indicated that
two short cRel- and cEts1-like elements in the 5’-flanking region of Arfrp1
are critical for the regulation of Arfrp1 expression (Mueller et al., 2002a).
Arfrp1 null-mutant mice, generated by gene targeting in embryonic stem
cells, were the first knockout mice of an Arf or Arl protein (Mueller et al.,
2002b). Heterozygous Arfrp1 mutants developed normally, whereas
homozygosity for the mutant allele resulted in embryonic lethality. Cultured
340
16 SCHÜRMANN AND JOOST
Figure 4. Schematic overview of the egg cylinder stage (E6.5) and the primitive streak stage
(E7.5) in control and Arfrp1-/- mouse embryos. (PS = primitive streak).
Sar1 exhibits weak similarity with the Arf family (30% identity with Arf1
and Arf5). The GTPase controls protein-protein and protein-lipid
interactions that direct budding from the endoplasmic reticulum (Springer et
al., 1999). In S. cerevisiae, only a single isotype was identified (Nakano and
Muramatsu, 1989), whereas two isotypes, Sar1a and Sar1b (91% identity)
were found in mammalian cells (Kuge et al., 1994). Unlike Arf proteins,
Sar1 lacks the myristoylated glycine residue at position two, and does not
undergo any other lipid modification. In NRK and CHO (Chinese hamster
ovary) cells, Sar1 was detected in the juxtanuclear Golgi region; in rat
pancreatic insulin cells, the protein was abundant at smooth transitional
elements of the endoplasmic reticulum (ER), and at vesicular profiles in the
proximal Golgi cisternae facing the transitional region (Kuge et al., 1994).
Sar1 is an essential component of COPII vesicle coats, and regulates the
selective export of membrane-bound and soluble proteins from the ER. The
COPII coat forms by the sequential recruitment of Sar1 and two large
complexes, Sec23/24 and Sec13/31 (Barlowe et al., 1993; Matsuoka et al.,
1998), and is necessary for the deformation of ER membranes into vesicles
as well as for the selection of cargo molecules (Schekman and Orci, 1996;
Rothman and Wieland, 1996). Sar1•GTP exhibits the unique ability to
interact directly with both lipid membranes and Sec23/24; therefore, the
switch between the GDP and GTP-bound forms controls assembly and
disassembly of COPII coats. Assembly is driven by the exchange of GDP
for GTP, which is catalyzed by Sec12. Sec12 is a transmembrane ER
glycoprotein containing a 40 kDa cytoplasmic domain and a ∼10 kDa
lumenal domain. The cytosolic domain operates independently of
membranes as a Sar1-specific GEF (Barlow and Schekman, 1993;
342
18 SCHÜRMANN AND JOOST
The conformational changes that accompany the binding of GDP and GTP
can alter the affinity of the GTPases for proteins, lipids, and membranes.
These conformational changes are centered in two critical regions, referred
to as switch I and switch II (Lacal and McCormick, 1993). Residues in these
switches make direct contact with effectors and GAPs in a variety of
GTPases, including Arfs (Goldberg, 1998; Goldberg, 1999). The
interactions and the mechanism of regulation of Arf proteins differ from
those of other GTPases of the Ras superfamily. Arf proteins have an
additional nucleotide-sensitive region, the “myristoyl switch”, an extension
in the N-terminus and a covalently attached myristate which cooperate to
coordinate GTP binding (activation) and membrane association (Goldberg,
1999). In addition, there is evidence that the N-terminus may modify
effector binding or activity (Kahn et al. 1992; Zhu et al., 2000). The N-
terminal region (residues 1-17) of Arf is sufficient to confer Arf activity and
increase GTPase activity to an Arl protein, despite the distance between the
N terminus and the switch or nucleotide binding region (Kahn et al., 1992).
Amor, et al. (2001) analyzed the structure of yeast Arf2 and Arl1 and
reported that the secondary structure of GDP-bound yeast Arf2, yeast Arl1
and human Arf1 were essentially identical. Their structures include seven β-
strands, six α-helices, and 12 connecting loops. The core of the protein is an
invariant six-stranded β-sheet surrounded by six α-helices. The seventh
strand forms an edge to the core and corresponds to the switch I region
(Lacal and McCormick, 1993). The N-terminal α-helix (αNT) is wedged
between the C-terminal helix α-E and loop L-2/3 which connects strands β2
and β3 (also referred to as the interswitch region, ISR). The presence of
αNT is in contrast to the rather undefined secondary fold seen for the N-
terminal sequence in the Arl3 model (see Figure 5; Hillig et al., 2000). Like
Arl3•GDP (Hillig et al., 2000), yeast Arl1•GDP appears to form a covalent
ARF-LIKE PROTEINS 343
19
Figure 5. Ribbon diagram of Arl3•GDP and Arl2•GTP (Hanzal-Bayer et al., 2002), with
switches in blue, interswitch region in green, N-terminus in yellow, C-terminal helix in
magenta, nucleotides in orange, and Mg2+ as red sphere (see arrow).
344
20 SCHÜRMANN AND JOOST
appear to be essential for its function, since knock-in of the Arl1-S31 mutant
produced no effect in S. cerevisiae.
In contrast to Arf1, Arf2 and Arf6, the electrostatic surface of yeast Arl1
is characterized by an overall negative electrostatic potential. Arl1 is N-
myristoylated but, in contrast to Arf proteins, no GTP-dependent binding to
membranes or lipid vesicles has been detected. The difference in the
electrostatic potential led to the hypothesis that the binding of Arl1 to
membranes is dependent on protein-protein interactions at the membrane
(Amor et al., 2001).
The comparison of the structures of Arfs with that of Arl1 revealed
differences in the N-terminal region. The 17 N-terminal amino acids of
Arfs, which form the αNT and loop (L-NT), are involved in membrane
binding, nucleotide affinity, phospholipid dependence of GTP-binding, and
nucleotide hydrolysis (Kahn et al., 1992; Kahn et al., 1996). The N-terminal
helix and the length of the loop L-NT can affect the structure of switch I and
the interswitch region and therefore alter the nucleotide binding (Kahn et al.,
1992; Zhu et al., 2000). In comparison to Arf1 and Arf6, the loop L-NT in
yeast Arl1 is much longer, and this difference was proposed to be
responsible for different biophysical and biochemical properties of Arf and
Arl proteins (Amor et al., 2001).
Like Arl1, the structure of Arl3 predicts that the N-terminal extension
folds into an elongated loop region, suggesting that Arl3 releases its N-
terminus and undergoes a β-sheet register shift upon the binding of GTP.
Structure as well as kinetic experiments demonstrated high affinity GDP (but
not GTP) binding in the absence of Mg2+. The disturbed magnesium binding
site and the lack of Mg2+-dependence of GDP binding distinguish Arl2 and
Arl3 from Arf proteins. In contrast to Arf proteins, the conformational
change of Arl2/3•GTP did not require the presence of membranes and might
thus be energetically unfavored (Hillig et al., 2000).
Recently, Hanzal-Bayer, et al. (2002) presented the crystal structure of
full-length Arl2•GTP in a complex with its effector PDEδ. In this complex,
Arl2•GTP shows a typical G domain fold with six-stranded β sheet
surrounded by five α helices, with an additional α helix at the N terminus.
Because Arl3 is the closest relative of Arl2 (53% identity, Figure 1) and also
a binding partner of PDEδ (Figure 2), the authors compared the structure of
Arl2•GTP with Arl3•GDP (Figure 5). During nucleotide exchange, the
interswitch region of Arl2 has to undergo a β sheet register shift, with β
strands β2 and β3 sliding by two residues relative to the remaining β sheet.
This shift results in displacement and conformational change of the N-
terminus, which appears to interact with a membrane, as observed with Arf
proteins (Hanzal-Bayer et al., 2002).
ARF-LIKE PROTEINS 345
21
REFERENCES
Allan, B. B., Moyer, B. D., and Balch, W. E. (2000). Rab1 recruitment of p115 into a cis-
SNARE complex: programming budding COP-II vesicles for fusion. Science, 289, 444-
448.
Amor, J. C., Horton, J. R., Zhu, X., Wang, Y., Sullards, C., Ringe, D., Cheng, X., and Kahn,
R. A. (2001). Structures of yeast Arf2 and Arl1: distinct roles for the N terminus in the
structure and function of Arf family GTPases. J. Biol. Chem., 276, 42477-42484
Aridor, M., Fish, K. N., Bannykh, S., Weissman, J., Roberts, T. H., Lippincott-Schwartz, J.,
and Balch, W. E. (2001). The Sar1 GTPase coordinates biosynthetic cargo selection with
endoplasmic reticulum export site assembly. J. Cell Biol., 152, 213-229.
Aridor, M., Weissman, J., Bannykh, S., Nuoffer, C., and Balch, W. E. (1998). Cargo selection
by the COP-II budding machinery during export from the ER. J. Cell Biol., 141, 61-70.
Balch, W. E., McCaffery, J. M., Plutner, H., and Farquhar, M. G. (1994). Vesicular stomatitis
virus glycoprotein is sorted and concentrated during export from the endoplasmic
reticulum. Cell, 76, 841-852.
Barlowe, C., d'Enfert, C., and Schekman, R. (1993). Purification and characterization of
SAR1p, a small GTP-binding protein required for transport vesicle formation from the
endoplasmic reticulum. J. Biol. Chem., 268, 873-879.
Barlowe, C., and Schekman, R. (1993). SEC12 encodes a guanine-nucleotide-exchange factor
essential for transport vesicle budding from the ER. Nature, 365, 347-349.
Bhamidipati, A., Lewis, S. A., and Cowan, N. J. (2000). ADP ribosylation factor-like protein
2 (Arl2) regulates the interaction of tubulin-folding cofactor D with native tubulin. J. Cell.
Biol., 149, 1087-1096.
Boman, A. L., Kuai, J., Zhu, X., Chen, J., Kuriyama, R., and Kahn, R. A. (1999 ). Arf
proteins bind to mitotic kinesin-like protein 1 (MKLP1) in a GTP-dependent fashion. Cell
Motil. Cytoskeleton., 44, 119-132.
Breiner, M., Schürmann, A., Becker, W., and Joost, H.-G. (1996). Cloning of a novel member
(Arl5) of the Arf family of Ras related GTPases. Biochim. Biophys. Acta., 1308, 1-6.
346
22 SCHÜRMANN AND JOOST
Brown, H. A., Gutowski, S., Moomaw, C. R., Slaughter, C., and Sternweis, P. C. (1993).
ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates
phospholipase D activity. Cell, 75, 1137-1144.
Cavenagh, M. M., Breiner, M., Schürmann. A., Rosenwald, A. G., Terui, T., Zhang, C.,
Randazzo, P. A., Adams, M., Joost, H.-G., and Kahn, R. A. (1994). ADP-ribosylation
factor (Arf)-like 3, a new member of the Arf family of GTP-binding proteins cloned from
human and rat tissues. J. Biol. Chem., 269, 18937-18942.
Clark, J., Moore, L., Krasinskas, A., Way, J., Battey, J., Tamkun, J., and Kahn, R. A. (1993).
Selective amplification of additional members of the ADP-ribosylation factor (Arf)
family: cloning of additional human and Drosophila Arf-like genes. Proc. Natl. Acad. Sci.,
USA, 90, 8952-8956.
Cockcroft, S., Thomas, G. M., Fensome, A., Geny, B., Cunningham, E., Gout, I., Hiles, I.,
Totty, N. F., Truong, O., and Hsuan, J. J. (1994). Phospholipase D: a downstream effector
of Arf in granulocytes. Science, 263, 523-526.
Cook, T. A., Ghomashchi, F., Gelb, M. H., Florio, S. K., and Beavo, J. A. (2001). The delta
subunit of type 6 phosphodiesterase reduces light-induced cGMP hydrolysis in rod outer
segments. J. Biol. Chem., 276, 5248-5255.
Dascher, C., and Balch, W. E. (1994). Dominant inhibitory mutants of Arf1 block
endoplasmic reticulum to Golgi transport and trigger disassembly of the Golgi apparatus.
J. Biol. Chem., 269, 1437-1448.
Donaldson, J. G., Kahn, R. A., Lippincott-Schwartz, J., and Klausner, R. D. (1991). Binding
of Arf and beta-COP to Golgi membranes: possible regulation by a trimeric G protein.
Science, 254, 1197-1199.
D’Souza-Schorey, C., Boshans R. L., McDonough, M., Stahl, P. D., and Van Aelst, L. (1997).
A role for POR, a Rac1-interacting protein, in ARF6-mediated cytoskeletal
rearrangements. EMBO J., 16, 5445-5454.
Fiore, C., Trezeguet, V., Le Saux, A., Roux, P., Schwimmer, C., Dianoux, A. C., Noel, F.,
Lauquin, G. J., Brandolin, G., and Vignais, P. V. (1998). The mitochondrial ADP/ATP
carrier: structural, physiological and pathological aspects. Biochimie, 80, 137-150.
Florio, S. K., Prusti, R. K., and Beavo, J. A. (1996). Solubilization of membrane-bound rod
phosphodiesterase by the rod phosphodiesterase recombinant delta subunit. J. Biol. Chem.,
271, 24036-24047.
Gillespie, P. G., Prusti, R. K., Apel, E. D., and Beavo, J. A. (1989). A soluble form of bovine
rod photoreceptor phosphodiesterase has a novel 15-kDa subunit. J. Biol. Chem., 264,
12187-12193.
Görlich, D., and Mattaj, I. W. (1996). Nucleocytoplasmic transport. Science, 271, 1513-1518.
Goldberg, J. (1998). Structural basis for activation of Arf GTPase: mechanisms of guanine
nucleotide exchange and GTP-myristoyl switching. Cell, 95, 237-248.
Goldberg, J. (1999). Structural and functional analysis of the Arf1-ArfGAP complex reveals a
role for coatomer in GTP hydrolysis. Cell, 96, 893-902.
Graham, B. H., Waymire, K. G., Cottrell, B., Trounce, I. A., MacGregor, G. R., and Wallace,
D. C. (1997). A mouse model for mitochondrial myopathy and cardiomyopathy resulting
from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat.
Genet., 16, 226-234.
Hanzal-Bayer, M., Renault, L., Roversi, P., Wittinghofer, A., and Hillig R. C. (2002). The
complex of Arl2-GTP and PDE delta: from structure to function. EMBO J., 21, 2095-
2106.
Hillig, R. C., Hanzal-Bayer, M., Linari, M., Becker, J., Wittinghofer, A., and Renault, L.
(2000). Structural and biochemical properties show Arl3-GDP as a distinct GTP binding
protein. Structure Fold. Des., 8, 1239-1245.
ARF-LIKE PROTEINS 347
23
Honda, A., Nogami, M., Yokozeki, T., Yamazaki, M., Nakamura, H., Watanabe, H.,
Kawamoto, K., Nakayama, K., Morris, A. J., Frohman, M. A., and Kanaho, Y. (1999).
Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G
protein Arf6 in membrane ruffle formation. Cell, 99, 521-532.
Hoyt, M. A., Stearns, T., and Botstein, D. (1990). Chromosome instability mutants of
Saccharomyces cerevisiae that are defective in microtubule-mediated processes. Mol. Cell
Biol., 10, 223-234.
Huang, C. F., Buu, L. M., Yu, W. L., and Lee, F. J. (1999). Characterization of a novel ADP-
ribosylation factor-like protein (yArl3) in Saccharomyces cerevisiae. J. Biol. Chem., 274,
3819-3827.
Ingley, E., Williams, J. H., Walker, C. E., Tsai, S., Colley, S., Sayer, M. S., Tilbrook, P. A.,
Sarna, M., Beaumont, J. G., and Klinken, S. P. (1999). A novel ADP-ribosylation like
factor (Arl-6), interacts with the protein-conducting channel SEC61beta subunit. FEBS
Lett., 459, 69-74.
Jacobs, S., Schilf, C., Fliegert, F., Koling, S., Weber, Y., Schürmann, A., and Joost, H.-G.
(1999). ADP-ribosylation factor (Arf)-like 4, 6, and 7 represent a subgroup of the Arf
family characterization by rapid nucleotide exchange and a nuclear localization signal.
FEBS Lett., 456, 384-388.
Jacobs, S., Schürmann, A., Becker, W., Böckers, T. M., Copeland, N.G., Jenkins, N. A., and
Joost, H.-G. (1998). The mouse ADP-ribosylation factor-like 4 gene: two separate
promoters direct specific transcription in tissues and testicular germ cell. Biochem. J., 335,
259-265.
Kahn, R. A., and Gilman, A. G. (1984). ADP-ribosylation of Gs promotes the dissociation of
its alpha and beta subunits. J. Biol. Chem., 259, 6235-6240.
Kahn, R. A., and Gilman, A. G. (1986). The protein cofactor necessary for ADP-ribosylation
of Gs by cholera toxin is itself a GTP binding protein. J. Biol. Chem., 261, 7906-7911.
Kahn, R. A., Kern, F. G., Clark, J., Gelmann, E. P., and Rulka, C. (1991). Human ADP-
ribosylation factors. A functionally conserved family of GTP-binding proteins. J. Biol.
Chem., 266, 2606-2614.
Kahn, R. A., Randazzo, P., Serafini, T., Weiss, O., Rulka, C., Clark, J., Amherdt, M., Roller,
P., Orci, L., and Rothman J. E. (1992). The amino terminus of ADP-ribosylation factor
(Arf) is a critical determinant of Arf activities and is a potent and specific inhibitor of
protein transport. J. Biol. Chem., 267, 13039-13046.
Kahn, R. A., Terui, T., and Randazzo, P. A. (1996). Effects of acid phospholipids on Arf
activities: potential roles in membrane traffic. J. Lipid Mediat. Cell. Signal., 14, 209-214.
Kanoh, H., Williger, B. T., and Exton, J. H. (1997). Arfaptin 1, a putative cytosolic target
protein of ADP-ribosylation factor, is recruited to Golgi membranes. J. Biol. Chem., 272,
5421-5429.
Klausner, R. D., Donaldson, J. G., and Lippincott-Schwartz, J. (1992). Brefeldin A: insights
into the control of membrane traffic and organelle structure. J. Cell Biol., 116, 1071-1080.
Kuehn, M. J., Herrmann, J. M., and Schekman, R. (1998). COP-II-cargo interactions direct
protein sorting into ER-derived transport vesicles. Nature, 391, 187-190.
Kuge, O., Dascher, C., Orci, L., Rowe, T., Amherdt, M., Plutner, H., Ravazzola, M.,
Tanigawa, G., Rothman, J. E., and Balch, W. E. (1994). Sar1 promotes vesicle budding
from the endoplasmic reticulum but not Golgi compartments. J. Cell Biol., 25, 51-65.
Kuriyama, R., Gustus, C., Terada, Y., Uetake, Y., and Matuliene, J. (2002). CHO1, a
mammalian kinesin-like protein, interacts with F-actin and is involved in the terminal
phase of cytokinesis. J. Cell Biol., 156, 783-790.
Lacal, J. C. and McCormick, F. (1993). The Ras superfamily of GTPases. Boca Raton, FL.
CRC Press.
348
24 SCHÜRMANN AND JOOST
Lee, F. J., Moss, J., and Vaughan, M. (1992). Human and Giardia ADP-ribosylation factors
(Arfs) complement Arf function in Saccharomyces cerevisiae. J. Biol. Chem., 267, 24441-
24445.
Levy, S. E., Chen, Y. S., Graham, B. H., and Wallace, D. C. (2000). Expression and sequence
analysis of the mouse adenine nucleotide translocase 1 and 2 genes. Gene, 254, 57-66.
Lewis, S. A., Tian, G., and Cowan, N. J. (1997). Thel alpha and beta tubulin folding
pathways. Trends Cell Biol., 7, 479-485.
Lin, C. Y., Huang, P. H., Liao, W. L., Cheng, H. J., Huang, C. F., Kuo, J. C., Patton, W. A.,
Massenburg, D., Moss, J., and Lee, F. J. (2000). Arl4, an Arf-like protein that is
developmentally regulated and localized to nuclei and nucleoli. J. Biol. Chem., 275,
37815-37823.
Linari, M., Hanzal-Bayer, M., and Becker, J. (1999a). The delta subunit of rod specific cyclic
GMP phosphodiesterase, PDE delta, interacts with the Arf-like protein Arl3 in a GTP
specific manner. FEBS Lett., 458, 55-59.
Linari, M., Ueffing, M., Manson, F., Wright, A., Meitinger, T., and Becker, J. (1999b). The
retinitis pigmentosa GTPase regulator, RPGR, interacts with the delta subunit of rod cyclic
GMP phosphodiesterase. Proc. Natl. Acad. Sci., USA, 96, 1315-1320.
Lowe, S. L., Wong, S. H., and Hong, W. (1996). The mammalian Arf-like protein 1 (Arl1) is
associated with the Golgi complex. J. Cell. Sci., 109, 209-220.
Lu, L., Horstmann, H., Ng, C., and Hong, W. (2001). Regulation of Golgi structure and
function by Arf-like protein 1 (Arl1). J. Cell. Sci., 114, 4543-4555.
Marzesco, A. M., Galli, T., Louvard, D., and Zahraoui, A. (1998). The rod cGMP
phosphodiesterase delta subunit dissociates the small GTPase Rab13 from membranes. J.
Biol. Chem., 273, 22340-22345.
Matsuoka, K., Orci, L., Amherdt, M., Bednarek, S. Y., Hamamoto, S., Schekman, R., and
Yeung, T. (1998). COP-II-coated vesicle formation reconstituted with purified coat
proteins and chemically defined liposomes. Cell, 93, 263-275.
Meindl, A., Dry, K., Herrmann, K., Manson, F., Ciccodicola, A., Edgar, A., Carvalho, M. R.,
Achatz, H., Hellebrand, H., Lennon, A., Migliaccio, C., Porter, K., Zrenner, E., Bird, A.,
Jay, M., Lorenz, B., Wittwer, B., D'Urso, M., Meitinger, T., and Wright A. (1996). A gene
(RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-
linked retinitis pigmentosa (RP3). Nat. Genet., 13, 35-42.
Moyer, B. D., Allan, B. B., and Balch, W. E. (2001). Rab1 interaction with a GM130 effector
complex regulates COP-II vesicle cis--Golgi tethering. Traffic 2, 268-276.
Mueller, A. G., Joost, H.-G., and Schürmann A. (2002a). Mouse Arf-Related Protein 1:
Genomic Organization and Analysis of Its Promoter. Biochem. Biophys. Res. Commun.
292, 113-120.
Mueller, A. G., Moser, M., Kluge, R., Leder, S., Blum, M., Büttner, R., Joost, H.-G., and
Schürmann, A. (2002b). Embryonic lethality caused by apoptosis during gastrulation in
mice lacking the gene of the ADP-ribosylation factor-related protein 1. Mol. Cell. Biol.,
22, 1488-1494.
Murtagh, J. J., Jr, Lee, F. J., Deak, P., Hall, L. M., Monaco, L., Lee, C. M., Stevens, L. A.,
Moss, J., and Vaughan, M. (1993). Molecular characterization of a conserved, guanine
nucleotide-dependent ADP-ribosylation factor in Drosophila melanogaster. Biochemistry,
32, 6011-6018.
Nakano, A. and Muramatsu, M. (1989). A novel GTP-binding protein, Sar1p, is involved in
transport from the endoplasmic reticulum to the Golgi apparatus. J. Cell Biol., 109, 2677-
2691.
Nigg, E. A. (1997). Nucleocytoplasmic transport: signals, mechanisms and regulation.
Nature, 386, 779-787
ARF-LIKE PROTEINS 349
25
Radcliffe, P. A., Vardy, L., and Toda, T. (2000). A conserved small GTP-binding protein
Alp41 is essential for the cofactor-dependent biogenesis of microtubules in fission yeast.
FEBS Lett., 468, 84-88.
Renault, L., Nassar, N., Vetter, I., Becker, J., Klebe, C., Roth, M., and Wittinghofer, A.
(1998). The 1.7 A crystal structure of the regulator of chromosome condensation (RCC1)
reveals a seven-bladed propeller. Nature, 392, 97-101.
Rothman, J. E. and Wieland, F. T. (1996). Protein sorting by transport vesicles. Science, 272,
227-234.
Schekman, R. and Orci, L. (1996). Coat proteins and vesicle budding. Science, 271, 1526-
1533.
Schürmann, A., Breiner, M., Becker, W., Huppertz, C., Kainulainen, H., Kentrup, H. and
Joost, H.-G. (1994). Cloning of two novel ADP-ribosylation factor-like proteins and
characterization of their differential expression in 3T3-L1 cells. J. Biol. Chem. 269,
15683-15688.
Schürmann, A., Koling, S., Jacobs, S., Saftig, P., Krauss, S., Wennemuth, G., Kluge, R., and
Joost, H.-G. (2002). Reduced sperm count and normal fertility in male mice with targeted
disruption of the ADP-ribosylation factor-like (Arl4) gene. Mol. Cell. Biol., 22, 2761-
2768.
Schürmann, A., Massmann, S., and Joost, H.-G. (1995). ARP is a plasma membrane-
associated Ras-related GTPase with remote similarity to the family of ADP-ribosylation
factors. J. Biol. Chem., 270, 30657-30563.
Schürmann, A., Schmidt, M., Asmus, M., Bayer, S., Fliegert, F., Koling, S., Massmann, S.,
Schilf, C., Subauste, M.C., Voss, M., Jakobs, K.H., and Joost, H.-G. (1999). The ADP-
ribosylation factor (Arf)-related GTPase Arf-related protein binds to the Arf-specific
guanine nucleotide exchange factor cytohesin and inhibits the Arf-dependent activation of
phospholipase D. J. Biol. Chem., 274, 9744-9751.
Sharer, J. D. and Kahn, R. A. (1999). The Arf-like 2 (Arl2)-binding protein, BART. J. Biol.
Chem,. 274, 27553-27561.
Sharer, J. D., Shern, J. F., Van Valkenburgh, H., Wallace, D. C., and Kahn, R. A. (2002).
Arl2 and BART Enter Mitochondria and Bind the Adenine Nucleotide Transporter. Mol.
Biol. Cell, 13, 71-83.
Smith, S. A., Holik, P. R., Stevens, J., Melis, R., White, R., and Albertsen, H. (1995).
Isolation and mapping of a gene encoding a novel human ADP-ribosylation factor on
chromosome 17q12-q21. Genomics, 28, 113-115.
Springer, S., Spang, A., and Schekman R. (1999). A primer on vesicle budding. Cell, 97, 145-
148.
Stearns, T., Hoyt, M. A. and Botstein, D. (1990). Yeast mutants sensitive to antimicrotubule
drugs define three genes that affect microtubule function. Genetics, 124, 251-262.
Stepien, G., Torroni, A., Chung, A. B., Hodge, J. A. and Wallace, D. C. (1992). Differential
expression of adenine nucleotide translocator isoforms in mammalian tissues and during
muscle cell differentiation. J. Biol. Chem., 267, 14592-14597.
Tamkun, J. W., Kahn, R. A., Kissinger, M., Brizuela, B. J., Rulka, C., Scott, M. P., and
Kennison, J.A. (1991). The arflike gene encodes an essential GTP-binding protein in
Drosophila. Proc. Natl. Acad. Sci., USA, 88, 3120-3124.
Tarricone, C., Xiao, B., Justin, N., Walker, P. A., Rittinger, K., Gamblin, S. J., and Smerdon,
S. J. (2001). The structural basis of Arfaptin-mediated cross-talk between Rac and Arf
signalling pathways. Nature, 411, 215-219
Tian, G., Lewis, S. A., Feierbach, B., Stearns, T., Rommelaere, H., Ampe, C., and Cowan, N.
J. (1997). Tubulin subunits exist in an activated conformational state generated and
maintained by protein cofactors. J. Cell. Biol., 138, 821-832.
350
26 SCHÜRMANN AND JOOST
Van Valkenburgh, H., Shern, J. F., Sharer, J. D., Zhu, X., and Kahn, R. A. (2001). ADP-
ribosylation factors (Arfs) and Arf-like 1 (Arl1) have both specific and shared effectors:
characterizing Arl1-binding proteins. J. Biol. Chem., 276, 22826-22837.
Weissman, J. T., Plutner, H., and Balch, W. E. (2001). The mammalian guanine nucleotide
exchange factor mSec12 is essential for activation of the Sar1 GTPase directing
endoplasmic reticulum export. Traffic, 2, 465-475.
Zhu, X., Boman, A. L., Kuai, J., Cieplak, W., and Kahn R. A. (2000). Effectors increase the
affinity of ADP-ribosylation factor for GTP to increase binding. J. Biol. Chem., 275,
13465-13475.